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Abstract
The Tec family tyrosine kinase, Itk, plays an important role in signal transduction
following T cell receptor engagement. Several prior studies have established the
importance of Itk in immune system processes, such as T cell development and T cell
activation. Additional biochemical studies have found that Itk specifically 
functions
within a multi-molecular signalosome complex
, which ultimately functions to provide a
platform by which Itk can phosphorylate and activate PLC-y 1 , a crucial step in T cell
activation. To further study how Itk regulates distinct immune outcomes via T cell
effector processes within the peripheral immune system
, and to further understand how
Itk functions in T cells in response to a physiological ligand-receptor interaction
, I
crossed Itk-deficient mice to mice transgenic for a TCR specific for a moth cytochrome C
peptide. My studies have established a unique role for Itk in several important aspects of
T cell function. Following T cell activation
, I identified an imperative role for Itk in
activation-induced cell death via FasL, a mechanism of immune homeostasis.
Furthermore, I found Itk plays a unique role in the process of T cell differentiation
, where
Itk positively regulates the induction of cytokine genes
, such as IL- , while negatively
regulating the induction of T-bet, a transcription factor important for Thl differentiation.
Lastly, following T cell differentiation
, I found that Itk mRNA and protein are up-
regulated during Th2 differentiation
, while Rlk, a related Tec kinase, disappears rapidly
fromTh2 cells, indicating a critical role for Itk in Th2 cell function. Collectively, my
thesis work has more clearly defined an important function for Itk not only in TCR
signaling, but also in immune processes such as T cell differentiation and activation-
induced cell death that are required for proper immune function.
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CHAPTER I.
INTRODUCTION
CD4+ T lymphocyte function within the mammalian immune system
Cells of the mammalian adaptive immune system serve several functions in the
response to pathogens , as well as in the regulation of allergic responses, autoimmunity,
transplant rejection, and tuor surveillance. While the immune system is composed of
many different cell types that encompass many different effector capabilities, T
lymphocytes are one of the most crucial elements of the adaptive immune system, and
often critically influence the outcome of any given response. During development in the
thymus, T lymphocytes acquire lineage-specific cell surface receptors, such as the T cell
receptor (TCR), several different classes of intracellular signaling molecules, as well as
transcription factors , which ultimately give the T cell its unique characteristics and ability
to respond and perform specific functions during an immune response. Following
development, non-self-reactive T lymphocytes are exported out of the thymus to the
peripheral immune system as mature naIve T cells ready for the surveilance of invading
organisms in the body.
Upon encounter with an invading organism, antigen-presenting cells (APCs)
resident in the host pick up proteins and/or particles of these organisms, either from the
extracellular environment or from intracellular compartents, and process these proteins
into peptides. Following this breakdown process , antigenic peptides become associated
with the major histocompatibility complex (MHC), which is exported to the cell surface
as an MHC:peptide complex. The APCs from infected tissues proceed to migrate to the
draining lymph nodes, a specialized lymphoid compartment that allows circulating T
cells to survey the resident APCs for foreign MHC:peptide complexes. When a T
lymphocyte specifically recognizes a foreign complex, it is quickly poised to alert the
immune system and direct an immune response via the secretion of cytokines and the
expression of specific soluble and membrane-bound molecules (IJ. The multitude 
biological processes that occurs through the life of a T lymphocyte wil be discussed in
further detail below.
T Cell Activation and Interleukin-
Depending on the stage of development of the T cell and its antigen recognition
history, a variety of different cellular responses can be induced, making this one of the
most fascinating aspects of T cell biology. Typically during an immune response
antigen-specific TCR stimulation initiates a complex series of signaling cascades within
the naIve T cell. Among other events, the activation of specific signaling cascades leads
to one of the hallmark events in T cells, which is the transcription and production of the T
cell growth factor, Interleukin-2 (IL-2) (2J. Regulated primarily at the transcriptional
level, the IL-2 promoter possesses binding sites for several families of transcription
factors, such as NFAT, AP- , and NF-KB , which are differentially regulated by upstream
biochemical signals initiated at the TCR. This wil be discussed in more detail later.
Ultimately, upon binding to its receptor, IL-2 initiates cell cycle progression and allows
antigen-reactive T cells to undergo a dramatic expansion within the lymphoid
comparent, a crucial component of effective immune responses.
T Cell Differentiation
Some of the earliest studies examining the immune response to infectious
pathogens observed an inclination to generate either an antibody-mediated or a cell-
mediated response , but never both. Further studies elucidated that antibody-mediated
responses were important in the defense against extracellular pathogens, such as
helminthes and most bacteria, presumably due to the fact that abundant amounts of
pathogen-specific immunoglobulins functioned to neutralize the invading pathogen.
Contrastingly, the observed cell-mediated responses appeared to be crucial for the
defense against intracellular organisms, such as viruses, certain bacteria, as well as
protozoans. This cellular-mediated form of immunity was characterized by a cytolytic
capability of certain cells in addition to the production of soluble mediators, known as
cytokines.
In 1986 , after several years of dissecting pathogen-specific responses, Mossman
and Coffman were able to identify mouse CD4+ T cell clones that had distinct functions
as well as the competence to secrete unique cytokines. These cytokines were in turn
found to be associated with either inflammatory immune responses , or with B cell help
(3-5). These distinct T cell clones were termed T helper 1 (Thl) or T helper 2 (Th2)
effector cells, respectively. Thl cells were found to preferentially produce IFN-y and
TNF-a , cytokines that could mediate delayed-type hypersensitivity (6). Th2 effector
cells , however, were characterized by the production ofIL- , IL- , and IL- , cytokines
that were able to generate IgE and IgG 1 responses from B cells (7). The physiological
relevance of these T cell clones was confirmed by Locksley and colleagues who
demonstrated that Th 1 and Th2 cells in fact exist in vivo during the immune response to
Leishmania major. Additionally, Sadick et al demonstrated that resistance to this
infection was correlated to the capacity to generate a Thl response (8 , 9).
In healthy individuals, following T cell development in the thymus, all CD4+ T
lymphocytes that are exported to the periphery are naIve and must be given the
appropriate activation signals to acquire the capability of performing effector functions
such as mediating inflammatory or humoral responses. The ability of a naIve CD4+ T
cell to differentiate into a Th 1 or Th2 effector cell is almost completely influenced by the
cytokine milieu present during the initial activation. Several in vitro and in vivo studies
have concluded that the time it takes for a naIve CD4+ T cell to commit to either the Thl
or Th2 lineage is only a few days (10). Therefore , during an in vivo response, upon T cell
encounter with an antigen, appropriate cytokines have to be present within hours to wield
any effect on T cell priming. While the initial source of these cytokines in vivo is stil
unclear, different cell tyes within the immune system, including T cells themselves, are
potential sources. For instance, NK cells are potent producers of IFN-y, a cytokine that
aids in the development of Th 1 cells , whereas basophils and mast cells are known to
secrete IL- , a Th2-driving factor. Needless to say, this is just a small ilustration of the
complexity of an immune response, which in most cases involves the orchestration of
many different cell types that possess many different functions.
As opposed to what occurs in healthy individuals , disregulation of CD4+ T cells
can have catastrophic consequences. For instance, a disproportionate amount of Thl
cytokines is often the cause of tissue destrction in many autoimmune diseases. Overall
Th 1 processes have been strongly associated with several autoimmune diseases such as
inflammatory bowel diseases (11), multiple sclerosis (12), and diabetes (13). Similarly,
excess Th2 cytokines have been associated with allergic asthma and atopic diseases (14).
In many circumstances, cytokines from an opposing subset can offer protective effects by
counter-acting factors that induce pathology.
Over the past decade , tremendous progress has been made in the understanding of
the mechanisms involved in the development and differentiation of CD4+ T cells into
either Thl or Th2 cells. Furthermore , the TCR-induced signal transduction pathways that
are activated following T cell stimulation that culminate in the transcription of genes
involved in naIve CD4+ T cell differentiation are becoming increasingly clear. The
dissection of these signaling pathways, which is the focus of a portion of my thesis work
wil be described in greater detail later. The understanding of all of these events is
imperative in efforts to control disease. Whether a host will succumb to or clear the
invading pathogen is dependent on the ability of the host immune system to generate the
proper response. The elicitation of an improper response can often lead to severe
immunopathology, and in certain circumstances, death. One of the greatest challenges
posed to immunologists today is the ability to understand the etiology of disease , but
more importantly, to find methods to specifically control it and elicit protective immune
responses.
T Cell Death
The immune system, akin to other organs in the mammalian system, has limited
space to function. Therefore, the immune system must maintain a balance between cell
proliferation and cell death, which is often termed homeostasis. As touched upon earlier
the numbers of white blood cells , such as lymphocytes and neutrophils , significantly
expands following infection. This expansion allows immune cells to differentiate into
effector cells, kil infected cells, produce antibodies to neutralize invading bacteria or
viruses, as well as perform many other functions. During this process , many harmful or
toxic cells are generated, such as cytotoxic and potentially autoreactive lymphocytes.
Furthermore , improper control of this process can lead to deleterious effects, such as
splenomegaly, which can often lead to red blood cell destruction, anemia, and
thrombocytopenia. Therefore, cell death mechanisms have evolved to allow the immune
system to contract cell numbers following an immune response, while concomitantly
maintaining repertoire diversity to ultimately maintain homeostasis (15, 16).
T lymphocytes can undergo apoptosis, or programmed cell death, through a
variety of different mechanisms. One mechanism, termed cytokine withdrawal, is a
passive form of apoptosis, where the deprivation of cytokines can induce cells to die.
While this process does require new protein synthesis, it can be strongly inhibited by the
membrane expression of Bcl-2 and Bcl-X. However, the process of mitochondrial
breakdown and apoptosis following cytokine withdrawal is not clear, and is stil an active
area of research.
Another mechanism of T cell death , termed activated-induced cell death (AICD)
occurs following repeated antigenic stimulation, which leads to the TCR-induced
upregulation of the death effector molecules, FasL and TNF. These death effector
molecules exert their function upon binding to their cognate receptors , Fas and TNF
receptors (tye 1 and 2), respectively, where molecules known as caspases are recruited
to the cytoplasmic death domains of these receptors , thereby initiating the cell death
process. The importance of this mechanism of apoptosis is exemplified in mice
possessing mutations in either Fas (lpr mice) or FasL (gld mice), which exhibit defects in
, i
T cell apoptosis, lymphoproliferation, as well as autoimmunity. Moreover, abnormalities
in the Fas gene in humans manifests as a severe autoimmune disorder (17- 19).
Apoptosis ' can occur throughout the life of a T cell, whether it be resting or
activated. Nevertheless , cell death is extremely important following antigenic challenge
to maintain tolerance and homeostasis in the immune system. Akin to T cell
differentiation, the understanding of the molecular basis of the TCR signaling pathway
which leads to T cell apoptosis is crucial for understanding disease processes. This aspect
of T cell biology wil be discussed in more detail later, as it is also a major focus of my
thesis work.
Tyrosine kinases
Over the past twenty years, significant progress has been made in elucidating
signaling pathways triggered by the engagement of immune cell receptors for antigen
such as the TCR, B cell receptor (BCR), and FCE receptor. In T lymphocytes, several
protein tyosine kinases are immediately phosphorylated and consequently activated
following TCR engagement. Tyrosine kinases are often regulated by phosphorylation
and in turn function to either positively or negatively regulate specific substrates by the
transfer of a phosphate group from adenosine trphosphate (A TP) to a tyosine residue on
the substrate. These phosphorylation events can also function to generate binding sites for
other proteins. For instance, a protein containing an Src homology 2 (SH2) domain can
bind to a phosphorylated tyosine, depending on the context. As touched upon earlier
signaling pathways that are initiated by these tyosine kinases can lead to a variety of
cellular outcomes , including cytoskeletal rearrangement, cytokine production, clonal
expansion, cell differentiation , and apoptosis.
Src and Syk family kinases
Based on specific motifs or sequence homology, kinases have been grouped into
families. Two of the initial cytoplasmic kinases that were discovered and characterized
in lymphocytes , Lck and Fyn, were revealed to be members of the largest family of non-
receptor protein tyosine kinases, the Src family. Following TCR activation, Lck and Fyn
are rapidly activated and function to phosphorylate specific tyosine residues on the
cytoplasmic domains of TCR components known as CD3 molecules. These
phosphorylation events occur within motifs known as immunoreceptor tyosine-based
activation motifs (IT AMs) on CD3 molecules. Several reports have demonstrated that
the phosphorylation of the IT AM motifs is crucial for signaling through antigen receptors
(20-23). Another TCR proximal kinase is ZAP- , a member of the Syk family of
tyrosine kinases. Following the phosphorylation of the ITAM motifs on CD3- , ZAP-
is recruited to this motif where it is phosphorylated by Lck, and in turn activated (20 , 24
25). In an effort to dissect TCR-initiated biochemical signaling events and connect them
to functional outcomes, many researchers make use of the immortalized Jurkat T cell
line. In the absence of the Src or Syk family kinases, Lck or ZAP- , respectively, Jurkat
cells fail to mobilize calcium, an importnt biochemical signaling event following T cell
stimulation. Additionally cells lacking either kinase fail to produce IL-2 following
activation (26, 27). The physiological consequence of mutations in one or more Src or
Syk family kinases is exhibited in mice, where either severe defects or blocks in T cell
development and function are observed. Furthermore, human patients possessmg
mutations in ZAP-70 also exhibit severe functional defects in peripheral T cells, which
result in a severe combined immunodeficiency (SCID) condition (28). Taken together
both genetic and biochemical data exemplify the importance of TCR proximal Src and
Syk family tyrosine kinases during thymic development as well as T lymphocyte
activation in the periphery.
PLC-y and Adaptor Proteins
While many of the events that immediately occur following TCR ligation are now
well-established, up until a few years ago , less was known about the substrates of these
TCR proximal molecules, and how these substrates affect more distal events such as T
cell proliferation, differentiation, and death. One crucial event during T cell activation is
the mobilization of intracellular calcium stored in the lumen of the endoplasmic reticulum
(ER). This process is known to activate several different families of signaling molecules
and, ultimately, transcription factors that wil activate genes essential in T cell activation
namely IL-2. Therefore many researchers have dedicated their efforts towards
elucidating the early TCR signaling events that are coupled to calcium mobilization.
Following TCR ligation, PLC-y cleaves phosphatidyl inositol bisphosphate (PIP ) into
two byproducts, inositol trisphosphate (IP ) and diacylglycerol (DAG). The released IP
binds to IP receptors in the ER membrane , which in turn triggers the release of stored
calcium. DAG, on the other hand, is thought to activate members of the PKC family as
well as Ras-GRP , thereby activating the Ras/Raf/MAP kinase pathway (see Figure 4).
Interestingly, the pharmacological agents, Ionomycin and PMA, which are often used to
stimulate T cells in vitro function by bypassing proximal TCR signaling molecules that
lead to PLC-y activation, by mimicking IP and DAG production, respectively. These
agents can fully activate T cells to induce cytokine secretion and express activation
markers , clearly exemplifying the importance of PLC-y activation in lymphocytes as a
crucial event for T cell activation (29).
Several years ago , Finco et al found that Jurkat cells deficient in LA T (linker of
activated T cells), a integral membrane protein with no enzymatic activity, possessed
defects in calcium flux, Ras activation, and ultimately IL-2 production (30). While LA T
was found to be a substrate of ZAP- , it was further discovered that LA T associates
with PLC-y following TCR ligation. In addition, this step was found to be dependent on
PI3-kinase , a kinase that converts PIP to phosphatidyl inositol bisphosphate (PIP
thereby providing a binding site for the PH-domain of PLC-y. PLC-y is phosphorylated
on multiple tyro sines following receptor engagement, and several pieces of evidence
would suggest that Syk family kinases play an important role in this event (31 J. However
an emergence of data over the past five years provide strong evidence that another family
of tyosine kinases, the Tec family, is directly involved in the activation ofPLC-
Tec family kinases
In 1990, almost twelve years following the discovery of the Src kinase, a new
type of non-receptor protein tyosine kinase, termed Tec (.trosine kinase xpressed in
hepatocellular ifarcinoma), was discovered in an effort to identify tyrosine kinases
involved in hepatocarcinogenesis (32J. Shortly thereafter, several other related proteins
were discovered and grouped into what is now recognized as the second largest family of
non-receptor tyrosine kinases, the Tec family. The importance ofTec family kinases was
highlighted in 1993 by the discovery that point mutations or disruptions in the gene
encoding one family member, Btk, leads to immunodeficiency diseases in both humans
and mice (X-linked agammaglobulinemia (XLA) and X-linked immunodeficiency (xid),
respectively) (33-35).
To date, the Tec family consists of eight members , only five of which are
expressed in mammals: BmxEtk, Btk/Atk, Itk/Tsk/Emt, Tec, and Rlk/Txk. In general
Tec family kinases are expressed in cells of the hematopoietic lineage, but are not
restricted to a paricular cell type. For instance , Tec is expressed in all hematopoietic
cells, while Itk and Rlk are restricted to T lymphocytes , NK cells , and mast cells. Btk is
expressed in all hematopoietic cells , with the exception of T lymphocytes and plasma
cells. Interestingly, akin to the other tyosine kinase families, some Tec kinases are
expressed in cells outside of the hematopoietic lineage; however, I wil only focus on
those expressed in the immune system.
Tec family structure and localization
The Tec , Syk, and Src family members have similar and distinctive strctures.
While each Src family kinase contains an SHI (kinase domain), SH2 , and SH3 domain
members of the Syk family possess an SHI domain, followed by two SH2 domains. The
Tec family, however, possess additional domains with distinctive functions. In addition to
possessing an SH 1 , SH2 , and SH3 domain, that is more similar to Src family kinases
most Tec family members also possess a Tec homology (TH) domain, which contains a
binding Btk motif, followed by one or two proline-rich region(s) (PRR).
Furhermore, Tec family kinases lack the C-terminal negative regulatory tyosine found
in Src kinases , suggesting a distinct mode of regulation for these proteins (see Figure 1).
With the exception of Rlk, all Tec kinases have an N-terminal Pleckstrn homology (PH)
domain , which associates with PIP and plays a role in targeting the proteins to the
membrane.
An important step in the activation of Tec family members following TCR
engagement is localization to the membrane. Recent work has demonstrated that Tec
kinases , via the PH domain, are targeted to lipid rafts or glycolipid-enriched membranes
(GEMs), which are membrane micro domains that are thought to facilitate the assembly of
signaling molecules upon receptor engagement (36, 37). This event is dependent on the
action of PI3-kinase , which converts PIP in the membrane to PIP , providing a binding
site for PH domain-containing proteins. The atypical Tec family kinase, Rlk, which lacks
the N-terminal PH domain, instead possesses N-terminal cysteine repeats, a post-
translational modification signal for palmitoylation. This palmitoylation event functions
to target Rlk to GEMs (38). Furthermore , as a result of an internal translation initiation
site, a shorter form of Rlk which is also expressed, translocates to the nucleus upon
activation, suggesting that Rlk may have distinctive functions in the nucleus and cytosol
(39). In fact, Takeba et al discovered that Rlk can function as a transcriptional activator
of the IFN-y gene, as wil be discussed later (40). While a nuclear function for Tec
family members in T cells appeared to be restricted to Rlk, very recent work from Perez-
Vilar et al found that Itk can also translocate to the nucleus in Jurkat cells via its
association with a nuclear importin Rchla/karyopherina (41). Future experiments wil be
required to elucidate the more precise role(s) ofTec family kinases in the nucleus and to
determne more specifically if and how they may modulate gene expression.
Figure 1: Domains of the Tec, Syk, and Src Family Kinases
Tec Domains: Similar to Src and Syk kinases, Tec kinases possess a C-terminal kinase
domain, followed by an SH2 domain. This is typically followed by an SH3 domain in the
Src and Tec family kinases , however, the Syk family lacks this domain and instead has
another SH2 domain. The unique characteristics of Tec family kinase strcture are in the
terminal region of the protein. Btk and Tec both possess two proline-rich regions
(PRRs), while Itk and Rlk only possess one. A Btk homology (BH) domain, the function
of which is stil not clear, and a Pleckstrin homology (PH) domain are N-terminal to the
PRR of Btk, Tec, and Itk. Rlk is the only known Tec family member that does not
possess an N-terminal BH and PH domains. Instead, Rlk possesses an N-terminal
cysteine-rich region, which, following palmitoylation, targets Rlk to the membrane. At
the C-terminus, Tec family kinases lack the regulatory tyrosine found in Src family
members.
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Positive and Negative Regulation of Uk Following TCR Stimulation
Positve Regulation
The mechanisms involved in the complex signals required for Tec kinase
activation, or positive regulation, have been elucidated by several groups over the past
several years. Much of this information was largely generated from several biochemical
experiments performed in cell lines or inferred from experiments performed in cells
lacking specific signaling molecules. Based on all of this information, a mechanism of
Tec family regulation has been generated. The currently accepted mechanism of Itk
activation and de-activation following TCR engagement is discussed below.
Immediately following TCR stimulation, Src and Syk family kinases are
activated, leading to the phosphorylation of two adaptor molecules, LA T, which is
constitutively associated with lipid rafts, and SLP- , a cytoplasmic adaptor protein.
Concurrently, stimulation leads to a PI3-kinase-dependent increase in PIP3 levels within
the cell membrane. The enrichment of PIP3 at the site of the activated receptor recruits
Itk to the membrane in a PH domain-dependent manner. Following this recruitment, a
multi-molecular signalosome complex consisting ofItk, PLC- , SLP- , Gads , and Grb-
2 form around LA T within lipid rafts. Itk is then transphosphorylated by a Src kinase
followed by Itk autophosphorylation (42), resulting in complete activation of the kinase.
Therefore, two events are critical for the proper activation and function of Itk and Tec
kinases, in general: localization to the membrane and tyosine phosphorylation (Figure
2)(reviewed in (43-46)).
As briefly mentioned earlier, successful T cell activation requires not only signals
emanating from the TCR, but also signals from costimulatory molecules , such as CD28
and ICOS. Data supporting a function for Tec family members downstream from CD28
is obscure. Early studies examining costimulatory function concluded that CD28 signals
are required for effcient IL-2 production and the prevention of anergy. In addition, it
was soon discovered that there were tyrosine phosphorylation events that occurred
following CD28 ligation. In an attempt to identify molecules that signal downstream
from CD28 , August and colleagues reported that Itk associated with the intracellular tail
ofCD28 and was rapidly phosphorylated following CD28 cross-linking (47). Additional
biochemical data from Gibson et al identified tyrosines in CD28 that were required for
the activation of Itk but not PI3-kinase (48). However, the integration of biochemical
signals that emanated from the TCR versus CD28 remained elusive. To further
understand the distinct signals from both the TCR and CD28 to determine where they
intersected, Michel and colleagues found that CD28 signals amplified PLC-y 1 and
calcium responses. Furthermore, their data suggested that CD28 may act to provide
activated Itk to the TCR- induced signalosome complex , thereby contributing to the
amplification of the calcium response (49). These data support a mechanism by which
CD28 provides a quantitative contribution to T cell activation. However, preliminary data
in our laboratory would suggest that Itk is not required for CD28 signaling (C.M. Li and
L.J. Berg, unpublished data).
Negative Regulation
One mechanism that likely contributes to the down-regulation of Itk activity is
through the action of the phosphatase PTEN, which converts the PH domain substrate
PIP , back to PIPz. This event functions to prevent further recruitment of Itk molecules
to the site of the activated receptor. However, until recently, little was known about other
mechanisms that may be involved in actually down-regulating Itk kinase activity. Recent
biochemical and strctural studies ofltk by Brazin and colleagues have demonstrated that
Itk kinase activity is inhibited by a direct interaction between the Itk SH2 domain and the
peptidyl-prolyl isomerase , cyclophilin A (CypA). Consistent with this, treatment of
Jurkat T cells with Cyclosporin A, an immunosuppressive drg that binds CypA and
inhibits calcineurin activity, disrupts this interaction and results in increased Itk
phosphorylation and activation of downstream targets (e. , PLC-yl). Using NMR
strctural analysis, this study also showed that the Itk SH2 domain could undergo a
proline-dependent conformational switch via a single prolyl imide bond. Furthermore
this cis/trans isomerization within Itk, which is thought to be catalyzed by CypA, directly
alters Itk binding specificity for substrates (50). These intriguing findings suggest a
novel mechanism of Itk regulation by CypA. Interestingly, the proline residue involved
in this isomerization reaction is not found in any of the other Tec kinase family members
suggesting that this mode of regulation may be unique to Itk (Figure 3).
Figure 2: Positive Mechanisms Regulating Itk Function
Following the engagement of the T cell receptor (TCR), Src family kinases, such as Lck
are activated. Lck phosphorylates the IT AM motifs within the CD3 chains, which in
turn recruits the Syk family kinase ZAP- , leading to ZAP- 70 phosphorylation and
activation by Lck. Activated ZAP-70 proceeds to phosphorylate the adaptor molecules
SLP-76 and LAT. Concurrently, PI3-kinase is activated, which catalyzes the conversion
of membrane-associated PIP to PIP , the substrate of PH domain-containing proteins
such as Itk and PLC-y I. Cyclophilin A (CypA) has been shown to be constitutively
associated with inactive Itk via Itk' s SH2 domain. However, the mechanism by which
CypA becomes dissociated is not known. Following Itk' s recruitment to the membrane
via its PH domain, a number of complex interactions ensue. While SLP-76 binds to the
SH2 and SH3 domains ofItk, the interaction of SLP-76 with Gads leads to an interaction
with LAT. Grb-2 can bind to the free PRR of Itk, which can also bind to LAT.
Furthermore, PLC-yl recruitment to the membrane via its PH domain allows the N-
terminal SH2 domain of PLC-y I to bind to a phosphotyrosine on LAT. These
interactions result in what is termed a signalosome complex. Lastly, following the
phosphorylation ofItk by a Src kinase, Itk can in turn autophosphorylate, then proceed to
phosphorylate and activate PLC-y 1.
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Figure 3: Mechanisms Down-Regulating the Activity ofItk
In T cells, following activation of PLC-yl by Itk, CD148 , a membrane-associated
phosphatase , is thought to either indirectly or directly dephosphorylate members of the
signalosome complex, such as LAT and SLP- , thereby terminating signaling.
Furthermore, PTEN is also thought to playa crucial role in the down-regulation ofItk, by
converting the PH domain substrate, PIP3, back to PIP , likely preventing the further
recruitment of Itk molecules. The mechanism by which CypA becomes re-associated
with Itk, and the mechanism by which Itk folds back into its inactive conformation are
not known.
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Downstream Effects of Tec Kinase Activation in T Lymphocytes
Several of the initial biochemical and genetic studies utilizing either cell lines or
lymphocytes from mice lacking a Tec family member have demonstrated that the absence
of Tec family kinases is associated with reduced calcium flux, reduced MAP kinase
activation and transcriptional activation, as well as cytoskeletal rearrangements following
receptor engagement. A sumary of these findings wil be discussed shortly, however, an
emphasis will be placed on Tec members expressed in T lymphocytes.
Btk, the most well-characterized kinase of all the Tec family members due to its
role in the diseases XLA in humans and xid in mice, is expressed in B lymphocytes (51
52). The role of Btk in proximal BCR signaling became apparent following the
observation that treatment of Btk/- cells with the pharmacological agents , PMA and
Ionomycin, bypassed the signaling defect, suggesting that Btk functioned upstream of
calcium and PKC activation (53 , 54). Biochemical analyses from Btk-deficient chicken
DT40 B cells revealed that the phosphorylation and activation ofPLC-y2 following BCR
stimulation was severely reduced (55 , 56). These findings led to the more recent
identification of the four Btk-dependent tyosine phosphorylation sites in PLC- , which
are all required for full BCR-coupled calcium mobilization (57).
Upon the identification and characterization of Btk function in B lymphocytes , it
became apparent that the T lymphocyte-restricted kinase Itk possessed functional
characteristics that closely resembled that of Btk (58). Liu and colleagues, one of the
first groups to generate Itk-deficient mice, established that Itk is important for the
phosphorylation and activation of PLC-yl in T cells (59 , 60). Wilcox and colleagues
more clearly defined the role of Itk in PLC-y I activation biochemically, and
demonstrated that, in fact, Itk directly phosphorylates PLC-yl (42 , 61). The function of
Rlk in TCR signaling is less clear. While Rlk appears to play an important role in the
phosphorylation ofPLC-yl by targeting the adaptor molecule SLP- , the absence ofRlk
in T lymphocytes does not impair IL-2 production and proliferative responses. However
the combined loss of Itk and Rlk results in exacerbated defects in TCR signaling, such as
PLC-yl activation and calcium mobilization, compared to the absence of Itk alone (62-
64). This will be discussed in more detail later.
As mentioned earlier, the phosphorylation and complete activation of PLC-y 1 , is a
crucial step in T cell activation (29). Upon activation, PLC-yl hydrolyzes PIP into two
byproducts, IP and DAG, which lead to calcium mobilization and activation of the
PKC/Ras/Raf pathways, respectively. More specifically, following IP production, IP
receptors in the ER membrane induce the release of stored calcium into the cytosol
which in turn leads to the activation of calcium release activated calcium (CRAC)
channels. This event allows the influx of calcium from the extracellular environment into
the cytosol. In lymphocytes, several cytosolic calcium-sensitive transcription factors
such as NFAT family members, NF-KB , and JNK, are activated. These factors promote
the expression of several genes essential for lymphocyte activation, such as IL-2. In fact
the nature of the calcium signal , whether sustained or transient, can have differential
effects on transcription factor activation. For instance, the NF A T family typically
requires a continuous rise in calcium to translocate to and remain localized in the nucleus
(65 66). The production ofDAG can activate members of the Protein Kinase C (PKC)
family. Activated PKCs are known to activate transcription factors such as NF-KB , and
components of the AP- l complex, c-Fos and c-Jun (67, 68). DAG is also involved in
activating Ras-GRP, which ultimately leads to the activation of the Ras/Raf/MAP kinase
pathway. Certain transcription factors , such as NFAT and AP- l components , can interact
cooperatively to properly drive transcription of specific effector genes (69, 70). NF-KB
activation is dependent not only on signals emanating from the TCR, but also CD28-
initiated signals (see Figure 4).
Figure 4: TCR Signaling Downstream From Itk
Signal transduction events initiated by the TCR and costimulatory molecules commences
with an early wave of activity by protein tyrosine kinases, such as Lck and ZAP-70 as
well as Tec family kinases, such as Itk and Rlk. One of the crucial events in T cell
activation following the activation of these kinases is the activation of PLC-y 1. In order
for this reaction to occur effciently, the adaptor molecules SLP-76 and LAT are required.
Activated PLC-yl cleaves membrane PIP into IP and DAG. Calcium activates the
calcineurin-dependent dephosphorylation of cytoplasmic NFAT, allowing NFAT to
translocate to the nucleus. DAG functions to activate distinct PKC isoforms and the Ras
pathway via Ras-GRP. Activated Ras recruits Raf, which consequently activates
multiple downstream mitogen-activated protein (MAP) kinases, such as ERK, JNK, and
p38. The MAP kinase pathways play an essential role in the phosphorylation and
activation of the transcription factors fos and jun, which dimerize to compose the AP-
transcription complex. In the nucleus, NF AT and AP- l factors bind cooperatively to
cytokine and effector gene promoters. Another factor important for T cell function is
NF-KB , which is dependent on TCR and CD28 activation. Following the dissociation of
IKB from the IKB/NF-KB complex, NF-KB can translocate to the nucleus and activate T
cell effector genes. Proper activation of all of these signaling pathways are required for
an effective T cell responses and immunity.
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Impairments in PLC-y activation, and ultimately in the production of IP and
DAG, can affect several downstream events in T lymphocytes. As mentioned above
both Btk-deficient and Itk-deficient cells possess impairments in the activation of PLC-
y1. Upon examination of signaling events downstream of PLC-yl in Itk-deficient cells
calcium mobilization, the activation of NF AT family members, MAP kinases , as well as
AP-l components, were all impaired following TCR activation, as would be predicted
based on our knowledge ofPLC-y (59 , 60 , 71-74 J. All of these events were strikingly
similar to what was found to occur in Btk-deficient B cells (57). However, Tec- and Rl-
deficient cells failed to exhibit any significant defects in any of the T cell signaling events
that were impaired in Itk cells (59, 75J. This observation suggested the possibility of
functional redundancy between these Tec family kinases. Therefore , Schaeffer et al took
the additional task of generating Rlk Itk- mice. The combinatorial mutations ofItk and
Rlk in CD4+ T lymphocytes exacerbated the defects observed in Itk-deficient cells (59
, 72). Interestingly, upon comparison ofItk, Rlk, and Tec expression levels in CD4+ T
lymphocytes, we found a hierarchical pattern of expression, where Itk was 2- fold greater
than Rlk and 100-fold greater than Tec. This finding strongly correlates with the severity
of the phenotypes observed in each ofthe Tec family-deficient mice (Figure 5).
Figure 5: Relative Expression Levels of Tec Family Members in CD4+ T Cells
Quantitative PCR analysis of mRNA levels of the Tec family kinases in CD4+ T
lymphocytes revealed that Itk is expressed at levels that are 2- fold greater than that of Rlk
and IOO-fold greater than that of Tec. This information strongly correlated with the
severity of the phenotypes that are observed in mice that lack one or more Tec family
kinases, where the most striking phenotype is observed in mice lacking both Itk and Rlk
and the least striking in mice .lacking Tec. Phenotye severity is based on several
observations, including impairments in T cell development, T cell function, and the
activation of specific biochemical pathways.
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Ultimately, all of the impaired events discussed above have significant and
numerous effects on transcriptional events and effector functions. Reduced NF AT
1 -
activation in Itk-deficient cells contributes to an impairment in the transcription of several
effector genes (60 , 72-74). One of the initial observations of T cell function in the
absence of Itk was an impaired proliferative capacity as a result of reduced IL-
production (60, 76). Studies of Ite- and Rlk Itk- mice have also revealed additional
roles for Tec kinases in regulating T cell effector functions. For instance, after TCR
stimulation in vitro, Rlk Itk- and Itk- CD4+ cells are defective in their ability to secrete
both Thl- and Th2-tye cytokines, a finding that correlates with reduced activation of
NFAT and AP- l transcription factors (72). As will be discussed later, the majority of my
thesis project involves a more careful examination of how Itk regulates distinct T cell
effector responses.
In the absence of the more TCR proximal tyrosine kinases, Lck and ZAP-
calcium mobilization and MAP kinase activation are completely abolished
demonstrating their necessity in TCR signaling (28 , 77). However, in the absence ofTec
kinases , as discussed above, all of the signals downstream from the TCR are merely
reduced in intensity and duration, suggesting that Tec kinases play more of a modulatory
role in receptor signaling. At this point, it is not clear whether this is a result of
redundancy of Tec kinase function or whether there are clearly distinct functions. In
order to better define Tec family kinases in TCR signal transduction, the generation of
mice deficient in all three T cell restricted Tec members (Itk, Rlk, and Tec) wil be
required.
Other pathways involving Tec kinases
During T cell activation, antigen receptor signaling is highly dependent on actin
cytoskeleton reorganization. This process allows numerous signaling molecules to
converge at the membrane to ultimately form complexes that are required for proper
signal transduction to the nucleus (78). In T lymphocytes, TCR signaling relies greatly
upon the rearrangement of actin filaments , which assist in the formation of the
immunological synapse, a strcture that is crucial for prolonged TCR signals (79). Other
cellular events following T cell activation, such as cell adhesion, are also highly
dependent on actin cytoskeleton integrity.
The first suggestion that Tec family kinases may contribute to actin cytoske1etal
reorganization in lymphocytes came from the finding that both Itk and Btk can bind to
WASP (Wiskott-Aldrich syndrome protein), a protein involved in the nucleation of new
actin fiaments (80 , 81). Data from Woods et al. demonstrated that after anti-CD3
antibody stimulation of Jurkat T cells, Itk can activate 131 integrins and f3-actin
polymerization following its membrane translocation (82). Previous data have also
supported a role for Itk in cytoskeletal reorganization where Itk-deficient cells possess
reduced cap formation following TCR stimulation (reviewed in (83)). Defective
reorganization of cytoskeletal structures may contribute to defects in calcium
mobilization in Itk-deficient cells.
Functional Roles of Tec Kinases in Biological Processes:
T cell Development
The discovery that mutations in Btk lead to defects in pre-B cell development due
to blocks in BCR-mediated proliferative responses was the first indication that Tec family
kinases are required for developmental processes. Following the generation of Itk-
deficient mice , one of the first detectable phenotypes was the striking reduction in the
total numbers of peripheral CD4+ cells, while CD8+ numbers were unaffected. This
indicated possible defects in thymic selection. While data from our laboratory suggest
that Ite- mice exhibit selective defects in the positive selection of CD4+ cells, and not
negative selection, further evidence from Schaeffer et al showed that both Itk and Rlk
Itk- thymocytes possess defects in both positive and negative selection, in addition to
exhibiting altered CD4:CD8 ratios, due to fewer matue CD4+ thymocytes and increased
numbers of CD8+ thymocytes (43- , 59 , 64, 84). Consistent with a model in which
diminished TCR signals in the absence of Tec kinases affects thymocyte fate, defects in
thymic selection correlate with reduced TCR signaling, resulting in reduced calcium
mobilization and reduced ERK-MAPK activation in T cells from Itk and Rlk Itk- mice
(64). Interestingly, in spite of the reduced ERK-MAPK signaling and the altered
CD4:CD8 ratio, detailed analysis of several TCR transgenic lines on an Itk background
did not reveal any alterations in CD4:CD8 lineage commitment in these mice (84). The
possibility that there are redundant and unique functions of Tec kinases in TCR signaling
was discussed earlier. The generation of Rlk
/- 
mice has revealed a seemingly
insignificant role for Rlk in T cell development and function. However, overexpression
ofRlk in Itk- mice led to a partial rescue of positive selection and calcium mobilization
I -
supporting the notion that Tec members may have redundant fuctions in T cells (62).
Effector Development and Immune Responses
Responses to viruses
The first study assessing the ability of Tec kinase-deficient cells to respond 
vivo examined antiviral immune responses to three different viruses , vesicular stomatitis
virus (VSV), vaccinia virus (VV), and lymphocytic choriomeningitis virus (LCMV) in
Itk- mice (85). Several different effector mechanisms are required for clearance of these
particular viruses. Therefore, this study allowed the assessment of CD8+ and CD4 + T cell
function, in addition to B cell function, in the absence of Itk. For instance , LCMV is
almost exclusively cleared by CD8+ cytotoxic T lymphocytes (CTL), whereas the
clearance of VV is more dependent on both CD4+ and CD8+ cells (86-90). Contrastingly,
clearance of VSV, which is exclusively eliminated by antibodies, requires a strong early
T cell-independent IgM response, followed by a more prolonged T cell-dependent IgG
response (91-93).
This study by Bachmann and colleagues found that CTL responses were reduced
2- to 6-fold against all three viruses, indicating a role for Itk in CD8 T cell function.
However, while LCMV was completely cleared by day 8 post-infection, the response to
VV was cleared with delayed kinetics. The difference between these two responses in Itk-
deficient mice may be a reflection of different mechanisms used by the host to eliminate
these viruses. Lastly, upon infection with VSV, Itk-deficient mice possess normal T cell-
independent and T -dependent B cell responses, and possessed no symptoms of
encephalitis (85). In summary, this study revealed an important, though not essential
role for Itk in CTL responses to viruses and antiviral immunity.
Intracellular and Extracellular Parasitic Responses and Allergic Responses
Prior studies performed by both Fowell et aI. and Schaeffer et al have shown that
the biochemical defects observed in Tec kinase-deficient T cells translate in vivo 
impaired immune responses upon infection with various pathogens (72 , 94). These
defects are observed in responses to pathogens requiring both Th 1 and Th2 effector
functions for clearance (Table I). For instance, mice deficient in Rlk, Itk, or both
possess graded defects upon infection with Toxoplasma gondii an intracellular protozoal
pathogen that normally induces a protective Th I immune response in wild type mice.
These data indicate that mice deficient in one or more Tec kinases are incapable of
mounting a protective Thl-tye CD4+ T cell response to this pathogen.
In contrast, a second study found that Itk- mice on both the C57BV6 and Balb/c
background were able to clear an infection of Leishmania major an intramacrophage
parasite that also requires a Thl response for protective immunity (94). This latter
finding is particularly interesting as L. major normally elicits a protective Th I response in
C57BV6 mice and a non-protective Th2 response in Balb/c mice. While at face value the
responses to T. gondii and L. major seem totally incompatible, it is possible that the
discrepancy may result from the different requirements for protective immunity to these
two pathogens. For instance T. gondii infects many cell types, proliferates and spreads
rapidly in the host, and requires a fast and robust IFN-y response to prevent lethality. In
contrast L. major infects primarily macrophages and dendritic cells, spreads slowly in
the host, and can be cleared by a slower and less robust Thl response (95). Thus, it is
possible that reduced kinetics, reduced efficiency, and a reduction in the overall
magnitude of the response in Itk mice compared to wild type mice might explain the
different outcomes in response to these two different pathogens.
The responses of Ite- mice to pathogens that require a Th2 effector response for
protective immunity are more consistent. In response to the nematode Nippostrongylus
brasilensis, Balb/c mice make a protective Th2 response , however Itk Balb/c mice fail
to clear the nematode and show a significant reduction in the number of cells making
IL-4 compared to wild type mice (94). Following this discovery, Schaeffer et al reported
that Itk mice on the mixed 129 x C57Bl/6 background were also unable to mount a
sufficient Th2-type response to the helminth Schistosoma mansoni (72). Consistent with
the overall reduction in the response to this pathogen, cells isolated from the lymph nodes
of infected Itk- mice produced less of the Th2 cytokines, IL- , IL- , and IL- , and more
of the Th 1 cytokine IFN -y, compared to cells from infected wild type mice.
Paradoxically, however, this study also showed that Rlk Itk- mice, which are more
defective in signaling and effector function in vitro were able to elicit a normal Th2
response to S. mansoni similar to that elicited in wild type mice infected with this
parasite. Thus , while the Rlk Itk- situation is unclear, Ite- mice seem to have a
significant defect in eliciting Th2 responses, presumably as a consequence of the CD4+ T
cells having an impaired ability to activate NF A Tc I and AP- , and ultimately, to produce
IL-
As discussed earlier, an immune response is an orchestration of events involving
many different cell tyes. Therefore, how T cells respond in vitro may not necessarily
"I"
reflect how they function in vivo. While these studies have clearly established that Tec
family kinases are critical components of signal transduction pathways that control T cell
differentiation, there are several remaining questions regarding the mechanisms by which
Tec kinases act on pathways affecting genes important in T cell differentiation. Part 
my thesis work entailed further clarification of the function of Itk during T cell effector
development or differentiation.
Table 1. T helper responses in Itl(
/- 
and Rlk- Itk- mice
Pathogen (Ref)
Protective
Wild Type Response
L. major (74) Thl (B6)
T. gondii (59) Thl
N. brasilensis (74) Th2 (Balb/c)
S. mansoni (72) Th2
MST is mean surival time.
Response of Itk- and/or Rle-Itk
Itk- (B6/129) = resistant
Itk- (Balb/c) = resistant
Itk- (B6) = susceptible (MST = 69 days)
Rlk/-Itk- (B6) = susceptible (MST = 41 days)
Itk- (Balb/c) = susceptible
Itk (B6) = susceptible
Rle-Itk I- (B6) = resistant
Work presented in this thesis
The primary focus of my thesis work sought to provide a better understanding of
how Itk functions in signaling pathways that regulate distinct immune outcomes. The
work presented here has provided new insights into the biology and function of Tec
kinases in several important aspects of CD4+ T cell effector fuction, such as AICD and
T cell differentiation.
Presented in chapter two, the first issue I focused on was the fuction of Itk in the
process of activation-induced cell death (AI CD) of CD4+ cells , an important mechanism
of immune homeostasis. Based on information known about the control of the FasL
promoter and its similarity to the IL-2 promoter, in addition to the striking increase in the
percentage of CD4+ cells with a memory/activated phenotype in Itk mice, we had
hypothesized that Itk may play an important role in the signaling pathway that leads to
FasL expression. Using several cellular and molecular approaches , I found that in the
absence of Itk, CD4+ cells possess an impairment in apoptosis via the Fas-FasL pathway
due to a substantial reduction in surface FasL expression by activated Itk CD4+ T cells.
Mechanistic analysis underlying this FasL defect was revealed to be the failure of Itk
cells to efficiently upregulate Egr2 , Egr3 , and consequently, FasL transcription after TCR
stimulation. Furthermore, I was able to demonstrate the physiological consequence of
these defects in vivo upon immunization with the superantigen staphylococcal enterotoxin
B (SEB), where CD4+ T cells from Itk mice were incapable of undergoing AICD
efficiently. (71). This study defined an important role for Itk in TCR signaling, leading to
cytokine gene expression and activation-induced cell death.
- I
The experiments presented in chapter three proceed to further define a role for Itk
in other CD4+ T cell effector functions. Due to the observation that Itk mice exhibit a
two- to three-fold increase in the percentage of CD4+ cells with an activated/memory
phenotype, we sought to examine the behavior and differentiation status of these cells in
order to gain clues as to how Itk may be regulating additional T cell effector functions.
While memory cells from Itk-deficient mice in fact behave like memory cells, as
determined by their ability to rapidly produce abundant amounts of IL- , following the
examination of the Thl and Th2 effector cytokilles IFN-y and IL- , respectively, we
found a striking increase in the numbers of memory cells that can produce either cytokine
in the spleen of Itk mice, compared to wild tye. This observation suggested that Itk
may function to regulate a balance between Th 1 and Th2 effector cytokine production
during differentiation. To better understand the function of Itk in CD4+ T cell
differentiation, we examined the ability of Itk-deficient cells bearing a transgenic TCR to
differentiate upon stimulation with the cognate antigen. From these experiments, a great
deal of variation was observed upon activation and differentiation of Itk- CD4+ T cells as
a result of the presence of previously-activated cells that expressed both the transgenic
TCR and endogenous alpha chains. These cells had been differentiated in vivo into either
the Th 1 or Th2 lineage, thus greatly impacting the differentiation of naIve cells in vitro.
As a result, we were unable to draw any conclusions about the function of Itk in the
differentiation of naIve CD4+ T cells. Chapter four more clearly defines an important
function for Itk in T cell differentiation.
As opposed to chapter three , chapter four examines the function ofltk in CD4+ T
cell differentiation in a more highly controlled in vitro system. The experiments
presented in this chapter sought to rectify the involvement of Itk in TCR signaling
pathways that lead to the activation of specific genes important in controlling T cell
differentiation. To understand the fuction of Itk durng T cell differentiation following
the activation of one specific TCR with a cognate antigen, and avoid the complication of
endogenous alpha chains and memory cells that obscured my experiments in chapter
three, we generated Itk-deficient mice that possessed the 5C.C7 TCR on the Rag2-
background. Since variation in TCR signal strength is known to generate different
outcomes in T cell differentiation, I utilized a controlled in vitro approach, which lacks
exogenous skewing cytokines , to ask whether Itk regulates the strength of the TCR signal
in a manner that would impact T cell differentiation. This method required varying the
dose of peptide that the T cells are initially exposed to , or using altered peptide ligands
that are recognized with a weaker avidity. These experiments demonstrated that Itk was
crucial for differentiation into the Th2 lineage. In an effort to identify the underlying
mechanism, I was able to make a previously unrecognized connection between Itk and its
negative regulatory role on the expression of T-bet, the alleged master switch of Thl
differentiation. Using exogenous cytokines to skew the T cells into either the Th 1 or Th2
lineage, I discovered that Itk plays an important role in the function of both lineages.
However, I found Itk to be more highly expressed in Th2 cells , compared to Thl , an
importnt event for optimal PLC-y I activation in Th2 cells. These data support a model
in which Itk is not only critically required for Th2 differentiation, but essential for proper
Th2 cell function.
Together, the data presented in this thesis demonstrate that the Tec family kinases
not only regulate signaling pathways affecting T cell activation and differentiation, but
. (
;i.
also pathways involved in effector mechanisms that lead to apoptosis. While it was
previously thought that Itk functions in a signaling pathway that activates cytokine and
effector genes, such as IL- , IL- , and FasL , my work has identified a novel connection
between Itk and genes that are involved in the transcriptional control of T cell
differentiation, such as T -bet. Overall, these studies have highlighted the complex
interactions between Itk and cellular processes, such as T lymphocyte activation
differentiation, effector fuctions, homeostasis, and apoptotic pathways.
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CHAPTER II.
THE FUNCTION OF ITK IN
ACTIV ATION-INDUCED
CELL DEATH
Introduction
Stimulation of the T cell antigen receptor (TCR) induces a variety of different
cellular responses, depending on the stage of development of the T cell and its antigen
recognition history. In mature T lymphocytes , stimulation of the TCR can induce
cytokine production, proliferation, anergy, or programmed cell death. In recent years , it
has become increasingly clear that apoptotic cell death following a strong immune
response is a major mechanism responsible for maintaining homeostasis in the immune
system. For instance, after prolonged activation, T cells undergo a process termed
activation-induced cell death (AICD), which is mediated by the induced expression of
factors such as tumor necrosis factor (TNF) and Fas ligand (FasL) (reviewed in (15)).
Activation of T cells via their TCR induces the synthesis of Fas (CD95), and its ligand
FasL (CD95L). The binding of Fas to FasL initiates a cascade of intracellular events in
the Fas-expressing cell that ultimately results in the apoptotic death of that cell (reviewed
in (16)). The importance of this mechanism of AICD in the immune system is
exemplified by the consequences of mutations in either the Fas or the FasL genes, which
result in uncontrolled lymphoproliferation and autoimmunity in both humans and mice
(17- 19).
The signaling pathways that lead to the activation of the FasL gene in T cells have
been a major focus of investigation in recent years. However, this pathway is still not
well understood. Several lines of evidence have suggested that specific TCR signaling
pathways induce the expression of FasL. For instance, Lck and ZAP- , members of the
Src and Syk family of non-receptor protein tyrosine kinases, respectively, have been
shown to be critical for TCR-mediated FasL expression; in contrast, FasL expression is
not dependent on Fyn, another proximal tyrosine kinase (96, 97). Furthermore, both
calcineurin and members of the MAP kinase (MAPK) ERK and JNK families have been
recognized as important members of the signaling pathway leading to the induction of
FasL expression (98- 102). In this study, we focused on the involvement of a Tec family
kinase, Itk, in the TCR-mediated upregulation of FasL, and the subsequent induction of
AICD.
The importance of Tec family kinases in the immune system is exemplified by
Btk, a relative of Itk that is expressed in B cells and mast cells. Mutations in Btk have
been linked to x- linked agammaglobulinemia (XLA) in humans and x- linked
immunodeficiency (xid) in mice (33-35). Biochemical studies have indicated a similar
role for Itk and Btk in antigen receptor signal transduction in T cells and B cells
respectively (44). Specifically, mice deficient in Itk exhibit defects in T cell development
and function. This is manifested as reduced numbers of peripheral CD4+ cells, indicating
a defect in thymic positive selection, as well as reduced cytokine production 
peripheral Itk- T cells (60, 76). Biochemical studies have shown that Itk-deficient CD4
T lymphocytes are defective in proximal TCR-initiated signaling events , such as the
activation of PLCy I and calcium mobilization (60). Furthermore, F owell et al
demonstrated that Itk-deficient CD4+ T cells possess defects in the nuclear translocation
ofNFATc following TCR ligation, which consequently results in the inability to produce
IL-4 and to elicit Th2-type responses in vivo (94). Since NFAT proteins are known to be
essential transcription factors for many effector genes such as IL- , FasL, CD40L, in
addition to IL- , these findings suggested that in the absence of Itk, other T cell effector
functions that are dependent on signals downstream of PLCyllCa /NFAT may be
affected.
To further characterize the role ofltk in CD4+ T cell effector function, we crossed
Itk- mice to 5C.C7 TCR transgenic mice (103), expressing a TCR specific for a moth
cytochrome c peptide (MCC 103) bound to the MHC class II molecule, IE (104). These
mice have provided a system for examining T cell signaling events and effector function
in response to the natural receptor- ligand interaction. In this report, we show that in
addition to calcium defects Itk CD4 + T cells are defective in the activation of the
ERKMAPK and JNK pathways, the expression of Egr3 and Egr2 , and consequently
FasL expression. Moreover, we demonstrate the physiological consequence of these
defects in vivo where T cells in Itk mice are unable to undergo effcient AICD in
response to a superantigen, SEB.
Results
Naive Itk- CD4+ T cells have defects in IL-2 production and proliferation in
response to MHC/peptide stimulation.
Numerous studies over the past few years have indicated that the recruitment and
activation of specific signaling pathways in T lymphocytes is determined by the nature of
the TCR:peptide:MHC interaction (reviewed in (105)). Nonetheless , prior in vitro
studies that have focused on elucidating the role of Itk in T cell signaling and effector
function have largely utilized antibodies to T cell surface receptors, such as CD3 and/or
CD28 , to trigger TCRIcostimulation signaling events. Moreover, while initial studies
demonstrated that Itk-deficient CD4+ cells have functional defects in response to anti-
CD3 stimulation (60 , 76), Itk has also been implicated as a negative regulator of CD28
costimulation (106). Therefore, we were interested in examining the role of Itk in TCR-
mediated signaling events in response to the physiological receptor/ligand interaction. To
accomplish this , we crossed Itk mice to mice transgenic for the 5C.C7 TCR, which is
specific for a moth cytochrome C peptide, MCC 103 bound to MHC II IE (104, 107).
To first determine the functional responses of TCR transgenic Itk T cells
purified CD4+ T cells from 5C.C7 Itk+ or SC.C7 Itk mice were stimulated in vitro with
MCC93- 103 peptide plus antigen-presenting-cells (APCs: IE and B7. 1-expressing CHO
cells). As shown in Figure 6A, we found a modest ( two-fold) decrease in the antigen-
induced proliferative responses of Itk CD4+ T cells compared to control T cells at all
peptide concentrations tested. In contrast, stimulation with a phorbol ester, PMA (P),
plus a calcium ionophore, ionomycin (I), induced comparable levels of proliferation
confirming previous data indicating that these pharmacological agents bypass the Itk
defect by directly activating the PKC/Ras and calcium pathways, respectively (76).
Previous studies had also indicated a defect in aCD3 antibody-induced IL-2 secretion by
Itk- T cells. To re-examine this issue with primary TCR transgenic T cells , we
determined the extent of IL-2 production by 5C.C7 Itk or 5C.C7 Itk cells after
stimulation with MCC 103 peptide and APCs. For these studies , we used intracellular
staining of permeabilized cells with an anti-IL-2 antibody. Figures 6B and 6C show the
percent of cells making detectable IL-2 following a 16-hour in vitro stimulation. Overall
we observed a 50% reduction in the responses of Itk- CD4+ T cells compared to control
T cells. Interestingly, these rather modest differences in the percent of responding cells
as measured by intracellular cytokine staining, correlate with much greater differences in
IL-2 secretion as measured by ELISA (data not shown). Thus , these data are in close
accordance with previously published experiments, utilizing anti-CD3 or anti-CD3 plus
anti-CD28 antibodies, showing decreased IL-2 production by naIve Itk T cells (60 , 76).
Figure 6: Naive Itk- CD4+ T cells have defects in IL-2 production and proliferation
in response to MHC/peptide stimulation
(A) Purified CD4+ T cells were stimulated in vitro with APCs and the indicated
concentrations of MCC 103 peptide or with PMA and Ionomycin (P+I), and proliferative
responses were measured. The data displayed are the averages of triplicate wells.
Standard deviations for the triplicates are shown as error bars along the y-axis.
(B) and (C) Purified 5C.C7 Itk+ and 5C.C7 Ite- CD4+ T cells were stimulated for 16
hours with APCs and MCC93- 103, or PMA and Ionomycin. Cells were then stained with
anti-CD4-Cy and anti-Vall-FITC , fixed, permeabilized, and stained intracellularly with
anti-IL- PE. Ten thousand CD4 Vall + events were collected on a flow cytometer. An
example of raw data is shown in (B), and a summary of one representative experiment
out of three is shown in (C).
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Itk- CD4+ T cells proliferate more vigorously than control T cells upon secondary
stimulation
Prior studies that have investigated the role of Itk in T cell signaling pathways
have focused primarily on the responses of naIve T cells that lack Itk. Therefore, we
were interested in determining how Itk- cells respond upon secondary stimulation. To
accomplish this , 5C.C7 Itk and 5C.C7 Itk- CD4+ T cells were stimulated in vitro with
M MCC93-103 peptide plus APCs, and expanded in medium containing IL-2 until
restimulation. In addition, to ensure a homogeneous population of activated T cells, these
stimulations were performed in Thl-skewing conditions (IL- 12 plus anti-IL-4 antibody).
On day 14 after the initial stimulation, cells were restimulated with a range of
concentrations of MCC93- 103 peptide plus APCs , and T cell proliferation was assessed.
Interestingly, Itk T cells proliferated far more vigorously than control (Itk+I- T cells
upon secondary stimulation, indicating that the control T cells had either failed to
proliferate or had undergone AICD (Figure 7 A). To ensure that these previously-
activated Itk- T cells stil possessed defects in IL-2 production in a secondary response
we performed intracellular IL- staining. These assays indicated that previously-
activated Itk- T cells consistently produced reduced levels of IL-2 over a wide range of
peptide concentrations (Figure 7B). These data support the notion that Itk- CD4+ T cells
retain a TCR signaling defect after secondary in vitro stimulation.
Figure 7: Itk- CD4+ T cells proliferate more vigorously than control T cells upon
secondary stimulation
- !
(A) and (B) 5C.C7 Itk and 5C.C7 Itk CD4+ T cells that were initially stimulated with
M of MCC93-103 were restimulated on day 14 , and proliferative responses were
measured. In (B), cells were restimulated on day 12 for 6 hours, and analyzed for IL-
production by intracellular staining. (C) Proliferative responses of 5C.C7 Itk and
5C.C7 Itk- CD4+ T cells that were restimulated in the presence of anti-FasL antibody or
an isotye control Ig (5 g/mL). Antibodies were added at time 0 and again at 20 hours.
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FasL up regulation is defective in Itk"
/- 
CD4+ T cells
FasL transcription is regulated by a number of factors, including NF-KB , NFAT
AP- l (fos/jun), and Egr family members, all of which are activated in response to TCR
o I
stimulation (108- 113). A previous study has demonstrated that Itk CD4+ T cells are
impaired in their ability to effciently translocate cytoplasmic NF A T to the nucleus upon
TCR stimulation (94). Together with our observation that Itk- T cells proliferate more
vigorously upon secondary stimulation compared to Itk 
+1- T cells , this finding suggested
that Itk- T cells may be impaired in the expression of FasL. As an initial effort to assess
whether proliferative differences between control and Itk cells were due to
differences in FasIFasL-mediated AICD , we repeated the secondary in vitro proliferation
assays in the presence of a neutralizing anti-FasL antibody (Figure 7C). These
experiments indicated that the presence of anti-FasL antibody, but not an isotype control
antibody, blocked AICD and restored the proliferative capacity of control (Itk+I- T cells.
In contrast, the anti-FasL antibody had no effect on the proliferative responses of Itk
cells. Interestingly, at high peptide concentrations (100nM), both wild type and Ite- T
cells undergo AICD in the presence of anti-FasL antibody. This is likely due to the
upregulation ofFasL in the Itk- T cells in response to very strong TCR signaling (lOOnM
peptide versus 10- or 10- nM peptide), which may be more difficult to block with the
concentrations of anti-FasL antibody used. Nonetheless, at lower concentrations of
peptide, it appears that Itk T cells fail to upregulate FasL after stimulation.
As an additional measure of FasL upregulation, previously-activated T cells were
restimulated with peptide and APCs for 9 hours , stained for surface Fas and FasL, and
analyzed by flow cytometry. As shown in Figure 8 , we observed induced surface
expression of FasL on Itk 
+1- T cells at all peptide concentrations, with maximal levels at
the highest peptide concentration tested (100nM). In contrast Itk T cells failed to
detectably upregulate FasL, except perhaps at the highest peptide concentration where a
slight shift in FasL staining can be seen. Both Itk+ and Itk- T cells show no difference
in the expression of Fas upon stimulation , indicating that differences in AI CD between
control and Ite- T cells are not due to differences in surface expression of Fas.
Figure 8: FasL upregulation is defective in Itk- CD4+ T cells
Previously-activated 5C.C7 Itk 
+1- 
and 5C.C7 Itk CD4+ T cells were restimulated on day
14 with APCs and the indicated concentrations of MCC93- 103 peptide. After 9 hours, cells
were stained for CD4, Vall; ' Fas , and FasL, and analyzed by flow cytometry. Ten
thousand CD4+ Va 11+ events were collected. In each panel the dotted line represents
non-stimulated cells , and the bold line shows staining of stimulated cells. These data are
representative of three independent experiments.
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To confirm that the decreased proliferative responses of Itk +1- T cells and the
increased induction of FasL expression correlated with increased apoptosis, wild tye and
Itk- T cells were stained with Annexin V and propidium iodide following stimulation.
As shown in Figure 9A and 9B , a substantial degree of apoptosis is induced in control T
cells following peptide stimulation, whereas Itk T cells require stimulation with 10
- fold higher concentrations of peptide to induce a comparable degree of apoptosis.
The presence of a neutralizing anti-FasL antibody was able to increase cell viability, on
average, by 2A- fold in stimulations of control T cells. In contrast, cell viability was only
increased by 1.3-fold when anti-FasL antibody was included in cultures of Itk T cells.
This observation further supports the conclusion that greater levels of fuctional FasL are
expressed on Ite compared to Itk- previously-activated CD4+ T cells. These data are
also consistent with a previous finding that thymocytes from Itk- mice are defective in
activation-induced cell death in response to anti-CD3 antibody stimulation (64).
One previous study has indicated that another Tec kinase family member, Btk
functions as an inhibitor of signaling through Fas in B cells (114). Therefore, to
determine if signaling through Fas is altered in Itk T cells , cells were treated with a Fas
agonist, soluble FasL (sFasL). As shown in Figure 9B , stimulation with sFasL led to
comparable levels of apoptosis in both Itk 
+1- 
and Itk T cells. These data indicate that
signaling through Fas is unpertrbed in Itk T cells.
J -
Figure 9: Decreased apoptosis correlates with defective FasL expression in
Itk-
/- 
CD4+ T cells
(A) and (B) Previously-activated 5C.C7 Itk+/- and 5C.C7 Itk/- CD4+ T cells were
- \
stimulated for 16 hours with MCC93- 103 peptide and APCs , in the presence of anti-FasL or
an isotype control Ig. Following stimulation, cells were stained with Annexin V and
Propidium Iodide (PI) and analyzed by flow cytometr. Panel (A) shows an example of
dot-plots of Annexin V versus PI fluorescence , and the numbers in the lower left
quadrant indicate the percentage of live cells present at the time of analysis. Panel (B)
shows a summary of data from all stimulation conditions. As a control, cells were
stimulated with soluble FasL (sFasL) alone to ensure comparable susceptibility to Fas-
mediated apoptosis of the Itk+/- and Itk-/- T cells. In each case, the percentage oflive cells
was determined by calculating the ratio of live cells in the treated wells to live cells in the
wells incubated in the absence ofMCC peptide.
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Although IL-2 is commonly recognized as a growth-promoting cytokine that
triggers survival and proliferative signals upon binding its receptor, IL-2 can also
potentiate AICD by inducing maximal FasL expression (115, 116). This is thought to
occur through the action of IL-2 receptor (IL-2R) -mediated transcription factors such as
SP- l (117). Furthermore , IL-2R signals have also been shown to down-regulate FLICE-
like inhibitory protein (FLIP), an anti-apoptotic molecule (118). Thus, signals through
the IL-2R can cooperate with TCR signals to provide a feedback mechanism that renders
activated T cells more susceptible to apoptotic death. In light of these data, we were
interested to determine if the reduced ability ofItk T cells to undergo AICD was due, in
part, to decreased levels of IL-2 production (Figure 7B). To address this issue
exogenous IL-2 was ,added to cultures during restimulation. We found that addition of
exogenous IL-2 did not enhance FasL-induced cell death or FasL surface expression on
Itk- T cells (data not shown), indicating that the defect in FasL expression is not
secondary to the decreased levels of IL- 2 production seen in Itk CD4+ T cells.
Furthermore , as both Itk+ and Itk T cells are cultured in an excess of exogenous IL-
during the primary stimulation, differences in IL-2R signaling are unlikely to account for
differential expression of FasL or responsiveness to AICD during the subsequent in vitro
stimulations.
';ih'
Calcium, ERK, and JNK pathways are defective in previously-activated Itk- CD4
T cells
Stimulation of the TCR leads to the activation of signaling pathways that
ultimately result in the generation of active transcription factors leading to new gene
expression (119). Previous biochemical studies have demonstrated that Itk plays a role in
the phosphorylation and activation ofPLCyl following stimulation of the TCR (60, 61).
Activated PLCyl then converts the membrane phospholipid, PIP , into IP3, an activator of
calcium release channels in the endoplasmic reticulum, and DAG, an activator of the Ras
and Protein Kinase C (PKC) pathways. A sustained increase in intracellular calcium
concentrations following TCR stimulation leads to the calcineurin-dependent
dephosphorylation of cytoplasmic NF A T, resulting in NF AT translocation to the nucleus
(120- 122). To confirm that previously-activated Itk CD4+ T cells retain the
biochemical defects characterized in primary resting Itk CD4+ T cells (60), intracellular
calcium mobilization was measured upon restimulation of 5C.C7 Itk T cells initially
stimulated with 2 M of MCC93-103 plus APCs and cultured for ten days in exogenous IL-
2. As demonstrated in Figure lOA Itk- T cells show a significant defect in calcium
mobilization compared to Itk 
+1- T cells following stimulation through the TCR. These
data indicate that previously-activated Itk T cells exhibit a comparable deficit in
signaling compared to freshly- isolated ex vivo Itk-I- T cells.
Recently, several reports focusing on Itk biochemistr have demonstrated that Itk
is recruited to the LAT/SLP-76 complex in response to TCR signaling, thereby providing
a scaffold for Itk to activate PLCy I , potentially by direct phosphorylation. These data
place Itk intermediate between proximal TCR signaling events and downstream events
such as the activation of the Ras pathway (36 , 123- 125) (reviewed in( 44)). Activated Ras
is known to activate the Raf/Mek/ERK pathway, which subsequently leads to the
transcription of fos proteins , and ultimately to the formation and activation of AP-
complexes (reviewed in (126)). In addition, the ERK proteins, ERKI and ERK , have
recently been shown to playa role in AI CD by inducing FasL transcription (99).
Consistent with these findings, the FasL promoter was also found to possess target sites
for AP- l transcription complexes (112). In light of these data, we were interested in
determining whether the reduced ability of Itk/- CD4+ T cells to upregulate FasL in
response to TCR signaling was due, in part, to defective activation of the Raf/Mek/ERK
pathway. As shown in Figure lOB , following anti-CD3 stimulation, Itk-/- T cells failed to
achieve maximal levels of phosphorylated ERK proteins over the course of a ten-minute
stimulation. In contrast, treatment with PMA and ionomycin, which bypass the proximal
signaling events, induced comparable levels of phosphorylated ERK in both Itk +/- and Itk-
/- T cells, demonstrating that there is no intrinsic defect in the ability of the Ras pathway
to activate ERK in the absence of Itk. These data are consistent with a previous report by
Schaeffer et al who demonstrated that Rlk/-Itk/- T cells and thymocytes show a marked
reduction in ERK phosphorylation following TCR stimulation (59, 64).
Activated Ras also plays a role in the activation of the MEKK- l/JNK pathway,
which is essential for transcriptional activation of the FasL promoter via the activation of
Jun (98 , 127). To further assess the role ofItk in the activation of the Ras pathway and
its downstream effectors , we examined the level of JNK/SAPK phosphorylation in Itk
cells upon TCR stimulation. As demonstrated in Figure lOB, the activation of the
JNK/SAPK pathway is also impaired in Itk/- CD4+ T cells. Similar to ERK
phosphorylation, treatment with PMA and ionomycin induced comparable levels of
SAPKlJNK phosphorylation in Itk+/- and Itk-/- cells. Collectively, these biochemical data
strongly suggest that Itk-/- CD4+ T cells are unlikely to accumulate normal levels of active
Fos and c-Jun, and thus , are likely to have reduced levels of AP- l complexes after TCR
stimulation.
Figure 10: Calcium, ERK, and JNK pathways are defective in previously-activated
Itk-
/- 
CD4+ T cells
(A) SC.C7 Itk+/- and SC.C7 Itk-/- CD4+ T cells were loaded with Fluo-3 and Fura-Red on
day 10 post-initial stimulation with 2 M of MCC93- 103 peptide. Intracellular calcium was
then measured in response to anti-CD3 antibody cross-linking, followed by ionomycin
stimulation. Data are displayed as the ratio of Fluo-3 to Fura-Red fluorescence.
(B) Previously-activated 5C.C7 Itk+/- and 5C.C7 Itk/- CD4+ T cells were restimulated on
day 14 by anti-CD3 antibody cross-linking for 0, 2, 5 , or 10 minutes. As a control , cells
were treated with PMA and ionomycin for 15 minutes. Total lysates were
immunoblotted with an anti-phospho-ERK (p-ERK1&2) or an anti-phospho-SAPKfJNK
(p-
SAPKfJNK) antibody. The membrane was stripped and reprobed for ERK or
SAPKfJNK protein , respectively.
Figure 10
700
;: 500
1a 400
300
600
SC.C7 Itk+l-
'Oo'''''''''' SC.C7 Itk-
'0.":'
200
100
t 200
anti-CD3f:- S.
biotin
SC.C7 Itk+l-
Anti-CD3f
10 P+I 
:-' ;-: =='"')"'+"_)"
400 600
lono.
800
Time (seconds)
SC.C7Itk-
Anti-CD3e
10 P+I Time (min)
..-_. 
I '".." J
. - 
't' j"tltr:;,.
, ,
;-i
~~~~
1;'"
-/f
;,"-;,
::T
jg- ! ... ... .
lfC J
1000
ERKI
ERK2
ERKI
ERK2
SAPKlJNK
SAPK/JNK
Reduced Egr2 , Egr3, and FasL transcription after TCR stimulation of Itk- T cells
Several transcription factors such NFAT, NFKB , Egr2 , as well as Egr3 , have been
1----
: I
implicated in the TCR-mediated activation of the FasL promoter. In fact, the FasL
promoter contains consensus sequences for NFAT, NFKB , Egr, as well as the AP-
factors , c-Fos and c-Jun (109, Ill , 128 , 129). The Egr2 and Egr3 genes are normally
expressed at low basal levels in resting T cells, and are transcriptionally induced
following TCR stimulation (130). Furthermore , the Egr2 and Egr3 promoters themselves
are targets of NF AT proteins, and in turn function as strong trans activators of the FasL
promoter (113). Consistent with these findings, the over-expression of either Egr2 or
Egr3 in T cell hybridomas or HeLa cells induces FasL transcription (109, 128).
Additional evidence also indicates that the induction of Egr2 and Egr3 transcription, and
consequently FasL expression, are inhibited by the calcineurin inhibitor, cyclosporin A
(CsA)(109, 128). In spite of these compelling data, there have been conflcting results
regarding which factor, Egr2 or Egr3 , is more critical for FasL transcription.
Nonetheless, the bulk of the evidence indicate that NFAT and Egr factors act
synergistically in the activation of the FasL promoter.
Recent studies have demonstrated that Itk CD4+ T cells are defective in the
nuclear translocation of NF A T upon TCR stimulation (94 J; furthermore , dominant-
negative Itk can inhibit TCR-induced NFAT-dependent transcription (36). Given these
observations , and the fact that the Egr2 and Egr3 promoters are regulated by NF A T, we
reasoned that Egr2 and Egr3 transcription might be defective in Itk- T cells, resulting in
impaired FasL transcription. To test this idea, we utilized real-time quantitative PCR
analysis (Q-PCR) to determine the mRA levels of Egr2 , Egr3 , FasL , and j3-actin in
resting and stimulated T cells.
Since Fas-dependent death can occur at low levels in naIve CD4+ T cells upon
strong stimulation of the TCR within the first 18 hours (131), we first sought to determine
the expression levels of the Egr2 , Egr3 , and FasL transcripts in naIve SC.C7 Itk+/- or Itk-
CD4+ T cells that were stimulated with anti-CD3 antibody for 0 , 6 , 18 , or 48 hours. For
these experiments, CD4+ CD44 T cells were sorted from mice of each genotype , to
prevent ambiguities caused by the presence of activated/memory T cells in the unsorted
populations. For the analysis of previously-activated T cells, SC.C7 Itk+/- and SC.C7 Ite-
CD4+ T cells were stimulated with 2 M of MCC 103 peptide plus APCs in T I skewing
conditions, and then expanded in IL-2. These cells were then restimulated on day 14
with anti-CD3 antibody for 0, 1 , 2 , 4 , and 6 hours.
Figure 11A shows an example of raw data obtained from this analysis. The
amount of PCR product present, as measured by fluorescence intensitY, is indicated for
each PCR cycle. As can be seen, the j3-actin curves for both samples (ltk+/- and Itk- ) are
virtally superimposable , indicating nearly identical amounts of cDNA in these samples.
In contrast, the FasL curves do not superimpose , indicating a difference in the copy
number of FasL transcripts between the stimulated Itk +/- and Itk/- cells.
interpolation of these data to a standard curve, absolute values for FasL copy numbers
can be obtained for each sample. To normalize for the amount of cDNA present in each
sample, a ratio of the average copy numbers of Egr2 , Egr3 , and FasL to j3-actin copy
numbers was calculated for each data point. The data from a representative experiment
of each type are shown in Figure lIB. This analysis demonstrated decreased levels of
. '
Egr2 , Egr3 , and FasL transcripts in primary ex vivo Itk/- CD4+ T cells after stimulation
although the magnitude of this reduction is modest. A more striking deficit was seen in
the analysis of previously-activated Itk-/- T cells, where we observed, on average , a 5- and
fold decrease in Egr2 and Egr3 levels , respectively, and a 3-fold decrease in levels of
FasL transcripts compared to the levels in the Itk +/- T cells at the peak of the response.
Interestingly, these data also clearly demonstrate the dramatic enhancement in TCR-
mediated Egr3 and FasL transcription in previously-activated compared to naIve CD4+ T
cells. For example , the peak of Egr3 expression in previously-activated Itk+/- T cells is
nearly 40-fold higher than in naIve T cells , as is the case for FasL as well. In contrast
peak Egr2 levels only increase by approximately two-fold in previously-activated
compared to naIve CD4+ T cells. These data are consistent with Egr3 playing a more
importnt role in FasL transcription than Egr2. Together these data clearly indicate that
signaling through Itk plays an important role in the TCR-induced upregulation of Egr
factors, and that impaired expression of Egr2 and Egr3 in Itk/- T cells correlates with
impaired FasL expression.
Figure 11: Reduced Egr2, Egr3, and FasL transcription after TCR stimulation of
Itk-/- T cells
2 X 106 purified naIve (CD44 SC.C7 Itk+/- or SC.C7 Itk/- CD4+ T cells were stimulated
with anti-CD3 antibody for 0 , 6 , 18 , and 48 hours (primary). For secondary cells, 2 X 10
SC.C7 Itk+/- and SC.C7 Itk-/- CD4+ were initially stimulated with 2!-M MCC peptide plus
APCs on day 0, and restimulated with anti-CD3 antibody on day 14 for 0, 1 , 2 , 4 , and 6
hours. Following stimulation, RNA was isolated and l!-g was reverse transcribed into
cDNA and subjected to real-time quantitative PCR analysis for I)-actin, FasL , Egr2 , and
Egr3.
(A) An example of raw data obtained from real-time quantitative PCR analysis. The
dashed line indicates the cycle threshold value at which individual samples were
compared.
(B) Egr2 , Egr3 , and FasL transcript levels were determined for naIve (primary) and
secondary cells. Each sample was run in trplicate and the average template copy number
was determined by interpolating the cycle threshold (C ) value on a standard curve.
These values were normalized to I)-actin transcript values determined for each respective
data point. The Y-axis represents the ratio of Egr2 , Egr3 , or FasL to I)-actin in the
sample. The error bars are the standard deviation of the Egr2 , Egr3 , or FasL values
obtained from triplicate reactions. These data are representative of three independent
experiments.
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CD4+ T cells in Itk-/- mice are defective in AICD in vivo
It has been well documented that mice deficient in the expression of Fas (lpr) 
FasL (gld) possess profound defects in the peripheral deletion of activated lymphocytes
and develop severe autoimmune disorders as a result of a failure to maintain peripheral T
cell tolerance (reviewed in (16)). Furthermore, CD4 + T cells from mice bearing the lpr 
gld mutations are resistant to TCR-mediated apoptosis upon anti-CD3 or superantigen
stimulation (132-135). When injected into mice, staphylococcal enterotoxin B (SEB), a
bacterial superantigen, selectively activates Vf38+ T cells. This leads first to the
expansion of Vf38+ T cells, followed by a steep decline in the percentage of these cells as
a result of Fas-mediated cell death (136 , 137). Thus, we were interested in determining
whether Itk-deficient T cells would possess defects in AICD in vivo as a result of the
defective FasL expression we observed in vitro. To assess this, we injected
Itk+/- and Itk/- mice with SEB and examined peripheral blood T cells on days 3 , 7, 11
and 15 post-injection. Figure 12 shows the percentage of CD4+ cells bearing Vf38 , or
Vf36 as a control , over the course of the response to SEB. Interestingly, Itk+/- and Itk/-
mice initially responded similarly to SEB , as seen by the equivalent increases in Vf38
CD4+ T cells on day 3 after injection. Following the expansion phase of the response
Itk +/- Vf38+ T cells underwent deletion , as has previously been reported. In contrast, Itk-
Vf38+ T cells survived to a much greater degree than control cells, indicative of reduced
AICD. Figure 12B demonstrates that both Itk+/- and Itk-/- mice had comparable
percentages of the control Vf36+ CD4+ T cells , which are not reactive to SEB. Overall
these data suggest that Itk-/- CD4+ T cells are inefficient at undergoing AICD, most likely
as a result of reduced FasL expression. Consistent with this conclusion, we routinely
observe a two-fold increase in the proportion of CD4+ T cells with an activated/memory
phenotype in Itk-/- compared to Itk
+/- 
control mice (data not shown). However, we cannot
rule out the possibility that the levels of IL- in vivo may be decreased in SEB-injected
Itk-/- mice, thereby rendering Itk/- CD4+ T cells less susceptible to FasL-mediated death.
Figure 12: CD4+ T cells in Itk-/- mice are defective in AICD in vivo
Itk+/- and Itk/- mice received intravenous injections of SEB on day O. Peripheral blood
was drawn from the tail vein on day - , 7 , 11 , and 15. Following RBC lysis , cells were
stained with anti-Vj38.1/8. FITC or anti-Vj36-FITC , and anti-CD4-Cy. The percentages
of Vj38+ and Vj36+ populations of the CD4 + subset were determined by F ACS analysis.
The data plotted are means 1: standard deviations of independent mice analyzed, n=2
Itk+/- , n=5 Itk- . These data are representative of two independent experiments.
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Discussion
Aberrant regulation of the Fas/FasL system has detrimental effects on the health
of an organism. Mutations in the Fas or FasL genes result in autoimmunity and
lymphadenopathy in mice, and autoimmune lymphoproliferative syndrome (ALPS) in
humans (17- 19). Conversely, increased expression of FasL in HIV- infected T cells has
been found to be a factor in the T cell depletion that ultimately causes AIDS (138, 139).
Currently, the signaling requirements for proper FasL expression are not completely
understood. Therefore, investigation of the molecular mechanisms regulating this
pathway is warranted. In our efforts to elucidate the role of a Tec-family kinase , Itk, in
CD4+ T cell effector function, we discovered that Itk plays a crucial role in the signaling
pathway that induces FasL expression.
Previous studies by several groups have established that Itk is important for T cell
effector functions, including cytokine production as well as the development of protective
immunity to pathogen infections (59, 60 , 76 , 94). The data presented in this manuscript
address the role of Itk in T cell homeostasis, as opposed to effector function, and
demonstrate that Itk is required for effcient apoptosis induced by TCR stimulation.
These experiments further strengthen the notion that Itk is a crucial component of the
TCR signaling cascade required for the transcription of genes important for proper
immune fuction. The physiological relevance of these findings is reflected in the altered
response ofItk- mice to the superantigen, SEB.
These results also support the notion that Itk may be involved in setting the
threshold for TCR signaling (64). In the absence ofItk, the effciency ofTCR signaling
is reduced, as assessed by a variety of biochemical and functional readouts, including
reduced PLC-yl activation, calcium mobilization, MAP-kinase activation, and cytokine
production. This reduced signaling lowers the overall effector response of the cell.
Given that the ability ofCD4+ T cells to upregulate FasL is dependent on the integration
of TCR signals, Itk/- T cells may require more receptor stimulation to attain a threshold
of signals great enough to induce FasL upregulation. This is consistent with our
observation that, at high peptide concentrations, Itk-/- T cells do upregulate low levels of
FasL, and can undergo AICD.
These experiments led to the surprising finding that, during the initial phase of the
response, Itk/- T cells expand comparably to Itk+/- T cells in response to SEB injection 
vivo. As previous studies have documented both reduced IL-2 production and
proliferation of Itk/- T cells in vitro these findings were somewhat unexpected. One
interesting explanation for this discrepancy is the possibility that SEB produces such a
strong activation signal in naIve T cells that FasL expression may be induced early during
the activation process. Thus, the net expansion of Vj38+ T cells in the control mice may
reflect the combined effects of proliferation being offset by some apoptosis. Consistent
with this possibility, upon infection of lpr/lpr mice with LCMV, there is a notable
increase in the rate of expansion of anti-viral CTLs during the initial phase of the
response compared to what is typically observed in wild type mice (140). Thus , T cells
in Itk/- mice may proliferate more poorly, but may also undergo less apoptosis, yielding
the same net outcome of Vj38+ T cell numbers at the peak of the response as are found in
Itk+/- mice.
While our data directly demonstrate reduced transcription of FasL in stimulated
Itk-/- T cells in vitro the interpretation of the in vivo experiments is clearly more complex.
Activation-induced cell death can involve the action of other molecules in addition to
Fas/FasL, such as TNF-a and Bcl-2 family members. We have not fully ruled out the
possibility that Itk T cells are defective in the expression of one or more of these
additional molecules, and that such differences might also contribute to the decreased
AICD of Itk cells in vitro and in vivo. Studies addressing this possibility are currently
underway. In addition, it is also possible that Itk- T cells express greater amounts of the
Flice-like inhibitory protein (PLIP), an inhibitor of the Fas pathway. Since IL-2 receptor
signaling inhibits FLIP transcription (118), it is possible that reduced production of IL-
by Itk- T cells in vivo may result in increased FLIP , thereby rendering Itk- T cells less
susceptible to Pas-mediated apoptosis. While differences in FLIP expression in vivo
between control and Itk- T cells wil be interesting to examine in the future, this concern
is unlikely to be relevant to our in vitro studies , as stimulated T cells were all cultured in
an excess of exogenous IL-2. Another concern is the observation by Bonfoco et al that
non-lymphoid FasL is essential for the deletion of SEB-reactive T cells (141J. These
investigators also demonstrated that T cell activation was necessary for the induction of
non-lymphoid FasL transcription. Therefore, we cannot fully rule out the possibility that
Itk- mice may be defective in the expression of cytokine(s) or effector molecule(s)
necessary to induce the upregulation of non-lymphoid FasL. Again, this possibility
applies only to the in vivo studies, and is not relevant to our in vitro studies using purified
T cells.
Finally, we also considered the possibility that reduced AICD in vivo by Itk
CD4+ T cells may reflect reduced activation and/or preferential differentiation of Itk
cells into Th2 effectors that express FasL poorly (142, 143J. These possibilities were
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tested by examining Vf38+ CD4+ T cells at the peak of the response (day 3) after SEB
injection. When examined by flow cytometry for a panel of activation markers, both
Itk and Itk- T cells showed comparable percentages of activated T cells. Furthermore
in vitro stimulation of these cells followed by intracellular staining for IL- , IFN-y, and
IL-4 indicated no increased proportion of IL- 4 producing cells among Itk T cells
compared to controls (data not shown). Thus we find it unlikely that the reduced AI 
we observe in vivo in Itk- mice is due to a skewed differentiation ofItk T cells into Th2
effectors.
Similar to the FasL gene, the Fas gene is transcriptionally regulated by factors
such as c-Fos and c-Jun. A report by Li et al demonstrated that, although PKC and JNK
are involved in the activation of the Fas gene upon TCR stimulation, PI3-kinase
calcineurin, and ERK kinases play no role in the signaling pathway leading to Fas
transcription (144 , 145). These findings suggest that the TCR signaling pathways leading
to Fas and FasL transcription are distinct. Our data support the notion that Itk does not
playa role in the TCR-mediated upregulation of Fas. Another recent study indicated that
Btk, a Tec kinase family member, acts as an inhibitor of the Fas signaling pathway in B
cells (114). Based on our observations that Itk T cells are equally susceptible to
apoptosis following treatment with soluble FasL, the possibility that Itk plays 
comparable role in the Fas signaling pathway in T cells seems unlikely.
Based on the data presented here, we speculate that Itk mice may have altered
susceptibility to autoimmune disease. For instance, experimental autoimmune
encephalomyelitis (EAE), which can be induced in mice upon adoptive transfer of
myelin-specific Thl cells, is a result of Thl CD4+ T cells initiating tissue damage to the
. "
':1'.
central nervous system (146, 147). Interestingly, mice possessing the lpr or gld
mutations are resistant to the induction ofEAE (148). These findings suggest that FasL-
expressing T cells may mediate apoptosis within a target tissue, thereby contrbuting to
the pathology of this disease. Given these observations , it is possible that Itk- mice may
also show decreased susceptibility to EAE. Alternatively, since the Fas/FasL pathway
has been shown to be crucial for the removal of autoreactive T cells in the periphery
(149), it is also possible that Itk mice may be more susceptible to other types of
autoimmune diseases. For instance, FasL-expressing CD4+ T cells have been shown to
be important in the deletion of autoreactive B cells (150), raising the intriguing possibility
that Itk- mice might have increased susceptibility to autoantibody-mediated autoimmune
diseases.
Figure 13: A model for the role of Itk in TCR-mediated FasL expression
Upon repeated activation of the TCR, the activation of Itk results in the activation of
several downstream pathways , which result in the effcient activation of the FasL gene.
Itk functions to activate PLC-y I , which in turn activates NF A T transcription factors via
the calcium pathway, as well as components of the AP- l transcription complex via the
activation of the ERKMAP kinase pathway. NFAT serves several functions once in the
nucleus. In addition to directly transactivating the FasL gene , NFAT transactivates the
promoters of two transcription factors, Egr2 and Egr3, also important in FasL
transcription. Following transcription and translation of Egr2 and Egr3 , these proteins
further drive the expression of FasL upon binding to the FasL promoter. Lastly, CD28
signals, in addition to TCR signals through Itk, activate NF-KB , another importnt factor
in FasL transcription.
Figure 13:
A model for the role of Itk in TCR-mediated FasL expression
Itk
NF-KB 
NFAT
ERK 
JNK
.. 
EJ!rJ 
Ap.
-Y EYl'2 
Fosl 
) ,' ,. ---..-- ..----. ----
KEYI-tI = a particular gcne
NW - ?- = transcription/translation event
= positive regulaiory event
CHAPTER III.
ABERRTIONS IN THE
PHENOTYPE OF CD4+ T
LYMPHOCYTES FROM
ITK-DEFICIENT MICE
Introduction
CD4+ lymphocytes playa critical role in the defense against many invading
organisms. Following the engagement of TCR/CD28 molecules on a naIve T cell with
specific MHC/peptide/B7 complexes on antigen-presenting cells (APCs), an intrcate
series of signaling cascades are activated which culminate in the transcription of genes
that are involved in differentiating a naIve CD4+ cell into an effector cell. Over the past
few years numerous studies have focused on the biochemical events that occur following
TCR stimulation and the consequence of the activation of specific signaling pathways on
T cell differentiation. The Tec family of nonreceptor tyosine kinases is now recognized
as an important player in TCR proximal signaling events.
The role of Tec family kinases in T cell effector function was initially discovered
by Liao et ai, who demonstrated that in the absence ofItk, CD4+ T cells were defective in
IL-2 production and consequently proliferation (76). Liu et al extended these findings by
demonstrating biochemically that
, 3:nalogous to Btk in BCR signaling, Itk is involved in
proximal TCR-mediated signaling events , as Itk-deficient cells were specifically impaired
in the phosphorylation of PLC-yl and as a result, in IP production and the mobilization
of intracellular calcium (60). Infectious disease studies in Itk-deficient mice have
revealed a general failure to elicit responses to several different types of pathogens
especially those that require a protective Th2 response , such as N. brasilensis and S.
Mansoni. Furthermore, upon skewing of CD4+ cells into the Th2 lineage in vitro Itk-
deficient cells exhibit severe defects in the ability to produce IL-4. This defect was
observed in both the C57BI/6 genetic background as well as the IL-4 permissive strain
Balb/c (72, 74). These data support a role for Itk in the process ofTh2 differentiation.
In striking contrast to the aforementioned impaired Th2 immune responses
observed in Itk- mice following infection, several studies have reported other phenotyic
abnormalities in unimmunized Itk-deficient mice that are suggestive of a bias toward
rather than away from, Th2 differentiation. For instance, Schaeffer et al reported that
although Itk-deficient mice fail to elicit a Th2 response to S. Mansoni unimmunized Itk
mice exhibit a 5-fold increase in the basal levels of 19B, an antibody subclass dependent
on IL- Other antibody subclasses were unaffected (72). Consistent with this
observation, Mueller and August observed that while Itk- mice are incapable of eliciting
an allergic asthmatic response to an OVA allergen, they exhibit increased OVA-specific
IgE responses , in addition to excessive levels of total IgE (151 J. Additional data from
our laboratory correlate with the observation that unimmunized Itk- mice exhibit a Th2
bias. Karen Liu, a former graduate student in the laboratory, observed germinal center
hyperplasia in the spleens and mild eosinophilia in the lymph nodes of Itk- mice, both of
which are dependent on type 2 cytokines (73). While the etiologies of these
abnormalities are unkown, they suggest Itk mice exhibit excess Th2-type cytokine
production.
Over the past few years , several studies have suggested that the recruitment and
activation of specific signaling pathways in T lymphocytes are determined by the nature
of the TCR:peptide:MHC interaction (reviewed in (105)). Furthermore , up to this point
all prior studies examining T cell function and signaling events in the absence of Itk have
utilized antibodies to CD3 and/or CD28 to trigger signaling events in T cells. In this
chapter we sought to understand the function of Itk both in vivo and in vitro 
characterizing the phenotype of T cells from Itk-deficient mice and T cell function in the
absence ofItk. More specifically, we examined the activation/memory status ofCD4+ T
cells in Itk mice compared to wild tye. Furthermore, we examined the ability of wild
tye and Itk- CD4+ T cells to produce the effector cytokines IFN-y and IL-4 immediately
ex vivo. Lastly, in order to understand how Itk may function in T cell receptor signaling
events that affect the process of CD4+ T cell differentiation in response to a natural
ligand:receptor interaction, we examined differentiation in vitro following the stimulation
of T cells bearing the transgenic 5C.C7 TCR with the natural ligand, MCC93-103 in the
context ofMHC II IE
The data presented in this chapter identify additional phenotyic abnormalities in
Itk-deficient mice in an attempt to understand further processes that Itk may be regulating
in CD4+ T cells. Although a mechanistic explanation for these observations is lacking,
the data indicate that Itk contributes to several T cell effector processes in vivo. 
correlation with data presented in chapter two , Itk-deficient mice possess an increase in
the percentage and numbers of CD4+ T cells that exhibit an activated/memory phenotype
indicating a role for Itk in homeostasis in vivo. Although Itk is not expressed in dendritic
cells (DCs), DC populations and activation status were unaltered in Itk mice, compared
to wild type. Interestingly, Itk-deficient mice exhibit an increase in the number of
memory CD4+ cells that can immediately produce either Thl or Th2 effector cytokines.
Nonetheless, even in a TCR transgenic situation, where the T cell repertoire is greatly
restricted, the presence of previously-activated cells greatly affects the differentiation of
naIve cells upon stimulation and in vitro culturing. Collectively these data indicate a role
for nk in regulating CD4+ T cell differentiation. Furthermore , in agreement with findings
made by other groups, these data emphasize the discrepancy between the selective defect
in Th2 immune responses and the abnormal Th2-type phenotype in unimmunized Itk-
deficient mice.
Results
Itk-deficient mice exhibit a 2- to 3-fold increase in the percentage and numbers of
CD4+ memory cells
In order to understand the function of Itk in other T cell processes, we were
interested in examining the phenotye of CD4+ T cells in unimmunized Itk mice
compared to wild tye. To accomplish this, we purified CD4+ T cells from both wild
type and Itk mice and stained these cells for a series of activation markers, such as
CD44, CD62L, CD25 , and CD69. As shown in Figure 14 , analysis of these activation
markers revealed that the CD4+ T cell population in Itk mice have a 2- to 3-fold
increase in the percentage of cells that possess a memory/activated phenotye. These
data strongly correlate with the failure to undergo AICD as discussed in chapter two.
To determine whether Itk may affect memory cell function and whether Itk-
deficient memory-like cells in fact behave like activated/memory cells, we stimulated
CD4+ T cells purified from the spleen of wild type and Itk mice (C57Bl/6 background)
with PMA (P) and Ionomycin (I) for 6 hours. Treatment of T cells with PMA and
Ionomycin bypasses proximal TCR signaling events, including Itk, and stimulates the
PKC and calcium pathways, respectively. Following stimulation, we stained cells for
CD44 and measured the ability of the CD44 population to produce IL-2 by intracellular
IL-2 staining and analysis by flow cytometry. Since memory cells (CD44 ) respond
rapidly and produce high levels of IL-2 compared to naIve cells, we expected to observe
increased IL-2 production in the memory population. As demonstrated in Figure 15A
cells with an activated/memory phenotype from both wild type and Itk mice produce
more IL-2 than naIve cells (CD44 ) as seen by the increased mean fluorescent intensity
in the CD44 population. In light of the fact that Itk-deficient mice tyically have less
peripheral CD4+ cells, as a result of a defect in positive selection, we calculated the
absolute number of IL-2 producing memory cells. As represented in Figure 15B , Itk-
deficient mice exhibit a two-fold increase in the numbers of memory cells producing IL-
compared to wild type. Similar observations were made in Itk-deficient mice on the
Balb/c genetic background, indicating that Itk likely plays a similar role, in terms of T
cell homeostasis, on both genetic backgrounds (data not shown). These data indicate that
in addition to possessing an increase in the percentage of CD4+ cells with a
memory/activated phenotype Itk mice also have more activated/memory cells than wild
type mice. These memory cells in Itk mice behave like memory cells by producing
more IL-2. The cause of T cell activation in vivo remains elusive. Collectively, however
our data support a role for Itk in T cell homeostasis and apoptotic processes.
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Figure 14: Itk-deficient mice exhibit a 2- to 3-fold increase in the percentage and
numbers of CD4+ memory cells
Splenocytes from Itk+/- and Itk/- mice were stained with antibodies to CD4, CD44
CD62L , CD69 , and CD25. Histograms were gated on the CD4+ cells and plotted for the
indicated activation marker. Data are representative from a combination of experiments
performed on different days.
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Figure 15: Increase in the number of CD44 cells producing IL-2 in Itk-
/- 
spleen
(A) 1 X 10 purified CD4+ cells from Itk+/- and Itk/- mice were stimulated for 6 hours
with PMA and Ionomycin. Golgi blocking reagents were added for the last 2 hours.
Following stimulation, cells were stained with anti-CD4-Cychrome and anti-CD44-FITC
fixed, permeabilized, and stained intracellularly with anti-IL- PE. Cells were analyzed
immediately by flow cytometry. (B) The total number of memory (CD44 ) cells
producing IL-2 represented in a bar graph.
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Itk may regulate CD4+ T cell differentiation in vivo
In an effort to determine whether Itk functions in the regulation of T cell
differentiation, we examined in vitro the differentiation status of the memory/activated
cells that are observed in vivo in Itk-deficient mice compared to wild type. To
accomplish this, we stimulated purified CD4+ T cells from wild type and Itk- mice
(C57BI/6 background) as before with P + I for 6 hours. Following stimulation, cells were
stained for CD44 , as above , followed by intracellular staining for IFN-y and IL-4. As
demonstrated in Figure 16A, following the ex vivo stimulation with PMA and Ionomycin
both wild type and Itk-deficient memory (CD44 ) cells rapidly produce IFN-
Interestingly, upon analysis of IL-4 production by memory cells in Figure 16B , a
significant percentage of Itk-deficient cells rapidly produced IL- , whereas virtally no
IL- producers were detected in wild tye mice. The memory populations that produce
IFN-y or IL-4 are in fact distinct populations as demonstrated in Figure 16C where IFN-
versus IL-4 is shown on a CD44 hi gated plot.
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Figure 16: ThllTh2 cytokine imbalance in Itk-deficient memory cells
Following the purification of splenic CD4+ T cells from both wild type and Itk mice
(C57Bl/6), 1 x 10 cells were left untreated or stimulated with PMA (2.5ng/ml) and
Ionomycin (375ng/ml) for 6 hours in a 96-well plate. After 4 hours , golgi-blocking
reagents were added to prevent cytokine secretion. The cells were then surface stained
with anti-CD4-Cy and anti-CD44-FITC, fixed, permeabilized, and stained intracellularly
with anti-IL- PE and anti-IFN- APC. Cells were then immediately analyzed by flow
cytometry. CD4+ cells plotted for CD44 versus IFN-y in (A) or versus IL-4 in (B). Panel
(C) represents CD4 CD44 gated cells plotted for IFN-y versus IL-4 to demonstrate that
these are distinct populations.
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Mice from the C57BL/I0 and Balb/c genetic backgrounds differ in their response
to certain pathogens. Experiments from several groups have revealed that while CD4+ T
cells from C57BL/IO mice are more prone to producing IFN-y and differentiating into
I -
Thl cells following activation , CD4+ T cells from Balb/c mice have a greater tendency to
produce IL-4 and differentiate into Th2 cells. Studies by Bix and colleagues identified
two genetic loci in Balb/c mice that could influence the intrinsic ability of a CD4+ T cell
to produce IL-4. These identified loci were determined to influence IL-4 production prior
to signals mediated by the IL-4 receptor (152). Therefore, we were interested in
determining whether Itk affects T cell differentiation similarly on both the C57BL/IO and
Balb/c genetic backgrounds. To address this, we examined the ability of memory
(CD44 ) cells in both wild type and Itk- mice on the C57BL/I0 (Figure 17 A) and Balb/c
(Figure 17B) genetic backgrounds to produce IFN-y and IL-4 immediately ex vivo
following stimulation with P + I. A comparison of total numbers of memory cells
producing effector cytokines is shown in Figure 17. Memory cells from wild tye mice
on both genetic backgrounds produced IFN-y, for reasons that are not clear. However
Itk-deficient mice on both genetic backgrounds exhibited a striking increase in the
numbers of cells producing IFN-y and the numbers of cells producing IL- , compared to
their wild type counterparts. This data indicates that Itk may be playing a similar role in
CD4+ T cell effector function on both genetic backgrounds.
11'
Figure 17: Increased numbers of IFN-y and IL-4 producers in Itk- spleen in both
the C57BL/l0 and Balb/c backgrounds
Bar graph representation of the numbers of CD44hi cells in the spleen producing either
IFN-y or IL-4 from wild type and Ite- mice on the (A) C57BL/l0 or (B) Balb/c genetic
backgrounds.
Figure 17
C57BL/1 0
350000
. IL-
300000
...
DIFN-
"g 250000
200000
= 150000
.
100000
50000
Itk+/+ Itk-
Baib/e
1800000
. IL-C1600000
1400000 DIFN-
1200000
,; 1000000
=: 800000
.
600000
...
-; 400000
200000
Itk+/+ Itk-
100
Altered T cell differentiation in vitro in the absence of Itk
In our initial attempts to determine how Itk functions in the process of T cell
differentiation, we examined the ability of wild type and Itk-/- T cells bearing the SC.C7
transgenic TCR to differentiate in vitro following stimulation with the cognate antigen
MCC93- 103 in the context of MHC class II IE . In these experiments , purified CD4+ T
cells from SC.C7 TCR transgenic Itk +/- and Itk/- mice were stimulated in vitro with the
MCC93- 103 peptide plus CHO cells transfected with MHC class II IE and B7. 1 (APCs) in
conditions that lacked any exogenous skewing cytokine. Therefore, the ability of the
cells to differentiate into either a Th 1 or a Th2 cell was solely based on the cytokines the
cells themselves produced. Following 4-7 days in culture we assessed T cell
differentiation by restimulating the cultured cells with APCs and MCC93-103 peptide and
stained them intracellularly for IFN-y and IL-4. The data presented in Figure 18A are
results from four separate experiments. While wild type cells in each experiment
uniformly differentiated into Thl cells, or IFN-y producers , variable results were obtained
from Itk-deficient cells. In several experiments Itk-deficient cells differentiated into Thl
cells, in others Th2 cells, and in many instances differentiated into a combination of both
Thl and Th2 cells. Surprisingly, upon further analysis of T cells from SC.C7 Itk-/- mice
the CD4+ T cells continued to exhibit an increase in the percentage of cells with a
memory phenotype. As shown in Figure 18B , in addition to a 3-fold increase in the
percentage of Itk-deficient CD4+ T cells possessing a memory phenotype, we also
consistently observed that the bulk of the CD44 population expressed low levels of the
transgenic TCR, Vall (Figure 18B). Together, these findings strongly suggest that T
cells expressing endogenous TCR a chains become activated in the SC.C7 Itk/- mice, and
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differentiate in vivo into either IFN-y- or IL- producing cells. Consequently, these
previously-activated cells likely affect the differentiation of naIve cells in vitro when total
purified CD4+ cells are stimulated in Figure 18A.
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Figure 18: 5C.C7 Itk-/- CD4+ T cells differentiate into both Thl and Th2 subsets
under non-skewing conditions
CD4+ T cells were purified from the spleens and lymph nodes of SC.C7 Itk+/- and SC.C7
Itk-/- littermates. CD4+ T cells (1 x 10 ) were cultured in 24-well plates with I!-M of
MCC 103 peptide plus 1 x 10 mitomycin C-treated CH27 cells (APCs). After 24 hours
. the cells were expanded in fresh medium containing IL-2. Following a 4- to 7-day
culture period, cells were restimulated with varying amounts of the MCC93- 103 peptide
and APCs for 6 hours. The final 2 hours included Golgi-blocking reagents. Cells were
then surface stained with anti-Vall-FITC and anti-CD4-Cy, fixed, permeabilized, and
stained intracellularly with anti-IL- PE and anti-IFN- APC. Cells were immediately
analyzed by flow cytometr. Panel (A) depicts data from four independent experiments
where cells had been restimulated with I!-M of MCC 103. Plots are gated on CD4+ and
Vall + cells. In panel (B), purified CD4+ cells from SC.C7 Itk+/- and SC.C7 Itk/- mice
were stained with anti-Val1-FITC and anti-CD44-Cy. The indicated FACS plot
demonstrates Vall versus CD44.
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11- Normal dendritic cell populations in Itk mice
Dendritic cells (DCs) are thought to be the main antigen-presenting cell in the
priming of T cells. The triggering by pathogens induces the maturation of DCs and the
expression of high amounts of MHC and co stimulatory molecules. In the mouse, DCs of
the spleen can be classified into two major subsets, either the lymphoid-derived (CDllc
CD8a+ CDllb-) or myeloid-derived (CDllc+ CDllb+). The myeloid-derived DCs can
further be broken down into either CD4+ or CD4-CD8a . Interestingly, these different
populations of dendritic cells are have been shown to selectively determine different
types of T cell-mediated immune responses (reviewed in (153 , 154)). For instance, the
subcutaneous injection of CD8a+ DCs loaded with antigen are capable of priming Thl
responses , whereas CD8a- DCs are capable of .priming Th2 responses (155). The
direction of T cell responses by CD8a- and CD8a + DCs directly corresponds to the
cytokines produced by these subsets (154). CD8a+ DCs are thought to directly induce
Th 1 responses by secreting copious amounts of IL- 12 (155). Furthermore , CD8a +
dendritic cells are thought to be involved in the deletion of CD4+ cells via a Fas-FasL
mechanism (156). Clearly, throughout an immune response, DCs and T lymphocytes are
constantly interacting.
In order to determine whether alterations in T cell function, as a result of the
absence of Itk, contributes to any alterations in dendritic cell populations in vivo in Ite-
deficient mice, we isolated the low-density fraction of cells from the spleen and analyzed
this fraction for DC markers by F ACS analysis. This fraction contains the bulk of splenic
dendritic cells (30% is CD11c ). As demonstrated in Figure 19A Itk mice possess
normal percentages and numbers of both myeloid- and lymphoid-derived DCs.
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Furthermore, as shown in Figure 19B , there are also normal percentages and numbers of
myeloid-derived subsets. These data suggest that the disregulation of T cells in the
absence ofItk does not affect dendritic cells on a population basis.
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Figure 19: Normal dendritic cell populations in Itk-
/- 
mice
The low-density fraction of spleen cells, which is typically 30% CD 11 c + , was isolated
from Itk+/- and Ite- mice. Cells were stained for a panel of dendritic cell markers. In
panel (A), live cells were gated and plotted for CDllc versus CD11b or CD8a. In panel
(B), CDllc+ cells were gated and plotted for CD4 versus CD8a or CD8j3 versus CD8a.
The percentage of the different dendritic cell populations are shown on the F ACS plot.
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Normal activation markers on dendritic cells from Itk- mice
Immature DCs primarily function in antigen uptake and processing into
MHC:peptide complexes. Upon their maturation into terminally differentiated DCs
which are capable of rapidly activating T cells, DCs upregulate numerous activation
markers on their cell surface. These molecules permit additional communication between
DCs and T cells. For instance, the upregulation of CD40L on recently activated T cells
binds to CD40 on dendritic cells , thereby inducing greater expression levels of the
molecules B7. 1 and B7.2. The upregulation ofB7. 1 and B7.2 provides the T lymphocyte
with the necessary co stimulatory signals required for complete activation (157). Hence
the communication between T lymphocytes and DCs is a dialogue where DCs can also
respond to T lymphocytes.
To determine whether DCs from Itk mice express greater levels of activation
markers that would correlate to the observed increase in the percentage of CD4 + with an
activated/memory phenotye, both myeloid (CDllc+ CDllb ) and lymphoid (CDllc
CD8a +) DCs were stained with antibodies recognizing a series of activation markers. As
shown in Figure 20 , there does not appear to be any strking difference in the expression
levels of B7. , B7. , CD40 , CD25 , and Fas between wild type and Itk- myeloid and
lymphoid dendritic cells. These data suggest that in vivo aberrations in T cell fuction in
the absence of Itk, such as T cell differentiation and cell death, do not correlate with DC
activation markers.
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Figure 20: Normal activation markers on dendritic cells from Itk- mice
As in Figure 19 , the low-density fraction of spleen cells isolated from wild tye and Itk-
mice were stained for the dendritic cell markers CD 11 c and CD 11 b, or CD 11 c and
CD8a , in addition to the activation markers B7. , B7. , CD40 , CD25, or Fas.
Histograms of these activation markers were gated on either CDllc /CDllb+ or
CD 11 c /CD8a + dendritic cells.
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Discussion
In this chapter, we sought to further clarify the role of Itk in additional CD4+ T
cell effector functions , such as T cell differentiation. In our efforts to elucidate Itk
function, we found that Itk-deficient mice exhibit a two- to three-fold increase in the
percentage and numbers of CD4+ T cells with an activated or memory phenotype, based
on the activation markers CD44 , CD62L, CD25 , and CD69. Cells exhibiting a memory
phenotype from Itk-deficient mice behaved like memory cells as characterized by the
production of high levels of IL-2. These data strongly correlate with data presented in
chapter two , where a defect in FasL-mediated activation-induced cell death was impaired
in Itk-deficient cells.
As discussed earlier, reports from Schaeffer et al and Fowell et al suggested that
Itk regulates T cell differentiation (72 , 74). In order to gain a better understanding of
whether Itk may regulate Thl and Th2 cytokine production in vivo we examined effector
cytokine production from memory/activated CD4+ T cells immediately ex vivo. 
found that the bulk of memory cells in Itk-deficient mice were Thl cells, or IFN-
producers, compared to wild type memory cells. Strikingly, however, a significant
number of Th2 cells, or IL-4 producers, were also detected in Itk-deficient mice , while
none were detected in wild type mice. This was observed in both Itk-deficient mice on
the C57Bl/6 and Balb/c genetic backgrounds. Lastly, this observation is in agreement
with data from Karen Liu, who observed by RNAse protection that upon stimulation of
CD4+ T cells directly ex vivo with anti-CD3 and anti-CD28 for 8 hours , that IL-4 was
expressed at higher levels in Itk- cells, compared to wild type (73).
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In an effort to gain a better understanding of how Itk may function in the T cell
differentiation process in vitro we examined the ability of wild type and Itk CD4+ T
cells expressing the transgenic receptor, 5C.C7 , to differentiate following stimulation
with the cognate antigen. Unfortnately, our ability to assess Itk' s function in the process
of T cell differentiation was greatly hindered by the presence of previously-activated cells
that had likely been skewed in vivo to either the Th I or Th2 lineage, ultimately yielding
tremendous variability in these experiments. Therefore, we re-examined the function of
Itk in CD4+ T cell differentiation in a more highly controlled in vitro system in Chapter
IV.
The origin and history of the IL-4 producing CD4 + T cells in the Itk- mice, at this
stage, remains a mystery. One possible explanation is that the repertoire of T cells
selected in the thymus of Itk- mice are either auto-reactive and become activated by
self-antigen, or alternatively, are reactive to an environmental antigen that induces
differentiation into the Th2 lineage. The explanation for why this occurs in Itk-deficient
mice , but not in wild type mice, has not been determined, but may relate to defects in
thymic selection or to an altered peripheral environment due to changes in the non- T cell
populations that express Itk. Nonetheless, several lines of evidence from Schaeffer et al
and our own laboratory support the hypothesis that there is some type of Th2-biased
immune response, autoimmune or otherwise , occurring in vivo. First, Schaeffer et al as
well as Mueller et al reported that Itk- mice have a 5-fold increase in serum IgE levels
an IL- dependent antibody subclass (72 , 151 J. Second, we have observed a significant
level of eosinophilia in the lymph nodes of Itk mice , which is likely the result of Th2
effector cells in vivo (73). Third, the phenotype observed in Tec family kinase-deficient
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mice is strikingly similar to that seen in mice possessing mutations in signaling molecules
such as LAT, JNK1 , and certain NFATs, all of which have all been implicated in the
same pathway( s) as Itk. This wil be discussed in much greater detail in Chapter VI.
Lastly, in order to determine if the absence of Itk results in any dendritic cell
abnormalities, we examined dendritic cell populations and dendritic cell activation
markers in the spleens of wild tye and Itk mice. We found that the absence of Itk does
not disrupt any dendritic cell populations in vivo. Furthermore, while Itk-deficient CD4
T cells exhibit an increase in the percentage of cells with an activated phenotype, as
discussed earlier, dendritic cells from Itk mice do not exhibit any incongruencies in
terms of activation markers.
In addition to signaling defects revealed in vitro mice lacking Itk exhibit other
phenotypic abnormalities that remain to be clarified. As touched upon earlier, in
correlation with the observed defect in FasL expression in Itk-deficient cells, CD4+ T
cells from Itk-deficient mice possess an increase in the percentage of CD4+ T cells with
an activated/memory phenotype, according to CD44. While the data indicate that Itk
may regulate an important aspect of T cell differentiation, we have not ruled out the
possibility that these phenotypic abnormalities are a consequence of other cell types, such
as mast cells, which may be disregulated in the absence of Itk.
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CHAPTER IV.
THE FUNCTION OF ITK IN CD4
LYMPHOCYTE DIFFERENTIATION
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Introduction
Triggering of the T cell antigen receptor (TCR) is one of the hallmarks of the
adaptive arm of the immune system during responses to pathogenic infection. Following
this highly specific interaction, a complex series of biochemical events taes place within
the T cell, involving the action of many signaling molecules including tyosine kinases
phosphatases , adaptor molecules , and others. Ultimately, these biochemical reactions
culminate in the activation of specific genes, whose products wil function in the
generation of a robust immune response to combat the invading organism. Over the past
several years , there has been an increasing amount of evidence, both in vitro and in vivo
demonstrating the importnce of the Tec family tyosine kinase, Itk, in the generation of
critical CD4+ T cell effector functions.
Expressed predominantly in T cells and mast cells, Itk is activated in response to
antigen receptor stimulation. Biochemical studies have indicated that signaling through
the TCR leads to Itk recruitment to a multimolecular complex that includes SLP-
LA T, Gads, Grb2 , and PLC-y 1 , providing a platform for Itk to interact with and
phosphorylate PLC-y 1 (46, 158). In support of this model , TCR stimulation of Itk
CD4+ T cell results in substantially impaired PLC-yl tyrosine phosphorylation and
activation, intracellular calcium mobilization, MAP kinase activation, as well as NF A 
nuclear translocation (59 , 60, 72 , 94). As a consequence, the transcription of numerous
cytokine and effector genes, such as IL- , IL- , IFN-y, and FasL are all reduced in
stimulated Itk CD4+ T cells (59 , 60 , 71 , 72, 94). Overall, these data have indicated that
TCR signaling in the absence ofltk is greatly diminished, but not entirely abolished.
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Interest in the role of Itk in CD4+ T cell effector function was heightened by
intriguing observations demonstrating that Itk- mice have impaired responses to
pathogenic infection. For instance , in response to T. gondii a pathogen that normally
elicits a protective Thl response, Itk-deficient mice succumb to the infection with a mean
survival time of 69 days (59). In contrast, in response to L. major a pathogen that
normally elicits a protective Thl response in C57BL/6 mice and a non-protective Th2
response in Balb/c mice, Itk-deficient mice on both genetic backgrounds mounted a
protective Thl response (94). However, in response to the nematode N. brasilensis
which elicits a protective Th2 response in Balb/c mice, Itk/- Balb/c mice were unable to
clear the infection. Further in vitro data demonstrated that an inability to translocate
NF A Tc to the nucleus following TCR activation contributed to the observed impairment
in IL-4 gene expression in Itk- cells, as well as to the failure of these cells to differentiate
into Th2 effector cells in vivo (94). Data from Schaeffer et al further supported these
observations by showing that, upon challenge with the helminth, S. mansoni, Itk- mice
generate a Th 1 effector response to this pathogen instead of the Th2 response normally
observed in wild type mice (72). Finally, recent work from Mueller and August
examined an allergic asthma response after priming with the antigen ovalbumin, and
found that Itk mice did not generate this allergic response (151). Collectively, these
data demonstrate that mice lacking Itk exhibit a selective and profound impairment in
generating Th2-polarized CD4+ T cell responses.
The ability of naIve CD4+ T cells to differentiate into Thl or Th2 effector cells is
regulated by a number of factors, the most important of which is the cytokine milieu
during T cell activation. Although many cell tyes, such as dendritic cells, natural kiler
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cells, and mast cells , can serve as a source of effector cytokines that influence T helper
cell differentiation, the initial source of these cytokines in vivo following pathogenic
infection is not always apparent. One hypothesis is that the T cells themselves produce
cytokines that affect their own fate. In this regard in vitro studies have demonstrated that
varying the strength of TCR signaling by altering antigen concentration or potency can
strongly influence T helper cell polarization (159- 167).
In this study we sought to clarify the role of Itk in T helper cell differentiation.
As described, all of the in vivo data indicate that T cells in Itk-deficient mice are unable
to mount a protective Th2 response. However, whether this reflects a defect in T helper
cell differentiation per se, a selective defect in Th2 cytokine production , or a defect in
cytokine production by cells of the innate immune system in Itk mice could not be
discerned from the previous studies (72 , 94). The most straight-forward possibility is that
impaired IL-4 production by Itk CD4+ T cells is responsible for this defect. Yet mice
lacking IL-4R or Stat6 can still elicit Th2 responses (168 , 169), suggesting that this
simple explanation may not be sufficient to account for the Th2-specific deficiency in
Itk- mice. Additionally, impaired cytokine production by other cell tyes may contrbute
to the ineffective Th2 responses in the absence of Itk. This latter possibility arises due to
the known expression of Itk in NK T cells (170), NK cells (171), and mast cells (172),
each of which can produce cytokines that may influence T helper cell differentiation. For
this reason, we investigated Itk CD4+ T cells for intrinsic defects in Th2 cytokine
production, transcription factor expression, and T helper cell differentiation.
In this report, we establish a highly controlled in vitro system to examine T helper
cell activation and differentiation. Using this system, we demonstrate that Itk CD4+ T
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cells are fully capable of differentiating into both Thl and Th2 effector subsets when
exposed to exogenous cytokines. However, these Th I and Th2 differentiated cells
exhibit profound defects in both IFN-y and IL-4 transcription and secretion, respectively.
In contrast, in the absence of exogenous cytokines Itk T cells fail to differentiate into
Th2 cells when stimulated in conditions that promote strong Th2 polarization by wild
tye T cells. These contrasting behaviors of wild tye vs. Itk- T cells correlated with a
dramatic overexpression of T-bet mRNA in Itk T cells within the first 12 hours
following TCR stimulation. We also found that differentiating wild tye Th2 cells up-
regulate Itk mRA and protein levels, and completely down-regulate expression of the
related Tec kinase, Rlk. Therefore, in the absence of Itk, CD4+ T cells possess an
intrinsic inability to differentiate into Th2 effector cells, as a result of two factors:
aberrantly high expression of T -bet plus a further deficit in TCR signaling due to the loss
ofRlk.
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Results
Itk- CD4+ T cells can effciently differentiate into polarized Thl and Th2 cells
Previous in vitro studies examining effector cytokine production by Itk- CD4+ T
cells have indicated that these cells show dramatic defects in effector cytokine
production. Based on ELISA data measuring cytokine secretion following restimulation
Itk- CD4+ T cells were found to be severely impaired in IL-4 secretion, with a less
profound defect in IFN-y secretion (72, 94). However, these studies did not address the
extent to which Itk- CD4+ T cells are defective in T helper cell differentiation per se
versus showing a selective defect in effector cytokine gene expression following TCR
restimulation. To examine this issue and determine if Itk CD4+ T cells are able to
differentiate into both Thl and Th2 cells in vitro we established a highly controlled 
vitro assay using homogeneous populations of naIve CD4+ T cells from Itk and Itk+
mice. To accomplish this Itk and Itk +1- mice were crossed to the SC.C7 TCR transgenic
line on a RAG- background. NaIve CD4+ T cells were isolated from these mice, and
stimulated in vitro with CH27 B lymphoma cells as antigen-presenting-cells (APCs) plus
the cognate antigen, a peptide derived from moth cytochrome c (MCC 103).
In our initial experiments, T cells were stimulated with APCs and 10nM of
MCC93- 103 peptide in both Thl-skewing (rIL- 12 + anti-IL4 antibody) and Th2-skewing
(rIL-4 + anti-IFN-y antibody) conditions for 3 days, in the presence of excess rIL-2. As
opposed to chapter II , 10nM of peptide was used here , as it was found to drive a higher
degree of differentiation. Following this 3-day culture period, cells were restimulated
with APCs and varying doses of the MCC93-103 peptide for 6 hours , and assayed for IFN-
and IL-4 by intracellular cytokine staining. Figure 21A shows raw data obtained from
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this analysis , indicating that, as expected, cells stimulated in Thl-polarizing conditions
produce IFN-y and not IL- , whereas cells stimulated in Th2-polarizing conditions
produce IL-4 and not IFN-y. In Figure 21B , these data are converted into a bar graph
format in which the percentage of cells that are producing either IFN-y or IL-4 are shown
as a function of the peptide concentration used for the restimulation. From these data, it
is clear that both Itk +/- and Itk/- cells are able to produce the appropriate effector cytokine
after stimulation in either Thl and Th2 polarizing conditions; furthermore, it is
interesting to note that in the absence of Itk, there is only a slight decrease in the
percentage of cells that have differentiated into effector cells of each lineage. However
upon examination of the mean fluorescence intensity of both IFN-y and IL-4 staining in
this assay, it is evident that, of the cells that are producing cytokine, on a per cell basis
Itk-/- T cells produce less of the respective cytokine than wild type T cells (data not
shown). A similar observation has been reported for IL-2 production by Itk-/- CD4+ T
cells (42). Overall, these data demonstrate that after stimulation in the presence of
skewing cytokines , nearly equivalent percentages of Itk-deficient cells differentiate into
both Thl and Th2 effector cells. We have consistently observed, as others have (173),
that upon stimulation of CD4 + T cells in either Th 1- or Th2-skewing conditions , a greater
proportion of cells differentiate into Th 1 effectors than Th2 effectors.
To determine if the amount of effector cytokines produced by Itk-deficient cells is
indeed decreased compared to wild type T cells, we restimulated both Th 1- and Th2-
skewed cells from Itk+/- and Itk/- cultures for 24 hours with APCs and varying
concentrations of the MCC93- 103 peptide, and then assayed for IFN-y and IL-4 in the
supernatants by ELISA. As shown in Figure 21C Itk/- Thl cells secrete 1.5- to 20Q-fold
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less IFN-y than Itk+/- T cells. Likewise, Th2 cells lacking Itk secrete 3.5- to 130-fold less
IL-4 than control T cells. In addition, we found similar reductions in IL-S and IL- l 0
secretion by Itk-deficient Th2 cells (data not shown). These results are comparable to
data reported by Fowell et al and Schaeffer et al following stimulation of Itk/- cells by
anti-CD3 antibody cross-linking (72, 94). However, it is apparent from the data
presented here that the magnitude of the deficiency observed varies significantly
depending on the dose of antigen used to restimulate the cells. This is consistent with
many of our observations on Itk-/- T cells , that the signaling deficiencies observed are
greatly exacerbated by suboptimal TCR stimulation (42, 71). This observation may
account for discrepancies in effector cytokine production profiles ofltk/- T cells reported
previously (72 94).
Thus far our data indicate that Itk/- CD4+ T cells can differentiate efficiently into
both Thl and Th2 effector cells , but that these differentiated cells are poor producers of
their respective effector cytokines. Based on the role of Itk in PLC-y 1 activation
downstream of the TCR, it seemed likely that the cytokine production defect resulted
from impaired transcriptional activation of the IFN-y and IL-4 genes, respectively, in
differentiated Itk/- T cells. To test for steady-state mRA levels of IFN-y and IL- , we
performed real-time quantitative RT-PCR on RNA prepared following a 6-hour
restimulation ofThl- and Th2-skewed cells. For these experiments , Itk+/- and Itk/- cells
were stimulated with APCs and varying concentrations of the MCC93-103 peptide. As
shown in Figure 21D , these data precisely parallel the cytokine secretion data, showing
greatly reduced transcripts for both IFN-y and IL-4 in Itk/- effector cells following TCR
stimulation. These findings confirm that reduced cytokine secretion by Itk-/- T cells is a
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consequence of reduced transcription of these cytokine genes in differentiated Itk
effector CD4+ T cells.
The data presented above strongly suggest that Itk CD4+ T cells have no
intrinsic defect in their ability to respond to extrinsic cytokine signals by differentiating
into the appropriate lineage of helper T cell. To assess this issue further, we examined
mRNA levels for two transcription factors, T-bet and GATA- , that are the master
regulators ofThl and Th2 differentiation, respectively (174, 175). Specifically, T-bet has
been shown to playa crucial role in chromatin remodeling at the IFN-y locus , as well as
in the induction of IL- 12R 2 expression, and ultimately controls the IL- 12/Stat4/IFN-
autocrine loop (176-179). Similarly, GATA-3 functions in several processes during Th2
differentiation, including chromatin remodeling at several Th2 cytokine loci, repression
of Stat4 , and its own autoactivation (180- 184). As shown in Figure 21E Itk Thl and
Th2 cells express comparable levels of T-bet and GATA- , respectively, compared to
Itk 
+1- cells. In addition, we examined the mRA levels for another transcription factor, c-
Maf, that is essential for trans-activation of the IL-4 promoter in Th2 cells (185). As can
be seen in Figure 21E Itk- Th2 cells show no reduction in c-Maf mRNA levels
compared to control Th2 cells. Taken together, these data demonstrate that, given
exogenous cytokines, Itk-deficient CD4+ T cells are fully capable of differentiating into
both Th I and Th2 cells, as evidenced by their normal frequency of effector cytokine
producers as well as by their expression of the signatue Th 1 or Th2 transcription factors.
Nonetheless, these cells are impaired in their ability to produce IFN-y and IL-4 ona per
cell basis compared to control T cells. As Itk Thl cells have wild type levels ofT-bet
and Itk Th2 cells have normal levels ofGATA-3 and c-Maf, it is likely that their defects
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in effector cytokine production reflect reduced activation of additional factors required
for the transcription of these cytokine genes.
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Figure 21: Itk- CD4+ T cells can efficiently differentiate into polarized Thl and Th2
cells
Purified CD4+ T cells from SC.C7 Itk+/- RAG-/- and SC.C7 Itk/- RAG-/- mice were
stimulated in vitro with APCs and peptide in Thl- or Th2-skewing conditions.
(A) Following 3 days of culture, cells were restimulated with fresh APCs and MCC93- 103
peptide for 6 hours , stained with anti-CD4-Cy and anti-Vall-FITC, fixed
permeabilized, and stained intracellularly with anti-IL- PE and anti-IFN- APC. Ten
thousand CD4+ Vall + events were collected on a flow cytometer. An example of raw
data is shown.
(B) Intracellular cytokine staining data from the experiment shown in (A) in bar graph
format, depicting the percentage of cells that are producing IFN-y or IL- , in the Thl- or
Th2-skewed cultures, respectively, in response to varying doses ofMCC93- 103.
(C) Following 7 days in culture, cells were restimulated for 24 hours with fresh APCs and
varying doses ofMCC93-103. Supernatants were analyzed for the production ofIFN-y and
IL- , respectively, by ELISA. Error bars indicate SD of values obtained from
stimulations performed in triplicate.
(D and E) Cells were restimulated for 6 hours on Day 7 with fresh APCs and varying
doses of MCC93-103. Following stimulation, RNA was isolated and I f,g was reverse
transcribed into cDNA and subjected to real-time quantitative PCR analysis for j3-actin
IFN-y, and IL-4 (D) or T-bet, GATA- , and c-Maf(E). The y-axis values represent the
respective transcript normalized to the j3-actin values determined for each sample. . Error
bars are the SD of transcript values obtained from trplicate reactions.
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Low avidity TCR stimulation promotes Th2 differentiation by Itk 
+1- but not by
Itk- CD4+ T cells
As described above, prevIOUS infectious disease studies examInIng Immune
responses of Itk mice to L. major S. mansoni and brasilensis had indicated that
Itk- T cells were selectively impaired in generating protective Th2 responses. To
determine whether these in vivo findings could result from intrinsic defects in Itk CD4
T cell responses, we sought to establish in vitro conditions to test this hypothesis. To
address this issue, we required a system that preferentially leads to Th2 differentiation by
wild type CD4 + T cells in the absence of overt skewing by cytokines and blocking
antibodies. Since our Itk mouse line is on a CS7Bl/6 background, we knew that
straight-forward in vitro stimulation of naIve CD4+ T cells with MCC peptide plus APCs
would lead to almost exclusive Thl polarization. However, a number of previous studies
have demonstrated that stimulation of naIve CD4+ T cells with high versus low avidity
TCR engagement can differentially promote Th 1 versus Th2 differentiation in the
absence of exogenous cytokines. Specifically, high concentrations of agonist peptide that
elicit robust activation of proximal TCR signaling molecules, leading to sustained
calcium influx and ERK activation, induce the generation of Th 1 cells, whereas altered
peptide ligands (APLs) or low concentrations of agonist peptide, that induce a transient
calcium response and weaker ERK signal, promote the generation ofTh2 cells (162 , 164
186- 189).
As shown in Figure 22, this phenomenon holds tre for naIve T cells purified
from Ite SC.C7 TCR transgenic RAG- mice. For these experiments, T cells were
initially stimulated with APCs plus a high (lOOnM) versus a low (lnM) concentration of
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MCC93- 103. T cells were also stimulated with high concentrations of two APLs
MCCTl02s and MCCA96s, that have previously been shown to be recognized with lower
affnities and to induce weaker responses by SC.C7+ T cells (190 , 191). After three days
of culture in the absence of any additional cytokines or blocking antibodies, T cells were
restimulated with fresh APCs and varying concentrations of the normal MCC93- 103
peptide for 6 hours. Cells were then stained intracellularly for IFN -y and IL-4 (as in
Figure 21A) and analyzed by flow cytometr. As can be seen in the raw data shown in
Figure 22A and summarized in bar graph format in Figures 22B- E, Itk +/- T cells
differentiate predominantly into IFN- producing cells following stimulation with a high
concentration of MCC93- 103, but become IL-4-secreting cells when initially stimulated
with a low concentration of MCC93-103. Both of the APLs induce a mixed response from
Itk+/- cells, with cultures displaying proportions of both IFN-y- and IL- producing cells.
Interestingly, when SC.C7 TCR transgenic RAG-/- Itk/- CD4+ T cells were stimulated
with these varying peptides and peptide concentrations, and then restimulated to test for T
helper cell differentiation, all of the stimulation conditions induced Itk/- T cells 
become IFN- producing cells (Figure 22A-E). Collectively, these data demonstrate that
upon stimulation with conditions that induce wild tye T cells to differentiate into Th2
cells , Itk-deficient T cells fail to do so , and instead differentiate into Th 1 cells. In some
cases , the cultures of Itk-deficient T cells contain a greater percentage of cells that have
differentiated, as measured by the total percent of cells producing effector cytokines (see
Figures 22C-E); this interesting phenomenon may be a consequence of the fact that Thl
cells are more effciently generated in vitro than Th2 cells (see Figure 21B).
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To further assess the differentiation status of cells stimulated in the various
conditions , we examined the levels of GAT A-3 and T -bet mRNAs 3 days post-
stimulation in Thl- and Th2-skewing conditions, as well as in the various non-skewing
conditions shown in Figures 22B-D. As shown in Figure 22F , Itk+/- as well as Itk/- cells
stimulated in Th 1 or Th2 polarizing conditions show the expected profiles of GAT A-
and T -bet mRNA expression. When the cells were stimulated in the absence of
exogenous cytokines and blocking antibodies, control T cells (Itk+/) exhibited an
interesting pattern ofT-bet and GATA-3 expression. Three days after stimulation with a
high concentration of the agonist peptide, Itk +/- T cells express substantial amounts of T-
bet mRA, but also show significant levels of GAT A-3 mRA. After stimulation with
conditions that promote Th2 differentiation these cells express dramatically high levels of
GAT A- , but very little T-bet mRNA, even in cultures that contain mixed populations of
IL-4- and IFN- producing cells. In contrast, Itk/- T cells express moderately high levels
of T -bet under all stimulation conditions (Figure 22F). It is particularly striking that Itk
cells also express substantial levels of GAT A-3 mRA, suggesting that the low avidity
TCR signals that promote GAT A-3 mRNA up-regulation are stil functional in the
absence of Itk. This dual expression of T-bet and GATA-3 may also account for the
increased proportion ofItk/- cells that produce both IFN-y and IL-4 compared to that seen
in Itk+/- cultures (Figure 22C D). Overall, these data indicate that Itk/- T cells
preferentially up-regulate T-bet and differentiate into IFN- producing cells under low
avidity TCR stimulation conditions that promote Th2 differentiation in wild type T cells.
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Figure 22: Low avidity TCR stimulation promotes Th2 differentiation by Itk
+/-
but
not by Itk- , CD4+ T cells
Purified CD4+ T cells from SC.C7 Itk+/- RAG-/- and SC.C7 Itk/- RAG-/- mice were
stimulated in vitro with APCs and either 100nM or InM of MCC 103, 100nM 
MCCTl02s, or 100nM of MCCA96s. Following 3 days in culture , cells were restimulated
for 6 hours and assayed for IFN -y and IL-4 production by intracellular cytokine stained as
described in Figure 21.
(A) An example of raw data showing cytokine staining profiles.
, C, D, E) The percentage of cells that produce either IFN-y, IL- , or both, are depicted
in bar graph formats corresponding to the initial stimulus: 100nM MCC93- 103 (B), InM
MCC93- 103 (C), 100nM MCCTlo2s (D), or 100nM MCCA96s (E).
(F) RNA was isolated from cells on Day 3 , transcribed into cDNA, and subjected to real-
time quantitative PCR analysis for I)-actin, T-bet, and GATA-3. The y-axis values
represent the respective transcript normalized to the I)-actin values determined for each
sample. Error bars are the SD of transcript values obtained from triplicate reactions.
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T -bet mRNA expression is aberrantly regulated by TCR signals in the absence of
Itk
The regulation of T -bet and GAT A-3 expressIOn during T helper cell
differentiation is complex, involving TCR signals, cytokine signals, and autocrine
feedback loops. In naIve CD4+ T cells, T-bet is expressed at low levels , and is
upregulated during Th 1 differentiation by a Statl-dependent pathway that is independent
of IL-12/STAT4 signals; ongoing T-bet expression is then required to maintain the
competence of cells to express IFN-y (176 , 178 , 179). Akin to T-bet, GATA-3 is thought
to maintain the competence of cells to activate transcription of the IL-4 gene (180, 183
184, 192, 193). In addition, GATA-3 also possesses the ability to inhibit Thl
differentiation by repressing Stat4, and ultimately, IFN-y transcription (180, 182). While
also expressed at low levels in naIve T cells, GATA-3 is activated following TCR
stimulation and auto activates its own transcription (181). In addition, IL-4 R signaling via
Stat6 can further increase GATA-3 levels (180). However, GATA-3 alone is not
sufficient for IL-4 transcription, and the action of several other factors such as JunB
NFATcl , and c-Mafare required (185 , 194 , 195).
The mechanism by which low levels ofT-bet and GATA-3 proteins are activated
in naIve T cells , as well as how the T-bet and GATA-3 genes are further upregulated
following TCR stimulation, has not been fully elucidated. However, our findings
suggested that TCR signaling via Itk may be critical for the proper regulation of T -bet
and/or GATA-3 levels in stimulated naIve CD4+ T cells. To address this possibility, we
examined the levels ofT-bet and GATA-3 mRNAs, as well as those for IFN-y and IL-
in Itk+/- and Itk-/- cells within the first 24 hours after stimulation. In this analysis we
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examined cells that had been stimulated with MCC 103 plus APCs in Thl- and Th2-
skewing conditions, as well as cells stimulated with the APCs plus the APL, MCCTlo2s,
in both non-skewing (no exogenous cytokine) and neutralizing (with anti-IL-4 and anti-
IFN-y antibodies) conditions. The APL stimulation conditions were specifically chosen
for their ability to induce divergent responses from Itk +/- and Itk/- cells , allowing us an
opportnity to determine the underlying molecular mechanism for the aberrant T helper
cell polarization of Itk/- cells in these experiments.
As shown in Figure 23A, naIve Itk+/- T cells up-regulate T-bet mRNA levels
following strong TCR stimulation in both Th 1 and Th2 skewing conditions, although
within 12 hours after stimulation there is a IO-fold excess ofT-bet mRA in the cells
cultured in IL-12 plus anti-IL-4 antibody. This difference is further enhanced by 24
hours after stimulation , by which time there is a 70-fold increase in T-bet mRA in the
Thl- versus the Th2-skewed cells. GATA-3 mRNA shows an inverse pattern of
expression in Itk+/- cells, with a ?IO-fold increase seen in Th2-skewed cells versus Thl-
skewed cells by 12 hours after stimulation (Figure 23B). These patterns of transcription
factor expression correlate nicely with cytokine gene expression, as shown in Figure
23C-D. IFN-y transcripts are induced at 12 hours following TCR stimulation in both sets
of polarizing conditions, but by 24 hours IFN-y transcripts have fallen in the Th2-skewed
cells, and continued to rise in the Thl-skewed cells, resulting in a lOO-fold difference
(Figure 23C). Similarly, IL-4 transcripts are just above the level of detection in the Th2-
skewed Itk+/- cells at 12 hours, and rise dramatically by 24 hours (Figure 23D).
Interestingly, the patterns of GATA-3 and IL-4 gene expression are nearly identical
between the Itk+/- and Itk-/- T cells stimulated under these conditions (Figure 23B, D). In
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contrast to Itk+ T cells Itk T cells show dramatic increases in T-bet mRNA levels at 12
hours after stimulation in both Thl- and Th2-skewing conditions, although the levels of
T -bet mRA do drop substantially by 24 hours in the Th2-skewed cells (Figure 23A). 
parallel Itk- Th2-skewed T cells also have higher levels of IFN-y transcripts at the 12
hour timepoint, which also diminish by 24 hours (Figure 23C). These data further
support the aberrant regulation of T-bet and/or IFN-y transcript levels immediately
following TCR stimulation of naIve Itk- T cells. Interestingly, this early Thl bias in the
response of Itk- T cells is quickly overtrned by the strong cytokine signals provided 
vitro with Th2-skewing conditions , indicating that Itk- T cells have normal responses to
IL-4 signaling pathways.
In an effort to address the mechanism by which Itk-deficient cells failed to
differentiate into Th2 cells in non-skewing conditions , we examined the levels of T -bet
GATA- , IFN-y, and IL-4 mRNAs in response to 100nM of MCCTlo2s, a condition that
induces a mixtue of Thl and Th2 cells in wild tye cultures but only Thl cells in Itk
cultures. To exclude the possibility that the initial cytokines produced by the cells could
feedback in an autocrine loop and influence gene expression , we performed these
stimulations in both non-skewing (no exogenous cytokines) as well as neutralizing
conditions (no cytokines plus anti-IL-4 and anti-IFN-y antibodies). As shown in Figure
23E, following the stimulation of cells in non-skewing conditions with MCCTlo2s, T-bet
expression is rapidly induced in Itk-deficient cells , while it is only weakly upregulated in
control Itk+ cells. Consistent with the recent finding that IFN- induced STATI signals
further upregulate T-bet expression (176), the presence of neutralizing anti-IFN-
antibody significantly reduces the T -bet expression in Itk cells by 24 hours. A similar
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pattern of expression is observed for IFN-y (Figure 23G). Conversely, GATA-
transcript levels are rapidly upregulated in both control and Itk/- cells at 12 and 24 hours
post stimulation, although only the Itk+/- cells produce detectable levels of IL-
transcripts (Figures 23F, H). These latter data are consistent with a previous report
demonstrating that wild type and Ite- cells regulate GATA-3 comparably (72). Taken
together, these data clearly demonstrate that in response to TCR signals , Itk-deficient
cells show a dramatic alteration in the regulation of T -bet mRA expression, but regulate
GATA-3 normally.
135
Figure 23: T -bet mRNA expression is aberrantly regulated by TCR signals in the
absence of Itk
Purified CD4+ T cells from SC.C7 Itk - RAG- and SC.C7 Itk - RAG- mice were
stimulated in vitro with APCs and MCC 103 in Thl- or Th2-skewing conditions (panels
D) or stimulated with APCs and 100nM of MCCTlo2s (panels E-H) in either non-
skewing (no exogenous cytokine) or neutralizing conditions (anti-IL-4 and anti-IFN-
antibodies). Cells were stimulated for either 0 , 12 , or 24 hours. Following the indicated
time points, RNA was isolated from cells, transcribed into cDNA, and subjected to real-
time quantitative PCR analysis for GATA-3 (A, E), T-bet (B , F), IL- G), or IFN-
, H). The y-axis values represent the respective transcript normalized to the GAPDH
values determined for each sample. Error bars are the SD of transcript values obtained
from trplicate reactions. The asterisk (*) next to the horizontal bar indicates the limit of
quantitation for the cytokine transcripts. The ratio for the limit of quantitation was
calculated by dividing the actual lowest quantifiable copy ofIFN-y or IL-4 cDNA by the
average GAPDH value.
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Collectively, the data presented above indicate that, after stimulation by low
avidity TCR engagement, Itk/- T cells express increased T -bet mRA and preferentially
differentiate into Thl cells. This is in direct contrast to Itk+/- T cells, which under these
same conditions express very little T -bet mRNA, and differentiate predominantly into IL-
producing cells. Since high avidity TCR engagement induces Thl differentiation from
both Itk+/- and Itk/- cells, we were interested in determining whether T-bet transcript
levels varied depending on the strength of the TCR signal. As shown in Figure 24, 12
hours following stimulation of naIve T cells with a range of MCC93-103 or MCCno2s
peptides in the presence of neutralizing antibodies to IL-4 and IFN-y, Itk+/- T cells show a
relatively uniform induction of T -bet mRA compared to unstimulated cells. In contrast
Itk-/- T cells express increased levels of T-bet mRNA as the strength of the TCR signal
decreases. These findings suggest, first of all, that the Th2-prone differentiation behavior
of wild tye T cells upon stimulation with low avidity TCR engagement is not due
primarily to a reduced induction of T -bet transcripts, but instead results from increased
GAT A-3 expression under these conditions. This conclusion is consistent with a
previous report demonstrating increased GATA-3 induction in T cells stimulated with
low avidity ligands (196) (data not shown). Second, these data suggest that Itk is
required for negative regulation of T -bet mRA expression following low avidity TCR
stimulation.
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Figure 24: Itk negatively regulates T-bet upon low avidity TCR stimulation
Purified CD4+ T cells from SC.C7 Itk - RAG- and SC.C7 Itk - RAG- mice were
stimulated with the indicated concentrations of either MCC93-103 or MCCno2s peptide
plus APCs for 0 or 12 hours in neutralizing conditions (with anti-IL-4 and anti-IFN-
antibodies). Following stimulation , RNA was isolated, transcribed into cDNA, and
subjected to real-time quantitative PCR analysis for T -bet and GAPDH. The y-axis
represents T-bet normalized to the GAPDH values determined for each sample. Error
bars are the SD of transcript values obtained from trplicate reactions.
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Itk is upregulated and Rlk is down regulated during Th2 differentiation
Several years ago, another Tec family tyosine kinase expressed primarily in T
lymphocytes, Rlk/Txk, was identified and was also found to contribute to the activation
of PLC-y, suggesting some functional redundancy within the Tec family (29, 63).
Interestingly, Takeba et al recently demonstrated that Rlk can function as a
transcriptional activator of the IFN-y gene by binding to the IFN-y promoter (40, 59),
suggesting a unique function for Rlk in differentiated Thl cells (197). In conjunction
with these findings , our own data indicating a role for Itk in negatively-regulating T -bet
expression suggested the possibility that Itk as well as Rlk may be differentially
expressed following T cell differentiation. To address this , we analyzed Itk and Rlk
mRNA and protein levels in wild type CD4+ T cells differentiating in vitro after
stimulation in Thl- versus Th2-skewing conditions. As shown in Figure 25A, we found
that Rlk mRA is rapidly downregulated within 6 hours following stimulation of naIve
cells in both Thl and Th2 conditions. However, Rlk transcripts begin to be upregulated
again in Thl cells after 24 hours and remain increased over the following 11 days of
culture, but fail to be re-induced in Th2 cells (Figure 25B). In contrast to Rlk, Itk mRA
levels are maintained in both Th 1 and Th2 conditions during the first 24 hours following
stimulation (Figure 25C); however, around 8 days post-stimulation in Th2 culture
conditions , Itk mRNA levels are upregulated (Figure 25D). Interestingly, analysis of the
putative promoter regions of Itk and Rlk provide some clues about their differential
regulation in Thl versus Th2 cells. Sequence analysis using the TRANSF AC database
htt://www.cbil.upenn.edu/tess) indicated that the promoter region of Itk contains
several canonical GAT A protein binding motifs, including GAT A-3 sites. In contrast
c- .
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the Rlk promoter region lacks GAT A-3 binding motifs, providing a potential explanation
for the lack ofre-expression ofRlk mRA in differentiating Th2 cells.
Analysis ofItk and Rlk protein levels in wild tye CD4+ T cells cultured in Thl 
Th2 skewing conditions confirmed the differential expression observed at the mRA
level. As shown in Figure 25E, Rlk protein is detectable in Thl , but not in Th2 cells
whereas Itk protein is present in both cell types, but at a significantly higher level in Th2
cells. Consistent with this latter observation, a recent report found that Itk mRA 
dramatically elevated in T cells from patients afflicted with atopic dermatitis, an
inflammatory skin disease in which Th2 cytokines playa major role (198). Overall these
findings are summarized in Figure 25F.
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Figure 25: Itk is up regulated and Rlk is downregulated during Th2 differentiation
Purified CD4+ T cells from SC.C7 Itk - RAG- and SC.C7 Itk - RAG- mice were
stimulated in Thl- or Th2-skewing conditions and harvested at 0 , 18 , and 24 hours (A
and C) as well as at I , 4, 8 , and 11 days post stimulation (B and D). Following the
indicated time points, RNA was isolated and subject to real-time quantitative PCR for
either Rlk (A and B) or Itk (C and D). Panels A and C represent Rlk and Itk copy
numbers, respectively, normalized to cell number equivalents. Panels Band D represent
Rlk and Itk copy numbers, respectively, normalized to GAPDH values. The asterisk (*
denotes that the indicated ratio is greater in these particular circumstances as a result of
GAPDH values being very low in naIve T cells compared to activated and expanding
cells in cultue.
(E) In the top panel x 10 Thl and Th2 cells were removed from culture at 8 (lane
3) and 11 (lane 2 4) days post stimulation. Lysates were blotted for Rlk.
In the bottom panel, lysates from x 10 Thl (lane 1), 9 x 10 Thl (lane 2), 3.5 x 10
Th2 (lane 3), and 0.9 x 10 Th2 cells at day II post stimulation were blotted for Itk.
As controls , lysates from Rlk/-Itk- CD4+ T cells and from the AE7 Thl cell line were
blotted for Rlk and Itk as indicated.
(F) A summary of the changes in Rlk and Itk expression levels in differentiating Th 1 and
Th2 cells. Differences between Th I and Th2 cells are first observed at 24 hours for Rlk
and at -day 8 of differentiation for Itk.
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Signaling deficiencies in Thl versus Th2 cells lacking Uk
A number of studies have indicated that there are differences in proximal TCR-
induced signaling pathways between Thl and Th2 effector subsets (199 , 200). For
instance , following TCR stimulation, Th2 cells do not efficiently phosphorylate ZAP-
or Fyn (201). Additionally, calcium mobilization is not sustained in Th2 cells following
activation, apparently as a result of more rapid calcium clearance from the cytosol (202-
204). The molecular basis for these observed differences is unclear; however, a recent
report from Balamuth et aI, demonstrated that Th 1 and Th2 cells differ in the
organization of their plasma membranes and their usage of lipid rafts , possibly leading to
the activation of distinct signaling pathways in these two cells types, and ultimately
affecting gene transcription (205).
To address whether signaling pathways in Thl and Th2 cells are affected by the
differential expression of Itk and Rlk, we assessed the ability of both wild tye and Itk-
deficient Thl and Th2 cells to activate PLC- , as well as the downstream ERK-MAP
kinase pathway. Based on our observations that Itk is more highly expressed in Th2 cells
and that Rlk is absent from Th2 cells , we hypothesized that Itk- Th2 cells would show a
greater deficit in the activation ofPLC-yl and downstream events. To test this, wild type
and Itk cells were stimulated and cultured in Thl- and Th2-skewing conditions for 11
days , a timepoint at which Itk is upregulated in Th2 cells and Rlk is absent. On day 11
cells were restimulated by anti-CD3 antibody cross- linking, and lysates prepared for
analysis. As shown in Figure 26 , both Itk Th 1 and Th2 cells show greatly impaired
phosphorylation of Tyrosine-783 on PLC- , one of the tyro sines that is crucial for the
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regulation ofPLC-yl (206), compared to the Itk control cells. Interestingly, Itk Th2
cells show a greater deficiency in PLC-y I phosphorylation than the Itk Th 1 cells.
A similar finding was obtained after analysis of ERK activation in Th 1 versus
Th2 cells lacking Itk. The ERK pathway is importnt in inducing the transcription ofFos
proteins, and thus, in the formation of AP- l complexes that are crucial for T helper cell
effector function (reviewed in (126)). In accordance with impaired PLC-yl activation
the phosphorylation of ERKI/ERK is more severely impaired in Itk Th2 versus Thl
cells (Figure 26). One potential caveat in this experiment is the observation that Itk +1-
Th2 cells show slightly reduced ERK activation compared to the control Thl cells; thus
Th2 cells, in general, may have a less potent ERK signaling pathway. Nonetheless
following TCR engagement Itk- Th2 cells are more impaired in their ability to activate
PLC-yl and ERK compared to both control Thl and Th2 cells, as well as Itk Thl cells.
Collectively, these data support a model in which Itk is not only crucial for the
differentiation of CD4 + T cells into Th2 effector cells, but may also be important for the
function of differentiated Th2 cells. The upregulation of Itk mRA and protein in Th2
cells is likely to be critical to compensate for the loss of Rl from these cells.
\ ":j'. ;, ...
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Figure 26: Signaling deficiencies in Thl versus Th2 cells lacking Itk
Purified CD4+ T cells from SC.C7 Itk - RAG- and SC.C7 Itk - RAG- mice were
stimulated in Th 1- or Th2-skewing conditions and cultured for 11 days. Cells were then
restimulated by anti-CD3 antibody cross-linking for either 0, I , or 2 minutes. Total
lysates were immunoblotted with an anti-phospho specific antibody to PLC-yl (P-PLC-
yl(PY783)) or anti-phospho-ERK (p-ERK1&2). The membrane was stripped and
reprobed for total PLC-y I , ERK, and Itk protein.
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Discussion
In this report, we demonstrate that Itk is involved in several aspects of T helper
cell differentiation. While previous biochemical studies demonstrated a quantitative
deficiency in TCR signaling pathways in the absence of Itk, the data described herein
indicate that Itk affects qualitative aspects of the TCR signal as well. We have shown
that the activation of Itk following stimulation with low avidity TCR ligands is a critical
factor in promoting Th2 differentiation by negatively-regulating T-bet mRA expression.
Thus , these findings have important implications for understanding the mechanism by
which different strengths of TCR engagement can lead to distinct fates during T cell
differentiation, as well as to the activation of distinct subsets of effector functions.
These data have clarified the mechanism by which Itk influences T helper cell
differentiation. Two previous studies established that Itk mice are impaired in their
ability to generate a protective Th2 response to pathogens such as brasilensis or S.
mansoni (72, 74). However, it was not clear whether this resulted from a simple deficit
in IL-4 production, or was the result of a more complex impairment in Th2 differentiation
by Itk CD4 + T cells. Furthermore, the molecular explanation for the observation that
Itk-deficient mice preferably generate a Thl response to pathogens that normally elicit a
Th2-response also remained a mystery (72 , 74). Our data have demonstrated that Itk
CD4+ T cells are fully capable of differentiating into either Thl or Th2 effector subsets
when exposed to the appropriate cytokines in their environment. But, as previously
reported, the resulting Thl or Th2 effector cells have significant impairments in their
ability to produce each subset of effector cytokines (72 , 74). Interestingly, we find that
the magnitude of the impairment in cytokine production varies depending on the dose of
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peptide Ag with which the cells are restimulated, providing a potential explanation for
discrepancies between previous reports examining IFN-y and IL-4 production by Itk
cells (72, 94).
Our most significant finding is the demonstration that Itk plays a critical role in
determining the fate of T cells differentiating in response to low versus high avidity TCR
signals in the absence of exogenous cytokines. These data provide an interesting contrast
to several reports demonstrating that weak TCR signaling induced by low antigen dose
or by low affinity TCR ligands (APLs), induces transient calcium mobilization and ERK
activation, and promotes differentiation into the Th2 lineage (186 , 187, 189). Based 
these reports , one might have predicted that Itk CD4+ T cells would be more prone to
differentiate into Th2 cells , as several studies have shown that Itk-deficient CD4+ T cells
have defects in calcium mobilization and ERK activation following TCR stimulation (59
, 64 , 71 J. However, the experiments presented here argue that, in the absence of Itk
several aspects of T cell activation and differentiation are altered, the net result of which
is to favor Th lover Th2 differentiation.
The first obvious alteration in Itk CD4+ T cells is their poor production ofIL-
as first described by F owell and colleagues (74 J. Our data show that, in contrast to Itk +1-
T cells stimulated with an APL, in which IL-4 transcripts can be detected within 24 hours
after stimulation Itk T cells fail to accumulate IL-4 mRNA under these same
conditions. This defect is not a result of impaired GATA-3 expression, as Itk and Itk
cells have identical levels of GAT A-3 mRA following stimulation with low avidity
TCR signals. Instead, as reported previously, the initial impairment in IL-4 transcription
is likely a result of defective NF A Tc translocation (94), and may be linked 
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inappropriate modulation of the ratio of NFATc1 and NFATc2 in the nucleus (207).
Interestingly, the defect in Th2 differentiation observed with Itk T cells stimulated in
non-skewing conditions can be overcome by addition of exogenous IL- , which not only
induces GATA- , thus activating endogenous IL-4 expression , but more importantly, also
suppresses Th I development.
The second, and most striking alteration we observed upon activation of Itk-
deficient T cells by low avidity TCR engagement was the rapid induction of T -bet
expression. To date, little is known about the regulation of T -bet gene expression in
response to TCR stimulation. The data presented here indicate that Itk signaling
functions in a pathway that inhibits this expression. A recent study by Hartenstein and
colleagues found that T-bet mRA levels fail to be repressed in JunB- T cells that have
been skewed towards the Th2 lineage (208), suggesting that JunB activity is required to
repress T-bet mRNA induction during Th2 differentiation. Consistent with this
observation, analysis of the putative T -bet promoter sequence using the TRANSF AC
database indicates the presence of several canonical AP- l binding sites
(http://www.cbiI.upenn.edu/tess). In addition, activation of JunB in T cells is mediated
by JNK (194), a signaling pathway we have previously shown to be deficient in Itk
CD4+ T cells (71). These conclusions are also consistent with the data of Schwartzberg
and colleagues demonstrating impaired AP- l activation in T cells lacking Itk (72). Thus
one explanation to account for the aberrant expression of T-bet in Itk- CD4+ T cells
stimulated by low avidity TCR engagement is that reduced JNK signaling leads to
impaired JunB activation and a failure to repress T-bet mRA induction. Alternatively,
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our data do not rule out the possibility of a direct affect of Itk on T -bet function that
ultimately feeds back to inhibit T -bet expression.
As opposed to the aberrant regulation of T -bet expression in Itk-deficient cells
GATA-3 induction remained largely intact. Several reports have suggested that NF-KB
activation via TCR plus CD28 signaling is a crucial event in the induction of GAT A-
transcription , but has no bearing on T-bet or IFN-y expression (209 , 210). In accordance
with this finding, Fowell et al have previously found that NF-KB activation is unaltered in
Itk T cells following TCR/CD28 stimulation (74). Thus, our data showing a role for Itk
signaling in the regulation of T -bet, but not GAT A- , expression is consistent with the
known pathways modulating these importnt transcription factors.
Our data also support a model proposing that the strength of TCR signaling
influences Thl versus Th2 differentiation by differential induction- of GA TA- , rather
than T -bet. Our own data demonstrate that the levels of T -bet mRNA induced within 12
hours in normal CD4+ T cells stimulated with a wide range of antigen concentrations and
affinities are remarkably constant. In- contrast, we find that GAT A-3 mRNA levels
increase as the strength of the TCR signal declines (data not shown), as has previously
been reported (196). Thus, when T cells are stimulated under high avidity conditions
modest levels ofT-bet are induced together with low GATA-3 levels. These conditions
promote IFN-y transcription, leading to feedback through the IFN-y receptor to induce
more T -bet, and thus to Th 1 differentiation. While T -bet itself is not thought to directly
repress Th2 cytokine loci , enhanced T -bet expression ultimately results in a secondary
effect of IFN-y mediated repression of the IL-4 gene , consistent with that described by
Elser and colleagues (211). In contrast, following stimulation with low avidity ligands
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naIve CD4+ T cells induce modest levels ofT-bet, but greatly increased levels of GAT A-
3. Due to the dramatic auto-activation property of GATA-3 (181), plus its ability to
suppress Thl differentiation (180), this early increase in GATA-3 expression may be
sufficient to lead to Th2 polarization in the absence of exogenous cytokines. Lastly, the
co stimulatory molecules CD28 and CTLA-4 have both been found to influence T cell
differentiation in the context of strong versus weak TCR signals (212 213). Therefore
we have not ruled out the possibility that Itk may playa role downstream from these
costimulatory molecules. This possibility is discussed fuher in figure 27.
While this report provides insight into the function of Itk in CD4+ T cell
differentiation, the role of Rlk is less clear. Although T cells from Rle-Itk- mice have
more severe impairments in TCR signaling than those lacking Itk alone (59), Rlk- Itk-
mice generated a protective Th2 immune response to S. Mansoni while Itk mice could
not, and instead, generated an inappropriate Thl response (72). One possible explanation
for this discrepancy is that the absence of Rlk in the Rlk Itk T cells leads to a selective
defect in IFN-y transcription, resulting in a bias towards Th2 differentiation. Consistent
with this hypothesis Rlk- Itk- mice are unable to generate a protective Th 1 response to
T. gondii infection (59). However, another possibility to explain the disparity in
differentiation observed between Rlk- Itk- and Itk cells is abnormal regulation ofT-bet
and/or GATA-3 expression. In fact, CD4+ T cells from Rlk Itk- mice showed impaired
repression of GATA-3 mRA 24 hours following anti-CD3 and anti-CD28 antibody
cross-linking compared to wild type cells. These findings, together with our own data
suggest a previously unappreciated connection between the Tec family kinases Rlk and
Itk, and the factors controlling T helper cell differentiation , GAT A-3 and T -bet.
153
Figure 27: A model for Itk in the process of CD4+ T lymphocyte differentiation and
effector function
The genes encoding the effectorcytokines IFN -y and IL-4 are normally in a repressed
state in naIve CD4+ T cells. In order for these genes to be accessible for transcription, the
master regulators of T cell differentiation, T-bet and GATA- , are required for the
remodeling of chromatin at the respective locus. Thus, it is currently believed that
following the activation of T lymphocytes through the TCR, two crucial events must
occur for differentiation to occur: the activation of specific loci , otherwise known as
chromatin remodeling, and acute transcriptional effects that induce transcription only at
remodeled gene targets. The data presented in this chapter support a model in which the
strength of signal through the TCR affects T cell differentiation by the differential
regulation of GAT A-3 expression, and not T -bet, as well as the activation of specific
transcription factors involved in the acute phase. This figure will present models which
depict our current view on how .Itk regulates not only factors involved in the acute
transcription of cytokine genes, but also molecules which participate in the competency
to express these genes following different modes of stimulation.
(A) STRONG TCR SIGNAL: Prior to activation, naIve CD4+ T lymphocytes express
low levels of the master regulators of Th I and Th2 differentiation, T -bet and
GATA- , respectively. Our data indicate that upon ligation of the TCR with a
strong signal , T-bet and GATA-3 are both modestly upregulated in a fashion that
is not dependent on Itk. The (*) denotes that other Tec family members may be
activated upon a strong TCR signal , which may reduce the requirement for Itk
function. Additionally, high avidity signals via Itk activate transcription factors
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such as NF A Tp, that promote IFN-y transcription. Upon feedback through its
receptor, IFN- induces more T-bet, which ultimately wil drive Thl
differentiation , and suppress Th2 development.
(B) WEAK TCR SIGNAL: Upon recognition of a low affinity ligand or a weak TCR
signal, T -bet and GAT A-3 are induced via an Itk- independent mechanism.
However, our data indicate , as observed by others, that GAT A-3 mRNA levels
are increased as the strength of the TCR signal is reduced. Increased GAT A-
leads to Th2 polarization via the maintenance of the IL-4 locus in an open state
as well as in its own auto-activation. Furthermore, reduced TCR signaling
activates factors, such NF A Tc , important in IL-4 transactivation. Once secreted
IL-4 feedbacks through its receptor to induce more GATA-3 expression, thus
amplifying an autocrine loop. The data presented in this chapter demonstrate
that T -bet levels are unaltered in low avidity conditions. Our data support a role
for Itk in the active repression of T -bet upon recognition of a weak ligand, which
would ultimately assist in driving T cells down the Th2 pathway, and suppress
Thl development.
(C) EFFECTOR FUNCTION: Once differentiation into either the Thl or Th2lineage
has taken place, Itk functions in signaling pathways that lead to optimal cytokine
production in both subsets. Signals through Itk activate PLC-y 1 , which are
crucial for the activation of downstream molecules such as NF A T and
components of the AP- l transcriptional complex. Our data indicate that the
up regulation ofItk in Th2 cells is an importnt event for proper Th2 function.
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Disclaimer:
The above models are one interpretation of the data presented in this chapter. However
we have not ruled out the possibility that Itk may playa role in signaling through
costimulatory receptors , such as CD28 and CTLA-4. Both CD28 and CTLA-4 affect T
cell differentiation in part by controlling the strength of signal through the TCR. For
instance, CD28 signals favor Th2 differentiation, whereas ligation of CTLA-4 promotes
Thl differentiation. These costimulatory molecules can only mediate their effects upon
binding to their ligand following TCR engagement (212, 213). Precisely where CD28
and CTLA-4 signals intersect with TCR signals is not known. One alternative
interpretation of the data discussed in this chapter is that CD28 signals via Itk fuction in
a signaling pathway that is important for the proper inhibition of T -bet and upregulation
of genes importnt for Th2 differentiation. Likewise, CTLA-4-mediated signals could be
suppressed by Itk, which would also function to promote Th2 differentiation. Future
work addressing these possibilities wil be very informative.
Alternative Models of Lineage Commitment:
While this study is in agreement with most reports that examined the strength of the TCR
signal and its ' influence on T cell differentiation , conflicting data has led to the proposal
of alternative models of lineage commitment. While the bulk of the data suggest that
strong TCR signals induce Th I differentiation and weak TCR signals induce Th2
Hosken and colleagues proposed a three-tiered mode of regulation, where both strong and
weak signals would lead to Th2 differentiation, and intermediate signals would result in
Thl differentiation (162). The discrepancies between these two models are likely a result
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of different in vitro systems. For instance, one of the main variables in these experiments
is the type of APC being used, which can greatly impact T cell differentiation as
discussed in chapter In with dendritic cells. Thus, it would be interesting to examine the
role of Itk in the process of T cell differentiation upon stimulation with different tyes of
APCs.
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Figure 27B Weak TCR signal
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Figure 27C: The role of Itk in Thl and Th2 effector cells
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CHAPTER V.
DISCUSSION AND FUTURE DIRECTIONS
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A brief synopsis
The data presented in this thesis have defined an important role for the tyosine
kinase, Itk, in several CD4+ T cell effector functions, such as AI CD and T cell
differentiation, which are required for proper immune function. The knowledge of how
both of these processes are regulated at the molecular and cellular levels is imperative in
efforts to control disease processes.
Chapter II demonstrates a crucial role for Itk in the signaling pathway that leads to
activation-induced cell death via FasL. In this chapter, CD4+ T cells from both wild tye
and Itk-/- mice were initially stimulated with a high level of peptide , rendering wild tye
cells more susceptible to AICD. Following restimulation, wild type cells underwent
AICD , whereas Itk-deficient cells failed to. Further characterization of this deficiency
revealed that Itk/- cells were impaired in their ability to activate specific signaling
pathways, which resulted in the failure to upregulate the transcription of the regulatory
factors Egr2 and Egr3, and ultimately FasL. This study more clearly defined the
function ofItk in the process of FasL-mediated cell death.
Chapter III attempted to clarify the role of Itk in other CD4+ T cell effector
functions. Interestingly, in correlation with our findings in chapter II , we found that Itk-
deficient mice possessed an increase in the percentage of CD4 + T cells with an activated
or memory phenotye. In addition, we found there to be a vast increase in the numbers
of CD4+ memory cells producing both Thl or Th2 cytokines in Itk-/- mice, indicating that
Itk may regulate T cell differentiation. Unfortnately, further efforts to address the role
of Itk in the process of naIve T cell differentiation in vitro was hindered by the presence
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of previously-activated cells which had been skewed in vivo to either the Th 1 or Th2
lineage. Thus, we utilized a more highly-controlled in vitro approach in chapter IV.
Chapter IV further elucidated the role of Itk in the process of CD4 + T cell
differentiation. As opposed to chapters II and III , a slightly different in vitro approach
was utilized. The experiments presented in this chapter revealed that naIve Itk/- CD4 + T
cells respond normally to cytokine skewing signals, and can differentiate effciently into
either Thl or Th2 lineage cells. In the absence of skewing cytokines , wild type CD4+ T
cells stimulated with low avidity ligands preferentially express GATA-3 mRNA and
differentiate into Th2 cells. Under these same stimulation conditions, Itk/- T cells
produce large amounts of T-bet mRNA, and differentiate into IFN- producing cells.
These findings not only provide a molecular explanation for the essential role of Itk in
Th2 differentiation, but also provide insight into the mechanisms of how altering the
strength of TCR signaling can generate qualitatively different signals leading to altered T
cell fates in differentiation.
A connection between CD4+ T cell death and differentiation in Itk-/- mice
While the aberrations in AICD and T cell differentiation observed in vitro in Itk-
deficient T cells appear to be distinct, as discussed in chapters II and IV , respectively, we
have not ruled out the possibility that there may be a connection between the two defects
in vivo. This possibility is raised due to the disparity between the experiments presented
in chapter IV, where I discovered that in situations in which wild type cells undergo Th2
differentiation, Itk-deficient cells failed to do so, and Chapter III, where I identified an
increase in the percentage of CD4+ cells with a memory phenotype in Itk/- mice that can
immediately produce the Th2 effector cytokine IL-4. This disparity was also observed by
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other groups where Itk-/- mice are clearly unable to elicit Th2 responses to many different
pathogens, yet unimmunized Itk/- mice possess a 5- fold increase in basal levels of IgE
germinal center hyperplasia, and the presence of mild eosinophilia, all of which are
suggestive of excess Th2-tye cytokine production (72, 73 151).
While at first glance it is difficult to reconcile, these findings suggest the
possibility that mice deficient in signaling molecules of this particular biochemical
pathway not only possess defects in T cell function, but also defects in the function of
other cell types that express these signaling molecules, such as mast cells. Consequently,
alterations in the function of mast cells may contribute to an environment in which T cell
activation and differentiation are dramatically affected. In chapter III, which describes an
increase in the percentage of CD4+ cells with a memory phenotye in Itk-/- mice, it is not
clear how or why these cells are being activated compared to wild type. Nevertheless
the data in chapter IV would argue that following activation, Itk/- cells would
preferentially differentiate into Th 1 cells, unless exposed to IL-4 produced by another
cell tye. Furthermore, as discussed in chapter II, defects in AI CD would likely result in
the accumulation of CD4+ cells with a memory/activated phenotype that have
differentiated into either the Thl or Th2 lineage. Below, I elaborate on the remarkable
similarities of the phenotypes of mice deficient in these signaling proteins and the
likelihood that these phenotypes may not necessarily be a result of CD4+ T cell intrinsic
defects, but may in fact be a combination of intrnsic and extrinsic CD4+ T cell defects.
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Similarities of Itk-
/- 
mice to other signaling-deficient mice
Tec family kinases function in the phosphorylation and activation of PLC-yl via
the formation of a multi-molecular signalosome complex that includes Grb2, Gads
SLP- , LAT, and PLC-yl. Recently, two independent groups, Aguado et al (214) and
Sommers et al (215), described mice that expressed only a mutated form of LAT
LATY136F . Previous work had shown that Y136 of LAT is required for the binding and
activation of PLC-yl in response to TCR stimulation (216-218)lnterestingly, the
LATY136F mutant mice have a very similar biochemical and physiological phenotype
when compared to Tec kinase-deficient mice. Similarly, mutation of another TCR
signaling molecule, Vavl , which has also been shown to be important for the full
activation of PLC-yl (219), results in mice with a similar T cell deficiency (220-222).
Based on their role in PLC-yl activation, it is not surrising that each of these molecules
has also been shown to playa role in regulating calcium mobilization in T cells.
Downstream of PLC-yl activation, IP generation, and subsequent calcium
mobilization, transcription factors of the NF A T family are rapidly dephosphorylated and
activated by the calcium-dependent phosphatase , calcineurin. This dephosphorylation
allows NF A T molecules to translocate to the nucleus where they bind to specific
promoter sequences and activate transcription. The three NF AT family members
expressed in T cells , NFATcl (NFATc, NFAT2), NFATc2 (NFATp, NFAT1), and
NFATc3 (NFAT4 , NFATx) appear to have overlapping as well as unique functions , as
has been elucidated by studies of mice with single as well as multiple mutations in NF 
family members (223). Predictably, several groups including our own have found Itk-
and Rlk/-Itk-/- CD4+ T cells have a defect in NFAT activation and/or translocation
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following TCR stimulation, most likely as a result of the defects in calcium mobilization
(72 , 73 , 94). The resemblance of the phenotypes observed in Itk/-, Rlk- Itk- , as well as
the LATY136F mice, with those observed in several NFAT knock-outs is quite intriguing,
and further confirms the notion that disruption of PLC-yl activity results in defective
NF A T activation, which in turn affects a number of T cell effector functions.
The most striking similarities seen among these signaling protein-deficient mice
involves alterations in CD4+ T cell homeostasis and the apparent in vivo skewing to a
Th2-dominated environment in non-immunized mice. Two groups independently
generated the LATY136F mice and both described the peripheral CD4+ T cells isolated
from these mice as having an activated phenotype (CD62L , CD44 \ CD69 ), showing
defects in TCR -mediated cell death, and selective production of type-2 cytokines (214
215). Furthermore in vitro CD4+ T cells from LATY136F mice are defective in calcium
mobilization, IL-2 production, and FasL expression, analogous to the milder defects seen
in Itk-deficient CD4+ T cells. Unlike Itk/- and Rlk Itk-/- cells , the ERK pathway
remained intact in the LATY136F T cells for re sons that are not clear. Interestingly, both
groups alluded to the fact that, as a result of impairments in thymic selection, cells
reactive towards self-ligands may be escaping from the thymus. While both studies
described similar phenotypes of the LA T Y136F mice, Aguado et al maintained their mice
on the Balb/c background, whereas Sommers et al maintained their mice on the C57Bl/6
background. Thus , genetic differences between these two mouse strains that affect Th 
vs. Th2 differentiation in other circumstances appear unrelated to the phenotype observed
in the LA T Y136F mice.
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Mice deficient in NF A T family members also share some of the common
phenotyes with the Tec family-deficient and LATY136F mice , but the relationships are
more complex. NFATcl-/- mice are unable to induce Th2 responses, as demonstrated by
decreased IL-4 production by T cells from these mice (195 , 224). Remarkably, while
CD4+ T cells from NFATcl-deficient mice possess a reduced proliferative capacity 
vitro they exhibit no defect in IL- , IFN-y, nor TNF-a production, when skewed in Thl
conditions in vitro. A second NFAT family member, NFATc2 , which is expressed at
high levels in resting T cells and then downregulated following activation (225), has been
found to directly regulate the expression of NF A Tc 1 by trans activating the NF A Tc 1
promoter following TCR activation (226). Interestingly, lymphocytes from mice
possessing mutations in NF A Tc2 exhibit an activated phenotype, show moderate
increases in IL-4 production, and have defects in activation-induced cell death in addition
to severe eosinophilia in the lungs (227). Furher studies by Hodge et al (228) and Kiani
et al (229), demonstrated that NFATc2 is required for the termination of the late-phase of
IL-4 transcription , and ultimately for the down-regulation of the Th2 response. NFATc3
comparable to NF A Tc2 , is expressed in resting T cells and is downregulated following
activation (225). NF A Tc3-deficient peripheral T cells , although they lack defects in
cytokine production, have an activated phenotype and exhibit increased apoptosis as a
result of elevated FasL expression (230). These latter data are consistent with the notion
that NFATc3 may function to repress FasL expression and thus, may play an importnt
role in T cell survival.
Mice containing combined mutations in NF AT family members have proven to be
invaluable in the dissection of NF AT-regulated pathways. NF A Tc2/NF A Tc3
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doubly-deficient mice develop a lymphoproliferative disorder, as a result of increased
resistance to apoptosis. These mice have allergic blepharitis, interstitial pneumonitis, and
1000-10000- fold increase in serum IgG 1 and IgE levels, secondary to a dramatic and
selective increase in Th2 cytokines (225J. In contrast, T cells from mice containing
combined mutations in both NF A Tel and NF A Tc2 exhibit an activated phenotype, but
show substantial defects in the development of multiple effector functions , such as
cytokine production, surface effector molecule expression, and cytolytic activity (231 J.
All of the above findings suggested that, while NFATcl may playa positive role in
proliferative functions , NF A Tc2 and NF A Tc3 essentially function to repress specific T
cell functions. These data imply that, depending on the strength or quality of the TCR
signal, some NF A T family members may be selectively activated relative to others.
Furthermore, it is evident that lymphoid homeostasis and Th2 development require a
critical balance among NF AT family member activities.
Alterations in the balance ofNFAT family member activation is likely to affect T
helper cell differentiation and effector function. Based on the observations arising from
analyses of NF AT-deficient T cells, it seems likely that upon stimulation of T
lymphocytes lacking Itk, Rlk and Itk, or LA T, there would be an initial defect in NF A Tc2
activation, followed by a more substantial defect in NFATc2- induced NFATcl
upregulation. In addition, as a result of their impairment in NF A T activation, Itk/- and
Rlk- Itk/- T cells may also show decreased repression mediated by NFATc2 and
NF A Tc3 , providing an explanation for many of the observed defects in T cell effector
functions seen in these cells, as well as those expressing LATY136F. The more severely
impaired Rlk/-Itk/- CD4+ T cells may be more akin to the NFATcl/c2 double knockout
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cells , where there is a more profound defect in NF AT-mediated effector functions. The
relationship between Itk, Rlk , and LA T , signaling molecules that function to amplify
calcium signals, and NF A Ts, calcium sensitive transcription factors, as well as the
relationship between NF A Ts and specific effector genes , may not be a simple one. To
obtain a clearer picture of the aforementioned relationships , it wil be necessary to
determine how individual NF A T molecules are spatia-temporally regulated in T cells
during T cell stimulation, expansion, and contraction.
Lastly, another T cell signaling protein, JNK (c-jun N-terminal kinase), has also
been implicated in pathways downstream of Itk activation and other proximal TCR
signaling events. We have shown that Itk/- CD4+ T cells are defective in the activation of
the JNK pathway, a defect which is likely to contribute to the impaired FasL expression
in these cells (232). CD4+ T cells from JNKl-deficient mice synthesize augmented levels
of IL- , but normal levels of IFN-y, when stimulated in vitro in non-skewing conditions
(233). NFATcl has been identified as a substrate for JNKl , and may function to inhibit
Th2 responses (233). Consistent with this, JNKr/- mice are susceptible to Leishmania
infection, which is not due to their inability to make a Thl response, but rather is due to
their inability to suppress the development of a Th2 response (234). Exactly how
disregulation of JNI signaling in Itk/- mice contributes to the T helper imbalance seen
in these mice is unclear.
Despite all of the intriguing similarities and differences that exist between the
aforementioned signaling protein-deficient mice, all of the current models of TCR
signaling, in regards to T cell differentiation , fail to reconcile many of the in vivo findings
in these knock-out mice. Perhaps a better understanding of the complex interactions and
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cross-talk between all these signaling molecules through gene expression array analyses
wil aid in our future understanding of how these signaling molecules and pathways
integrate to affect T cell activation and differentiation.
While T helper cell differentiation can clearly be altered by modification of genes
within the T cells themselves, it is clear that environmental factors, especially cytokines
elicited from other cell types can also influence this process. In vivo in addition to T
cells, mast cells are believed to be another major source of IL-4. Interestingly, Tec
family kinases , the adaptors SLP-76 and LAT, and the NFAT family of transcription
factors, are all involved in signaling within mast cells. Thus , it is possible that, along
with intrnsic T cell changes in the signaling mutants discussed, disruption of signaling in
mast cells may affect the T cell phenotype observed in these mutant mice. Mast cell
defects may indirectly result in imbalances in the cytokines that are available to T cells
during T cell activation, thereby altering the differentiation process. This argument wil
be discussed below.
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Table II: Similar phenotyes of mice deficient in T cell signaling proteins
Chart compares biochemical defects as well as the in vivo phenotypes of various T cell
signaling molecule knockouts. ND = Not Done, or unpublished. NA = Not Applicable.
Biochemical findings were either done in peripheral T cells or thymocytes with the
exception of those for SLP- , which were done in a SLP-76 deficient Jurkat T cell line.
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A role for Itk in the regulation of Mast Cell function?
A role for mast cells in the Th2-type skewing observed in the mutant mice
described above is a likely possibility, as mast cells play an integral role in Th2 effector
responses. Cross-linking of the high affinity IgE receptor, FCERl , activates mast cells by
initiating signal transduction events that result in two general responses; an early
degranulation response in which molecules such as TNF-a , IL- , and histamine are
immediately released, as well as a response where mediators such as other interleukins
and chemokines are newly synthesized. Two Src family kinases , Fyn kinase and Lyn
kinase, initiate signaling downstream of the FCERl. However, evidence from several labs
has indicated that the Tec kinase, Btk, functions in a Lyn-dependent pathway, that
involves the action ofSLP- , LAT, Vavl , as well as PLC- , which ultimately leads to
calcium mobilization (235 , 236). In addition to Btk, Itk is also expressed in mast cells
and becomes phosphorylated following cross-linking of FCERl (237 , 238). There is
substantial evidence indicating a role for Btk in mast cell function (239), but little is
currently known about the role of Itk in these cells. Both PLC-y 1 , which is activated by
Itk in T cells, and PLC- , which is activated by Btk in B cells, associate with this
complex , suggesting a possible role for both of these Tec kinases in mast cell signaling.
In mast cells , the activation of both of these PLC-y isoforms is believed to be important
for calcium responses and for the activation of the NF A T family of transcription factors
signals that are critical for optimal mast cell fuction and cytokine production (See (236)
for review). While the role for Itk in mast cells remains elusive, leaving open the
possibility that the disregulation of mast cells in the absence of Itk might affect T cell
homeostasis and/or differentiation, it has been found by Nadler et al that Lyn-deficient
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mast cells in fact possess enhanced degranulation responses (240). Thus, it is possible
that Itk may playa negative regulatory role in mast cells. Future work will address this
possibility.
Tec kinases and T cell anergy
As discussed earlier, self-reactive lymphocytes are typically deleted during
thymic development, however, T lymphocytes can be tolerized to self antigens in the
periphery via a number of different mechanisms. The maintenance of tolerance in the
peripheral immune system is vital for homeostasis. Needless to say, mechanisms of
immune tolerance are an intense area of investigation due to its clinical importance in the
treatment of autoimmunity and transplantation. One mechanism of tolerance involves a
subset of CD4+ T lymphocytes that exhibit regulatory properties, such as the ability to
produce immunosuppressive cytokines such as TGF-j3 and IL- IO (241). Another
mechanism, termed anergy, involves the uncoupling of the TCR and the activation of
specific downstream signaling pathways. The tolerizing stimulus to the T cell tyically
commences upon partial activation as a result of an imbalance in TCR signals without
costimulatory signals. Ultimately, this process induces the T cell to enter a long-lasting
state of unresponsiveness, makng these cells refractory to TCR and costimulatory signals
(242-244). More specifically, anergic T cells fail to produce IL-2 upon stimulation with
the cognate antigen, however, the anergic state can be overcome upon exposure to IL-
(245). To date, there have been no studies addressing the function of Tec family kinases
in either mechanism of T cell tolerance. The function of Itk in T cell tolerance may be an
exciting area to pursue in future studies for reasons that wil be discussed below.
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One of the characteristic features of a tolerizing stimulus that will ultimately
induce anergy is the ability of this stimulus to activate the calcium pathway. Several
reports have demonstrated that by treating T cells with the calcium ionophore
ionomycin, can induce anergy. This induction can be blocked upon treatment with the
chelating reagent EGT A as well as with the calcineurin inhibitor, cyclosporin A (CsA)
(242). Stimulation of T cells with an altered peptide ligand (APL) possessing weak
agonistic properties, can elicit a weak calcium signal. This tye of T cell stimulation has
also been implicated in T cell anergy induction (190 , 243 , 244 J. As discussed in great
detail earlier, calcium mobilization results in the calcineurin-dependent
dephosphorylation of cytoplasmic NF AT. Following its nuclear translocation, NF A T
cooperatively interacts with AP- l (Fos/Jun dimer) to induce several cytokine and effector
genes. Calcium mobilization is completely dependent on TCR signals alone and is not
coupled to co stimulatory molecules. Thus, NF AT activation is virtally independent of
costimulatory receptors and dependent on the TCR alone. Costimulation, however, is
required for the efficient activation of AP- l and NF-KB activity. Interestingly, T cells
lacking NFATI are resistant to the induction of anergy. Macian et al revealed that
NFATI induces T cell anergy when restricted from interacting with AP- , its
transcriptional parter (246). This information leads me to speculate that Itk may play an
important role in the induction of anergy. Itk plays an important role in the effcient
mobilization of intracellular calcium. Given that suffcient calcium signals are required
for the induction of anergy, one could surmise that Itk-deficient cells may in fact be more
resistant to tolerization.
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T regulatory cells (T Reg), a subset of CD4+ cells important for homeostasis, are
characterized by the cell surface expression of CD25 as well as CTLA-4 (247). Chen et
al have demonstrated that upon cross-linking of CTLA-4 is able to induce the secretion of
TGF -(3, an immunoregulatory cytokine. The role of Itk in the development and function
of T Reg cells is presently unknown. Furthermore, whether Itk functions in signals
downstream from co stimulatory molecules, such as CTLA- , as well as in the signaling
pathway that leads to TGF 
-(3 production remains to be learned.
Tec family members may directly affect gene expression
Recent progress has provided additional insights into Tec kinase fuctions within
immune cells. As mentioned earlier, Rlk can translocate to the nucleus upon TCR
stimulation. A recent paper from Takeba et al demonstrated that Rlk can bind to regions
of the IFN-y promoter and increase promoter activity. Interestingly, this event is
dependent on Rlk phosphorylation, presumably in response to TCR engagement (39 40).
Other Tec family members, such as Btk and Bmx, have been previously shown to interact
with transcription factors (reviewed in (44)), suggesting that these proteins may play
more direct roles in affecting gene transcription. Btk, which is mainly localized to the
cytoplasm in resting cells , translocates to the cell membrane following BCR or growth
factor stimulation. In addition, a recent study has found that Btk can undergo
nucleocytoplasmic shuttling in a nuclear export signal (NES)-dependent manner (248).
The role of Btk in the nucleus was clarified by the findings of Egloff et aI. , who showed
that Btk could associate with and phosphorylate a transcriptional regulator, BAP/TFII-
in B cells following BCR engagement (249). Likewise, Btk was also found to associate
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with another transcription factor, STATSA, following the engagement of the BCR (2S0).
These finding support a previously unrecognized role for Tec family kinases as direct
modulators of gene expression.
This newly proposed function for Tec kinases in gene regulation appears to be
family-wide. Recent work from Perez-Vilar et al demonstrated that Itk can associate
with a nuclear importin protein, termed Rchla/karyopherina , thereby allowing it to
trans locate to the nucleus (41). Furthermore , Laurie Glimcher and colleagues have
observed a direct interaction of Itk with the Thl-specific transcription factor, T-bet.
Preliminary data from her laboratory suggests that Itk may in fact regulate T -bet function
by a phosphorylation event (personal communication). Needless to say, much work is
required to understand how Tec family kinases can not only function in cytoplasmic
events , such as the activation of PLC-y and downstream, signaling pathways, but also in
nuclear events, such as the activation or regulation of transcription factors.
Final word
T cell signaling research today seeks to clarify the intersecting and diverging
branches of antigen receptor signaling pathways in order to understand how distinct
immune outcomes are regulated at the molecular and cellular level. Ultimately, this wil
allow researchers to develop new methods that allow the elicitation of the desired
immune response to control disease. Determination of the precise and possibly unique
role of each Tec family kinase in T cells wil require further investigations using a
combination of genetics and biochemistr. While one caveat of these genetic studies is
the possibility that when one member of the Tec family is absent, compensatory
177
mechanisms may emerge to counteract the imbalance, we favor the notion that under
normal physiological circumstances, each Tec kinase family member has a specific and
non-redundant role in hematopoietic cell signaling. Supporting this idea, individual Tec
kinases show distinct requirements for activation, such as the dependence on PI3K, in
addition to the common need for phosphorylation by a Src kinase. Furthermore
activation of Tec kinases in T cells leads to unique downstream consequences, as
ilustrated by the observation that Rlk, but not Itk, can trans locate to the nucleus and act
as a transcription factor. Future work with Tec family kinases should begin to reveal
more precisely the roles of Itk, Rlk and Tec in T cell signaling.
Collectively, all of the data presented and discussed in this thesis underscore the
important role of TCR signals in maintaining the appropriate balance of T cell survival
activation, and differentiation, and further emphasize the importance of Tec kinases in
regulating these processes that are crucial for proper immune function.
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CHAPTER VI.
MATERIALS AND METHODS
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Mice
In chapters II and III , SC.C7 TCR transgenic mice (107) on the BIO.BR (H-
background were crossed to Itk-/- mice (60). Itk+/- and Itk/- mice, which had been
backcrossed to the CS7BL/lO background for at least 8 generations were used for SEB
injection experiments. In chapter three, Itk+/- and Ite- mice, which had been backcrossed
to the CS7BL/I0 background for at least 10 generations were used. Itk/- mice on the
Balb/c background used in chapter three were backcrossed at least 8 generations (a gift
from D. Fowell (74)). All mice used were between 6 and 10 weeks of age and
maintained in a specific-pathogen free facility. In chapter IV, Itk-deficient mice
previously generated in our laboratory . (60) were backcrossed to the CS7BL/I0
background ::10 generations. These mice were crossed to SC.C7 TCR transgenic RAG-
mice (Jackson Laboratories , Bar Harbor, ME) to ultimately generate H- SC.C7 Itk+/-
RAG-/- and SC.C7 Itk-/- RAG-/- mice. All mice used for these experiments were between
6 to 10 weeks old and were maintained in a specific-pathogen-free facility.
Purifcation of CD4+ T cells
For chapters II and III, spleens and lymph nodes were removed from 6- to lO-week old
SC.C7 Itk+/- and SC.C7 Ite- littermates. Following RBC lysis, single-cell suspensions
were incubated with anti-CD4-coated magnetic microbeads and passed through LS
columns according to the manufacturer s protocol (Miltenyi Biotec, Auburn, CA). In
chapter IV, spleens and lymph nodes were removed from SC.C7 Itk+/- RAG-/- and SC.C7
Itk-/- RAG- littermates. Following RBC lysis , spleen and lymph node cells were pooled
and single-cell suspensions were incubated with anti-CD4 magnetic microbeads. The
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cells were then run through a Miltenyi Biotech AutoMACs separation system to
positively select CD4+ cells according to the manufacturer s protocol (MiItenyi Biotec
Auburn, CA). Purified CD4+ T cells were pooled and resuspended in RPMI 1640 (Gibco
Bethesda, MA) supplemented with 10% fetal calf seru (Hyclone , Logan, UT), 2mM L-
glutamine, 100 U penicilin, 100!Jg/mL streptomycin, 10mM HEPES , and 50!JM j3-ME.
This purification routinely yielded 90-97% CD4+ Va 11 + T cells. On the Rag-deficient
background, all purified CD4+ cells were consistently ?96% naIve (CD44 , CD62L
and expressed the 5C.C7 TCR, which is specific for moth cytochrome C (MCC93- 103).
In vitro activation of CD4+ T cells
For in vitro activations in chapters II and III, I X CD4+ T cells were cultured in 24-
well plates with 2!JM of MCC93-103 peptide (DLIA YLKQA TK)(Tufts Microchemistr
Facility, Medford, MA) plus 1 X 10 Mitomycin C-treated (Calbiochem, La Jolla, CA)
B7. 1-expressing CHO cells (251). In chapter II , cultures were all performed under
Thl-skewing conditions (anti-IL-4 (l!Jg/mL) and rIL-12 (lng/mL) (R&D , Minneapolis
MN)). After 24 hours, the cells were transferred into and expanded in fresh medium
containing 5 ng/mL ofIL-2 (Pharmingen, San Diego CA). Addition ofIL-2 immediately
upon primary stimulation had no effect on the secondary responses of Itk+/- or Itk-/- cells.
Following stimulation, cells were maintained in medium supplemented with IL-2 until
restimulation. Itk+/- and Itk/- T cells expanded comparably with these stimulation
conditions , and similar numbers of cells were recovered from both types of cultures prior
to secondary stimulation.
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In chapter IV, lx106 purified SC.C7 Itk+/- RAG-/- and SC.C7 Itk/- RAG-/- cells were
activated with lxl06 Mitomycin-C treated CH27 cells (B cell lymphoma line, IEk+ and
) in a variety of different conditions. For Thl-skewing conditions , cultures were
supplemented with rIL- 12 (lng/ml) and anti-IL-4 antibody (l!Jg/ml), while Th2-skewing
conditions included rIL-4 (lOng/ml) and anti-IFN-y antibody (0. !Jg/ml; R&D
Minneapolis, MN). Cells stimulated in skewing conditions were activated with 10nM of
MCC93- 103 peptide plus CH27 cells. Cells stimulated in a variety of non-skewing
conditions (no exogenous cytokines or antibodies added) were stimulated with the
indicated amounts of MCC93-103, MCCTlo2s, or MCCA96s peptide plus CH27 cells as
APCs. After 24 hours, culture media for both skewed and non-skewed conditions was
supplemented with rIL-2 (S ng/ml). Cells were expanded and maintained in their
respective culture conditions until restimulation.
Antibodies and Flow Cytometry
Cells were stained with the indicated antibodies in HBSS supplemented with 3% FCS for
30 minutes on ice. Cells were then washed and analyzed on a Becton Dickinson
ACSCalibur. Data was analyzed using CellQuest software. The antibodies and flow
cytometr reagents used were anti-CD4-CyChrome, anti-Vall-FITC , anti-V!)8. 1/8.2-
FITC, anti- V!)6-FITC , anti-Fas-biotin, anti-CD69- , anti-CD44-FITC, anti-CD62L-
anti-CD2S- , anti-CD8-APC , anti-CDllc-FITC , anti-CDllb- , anti-CD8-Cychrome
anti-CD40- , anti-B7. , anti-B7. , anti-CD62L- , anti-IL- , anti-IL-
and anti-IFNy-APC , streptavidin-PE (Pharmingen), and anti-FasL-PE (eBioscience, San
Diego , CA).
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In vitro Proliferation Assay
For primary proliferation assays, 5 X CD4+ Val1 + T cells were stimulated with
MCC93- 103 peptide plus 5 X 10 Mitomycin C-treated CHO cells expressing IE and B7.
in a volume of 200 L for 48 hours. As a control , cells were stimulated with PMA
(Sigma; 2.5ng/mL) and Ionomycin (Calbiochem; 375ng/mL): 3 (H)thymidine (NEN
Boston, MA) was added at Ci/well and incubated for an additional 20 hours, and plates
were harvested on a Tomtec Harvester 96 and 3 (H)thymidine incorporation was
quantified on a Perkin Elmer Trilux microbeta counter. Secondary proliferation assays
were performed on day 14 post-initial stimulation, the point at which the cells were no
longer dividing. Previously-activated cells were removed from culture, washed, counted
and as in the primary proliferation assay, 5 X 10 CD4 + Vall + T cells were stimulated.
For the blocking of FasL-mediated AICD in vitro cells were stimulated in the same
conditions as above with the addition of anti-FasL (MFL3) or an isotype control Ig
(eBioscience) added at 5 g/mL to each well at 0 and 20 hours.
Functional Assay for FasL-induced apoptosis
The induction of FasL-mediated cell death was determined by Annexin V-FITC
(Pharmingen) and propidium iodide (Sigma) staining 15 to 20 hours after 3 X 10 T cells
were stimulated with 5 XI0 CHO (IE - and B7. positive) cells and MCC93- 103 peptide.
g/mL ofanti-FasL or an isotype control Ig was added at 0 and again at 10 hours post-
stimulation where indicated. Soluble FasL (sFasL) was pre-bound for 30 minutes
followed by addition of a cross-linking enhancer Ig (Alexis Corp. , San Diego , CA) at 2
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hours post-stimulation. Cells were immediately analyzed by flow cytometr. Specific
apoptosis was determined by calculating the ratio of live cells in the treated wells to live
cells in the wells incubated in the absence of MCC peptide.
Intracellular Cytokine Staining
In chapter II, 3 X 10 T cells were cultured with 5 X 10 (IE and B7. 1-expressing) CHO
cells and MCC93-103 peptide, or PMA (2.5ng/mL) and Ionomycin (375ng/mL) for 6 hours
in a 96-well plate. In chapter IV, 3x10 T cells were restimulated with lxl0 CH27 cells
and the indicated concentrations of MCC93-103 for 6 hours in a 96-well plate. Golgi
StopTM and/or Golgi PlugTM (Pharmingen) were added for the last three hours. All cells
were stained for approximately 15 minutes , fixed for 20 minutes, then permeabilized and
stained intracellularly with either anti-IL- , anti-IL- , and/or anti-IFN- APC
according to the CytofixiCytopermTM kit protocol (Pharmingen). Cells were immediately
analyzed by flow cytometr on a BD F ACSCalibur. Ten thousand CD4+ events were
tyically collected.
In chapter III, for the ex vivo stimulation of splenic CD4+ cells, following the purification
of CD4+ cells from both Itk+/- and Itk/- mice, I X cells were stimulated with PMA
(2.5ng/mL) and Ionomycin (375ng/mL) for 6 hours. To assess the differentiation status
of T cells initially stimulated in non-skewing conditions, 3 X cells were
restimulated with 5 X 10 (lE - and B7. 1-expressing) CHO cells and MCC93-103 peptide
or PMA and Ionomycin for 6 hours in a 96-well plate. Golgi StopTM and/or Golgi Plug
(Pharmingen) were added for the last two hours. For ex vivo stimulation, cells were
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stained with anti-CD44-FITC and anti-CD4-Cy. For in vitro restimulation, cells were
stained with anti-Vall-FITC and anti-CD4-Cy. Similar procedures were followed as
indicated above.
Calcium Flux
Day 8 post-initial stimulation with peptide and APCs , 5 X 5C.C7 Itk+/- and 5C.C7
Itk-/- CD4+ cells were incubated with 3""g/mL Fluo-3 and 5""g/mL of Fura-Red
(Molecular Probes , Eugene, OR) in RPMI containing 3%FCS for 45 minutes. Cells were
washed twice and incubated in the dark at room temperature for 30 minutes. I X 
cells were placed in ImL of 37 C serum-free RPMI and analyzed on a Becton Dickinson
Flow Cytometer. Baseline calcium was measured, cells were then stimulated with anti-
CD3E-biotin (145-2Cll; 25""g) (Pharmingen) for 45 seconds, followed by streptavidin
(Gibco; 40""g) cross- linking for 5 minutes. Ionomycin (1 ""g) was added at 6 minutes.
Data were analyzed by calculating the mean fluorescence ratio ofFluo-3 (FL1) and Fura-
Red (FL3) using F ACSAssistant(8 software.
Western Blot analysis
In chapter II, on day 14 post-stimulation with 2""M of MCC 103, 3 X 10 5C.C7 Itk+/-
and 5C.C7 Itk/- CD4+ T cells were incubated on ice in 120""L of RPMI-O containing
25""g/mL of biotinylated a- CD3E for 10 minutes. Cells were quickly spun and
resuspended in 120""1 of RPMI-O containing 50""g/mL of streptavidin and incubated in a
C water bath for 0 , 5 , or 10 minutes. As a positive control , cells were stimulated
with PMA (2.5ng/mL) and Ionomycin (375ng/mL) for 15 minutes at 37 C. Ice-cold IX
185
PBS containing 20mM NaF and ImM Na3 V04 was added to stop the reactions. Cells
were quickly spun and lysed for 15 minutes on ice in lysis buffer containing 25mM
Hepes (pH 7.5), 150mM NaCI, ImM EDTA, ImM EGTA 1% Triton X- I00 , ImM
PMSF , ImM Na3 , and 10 g/mL leupeptin. Totallysates were cleared and resolved
by 10% SDS-PAGE, transferred to an Immobilon-P membrane (Milipore , Bedford
MA), blocked, and blotted for Phospho-p44/42 MAP Kinase or Phospho-SAPK/JNK
(Cell Signaling, Beverly, MA). Following incubation with an HRP-conjugated secondary
antibody, membranes were developed by ECL, stripped, and re-probed for total p44/42
MAP Kinase or SAPKlJNK protein (Cell Signaling).
In chapter IV, for the analysis of Tec family protein levels, 3.5x106 cells were removed
from culture at indicated time points and lysates prepared as described below. The AE7
Thl clone (gift from Vijay Kuchroo) (252) and lysates from Rlk/-Itk/- were used as
positive and negative controls, respectively. For the analysis of signaling events
following TCR cross-linking, 5C.C7 Itk+/- RAG-/- and 5C.C7 Itk-/- RAG-/- Thl and Th2
cells were restimulated on Day II following primary stimulation as follows. Cells were
incubated on ice in120 L ofRPMI-O containing 25 g/mL ofbiotinylated a-CD3E for 10
minutes, quickly spun, and resuspended in 120 1 of RPMI-O containing 50 g/mL of
streptavidin and incubated in a 37 C water bath for 0, I , or 2 minutes. Ice-cold IX PBS
containing 20mM NaF and ImM Na3 was added to stop the reactions. Cells were
quickly spun and lysed on ice in buffer containing 25mM Hepes (pH 7.5), 150mM NaCI
ImM EDTA, ImM EGTA 1% Triton X- I00, ImM PMSF , ImM Na3V04, 10 g/mL
aprotinin, and 1 g/mL leupeptin for 15 minutes. Celllysates were cleared and run on a
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10% SDS-PAGE , transferred to an Immobilon-P membrane (Milipore, Bedford, MA),
blocked, and blotted with the indicated antibody in 1% BSA. For Tec family protein
levels , membranes were blotted with anti-Itk (lOB2 and 2Fl2 mAb mix)(253), or anti-
Rlk (Santa Cruz). For the examination of signaling events in wild type and Itk-/- Thl and
Th2 cells, membranes were blotted for Phospho-783 PLC-yl (Biosource International), or
Phospho-p44/42 MAP Kinase (Cell Signaling, Beverly, MA). Following incubation with
an HRP-conjugated secondary antibody, membranes were developed by ECL, stripped
and re-probed for total PLC-yl protein (Upstate Biotech, Inc.), p44/42 MAP Kinase
(Cell Signaling), or anti-Itk (lOB2 and 2F12 mAb mix)(253J.
Real-time Quantitative PCR
In chapter II, purification of naIve CD4+ T cells was performed by staining MACS-
purified CD4+ cells with anti-CD4-Cy and anti-CD44-FITC , and sorting for CD4+ CD44
cells on a Becton Dickinson F ACS Star. 2 X sorted cells were incubated in media
containing 5!-g/mL of biotinylated anti-CD3E for 20 minutes on ice, followed by
resuspension in media containing 2.5!-g/mL of streptavidin and 5ng/mL of IL-2 for 0 , 6
, or 48 hours in a 24-well plate. For secondary stimulations, 2 X previously
activated T cells were restimulated as above for 0 , I , 2 , 4 or 6 hours.
In chapter IV , for the analysis of cytokine gene expression during secondary stimulation
3xl0 T cells were restimulated with 5xl05 CH27 cells and the indicated concentrations
of MCC93- 103 in a 48-well plate for 6 hours. For the analysis of gene expression levels of
IFN-y, IL- , T-bet, and GATA-3 after the primary stimulation, 4xl0 purified naIve
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CD4+ T cells were stimulated with 3xl0 Mitomycin C-treated CH27 cells and the
indicated concentration of peptide for either 0 , 12 , or 24 hours in a 96-well plate. For the
analysis of Tec family members during T cell differentiation, CD4+ T cells were skewed
as above, and cells were removed from culture at the indicated time points.
Following each time point, cells were removed from the plate and total RNA was isolated
using the Qiagen RNeasy kit (Valencia, CA) according to the manufacturer s protocol.
Following DNAse treatment (Promega, Madison, WI), RNA was reverse transcribed into
cDNA using Superscript II and Random Hexamers (Invitrogen, Carlsbad, CA) according
to the manufacturer s protocol. Real-time quantitative PCR amplification was performed
on a Bio-Rad iCycle?M. using SYBRCI Green PCR Core Reagents (PE Applied
Biosystems, Foster City, CA). To quantify the amount of cDNA for an individual
transcript, SYBRCI Green fluorescence, was measured at the end of each cycle. The
cycle threshold (C ), the cycle at which exponential growth of the PCR product is first
detected, was determined for known concentrations of plasmid DNA, and a standard
curve was created. Template copy numbers were calculated for each sample by
interpolating the C values on the standard curve using the iCyclerTM software. All
samples and standards were run in triplicate for any given experiment. In chapter the
values of FasL, Egr3 , and Egr2 were nOlmalized to f3-actin by dividing the average copy
number of the respective transcript by the average copy number of f3-actin in the
respective sample. From g of RNA, we consistently found there to be approximately 5
XI 0 copies of f3-actin in naive cells and 1.3 X 10 copies in restimulated cells.
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F or details of the PCR reactions presented in chapter II refer to (71 J. For PCR reactions
presented in chapter IV, template DNA was initially denatured at 95 C for 10 min
followed by 40 cycles of denaturation at 95 C for 25s , 25s of primer annealing at 62
58 o , 60 , 59 , 53 o , 60 , 61.7 , 54 , 58 , or 63 C for -actin, GAPDH
GATA- , T-bet, c-MAF, Itk, Rlk, Tec, IFN-y, and IL-4 respectively, and lastly a 25s
extensions step at 72 C. Primers sequences were as follows -actin sense 5'
CGAGGCCCAGAGCAAGAGAG- , antisense 5' -CGGTTGGCCTT AGGGTTCAG-
GAPDH sense 5' ATGTGTCCGTCGTGGATCTGA- , antisense 5' CCTGCTTCACC
ACCTTCTTGA T - , IFN-y sense 5' -CCTGCAGAGCCAGA TT A TCTC- , antisense
5' -CCTTTTTCGCCTTGCTGTTGC- , IL-4 sense 5' -CGAAGAACACCACAGAGAG
TGAGCT- , antisense 5' GACTCATTCATGGTGCAGCTTATCG- , GATA-3 sense
5' -GAAGGCAGGGAGTGTGTGAA- , antisense 5' TGTCCCTGCTCTCCTTGCTG-
, T-bet sense 5' GGGCTGCGGAGACATGCTGA- , antisense 5' GGCTCGGGATA
GAAGAACG- , c-MAF sense 5' AGCAGTTGGTGACCATGTCG- , antisense 5'
TGGAGA TCTCCTGCTTGAGG- , Itk sense 5' -CTCCGCT A TCCAGTTTGCTCC-
antisense 5' -GTCCTTGTTGAGCCAGT AGCC- , Rlk sense 5' TCAA TCCAACAGA
GGCGGG- , antisense 5' CCGCTCTCTTCAGTGCCAA- , Tec sense 5' GTTTGGA
GTGGTGAGGCTT- , antisense 5' GGTAACGATGTAGATGGGC- Specific
products were verified by melt-curve analysis and gel electrophoresis. For the generation
of standard curves , plasmids containing cDNA clones of Egr3 (gift from Jeffrey
Milbrandt, Washington University School of Medicine, St. Louis, MO), FasL (gift from
Ann Marshak-Rothstein, Boston University Medical Campus, Boston, MA), and -actin
(gift from Rachel Gerstein, University of Massachusetts Medical School, Worcester
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MA) were utilized. A 190bp fragment of Egr2 (135-324) was cloned into pGEM(I- T
Easy (Pro mega) and used for the generation of a standard curve , GAT A - 3 (gift from Ken
Murphy, Washington University School of Medicine , St Louis, MO), T-bet (gift from
Nezih Cereb of Histogenetics, Inc. and Center for Genetic Polymorphisms , Hawthorne
NY), c-MAF (gift from Laurie Glimcher, Harvard School of Public Health, Rlk (gift from
Pam Schwartzberg, National Institutes of Health, Bethesda, MD), IFN-y (gift from
Anjana Rao, Harvard Medical School), and IL-4 (gift from Mark Bix, University of
Washington, Seattle, W A) were used. Full-length cDNA clones of Itk and Tec were
generated in our laboratory (254, 255).
SEB-induced deletion in vivo
Itk+/- and Itk/- littermates were injected intravenously with 75!-g of SEB (Toxin
Technology, Sarasota, FL) on Day O. Mice were tail bled on days - , 3 , 7, 11 , and 15
into Alsever s solution. Following red blood cell lysis , cells were stained with anti-
Vj38. 1/8. FITC or anti-Vj36-FITC, and anti-CD4-PE. Ten thousand live CD4+ events
were collected on a flow cytometer and the percentage of CD4+ cells expressing Vj38 or
Vj36 was determined.
Isolation of Splenic Dendritic Cells
Spleens from either wild type or Itk/- mice were removed, teased apart with forceps , and
collagenase digested in RPMI-2% FCS with DNAse at 37 C for 40 minutes. 10mM
EDT Awas added for the last 5 minutes. Cells were pipetted vigorously, and then fitered
over a wire mesh and a nylon mesh into a fresh tube. Following two washes in
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HBSS/EDTA/CS , cells were resuspended in cold 14.5% Nycodenz (Sigma), and spun
for 15 minutes at 1500g at 4 C. The low density fraction was obtained from the interface
which contains approximately 30% CD 11 c + cells.
Cytokine ELISA
5xl0 T cells that were initially stimulated in Thl- and Th2-skewing conditions were
restimulated with 5xl0 CH27 cells and the indicated concentrations ofMCC93- 103 for 
hours in a 96-well plate. Supernatants were serially diluted and assayed for IFN-y, IL-
IL- , and IL- I0 using cytokine detection kits from Becton Dickinson.
191
CHAPTER VII.
REFERENCES CITED
192
Schwart, RH. lymphocyte recognition of antigen in association with gene
products of the major histocompatibility complex. Ann. Rev. Immunol. , 1985.
237-261.
Smith, K.A. lnterleukin 2. Annu. Rev. Immunol. , 1984. 2: p. 319-333.
Mosmann, T. , et aI. Two types o.fmurine helper T cell clone. I Definition
according to profiles of lymphokine activities and secreted proteins. J Immunol
1986. 136(7): p. 2348-57.
Kim, J. , et aI. Distinct functional phenotypes of cloned la-restricted helper T
cells. JExpMed, 1985. 162(1): p. 188-201.
Stout, RD. and K. Bottomly, Antigen-specifc activation of effector macrophages
by IFN-gamma producing (THl) T cell clones. Failure of IL- producing (TH2) T
cell clones to activate effector function in macrophages. J Immunol , 1989. 142(3):
p. 760-
Cher, D.J. and T.R Mosmann Two types of murine helper T cell clone. 
Delayed-type hypersensitivity is mediated by THI clones. J Immunol, 1987.
138(11): p. 3688-94.
Killar, L. , et aI. Cloned, la-restricted T cells that do not produce interleukin 4(IL
4)/B cell stimulatory factor 1 (BSF- l) fail to help antigen-specifc B cells. 
Immunol, 1987. 138(6): p. 1674-
Locksley, RM. , et aI. Induction ofThl and Th2 CD4+ subsets during murine
Leishmania major infection. Res Immunol , 1991. 142(1): p. 28-32.
Sadick, M. , et aI. Murine cutaneous leishmaniasis: resistance correlates with
the capacity to generate interferon-y in response to leishmania antigens in vivo. 
10.
ImmunoI. , 1986. 136: p. 655-661.
Nakamura, T. , et aI. Polarization of IL-4- and IFN-gamma-producing CD4+ T
cells following activation of naive CD4+ T cells. J Immunol, 1997. 158(3): p.
1085-94.
11. Neurath, M. , S. Finotto, and L.H. Glimcher The role of ThllTh2 polarization in
mucosal immunity. Nat Med, 2002. 8(6): p. 567-73.
Lafaile, J. The role of helper T cell subsets in autoimmune diseases. Cytokine12.
Growth Factor Rev, 1998. 9(2): p. 139-51.
193
20.
21.
22.
23.
24.
25.
13. Brumeanu, T. , C.A. Bona, and S. Casares T-cell tolerance and autoimmune
diabetes. Int Rev Immunol, 2001. 20(2): p. 301-31.
Robinson, D. Th-2 cytokines in allergic disease. Br Med Bull, 2000. 56(4): p.14.
956-68.
15. Lenardo , M. , et aI. Mature T lymphocyte apoptosis-- immune regulation in a
dynamic and unpredictable antigenic environment. Annu Rev Immunol, 1999. 17:
16.
17.
221-53.
Nagata, S. Fas ligand- induced apoptosis. Annu Rev Genet, 1999. 33: p. 29-55.
Fisher, G. , et aI. Dominant interfering Fas gene mutations impair apoptosis in
a human autoimmune lymphoproliferative syndrome. Cell, 1995. 81(6): p. 935-46.
18. Rieux-Laucat, F. , et aI. Mutations in Fas associated with human
lymphoproliferative syndrome and autoimmunity. Science, 1995. 268(5215): p.
1347-
19. Watanabe-Fukuaga, R. , et aI. Lymphoproliferation disorder in mice explained
by defects in Fas antigen that mediates apoptosis. Nature, 1992. 356(6367): p.
314-
Chan, AC. , et aI. The zeta chain is associated with a tyrosine kinase and upon T-
cell antigen receptor stimulation associates with ZAP- 70, a 70-kDa tyrosine
phosphoprotein. Proc Natl Acad Sci USA, 1991. 88(20): p. 9166-70.
Weiss , A. , et aI. Signal transduction by the T cell antigen receptor. Semin
Immunol, 1991. 3(5): p. 313-24.
Irving, B.A. and A. Weiss The cytoplasmic domain of the T cell receptor zeta
chain is suffcient to couple to receptor-associated signal transduction pathways.
Cell, 1991. 64(5): p. 891-901.
Romeo et aI. Activation of immune system effector function by T-cell or Fc
receptor intracellular domains. Cold Spring Harb Symp Quant BioI , 1992. 57: p.
117-25.
Iwashima, M. , et aI. Sequential interactions of the TCR with two distinct
cytoplasmic tyrosine kinases. Science, 1994. 263(5150): p. 1136-
Hatada, M. , et aI. Molecular basis for interaction of the protein tyrosine kinase
ZAP- 70 with the T-cell receptor. Nature, 1995. 377(6544): p. 32-
194
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
Straus, D.B. and A. Weiss Genetic evidence for the involvement of the lck
tyrosine kinase in signal transduction through the T cell antigen receptor. Cell
1992. 70: p. 585-593.
Williams , C.M. and S.J. Gall The diverse potential effector and
immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol
2000. 105(5): p. 847-59.
Chan, A. , et aI. ZAP-70 deficiency in an autosomal recessiveform of severe
combined immunodeficiency. Science, 1994. 264(5165): p. 1599-601.
Veri, M. , et aI. Membrane raft-dependent regulation of phospholipase
Cgamma- l activation in T lymphocytes. Mol Cell Bioi, 2001. 21(20): p. 6939-50.
Finco , T. , et aI. LAT is required for TCR-mediated activation of PLCgamma1
and the Ras pathway. Immunity, 1998. 9(5): p. 617-26.
Wiliams, B.L. , et aI. Genetic evidence for diferential coupling of Syk family
kinases to the T-cell receptor: reconstiution studies in a ZAP- 70-deficient Jurlct
T- cell line. Mol Cell Bioi, 1998. 18(3): p. 1388-99.
Mano , H. , et aI. A novel protein-tyrosine kinase, tec, is preferentially expressed
in liver. Oncogene, 1990. 5(12): p. 1781-
Thomas , J. , et aI. Colocalization of X- linked agammaglobulinemia and X-
linked immunodeficiency genes. Science, 1993. 261(5119): p. 355-
Tsukada, S. , et aI. Deficient expression of a B cell cytoplasmic tyrosine kinase in
human X-linked agammaglobulinemia. Cell , 1993. 72(2): p. 279-90.
Rawlings, D. , et aI. Mutation of unique region of Bruton's tyrosine kinase in
immunodeficient XID mice. Science, 1993. 261(5119): p. 358-61.
Bunnell , S. , et aI. Biochemical interactions integrating Itk with the T cell
receptor- initiated signaling cascade. J Bioi Chem, 2000. 275(3): p. 2219-30.
Yang, W. , et aI. Tec kinase signaling in T cells is regulated by
phosphatidylinositol 3-kinase and the Tec pleckstrin homology domain. 
Immunol, 2001. 166(1): p. 387-95.
Czar, M. , et aI. Biochemical and genetic analyses of the Tec kinases Itk and
Rlk/Txk. Biochem Soc Trans, 2001. 29(6): p. 863-
195
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
39. Debnath, J. , et aI. rlk/TXK encodes two forms of a novel cysteine string tyrosine
kinase activated by Srcfamily kinases. Mol Cell BioI, 1999. 19(2): p. 1498-507.
40. Takeba, Y. , et aI. Txk, a member of non receptor tyrosine kinase ofTecfamily,
acts as a Thl cell-specifc transcriptionfactor and regulates IFN-gamma gene
transcription. PG 2365- 70. J Immunol, 2002. 168(5).
Perez- Villar, J. , et aI. Nuclear localization of the tyrosine kinase ltk and
interaction of its SH3 domain with karyopherin alpha (Rchl alpha). Int Immunol
2001. 13(10): p. 1265-74.
Wilcox, H. M. and L.J. Berg, Itk phosphorylation sites are required for functional
activity in primary T cells. J Bioi Chem, 2003.
Smith, C.I. , et aI. The Tecfamily of cytoplasmic tyrosine kinases: mammalian
Btk, Bmx, ltk, Tec, Txk and homologs in other species. Bioessays , 2001. 23(5): p.
436-46.
Lewis, C.M. , et aI. Tec kinases: modulators of lymphocyte signaling and
development. Curr Opin Immunol, 2001. 13(3): p. 317-25.
Yang, W. , et aI. Tec kinases: afamily with multiple roles in immunity.
Immunity, 2000. 12(4): p. 373-82.
Miler, A.T. and L.J. Berg, New insights into the regulation and functions ofTec
family tyrosine kinases in the immune system. Curr Opin Immunol, 2002. 14(3): p.
331-40.
August, A. , et aI. CD28 is associated with and induces the immediate tyrosine
phosphorylation and activation of the Tecfamily kinase ITK/EMT in the human
Jurkat leukemic T-cell line. Proc Natl Acad Sci USA, 1994. 91(20): p. 9347-51.
Gibson, S. , et aI. Effcient CD28 signallng leads to increases in the kinase
activities of the TECfamily tyrosine kinase EMT/ITK/TSK and the SRCfamily
tyrosine kinase LCK. Biochem J, 1998. 330(Pt 3): p. 1123-
Michel , F. , et aI. CD28 as a Molecular Amplifer Extending TCR Ligation and
Signaling Capabilties. Immunity, 2001. 15(6): p. 935-45.
Brazin, K.N. , et aI. Regulation of the tyrosine kinase ltk by the peptidyl-prolyl
isomerase cyclophiln A. Proc Natl Acad Sci USA, 2002: p. in press.
196
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
Vihinen, M. and e. aI. BTKbase: a database of XLA-causing mutations.
ImmunoI. Today, 1995. 16: p. 460-465.
Desiderio , S. Role of Btk in B cell development and signaling. Curr Opin
Immunol, 1997. 9(4): p. 534-540.
Khan, W. , et aI. Defective B cell development andfunction in Btk-deficient
mice. Immunity, 1995. 3(3): p. 283-99.
Rigley, K.P. , et aI. Analysis of signaling via surface immunoglobulin receptors
on B cellsfrom CBA/N mice. Eur J Immunol, 1989. 19(11): p. 2081-
Fluckiger, A.c. , et aI. Btk/Tec kinases regulate sustained increases in
intracellular Ca2+ following B-cell receptor activation. Embo J, 1998. 17(7): p.
1973-85.
Takata, M. and T. Kurosaki A role for Bruton 's tyrosine kinase in B cell antigen
receptor-mediated activation of phospholipase C-gamma 2. J Exp Med, 1996.
184(1): p. 31-40.
Tomlinson, M. , et aI. A conditonal form of Bruton s tyrosine kinase is
suffcient to activate multiple downstream signaling pathways via PLC Gamma 2
in B cells. BMC Immunol, 2001. 2(1): p. 4.
Heyeck, S.D. and L.J. Berg, Developmental regulation of a murine T cell-specifc
tyrosine ldnase gene, Tsk. Proc. NatI. Acad. Sci. USA, 1993. 90: p. 669-673.
Schaeffer, E. , et aI. Requirementfor Tec kinases Rlk and ltk in T cell receptor
signaling and immunity. Science, 1999. 284(5414): p. 638-41.
Liu, K.Q. , et aI. T cell receptor-initiated calcium release is uncoupled from
capacitative calcium entr in ltk-deficient T cells. J Exp Med, 1998. 187(10): p.
1721-
Perez- Vilar, J.J. and S.B. Kanner Regulated association between the tyrosine
kinase Emt/ltk/Tsk and phospholipase- C gamma in human T lymphocytes. 
Immunol, 1999. 163(12): p. 6435-41.
Sommers , c.L. , et aI. A role for the Tec family tyrosine kinase Txk in T cell
activation and thymocyte selection. J Exp Med, 1999. 190(10): p. 1427-38.
197
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
Schneider, H. , et aI. Resting lymphocyte kinase (Rlk/Txk) targets lymphoid
adaptor SLP- 76 in the cooperative activation ofinterleukin-2 transcription in T-
cells. J BioI Chem, 2000. 275(6): p. 3835-40.
Schaeffer, E.M. , et aI. Tec Family Kinases Modulate Thresholds for Thymocyte
Development and Selection. J Exp Med, 2000. 192(7): p. 987- 1000.
Shibasaki , F. , et aI. Role ofkinases and the phosphatase calcineurin in the
nuclear shuttling of transcription factor NF-AT4. Nature , 1996. 382(6589): p.
370-373.
Timmerman, L.A. , etaI. Rapid shuttling ofNF-AT in discrimination ofCa2+
signals and immunosuppression. Nature, 1996. 383: p. 837- 840.
Nishizuka, Y. Protein kinase and lipid signalingfor sustained cellular
responses. Faseb J, 1995. 9(7): p. 484-96.
Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and
activation ofprotein kinase C. Science, 1992. 258(5082): p. 607- 14.
Macian , F. , C. Garcia-Rodriguez, and A Rao Gene expression elicited by NFAT
in the presence or absence of cooperative recruitment of Fos and Jun. PG - 4783-
95. Embo J, 2000. 19(17).
Macian, F. , C. Lopez-Rodriguez, andA. Rao Partners in transcription: NFAT
and AP- l. Oncogene, 2001. 20(19): p. 2476-89.
Miller, AT. and L.J. Berg, Defective FasL expression and activation-induced cell
death in the absence of Itk. J. ImmunoI. , 2002: p. in press.
Schaeffer, E. , et aI. Mutation ofTec family kinases alters T helper cell
diferentiation. Nat Immunol, 2001.
Liu, K.Q. Role of Itk in T cell activation and signal transduction in Division of
Medical Sciences. 1998 , Harvard University: Cambridge, MA. p. 156.
Fowell , D. , et aI. Impaired NFATc translocation andfailure ofTh2
development in Itk- deficient CD4+ T cells. Immunity, 1999. 11(4): p. 399-409.
Ellmeier, W. , et aI. Severe B cell deficiency in mice lacking the tec kinase family
members Tec and Btk. J Exp Med, 2000. 192(11): p. 1611-24.
Liao , X.C. and D.R. Littan Altered T cell receptor signaling and disrupted T
cell development in mice lacking Itk. Immunity, 1995. 3(6): p. 757-69.
198
77.
78.
79.
82.
83.
84.
85.
86.
87.
88.
Donnadieu, E. , et aI. Diferential roles of Lck and Itk in T cell response to antigen
recognition revealed by calcium imaging and electron microscopy. J Immunol
2001. 166(9): p. 5540-
Acuto, O. and D. Cantrell T cell activation and the cytoskeleton. Annu Rev
Immunol, 2000. 18: p. 165-84.
Monks, C. , et aI. Three-dimensional segregation of supramolecular activation
80.
clusters in T cells. Nature, 1998. 395(6697): p. 82-
Baba, Y. , et aI. Involvement of wiskott-aldrich syndrome protein in B-cell
81.
cytoplasmic tyrosine kinase pathway. Blood, 1999. 93(6): p. 2003- 12.
Bunnell, S. , et aI. Identifcation of Itk/Tsk Src homology domain ligands. 
Bioi Chem, 1996. 271(41): p. 25646-56.
Woods, M. , et aI. A novel function for the Tecfamily tyrosine kinase Itk in
activation of beta integrins by the T-cell receptor. Embo J, 2001. 20(6): p. 1232-
44.
Tsoukas , C.D. , et aI. Itk/Emt: a link between T cell antigen receptor-mediated
Ca2+ events and cytoskeletal reorganization. Trends Immunol , 2001. 22(1): p.
17-20.
Lucas , J. , L.O. Atherly, and L.J. Berg, The absence of Itk inhibits positive
selection without changing lineage commitment. J Immunol , 2002. 168(12): p.
6142-51.
Bachmann, M. , D.R. Littman, and x.c. Liao Antiviral immune responses in
Itk-deficient mice. J Virol, 1997. 71(10): p. 7253-
Binder, D. and T.M. Kundig, Antiviral protection by CD8+ versus CD4+ T cells.
CD8+ T cells correlating with cytotoxic activity in vitro are more effcient in
antivaccinia virus protection than CD4-dependent IL. J Immunol , 1991. 146(12):
4301-
Kagi, D. , et aI. Cytotoxicity mediated by T cells and natural killer cells is greatly
impaired in perforin-deficient mice. Nature, 1994. 369(6475): p. 31-
Kagi, D. , et aI. The roles of perf orin- and Fas-dependent cytotoxicity in
protection against cytopathic and noncytopathic viruses. Eur J Immunol , 1995.
25(12): p. 3256-62.
199
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
Kundig, T.M. , et aI. Fewer protective cytotoxic T-cell epitopes than T-helper-cell
epitopes on vesicular stomatitis virus. J Viral, 1993. 67(6): p. 3680-
Ramshaw, I. , et aI. Expression of cytokines by recombinant vaccinia viruses: a
model for studying cytokines in virus infections in vivo. Immunol Rev, 1992. 127:
p. 157-82.
Bachmann, M. , et aI. How many specifc B cells are needed to protect against a
virus? J Immunol , 1994. 152(9): p. 4235-41.
Bachmann, M. , H. Hengarter, and R.M. Zinkemagel T helper cell-
independent neutralizing B cell response against vesicular stomatitis virus: role
of antigen patterns in B cell induction? Eur J Immunol , 1995. 25(12): p. 3445-51.
Lefrancois, L. Protection against lethal viral infection by neutralizing and
nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo. 
Virol, 1984. 51(1): p. 208- 14.
Fowell , D. , et aI. Impaired NFATc translocation andfailure ofTh2
development in Itk- deficient CD4+ T cells. Immunity, 1999. 11(4): p. 399-409.
Scott, P. and C.A. Hunter Dendritc cells and immunity to leishmaniasis and
toxoplasmosis. Curr Opin Immunol, 2002. 14(4): p. 466-70.
Eischen, C.M. , et aI. ZAP- 70 tyrosine kinase is requiredfor the up-regulation of
Fas ligand in activation-induced T cell apoptosis. J Immunol , 1997. 159(3): p.
1135-
Gonzalez-Garcia, A. , et aI. Lck is necessary and suffcient for Fas-ligand
expression and apoptotic cell death in mature cycling T cells. J Immunol , 1997.
158(9): p. 4104- 12.
Faris, M. , et aI. The c-Jun N-terminal kinase cascade plays a role in stress-
induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. 
Immunol, 1998. 160(1): p. 134-44.
van den Brink, M. , et aI. The extracellular signal-regulated kinase pathway is
requiredfor activation- induced cell death ofT cells. J Bioi Chem, 1999. 274(16):
p. 11178-85.
200
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
Zhang, J. , et aI. Regulation offas ligand expression during activation-induced
cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-
terminal kinase. J Exp Med, 2000. 191(6): p. 1017-30.
Zhu, L. , et aI. Role of mitogen-activated protein kinases in activation- induced
apoptosis ofT cells. Immunology, 1999. 97(1): p. 26-35.
Vilalba, M. , et aI. Protein kinase ctheta cooperates with calcineurin to induce
Fas ligand expression during activation- induced T cell death. J Immunol, 1999.
163(11): p. 5813-
Seder, R.A. , et aI. CD28-mediated costimulation of interleukin (IL-
production plays a critical role in T cell primingfor IL-4 and interferon gamma
production. J Exp Med, 1994. 179(1): p. 299-304.
Fink, P. , et aI. Correlations between T-cell specifcity and the structure of the
antigen receptor. Nature, 1986. 321(6067): p. 219-26.
Alberola-Ila , J. , et aI. Diferential signaling by lymphocyte antigen receptors.
Annu Rev Immunol, 1997. 15: p. 125-54.
Liao , X. , et aI. ltk negatively regulates induction ofT cell proliferation by
CD28 costimulation. J Exp Med, 1997. 186(2): p. 221-
Jorgensen, lL. , et aI. Mapping T-cell receptor-peptide contacts by variant
peptide immunization of single-chain transgenics. Natue, 1992. 355(6357): p.
224-30.
Kasibhatla, S. , L. Genestier, and D.R. Green Regulation offas-ligand expression
during activation- induced cell death in T lymphocytes via nuclear factor kappaB.
J BioI Chem, 1999. 274(2): p. 987-92.
Mittelstadt, P.R. and J.D. Ashwell Cyclosporin A-sensitve transcription factor
Egr-3 regulates Fas ligand expression. Mol Cell Bioi , 1998. 18(7): p. 3744-51.
Dzialo-Hatton, R. , et aI. Diferential expression offas ligand in thl and th2 cells
is regulated by early growth response gene and nfat family members. J Immunol
2001. 166(7): p. 4534-42.
Li-Weber, M. , O. Laur, and P.H. Krammer Novel Egr/NF-AT composite sites
mediate activation of the CD95 (APO- 1/Fas) ligand promoter in response to T
cell stimulation. Eur J Immunol , 1999. 29(9): p. 3017-27.
201
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
Matsui, K. , et aI. Role of activator protein-1 in TCR-mediated regulation of the
murinefasl promoter. J Immunol, 2000. 164(6): p. 3002-
Rengarajan, J. , et aI. Sequential involvement ofNFAT and Egr transcription
factors in FasL regulation. 
Immunity, 2000. 12(3): p. 293-300.
Vassilev, A. , et aI. Bruton s tyrosine kinase as an inhibitor of the Fas/CD95
death- inducing signaling complex. J BioI Chem, 1999. 274(3): p. 1646-56.
Lenardo , M. Interleukin-2 programs mouse alpha beta T lymphocytes for
apoptosis. Nature, 1991. 353(6347): p. 858-61.
Zheng, L. , et aI. T cetl growth cytokines cause the superinduction of molecules
mediating antigen- induced T lymphocyte death. J Immunol, 1998. 160(2): p. 763-
Xiao , S. , et aI. FasL promoter activation by IL-2 through SP and NF AT but not
Egr-2 and Egr- 3. Eur J Immunol , 1999. 29(11): p. 3456-65.
Refaeli, Y. , et aI. Biochemical mechanisms ofIL-2-regulated Fas-mediated T cell
apoptosis. Immunity, 1998. 8(5): p. 615-23.
Lin 1. and A. Weiss T cell receptor signallng. J Cell Sci, 2001. 114(Pt 2): p.
243-
Ruff, V.A. and K.L. Leach Direct demonstration ofNFATp dephosphorylation
and nuclear localization in activated HT-2 cells using a specifc NFATp
polyclonal antibody. J Bioi Chem, 1995. 270(38): p. 22602-
Loh et aI. Calcineurin binds the transcriptionfactor NFAT1 and reversibly
regulates its activity. J Bioi Chem, 1996. 271(18): p. 10884-91.
Loh et aI. T-cell receptor stimulation elicits an early phase of activation and
a later phase of deactivation of the transcription factor NF AT 1. Mol Cell Bioi
1996. 16(7): p. 3945-54.
Ching, K.A. , et aI. TCR/CD3-lnduced activation and binding of Emt/ltk to linker
of activated T cell complexes: requirement for the Src homology domain. 
Immunol, 2000. 165(1): p. 256-62.
Shan, X. and R.L. Wange ltk/Emt/Tsk activation in response to CD3 cross-
linking in Jurkat T cells requires ZAP- 70 and Lat and is independent of
membrane recruitment. J BioI Chem, 1999. 274(41): p. 29323-30.
202
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
, y.W. , et aI. Interaction ofSLP adaptors with the SH2 domain ofTecfamily
kinases. Eur J Immunol , 1999. 29(11): p. 3702- 11.
, B. and M. Karin Mitogen-activated protein kinase cascades and regulation of
gene expression. Cur Opin Immunol, 1996. 8(3): p. 402- 11.
Faris, M. , et aI. Stress-induced Fas ligand expression in T cells is mediated
through a MEK kinase I-regulated response element in the Fas ligand promoter.
Mol Cell Bioi, 1998. 18(9): p. 5414-24.
Mittelstadt, P.R. and J.D. Ashwell Role of Egr-2 in up-regulation of Fas ligand
in normal T cells and aberrant double-negative lpr and gld T cells. J Bioi Chem
1999. 274(5): p. 3222-
Li-Weber, M. , et aI. A regulatory element in the CD95 (APO- lIFas) ligand
promoter is essentialfor responsiveness to TCR-mediated activation. Eur J
Immunol, 1998. 28(8): p. 2373-83.
Gashler, A. and V.P. Sukatme Early growth response protein I (Egr-I):
prototype of a zinc-jnger family of transcription factors. Prog Nucleic Acid Res
Mol Bioi 1995. 50: p. 191-224.
Kishimoto, H. and J. Sprent Strong TCR ligation without costimulation causes
rapid onset ofFas- dependent apoptosis of naive murine CD4+ T cells. 
Immunol, 1999. 163(4): p. 1817-26.
Bossu, P. , et aI. Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to
receptor-mediated tolerance and apoptosis. J Immunol, 1993. 151(12): p. 7233-
Ettinger, R. , et aI. Fas ligand-mediated cytotoxicity is directly responsible for
apoptosis of normal CD4+ T cells responding to a bacterial superantigen. 
Immunol, 1995. 154(9): p. 4302-
Russell, J. , et aI. Mature T cells of autoimmune lpr/lpr mice have a defect in
antigen-stimulated suicide. Proc Natl Acad Sci USA, 1993. 90(10): p. 4409- 13.
Wang, J.K.M. , et aI. CD4+ T cells reactivated with superantigen are both more
sensitve to FasL-mediated kiling and express a higher level of FasL. Cell
Immunol, 1997. 179(2): p. 153-64.
203
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
White, J. , et aI. The V beta-specifc superantigen staphylococcal enterotoxin B:
stimulation of mature T cells and clonal deletion in neonatal mice. Cell , 1989.
56(1): p. 27-35.
Scott, D. , W.I Kisch, and AD. Steinberg, Studies ofT cell deletion and T cell
anergy following in vivo administration of SEB to normal and lupus-prone mice. 
Immunol , 1993. 150(2): p. 664-72.
Baumler, C. , et aI. Activation of the CD95 (APO- lIFas) system in T cells from
human immunodeficiency virus type- infected children. Blood, 1996. 88(5): p.
1741-
Westendorp, M. , et aI. Sensitization ofT cells to CD95-mediated apoptosis by
HIV- i Tat and gpi20. Natue, 1995. 375(6531): p. 497-500.
Lohman, B. , B.S. Razvi , and R.M. Welsh lymphocyte downregulation after
acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions.
J Virol, 1996. 70(11): p. 8199-203.
Bonfoco , E. , et aI. Inducible nonlymphoid expression of Fas ligand is responsible
for superantigen-induced peripheral deletion ofT cells. Immunity, 1998. 9(5): p.
711-20.
Suda, T. , et aI. Expression of the Fas ligand in cells ofT cell lineage. J Immunol
1995. 154(8): p. 3806- 13.
Varadhachary, AS. , et aI. Diferential abilty ofT cell subsets to undergo
activation- induced cell death. Proc Natl Acad Sci USA, 1997. 94(11): p. 5778-
83.
, X.R. , et aI. Transcriptional regulation of Fas gene expression by GA-binding
protein and AP-i in T cell antigen receptor. CD3 complex-stimulated T cells. 
BioI Chem, 1999. 274(49): p. 35203- 10.
Bruner, T. , et aI. Activation- induced cell death in murine T cell hybridomas.
Diferential regulation ofFas (CD95) versus Fas ligand expression by
cyclosporinA andFK506. Intlmmunol, 1996. 8(7): p. 1017-26.
Baron, IL. , et aI. Surface expression of alpha integrin by CD4 T cells is
requiredfor their entry into brain parenchyma. J Exp Med, 1993. 177(1): p. 57-
68.
204
147.
148.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.
Kuchroo, V. , et aI. Cytokines and adhesion molecules contribute to the abilty
of myelin proteolipid protein-specifc T cell clones to mediate experimental
allergic encephalomyelitis. J Immunol, 1993. 151(8): p. 4371-82.
Waldner, H. , et aI. Fas- and FasL-deficient mice are resistant to induction of
autoimmune encephalomyelitis. J Immunol, 1997. 159(7): p. 3100-
Singer, G.G. and A.K. Abbas The fas antigen is involved in peripheral but not
thymic deletion ofT lymphocytes in T cell receptor transgenic mice. Immunity,
1994. 1(5): p. 365-71.
Rathmell, J. , et aI. CD95 (Fas)-dependent elimination of self reactive B cells
upon interaction with CD4+ T cells. Nature, 1995. 376(6536): p. 181-
Mueller, C. and A. August Attenuation of Immunological Symptoms of Allergic
Asthma in Mice Lacking the Tyrosine Kinase ITK. J Immunol , 2003. 170(10): p.
5056-63.
Bix, M. , et aI. Genetic regulation of commitment to interleukin production by a
CD4(+) T cell-intrinsic mechanism. PG - 2289-99. J Exp Med, 1998. 188(12).
Guermonprez , P. , et aI. Antigen presentation and T cell stimulation by dendritic
cells. Annu Rev Immunol, 2002. 20: p. 621-67.
Liu, YJ. , et aI. Dendritic cell lineage, plasticity and cross-regulation. Nat
Immunol, 2001. 2(7): p. 585-
Maldonado-Lopez, R. , et aI. CD8alpha+ and CD8alpha- subclasses of dendritic
cells direct the development of distinct T helper cells in vivo. J Exp Med, 1999.
189(3): p. 587-92.
Suss, G. and K. Shortan A subclass of dendritic cells kils CD4 T cells via
Fas/Fas-ligand- induced apoptosis. J Exp Med, 1996. 183(4): p. 1789-96.
Caux et aI. CD34+ hematopoietic progenitors from human cord blood
diferentiate along two independent dendritic cell pathways in response to GM-
CSF+TNF alpha. J Exp Med, 1996. 184(2): p. 695-706.
Lucas , J. , et aI. The role of Tec family kinases in T cell development and
function. Immunol Rev, 2003. 191: p. 119-38.
205
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.
Badou, A. , et aI. Weak TCR stimulation induces a calcium signal that triggers IL-
4 synthesis, stronger TCR stimulation induces MAP kinases that control IFN-
gamma production. PG - 2487-96. Eur J Immunol , 2001. 31(8).
Constant, S. , et aI. Extent ofT cell receptor ligation can determine thefunctional
diferentiation of naive CD4+ T cells. PG 1591-6. J Exp Med, 1995. 182(5).
Grakoui, A. , et aI. TCR-independent pathways mediate the effects of antigen dose
and altered peptide ligands on Th cell polarization. PG 1923-30. J Immunol
1999. 162(4).
Hosken, N. , et aI. The effect of antigen dose on CD4+ T helper cell phenotype
development in a T cell receptor-alpha beta- transgenic model.PG - 1579-84. J
Exp Med, 1995. 182(5).
Leitenberg, D. , et aI. CD4 regulation ofTCR signaling and T cell diferentiation
following stimulation with peptides of diferent affnities for the TCR. J Immunol
1998. 161(3): p. 1194-203.
Noble, A. , et aI. The balance of protein kinase and calcium signaling directs T
cell subset development. J Immunol , 2000. 164(4): p. 1807- 13.
Pfeiffer, c. , et aI. Altered peptide ligands can control CD4 T lymphocyte
diferentiation in vivo. J Exp Med, 1995. 181(4): p. 1569-74.
Tao, X. , et aI. Strength ofTCR signal determines the costimulatory requirements
for Thl and Th2 CD4+ T cell diferentiation. J Immunol, 1997. 159(12): p. 5956-
63.
Tao, X. , et aI. Induction of IL- producing CD4+ T cells by antigenic pep tides
altered for TCR binding. J Immunol, 1997. 158(9): p. 4237-44.
Jankovic , D. , et aI. Single cell analysis reveals that IL-4 receptor/Stat6 signaling
is not requiredfor the in vivo or in vitro development ofCD4+ lymphocytes with
a Th2 cytokine profile. J Immunol , 2000. 164(6): p. 3047-55.
Finelman, F. , et aI. Stat6 regulation of in vivo IL-4 responses. J Immunol
2000. 164(5): p. 2303- 10.
Gadue, P. and P.L. Stein NK T cell precursors exhibit diferential cytokine
regulation and require Itkfor effcient maturation. J Immunol, 2002. 169(5): p.
2397-406.
206
171.
172.
173.
174.
175.
176.
177.
178.
179.
180.
181.
182.
183.
Gibson, S. , et aI. Identifcation, cloning, and characterization of a novel human
T-cell-specifc tyrosine kinase located at the hematopoietin complex 
chromosome 5q. Blood, 1993. 82(5): p. 1561-72.
Kawakami , Y. , et aI. Activation and interaction with protein kinase of a
cytoplasmic tyrosine kinase, Itk/Tsk/Emt, on Fc epsilon RI cross-linking on mast
cells. J Immunol, 1995. 155(7): p. 3556-62.
Openshaw, P. , et aI. Heterogeneity of intracellular cytokine synthesis at the
single-cell level in polarized T helper 1 and T helper populations. J Exp Med
1995. 182(5): p. 1357-67.
Murphy, K.M. and S.L. Reiner The lineage decisions of helper T cells. Nat Rev
Immunol, 2002. 2(12): p. 933-44.
Grogan, J.L. and R.M. Locksley, T helper cell diferentiation: on again, off again.
Curr Opin Immunol , 2002. 14(3): p. 366-72.
Afkarian, M. , et aI. bet is a STATI-induced regulator ofIL-12R expression in
naive CD4+ T cells. Nat Immunol, 2002. 3(6): p. 549-57.
Lighvani, AA. , et aI. bet is rapidly induced by interferon-gamma in lymphoid
and myeloid cells. Proc Natl Acad Sci USA, 2001. 98(26): p. 15137-42.
Mullen, A. , et aI. Role ofT-bet in commitment ofTHl cells before IL-12-
dependent selection. Science , 2001. 292(5523): p. 1907- 10.
Szabo , S. , et aI. A novel transcription factor, T-bet, directs Thllineage
commitment. Cell, 2000. 100(6): p. 655-69.
Ouyang, W. , et aI. Inhibition ofThl development mediated by GATA-3 through
an IL- independent mechanism. Immunity, 1998. 9(5): p. 745-55.
Ouyang, W. , et aI. Stat6-independent GATA-3 autoactivation directs IL-
independent Th2 development and commitment. Immunity, 2000. 12(1): p. 27-37.
Usui , T. , et aI. GATA-3 Suppresses Thl Development by Downregulation ofStat4
and Not through Effects on IL-12Rbeta2 Chain or T-bet. Immunity, 2003. 18(3):
415-28.
Zhang, D. , et aI. Transcriptionfactor GATA-3 is diferentially expressed in
murine Thl and Th2 cells and controls Th2-specifc expression of the interleukin-
5 gene. J Bioi Chem, 1997. 272(34): p. 21597-603.
207
184.
185.
186.
187.
188.
189.
190.
191.
Zheng, W. and R.A. Flavell The transcriptionfactor GATA-3 is necessary and
suffcientfor Th2 cytokine gene expression in CD4 T cells. Cell, 1997. 89(4): p.
587-96.
Kim, J. , et aI. The transcription factor c-Maf controls the production 
interleukin-4 but not other Th2 cytokines. Immunity, 1999. 10(6): p. 745-51.
Leitenberg, D. and K. Bottomly, Regulation of naive T cell diferentiation by
varying the potency ofTCR signal transduction. PG - 283-92. Semin Immunol
1999. 11(4).
Boutin, Y. , et at Distinct biochemical signals characterize agonist- and altered
peptide ligand- induced diferentiation ofnaive CD4+ T cells into Th1 and Th2
subsets. J Immunol, 1997. 159(12): p. 5802-
Wulfing, et at Kinetics and extent ofT cell activation as measured with the
calcium signal. J Exp Med, 1997. 185(10): p. 1815-25.
Jorritsma, P. , J.L. Brogdon, and K. Bottomly, Role ofTCR-Induced
Extracellular Signal-Regulated Kinase Activation in the Regulation of Early IL-
Expression in Naive CD4(+) T Cells. J Immunol, 2003. 170(5): p. 2427-34.
Rabinowitz, J. , et at Altered T cell receptor ligands trigger a subset of early T
cell signals. Immunity, 1996. 5(2): p. 125-35.
Lyons , D. , et at A TCR binds to antagonist ligands with lower affnites and
192.
faster dissociation rates than to agonists. 
Immunity, 1996. 5(1): p. 53-61.
Lee, H.J. , et aI. GATA-3 induces T helper cell type (Th2) cytokine expression
and chromatin remodeling in committed Th1 cells. 
J Exp Med, 2000. 192(1): p.
105- 15.
193. Takemoto , N. , et aI. Cutting edge: chromatin remodeling at the IL-4/IL-
intergenic regulatory region for Th2-specifc cytokine gene cluster. 
J Immunol
194.
2000. 165(12): p. 6687-91.
, B. , et aI. Regulation of IL-4 expression by the transcription factor JunB
195.
during T helper cell diferentiation. Embo J, 1999. 18(2): p. 420;.32.
Ranger, A. , et at Delayed lymphoid repopulation with defects in IL- driven
responses produced by inactivation ofNF-ATc. PG 125-34. Immunity, 1998.
8(1).
208
196.
197.
198.
199.
200.
201.
202.
203.
204.
205.
206.
Ise , W. , et aI. Naive CD4+ T cells exhibit distinct expression patterns 
cytokines and cell surface molecules on their primary responses to varying doses
of antigen. J Immunol , 2002. 168(7): p. 3242-50.
Kashiwakura, J. , et aI. Txk, a nonreceptor tyrosine kinase of the Tecfamily, is
expressed in T helper type cells and regulates interferon gamma production in
human T lymphocytes. J Exp Med, 1999. 190(8): p. 1147-54.
Matsumoto , Y. , et aI. Identifcation of highly expressed genes in peripheral blood
T cells from patients with atopic dennatitis. Int Arch Allergy Immunol, 2002.
129(4): p. 327-40.
Smith, J. , Q. Tang, and lA Bluestone Partial TCR signals delivered by FcR-
nonbinding anti-CD3 monoclonal antibodies diferentially regulate individual Th
subsets. J Immunol, 1998. 160(10): p. 4841-
Fitch, F. , et aI. Diferential regulation of murine T lymphocyte subsets. Annu
Rev Immunol, 1993. 11: p. 29-48.
Tamura, T. , et aI. Early activation signal transduction pathways ofTh1 and Th2
cell clones stimulated with anti-CD3. Roles of protein tyrosine kinases in the
signal for IL-2and IL- 4 production. J Immunol, 1995. 155(10): p. 4692-701.
Gajewski, T. , S.R. Schell, and F.W. Fitch Evidence implicating utilzation 
diferent T cell receptor-associated signaling pathways by TH1 and TH2 clones. 
Immunol, 1990. 144(11): p. 4110-20.
Fanger, C. , AL. Neben , and M.D. Cahalan Diferential Ca2+ influx, KCa
channel activity, and Ca2+ clearance distinguish Th1 and Th2 lymphocytes. 
Immunol, 2000. 164(3): p. 1153-60.
Sloan-Lancaster, l , T.R. Steinberg, and P.M. Allen Selective loss of the calcium
ion signaling pathway in T cells maturing toward a T helper 
phenotype. 
Immunol, 1997. 159(3): p. 1160-
Balamuth, F. , et aI. Distinct patterns of membrane microdomain partitioning in
Th1 and th2 cells. Immunity, 2001. 15(5): p. 729-38.
Kim, H. , et aI. PDGF stimulation of inositol phospholipid hydrolysis requires
PLC-gamma phosphorylation on tyrosine residues 783 and 1254. Cell , 1991.
65(3): p. 435-41.
209
207.
208.
209.
210.
211.
212.
213.
214.
215.
216.
217.
218.
Brogdon, J. , D. Leitenberg, and K. Bottomly, The potency ofTCR signaling
diferentially regulates NFATc/p activity and early IL-4 transcription in naive
CD4+ T cells. PG - 3825-32. J Immunol, 2002. 168(8).
Hartenstein, B. , et aI. Th2 cell-specifc cytokine expression and allergen-induced
airway inflammation depend on JunB. Embo J, 2002. 21(23): p. 6321-
Das , J. , et aI. A critical role for NF-kappa B in GATA3 expression and TH2
diferentiation in allergic airway inflammation. Nat Immunol, 2001. 2(1): p. 45-
50.
Rodriguez-Palmero , M. , et aI. Triggering ofT cell proliferation through CD28
induces GATA-3 and promotes T helper type diferentiation in vitro and in vivo.
Eur J Immunol, 1999. 29(12): p. 3914-24.
Elser, B. , et aI. IFN-gamma represses IL-4 expression via IRF- J and IRF-
Immunity, 2002. 17(6): p. 703- 12.
Manickasingham, S. , et aI. Qualitative and quantitative effects ofCD28/B7-
mediated costimulation on naive T cells in vitro. J Immunol , 1998. 161(8): p.
3827-35.
Bour-Jordan, H. , et aI. CTLA-4 regulates the requirement for cytokine-induced
signals in T(H)2 lineage commitment. Nat Immunol, 2003. 4(2): p. 182-
Aguado , E. , el aI. Induction ofT helper type immunity by a point mutation in
the LAT adaptor. PG 2036-40. Science, 2002. 296(5575).
Sommers, C. , et aI. A LAT mutation that inhibits T cell development yet induces
lymphoproliferation. PG 2040-3. Science, 2002. 296(5575).
Lin, J. and A. Weiss Identifcation of the minimal tyrosine residues requiredfor
linker for activation ofT cell function. J Bioi Chem, 2001. 276(31): p. 29588-95.
Zhang, W. , et aI. Association ofGrb2, Gads, and phospholipase C-gamma J with
phosphorylated LAT tyrosine residues. Effect ofLAT tyrosine mutations on T cell
angigen receptor-mediated signaling. J Bioi Chem, 2000. 275(30): p. 23355-61.
Paz, P. , et aI. Mapping the Zap- 70 phosphorylation sites on LAT (linker for
activation ofT cells) requiredfor recruitment and activation ofsignallng
proteins in T cells. Biochem J, 2001. 356(Pt 2): p. 461-71.
210
219.
220.
221.
222.
223.
224.
225.
226.
227.
228.
229.
230.
231.
Reynolds, L.F. , et aI. Vavl transduces T cell receptor signals to the activation of
phospholipase C-gammal via phospho in os itide 3-kinase-dependent and -
independent pathways. PG 1103- 14. J Exp Med, 2002. 195(9).
Tarakovsky, A. , et aI. Defective antigen receptor-mediated proliferation of B
and Tcells in the absence ofVav. Nature , 1995. 374: p. 467-470.
Zhang, R. , et aI. Defective signallng through the T-and B-cell antigen receptors
in lymphoid cells lacking the vav proto-oncogene. Nature, 1995(374): p. 470-473.
Fischer, K. , et aI. Defective T-cell receptor signallng and positive selection of
Vav-deficient CD4+CD8+ thymocytes. Natue, 1995. 374: p. 474-477.
Crabtree, G.R. and E.N. Olson NFAT signaling: choreographing the social lives
of cells. Cell , 2002. 109 Suppl: p. S67-79.
Yoshida, H. , et aI. The transcription factor NF-ATcl regulates lymphocyte
proliferation and Th2 cytokine production. PG - 115-24. Immunity, 1998. 8(1).
Ranger, A. , et aI. Inhibitory function of two NF AT family members in lymphoid
homeostasis and Th2 development. PG - 627-35. Immunity, 1998. 9(5).
Zhou, B. , et aI. Regulation of the murine Nfatcl gene by NFATc2. J BioI Chem
2002. 277(12): p. 10704- 11.
Xanthoudaks , S. , et aI. An enhanced immune response in mice lacking the
transcription factor NFATI (published erratum appears in Science 1996 Sep
6;273(5280): 1325). Science, 1996. 272(5263): p. 892-
Hodge, M. , et aI. Hyperproliferation ' and dysregulation of IL-4 expression in
NF-ATp-deficient mice. PG 397-405. Immunity, 1996. 4(4).
Kiani, A. , et aI. Down-regulation of IL-4 gene transcription and control ofTh2
cell diferentiation by a mechanism involving NFATl. PG 849- 60. Immunity,
1997. 7(6).
Oukka, M. , et aI. The transcription factor NFAT4 is involved in the generation
and survival ofT cells. Immunity, 1998. 9(3): p. 295-304.
Peng, S. , et aI. NF ATcl and NF ATc2 together control both T and B cell
activation and diferentiation. PG 13-20. Immunity, 2001. 14(1).
211
232.
233.
234.
235.
236.
237.
238.
239.
240.
241.
242.
243.
Miller, A. T. and L.J. Berg, Defective Fas ligand expression and activation-
induced cell death in the absence of IL- inducible T cell kinase. J Immunol
2002. 168(5): p. 2163-72.
Dong, et aI. Defective T cell diferentiation in the absence of Jnkl. Science
1998. 282(5396): p. 2092-
Constant, S. , et aI. JNKI is required for T cell-mediated immunity against
Leishmania major infection. J Immunol, 2000. 165(5): p. 2671-
Kinet, J. Atopic allergy and other hypersensitvities. Curr Opin Immunol, 1999.
11(6): p. 603-
Rivera, J. , et aI. Macromolecular protein signaling complexes and mast cell
responses: a view of the organization ofIgE-dependent mast cell signaling. Mol
Immunol, 2002. 38(16- 18): p. 1253.
Kawakami, Y. , et aI. Tyrosine phosphorylation and activation of Bruton tyrosine
kinase upon FaR! cross- linking. Mol. Cell. BioI. , 1994. 14: p. 5108-5113.
Kawakami, Y. , et aI. Activation and interaction with protein kinase of a
cytoplasmic tyrosine kinase, Itk/Tsk/Emt, on FaR! cross- linking on mast cells. 
ImmunoI. , 1995. 155: p. 3556-3562.
Hata, D. , et aI. Involvement of Bruton's Tyrosine Kinase in FcepsilonR!-
dependent Mast Cell Degranulation and Cytokine Production. J Exp Med, 1998.
187(8): p. 1235-47.
Nadler, M.J. and J.P. Kinet Uncovering new complexites in mast cell signaling.
Nat Immunol, 2002. 3(8): p. 707-
Maloy, K.J. and F. Powrie Regulatory T cells in the control of immune pathology.
Nat Immunol, 2001. 2(9): p. 816-22.
Schwartz, R. Models ofT cell anergy: is there a common molecular
mechanism? J Exp Med, 1996. 184(1): p. 1-
Sloan-Lancaster, J. and P.M. Allen Altered peptide ligand-induced partial T cell
activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol
1996. 14: p. 1-27.
212
244.
245.
246.
247.
248.
249.
250.
251.
252.
253.
254.
255.
Sloan-Lancaster, J. , T.H. Steinberg, and P.M. Allen Selective activation of the
calcium signaling pathway by altered peptide ligands. J Exp Med, 1996. 184(4):
p. 1525-30.
Schwartz, R. Costimulation ofT lymphocytes: the role ofCD28, CTLA-4, and
B7/BBl in interleukin-2 production and immunotherapy. Cell, 1992. 71(7): p.
1065-
Macian, F. , et aI. Transcriptional mechanisms underlying lymphocyte tolerance.
Cell, 2002. 109(6): p. 719-31.
Salomon, B. , et aI. B7/CD28 costimulation is essentialfor the homeostasis of the
CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
Immunity, 2000. 12(4): p. 431-40.
Mohamed, A. , et aI. Nucleocytoplasmic shuttling of Bruton s tyrosine kinase. 
Bioi Chem, 2000. 275(51): p. 40614-
Egloff, A.M. and S. Desiderio Identifcation of phosphorylation sites for Bruton
tyrosine kinase within the transcriptional regulator BAP/TFll-1. J BioI Chem
2001. 276(30): p. 27806- 15.
Mahajan, S. , et aI. Transcription factor STAT5A is a substrate of Bruton I
tyrosine kinase in B cells. J Bioi Chem, 2001. 276(33): p. 31216-28.
Yelon, D. , et aI. Alterations in CD4 dependence accompany T cell development
and diferentiation. Int Immunol , 1996. 8(7): p. 1077-90.
Kovac , Z. and R.H. Schwartz The molecular basis of the requirement for antigen
processing ofpigeon cytochrome prior to T cell activation. J Immunol, 1985.
134(5): p. 3233-40.
Heyeck, S. , et aI. Lck ph osphorylates the activation loop tyrosine of the Itk
kinase domain and activates Itk kinase activity. J. BioI. Chem. , 1997. 272: p.
25401-25408.
Heyeck, S.D. and L.J. Berg, Developmental regulation of a murine T-cell-specifc
tyrosine kinase gene, Tsk. Proc Natl Acad Sci USA, 1993. 90(2): p. 669-73.
Yang, W. , et aI. Tee kinase signaling in T cells is regulated by
phosphatidylinositol 3- kinase and the Tec pleckstrin homology domain. 
Immunol, 2001. 166(1): p. 387-95.
213
APPENDIX I.
PUBLICATIONS
214
Defective Fas Ligand Expression and Activation-Induced Cell
Death in the Absence of IL-2- Inducible T Cell Kinase
Andrew T. Miler and Leslie J. Ber
The Tec famy tyrosine kiase, IL- inducible T cell kiase (Itk), plays an importt role in TCR signalg. Studies of T cell from
Itk-deficient mice have demonstrated that Itk is critical for the activation of phospholipase-Cy1, leadig to calcium mobilation
in response to TCR stiulation. Thi biochemical defect results in reduced IL-2 production by Itk-deficient T cell. To furter
characterie the downstream effects of the Itk deficiency, we crossed Itk- - mice to a TCR-trangenic lie and examed T cell
responses to stiulation by peptide plus APC. These studies show that Itk is requied for max activation of early growt
responses 2 and 3 and Fas ligand trancription after TCR stiulation. These transcriptional defects lead to reduced activation-
induced cell death of stiulated Itk- - T cell, both in vitro and in vivo. Together these studies defie an importt role for Itk
in TCR signg, leadig to cytokie gene expression and activation-induced cell death. The Journal of Immunology, 2002, 168:
2163-2172.
timulation of the TCR induces a variety of different cel-
lular responses, depending on the stage of development of
the T cell and its Ag recognition history. In matue T lym-
phocytes, stimulation of the TCR can induce cytokine production
proliferation, anergy, or programed cell death. In recent years, it
has become increasingly clear that apoptotic cell death following a
strong imune response is a major mechansm responsible for
mantaning homeostasis in the immune system. For instance, afer
prolonged activation, T cells undergo a process tenned activation-
induced cell death (AICD),3 which is mediated by the induced
expression of factors such as TNF and Fas ligand (FasL) (reviewed
in Ref. I). Activation ofT cells via their TCR induces the synthesis
of Fas (CD95), and its ligand, FasL (CD95L). The binding of Fas
to FasL initiates a cascade of intracellular events in the Fas-ex-
pressing cell that ultimately results in the apoptotic death of that
cell (reviewed in Ref. 2). The importance of this mechansm of
AICD in the imune system is exemplified by the consequences of
mutations in either the Fas or the FasL genes, which result in
uncontrolled Iymphoproliferation and autoimunity in both hu-
mans and mice (3-5).
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The signaling pathways that lead to the activation of the FasL
gene in T cells have been a major focus of investigation in recent
years. However, this pathway is stil not well understood. Several
lines of evidence have suggested that specific TCR signaling path-
ways induce the expression of FasL. For instace, Lck and ZAP-
70, members of the src and syk famly of nonreceptor protein ty-
rosine kinases, respectively, have been shown to be critical for
TCR -mediated FasL expression; in contrast, FasL expression is not
dependent on Fyn, another proximal tyrosine kinase (6, 7). Fur-
thennore, both calcineurn and members of the extracellular
signal-related kinase (ERK) MA kinase (MAK) and c-Jun
termnal kinase (JNK) families have been recognized as impor-
tant members of the signaling pathway leading to the induction of
FasL expression (8-12). In this study, we focused on the involve-
ment of a Tec famly kinase, ll- inducible T cell kinase (Itk), in
the TCR-mediated up-regulation of FasL and the subsequent in-
duction of AICD.
The importnce of Tec famly kinases in the imune system is
exemplified by Bruton s tyrosine kinase (Btk), a relative ofItk that
is expressed in B cells and mast cells. Mutations in Btk have been
linked to X-linked agamaglobulinemia in humas and X-linked
immunodeficiency (xid) in mice (13-15). Biochemical studies
have indicated a similar role for Itk and Btk in Ag receptor signal
transduction in T cells and B cells, respectively (16). Specifically,
mice deficient in Itk exhibit defects in T cell development and
function. Ths is maifested as reduced numbers of peripheral
CD4 + cells, indicating a defect in thymic positive selection, as
well as reduced cytokine production by peripheral itk- T cells
(17 18). Biochemical studies have shown that Itk-deficient CD4+
T lymphocytes are defective in proximal TCR-initiated signaling
events, such as the activation of phospholipase Cyl (pLCyI) and
calcium mobilization (17). Furennore, Fowell et al. (19) dem-
onstrated that Itk -deficient CD4 + T cells possess defects in the
nuclear translocation of NF-ATc following TCR ligation, which
consequently results in the inability to produce ll-4 and to elicit
Th2-type responses in vivo. Because NF-AT proteins are essential
transcription factors for many effector genes such as ll-2, FasL,
and CD40 ligand (CDI54), in addition to ll- , these findings sug-
gested that in the absence of Itk, other T cell effector functions that
are dependent on signals downstream ofPLCyl/Ca2+ /N-A T may
be affected.
0022- 1767/021$02.
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To furer characterize the role of Itk in CD4 + T cell effector
function, we crossed itk- mice to SC.C? TCR-transgenic mice
(20), expressing a TCR specific for a moth cytochrome c peptide
(MCC 103) bound to the MHC class II molecule, IE (21). These
mice have provided a system for examining T cell signaling events
and effector function in response to the natural receptor-ligand
interaction. In this report, we show that in addition to calcium
defects, itk- CD4+ T cells are defective in the activation of the
ERK/K and INK pathways, the expression of early growth
response (Egr) 3 and Egr2, and consequently FasL expression.
Moreover, we demonstrate the physiological consequence of these
defects in vivo, where T cells in itk- mice are unable to undergo
effcient AICD in response to a superantigen, staphylococcal en-
terotoxin B (SEB).
Materials and Methods
Mice
5C.C7 TCR trsgenic mice (22) on the BIO.BR (H-2") background were
crossed to itk -1- mice (17). itk +1- and itk -1- mice, which had been back-
crossed to the C57/BL6 background for at least eight generations, were
used for SEB injection experients. All mice used were between 6 and 12
wk of age and mataed in a specific-pathogen-free facility.
Preparation and activation of CD4+ T cells
Spleens and lymph nodes were removed from 6- to 12-wk-old 5C.C7
itk+ and 5C.C7 itk- litterates. After RBC lysis, single-cell suspen-
sions were incubated with anti-CD4-coated magnetic microbeads and
passed though LS + colums accordig to the manufactuer s protocol
(Miltenyi Biotec, Aubur, CA). Pufied CD4+ T cells were pooled and
resuspended in RPMII640 (Life Technologies, Gaithersburg. MD) sup-
plemented with 10% FCS (HyClone, Logan, UT), 2 mM L-glutae, 100
U penicilli, 100 ILg/ml streptomycin, 10 mM HEPES, and 50 I'M J3- ME.
Ths purcation routinely yielded 90-97% CD4+Yall + T cells (the
5C.C7 TCR is Vall +). For in vitro activations, I x 10 CD4+ T cells
were cultured in 24-well plates with 2 ILM 3-103 peptide (DLIA Y
LKQATK; Tufs Microchemistr Facilty, Medford, MA) plus I x 10
mitomycin C-treated (Calbiochem, La Jolla, CA) IE B7. I-expressing Chi-
nese hater ovar (CHO) cells (23). Cultues were al performed under
Thl-skewing conditions (anti-ll-4 (llLg/ml) and rll- 12 (I ng/ml; R&D
Mieapolis, MN. Afer 24 h, the cells were trferred into and expanded
in fresh medum contag 5 ng/ml ll-2 (BD PhaMigen, San Diego,
CA). Addition of IL-2 imedately on priar stiulation had no effect on
the seconda responses of itk+ or itk- cells. After stiulation, cells
were mataed in medum supplemented with ll-2 unti restiulation.
Itk+ and Itk- T cells expanded comparbly with these stiulation
conditions, and simlar numbers of cells were recovered from both types of
cultues before seconda stimulation.
Abs and flow cytometry
Cells were staed with the indicated Abs in HBSS supplemented with 3%
FCS for 30 mi on ice. Cells were then washed and analyzed on a BD
Biosciences (San Jose, CA) FACSCabur. Data were anyzed using
CellQuest software (BD Immunocytometr Systems, San Jose, CA). The
Abs and flow cytometr reagents used were anti-CD4-CyChrome (Cy),
anti- Y all-FlTC, anti- YJ38. l/8. FITC, anti- VJ36-FlTC, anti-Fas-biotin,
anti-CD69-PE, anti-CD44-FlTC, anti-CD25-PE, streptavidi-PE (BD
PhaMingen), and anti-FasL-PE (eBioscience, San Diego, CA).
In vitro proliferation assay
For prima proliferation assays, S x 10' CD4 +y all + T cells were stim-
ulated with MC 3-03 peptide plus 5 x 10' mitomycin C-treated CHO
cells expressing IE and B7. 1 in a volume of 200 ILl for 48 h. As a control
cells were stimulated with PMA (Sigm; 2.5 ng/ml) and ionomycin (Cal-
biochem; 375 ng/ml). (3H)Thymidine (NEN, Boston, MA) was added at I
ILCi/well and incubated for an additional 20 h, plates were harested oil a
Tomtec Harester 96 (Orange, CT), and (3H)thymdie incorporation was
quantified on a Triux microbeta counter (perkilmer, Wellesley. MA).
Seconda prolieration assays were performed on day 14 afer intial sti-
ulation, the point at which the cells were no longer dividig. Previously
activated cells were removed from cultue, washed, and counted, and, as in
the priar proliferation assay, S x 10' CD4+Yall + T cells were sti-
ulated. For the blockig of FasL-mediated AlCD in vitro, cells were sti-
ulated in the same conditions as above with the addition of anti-FasL
(MFL3) or an isotype control Ig (eBioscience) added at 5 ILg/ml to each
well at 0 and 20 h.
Functional assay for FasL-induced apoptosis
The induction of FasL-mediated cell death was determed by anexin
Y -FlTC (BD PhaMingen) and propidium iodide (Sigma) stag 15-20 h
afer 3 x 10 T cells were stimulated with S x 10' CHO (IE and B7.
positive) cells and MCC 103 peptide. Anti-FasL or an isotype control Ig
(5 ILg/ml) was added at 0 and agai at 10 h poststimulation where indi-
cated. Soluble FasL (sFasL) was prebound for 30 min. followed by addi-
tion of a cross-lig enhcer Ig (Alexis, San Diego, CA) at 2 h post-
stimulation. Cells were imediately analyzed by flow cytometr. Specific
apoptosis was determed by calculatig the ratio of live cells in the treated
wells to live cells in the wells incubated in the absence of MCC peptide.
Intracellular IL-2 staining
T cells (3 x IOS) were cultued with 5 x 10' (IE and B7. I-expressing)
CHO cells and MCC 103 peptide or with PMA (2.5 ng/ml) and ionomycin
(375 ng/ml) for 6 h in a 96-well plate. Golgi Stop and/or Golgi Plug (BD
PhaMigen) were added for the last 2 h. The cells were staed with
anti-Yall-FlTC and anti-CD4-Cy for 30 mi, fixed for 20 mi, then per-
meabilzed, and staed intracellularly with anti-ll- PE accordig to the
CytofixiCytoperm kit protocol (BD PhaMingen). Cells were imedately
analyzed by flow cytometr. Ten thousand CD4 +y all + events were
collected.
Calcium flux
Day 8 post-intial stiulation with peptide and APCs, 5 x 10 5C.C7
itk+ and 5C.C7 itr CD4+ cells were incubated with 3 ILg/ml fluo-
and 5 ILg/ml fura-Red (Molecular Probes, Eugene, OR) in RPMI conta-
ing 3% FCS for 45 mi. Cells were washed twice and incubated in the dak
at room temperatue for 30 mi. Cells (I x 106) were place in I ml of
C seru-free RPMI and analyzed on a BD Biosciences flow cytometer.
Baselie calcium was measured, and cells were then stimulated with anti-
CD3€-bioti (145-2Cll; 25 ILg) (BD PhaMigen) for 45 s, followed by
streptavidi (Life Technologies; 40 ILg) cross-ling for 5 mi. Ionomycin
(I ILg) was added at 6 mi. Data were anyzed by calculatig the mean
fluorescence ratio of fluo-3 and fua-Red using FACSAssistat software
(BD Biosciences).
ERK and stress-activated protein kinase (SAPK)/JNK
phosphorylation
On day 14 afer stiulation with 2 ILM MCC 3-03' 3 x 10 5C.C7 itk+
and SC.C7 itk- CD4+ T cells were incubated on ice in 120 ILl seru-free
RPMI contag 25 ILg/ml of biotiylated anti-CD3€ for 10 mi. Cells
were quickly spun and resuspended in 120 ILl seru-free RPMI contag
50 ILg/ml streptavidi and incubated in a 37 C water bath for 0, 2, 5, or 10
mi. As a positive control, cells were stiulated with PMA (2.5 ng/ml) and
ionomycin (375 ng/ml) for 15 mi at C. lee-cold 1 x PBS contag 20
mM NaP and I mM Na YO, was added to stop the reactions. Cells were
quickly spun and lysed for 15 mi on ice in lysis buffer contag 25 
HEPES (pH 7.5), 150 mM NaCI, 1 mM EDTA, 1 mM EGTA, 1 % Triton
IOO, 1 mM PMSF, 1 mM Na YO" and 10 ILg/mlleupepti. Totallysates
were cleared and resolved by 10% SDS-PAGE, tranfered to an lmo-
bilon-P membrane (Milipore, Bedord, MA), blocked and blotted for
phospho-p4/42 MAPK or phospho-SAPK/JNK (Cell Signaling, Beverly,
MA). Afer incubation with an HR-conjugated seconda Ab, membraes
were developed by ECL, strpped, and reprobed for total p4/42 MAK or
SAPK/JN protein (Cell Signalg).
Real- time quantitative PCR
Pucation of naive CD4 + T cells was performed by stang MACS-
pured CD4 + cells with anti-CD4-Cy and anti-CD44FlTC and sortg for
CD4+CD44'ow cells on a BD Biosciences FACSta. Sorted cells (2 x 106
were incubated in medium contag 5 ILg/ml biotiylate anti-CD3€ for
20 mi on ice, followed by resuspension in medum contag 2. ILg/ml
streptavidi and 5 ng/ml ll-2 for 0, 6, 18, or 48 h in a 24-well plate. For
seconda stimulations, 2 x 10 previously activated T cells were resti-
ulated as above for 0, 1, 2, 4, or 6 h. Cells were removed from the plate and
tota RNA was isolated using the Qiagen RNeasy kit (Yalencia, CA) ac-
cordig to the manufactuer s protocol. After DNase treatment (Pomega,
Madison, WI), llLg of tota RNA was reverse trscribed into cDNA using
Superscript II and Random Hexamers (Invitrogen, Carlsbad, CA) accord-
ing to the maufactuer s protocol. Rea-time quantitative PCR amplifica-
tion was perormed on a Bio-Rad iCycler using SYBR Green PCR Core
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Reagents (pE Applied Biosystems, Foster City, CA). To quantify the
amount of cDNA for an individual trscript, SYBR Green fluorescence
was measured at the end of each cycle. The cycle theshold (C;;, the cycle
at which exponential growt of the PCR product is first detected, was
detennned for known concentrations of plasmid DNA, and a stadad
cure was created Template copy numbers were calculated for each sam-
ple by interolatig the C, values on the stadad cue using the iCycler
software. Al samples and stadads were ru in trplicate for any given
experient. The values of FasL, Egr3, and Egr2 were nonnzed to f3-ac-
tin by dividig the average copy number of the respective transcript by the
average copy number of f3-acti in the respective sample. From I /-g RNA,
we consistently found there to be -5 x 10 copies of f3-actin in naive cells
and 1.3 x J08 copies in restiulated cells.
The PCR were as follows: templates were initialy denatued at 95 C for
10 mi followed by 40 cycles of denatuation at 95 C for 20 s, 25 s of
prier anealg at C, 62 C, 58 C, or 51 oc for f3-actin, FasL, Egr3, and
Egr2, respectively, and lastly a 72 C extension for 25 s. Prmers were: FasLsense 5 "TGGAACCGCTCTGATCTCTGG-3, antisense, 5' GGTT
TAGGGGCTGGTTGTTGC- ; Egr3 sense, 5' GCCCTTTGCCTGTGA
GTTCTG- , antisense. 5' CCCTTTCTCCGACTTCTTCTC- ; Egr2
sense, 5' CGTAGACAAATCCCAGTAA- , antisense, 5' TCTCTT
CTCTCCAGTCATGT- ; f3-actin sense, 5' CGAGGCCCAGAGCAA
GAGAG- , antisense, 5' CGGTTGGCCTTAGGGTTCAG- . Specific
products were veried by melt-cue analysis and gel electrophoresis. For
the generation of stadad cures, plasmids contag cDNA clones of
Egr3 (gif from J. Milbrandt, Washigton University School of Medcine,
St. Louis, MO), FasL (gi from A. Marhak-Rothtein, Boston University
Medical Capus, Boston, MA), and f3-acti (gift from R. Gerstein, Uni-
versity of Massachusetts Medical School, Worcester, MA) were used. A
190-bp frgment of Egr2 (135-324) was cloned into pGEM-T Easy (pro-
mega) and used for the generation of a stadad cure.
SEB- induced deletion in vivo
irk +1- and irk -1- littermtes were injected Lv. with 75 /-g SEB (Toxin
Technology, Sarasota, FL) on Day O. Mice were ta bled on days -1 , 3,
, 11, and 15 into Alsever s solution. Afer RBC lysis, cells were staed
with anti-Yf38. 118. FITC or anti-Yf36-FlTC and anti-CD4-PE. Ten thou-
sand live CD4 + events were collected on a flow cytometer, and the per-
centage of CD4 + cells expressing Y 138 or Y 136 was determed.
Results
Naive itk-/-CD4+ T cells have defects in lL-2 production and
proliferation in response to MHC/peptide stimulation
Numerous studies over the past few years have indicated that the
recruitment and activation of specific signaling pathways in T lym-
phocytes are determned by the nature of the TCR-peptide-MHC
interaction (reviewed in Ref. 24). Nonetheless, prior in vitro stud-
ies that have focused on elucidating the role of itk in T cell sig-
naling and effector function have largely used Abs to T cell surace
receptors, such as CD3 and/or CD28 , to trgger TCR/costimulation
signaling events. Moreover, although initial studies demonstrated
that itk-deficient CD4 + cells have functional defects in response to
anti-CD3 stimulation (17, 18), Itk has also been implicated as a
negative regulator of CD28 costimulation (2S). Therefore, we were
interested in examning the role of Itk in TCR-mediated signaling
events in response to the physiological receptor-ligand interaction.
To accomplish ths, we crossed itk- mice to mice transgenic for
the SC.C7 TCR, which is specific for a MCC peptide, MCC 3-03'
bound to MHC II IE (21, 22).
To fist determne the functional responses of TCR-transgenic
itk- T cells, purfied CD4+ T cells from SC.C7 itk+ or SC.C7
itk- mice were stimulated in vitro with MCC 103 peptide plus
APC (IE and B7. 1-expressing CRO cells). As shown in Fig. 
we found a modest (-2-fold) decrease in the Ag-induced prolif-
erative responses of itk- CD4+ T cells compared with control T
cells at all peptide concentrations tested. In contrast, stimulation
with a phorbol ester, PMA (P), plus a calcium ionophore , iono-
mycin (1), induced comparable levels of proliferation, confing
previous data indicating that these phanacological agents bypass
the itk -1- defect by directly activating the protein kinase C (pKC)/
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FIGUR 1. (A) Pued CD4 + T cells were stiulate in vitro with APCs
and the indicated concetrons of MC4Ho3 peptide or with PMA and iono-
myci (P + 1), and prolierve responses wer meaured Dat ar the aver-
ages of trplica wells. SD for the trplicate are shown as err bar along the
y-axis. and C, Pued sea itk+ and sea irk- CD+ T cells wer
stiulate for 16 h with APs and MC43-103 or with PMA and ionomyci.
Cells were then staed with anti-CD4-Cy and anti-Yall-FlTC, fied pee-abil and staed intrellularly with anti-1L2-PE. Ten thousand
CD4 +y all + events were collec on a flow cytometer. Example of raw
data; C, sw of one representative experent of th.
Ras and calcium pathways, respectively (18). Previous studies had
also indicated a defect in anti-CD3 Ab-induced IL-2 secretion
by itk- T cells. To re-examine ths issue with primar TCR-
transgenic T cells, we determned the extent of IL-2 production
by SC.C7 itk+ or SC.C7 itk- cells after stimulation with
MCC 103 peptide and APCs. For these studies, we used intra-
cellular staning of permeabilzed cells with an anti-IL-2 Ab. Fig.
I, Band C, shows the percent of cells makng detectable IL-2 afer
a I6-h in vitro stimulation. Overall, we observed a SO% reduction
in the responses of itk- CD4+ T cells compared with control T
cells. Interestingly, these rather modest differences in the percent
of responding cells, as measured by intracellular cytokine staining,
correlate with much greater differences in IL-2 secretion as mea-
sured by ELISA (data not shown). Thus, these data are in close
accordance with previously published experiments, using anti-
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CD3 or anti-CD3 plus anti-CD28 Abs, showing decreased IL-
production by naive itk- T cells (17, 18).
itk-/- CD4+ T cells proliferate more vigorously than control T
cells on secondry stimulation
Prior studies that have investigated the role of Itk in T cell signal-
ing pathways have focused primarly on the responses of naYve T
cells that lack Itk. Therefore, we were interested in determning
how itk- cells respond on secondar stimulation. To accomplish
ths, SC.C7 itk+ and SC.C7 itk- CD4+ T cells were stimulated
in vitro with 2 pM MCC 103 peptide plus APCs and expanded in
medium containing IL-2 until restimulation. In addition, to ensure
a homogeneous population of activated T cells, these stimulations
were performed in Thl-skewing conditions (IL- 12 plus anti-IL-
Ab). On cly 14 after the initial stimulation, cells were restiulated
with a range of concentrations of MCC 103 peptide plus APCs,
and T cell proliferation was assessed. Interestingly, itk -1- T cells
proliferated far more vigorously than control (itk+/- T cells on
secondary stimulation, indicating that the control T cells had either
failed to proliferate or had undergone AICD (Fig. 2A). To ensure
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FIGUR 2. and SC.C? itk+ and SC.C? itk- CD4+ T cells that
were intially stiulated with 2 ILM MCC l03 were restiulated on day
14, and proliferative responses were meaured. Cells were restiulated
on day 12 for 6 h and analyzed for lL-2 production by intrcellular stang.
C, Proliferative responses of SC.C? itk+ and SC.C? itk- CD4+ T cells
tht were restiulated in the presence of anti-FasL Ab or an isotype control
Ig (S ILglml). Abs were added at time 0 and agai at 20 h. P + I, PMA and
ionomycin; Ctl, control.
that these previously activated itk -1- T cells stil possessed defects
in IL-2 production in a secondar response, we performed intra-
cellular IL-2 staining. These assays indicated that previously ac-
tivated itk -1- T cells consistently produced reduced levels of IL-
over a wide range of peptide concentrations (Fig. 2B). These data
support the notion that itk- CD4+ T cells retain a TCR signaling
defect after secondar in vitro stimulation.
FasL up-regulation is defective in itk-/- CD4+ T cells
FasL transcription is regulated by a number of factors, including
NF-KB, NF- , AP- (fos/jun), and Egr famly members, all of
which are activated in response to TCR stimulation (26-31). A
previous study has demonstrated that itk- CD4+ T cells are im-
paired in their ability to effciently translocate cytoplasmic NF- A T
to the nucleus on TCR stimulation (19). Together with our obser-
vation that itk- T cells proliferate more vigorously on secondar
stimulation compared with itk+/- T cells, ths finding suggested
that itk -1- T cells may be impaired in the expression of FasL. As
an initial effort to assess whether proliferative differences between
control and itk- T cells were due to differences in FaslasL-
mediated AICD, we repeated the secondar in vitro proliferation
assays in the presence of a neutralizing anti-FasL Ab (Fig. 2C).
These experients indicated that the presence of anti-FasL Ab, but
not an isotype control Ab, blocked AICD and restored the prolif-
erative capacity of control (itk +1- T cells. In contrast, the anti-
FasL Ab had no effect on the proliferative responses of itk-
cells. Interestingly, at high peptide concentrations (100 nM, both
wild-type and itk- T cells undergo AICD in the presence of
anti-FasL Ab. Ths is likely due to the up-regulation of FasL in the
itk- T cells in response to very strong TCR signaling (100 nM
peptide vs 10- or 10- nM peptide), which may be more diffcult
to block with the concentrations of anti-FasL Ab used. Nonethe-
less, at lower concentrations of peptide, it appears that itk -1- 
cells fail to up-regulate FasL afer stimulation.
As an additional measure of FasL up-regulation, previously ac-
tivated T cells were restiulated with peptide and APs for 9 h
stained for surace Fas and FasL, and analyzed by flow cytometr.
As shown in Fig. 3, we observed induced surace expression of
FasL on ite T cells at all peptide concentrations, with maximal
levels at the highest peptide concentration tested (100 nM). In
contrast, itk -1- T cells failed to detectably up-regulate FasL, ex-
cept perhaps at the highest peptide concentration where a slight
shift in FasL staining can be seen. Both itk+ and itk- T cells
show no difference in the expression of Fas upon stimulation, in-
dicating that differences in AICD between control and itk-/- 
cells are not due to differences in surace expression of Fas.
To confirm that the decreased proliferative responses of itk+
T cells and the increased induction of FasL expression correlated
with increased apoptosis, itk+ and itk- T cells were stained
with anexin V and propidium iodide afer stimulation. As shown
in Fig. 4, a substantial degree of apoptosis is induced in control T
cells after peptide stimulation, whereas itk- T cells require stim-
ulation with 103- to 105 fold higher concentrations of peptide to
induce a comparable degree of apoptosis. The presence of a neu-
tralizing anti-FasL Ab was able to increase cell viability, on av-
erage, by 2. fold in stimulations of control T cells. In contrast
cell viabilty was only increased by 1.-fold when anti-FasL Ab
was included in cultues of itk- T cells. Ths observation fuer
supports the conclusion that greater levels of functional FasL are
expressed on ite compared with itk- previously activated
CD4 + T cells. These data are also consistent with a previous find-
ing that thymocytes from itk- mice are defective in activation-
induced cell death in response to anti-CD3 Ab stimulation (32).
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FIGUR 3. Previously activated SC.C7 itk+ and
SC.C7 itk- CD4+ T cells were restiulated on day
14 with APCs and the indicated concentrations of
MCC,3-103 peptide. After 9 h, cells were staed for
CD4, Vall , Fas, and FasL and analyzed by flow cy-
tometry. Ten thousand CD4+Vall + events were col-
lected. Dotted line, Nonstimulated cells; bold line, sta-
ing of stiulated cells. These data are representative of
thee independent experients.
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One previous study has indicated that another Tec kinase famly
member, Btk, functions as an inhbitor of signaling through Fas in
B cells (33). Therefore, to detennne whether signaling though
Fas is altered in itk- T cells, cells were treated with a Fas ag-
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FIGUR 4. and Previously activated SC.C7 itk+ and SC.C7
itk- CD4+ T cells were stimulated for 16 h with (wI) MCC,3-103
peptide and APCs, in the presence of anti-FasL or an isotype control Ig.
Following stimulation, cells were staed with anexin V and propidium
iodide (PI) and analyzed by flow cytometr. Example of dot plots of
anexin V vs propidium iodide fluorescence; numbers in the lower left
quadrant, percentage of live cells present at the time of analysis. Sum-
ma of data from all stiulation conditions. As a control (Ctl), cells were
stiulated with sFasL alone to ensure comparble levels of susceptibilty
with tht of Fas-mediated apoptosis of the itk +1- and itk -1- T cells. In each
case, the percentage of live cells was detennned by calculating the ratio of
live cells in the treated wells to live cells in the wells incubated in the
absence of MCC peptide.
Fas
omst, sFasL. As shown in Fig. stimulation with sFasL led to
comparable levels of apoptosis in both itk+ and itk- T cells.
These data indicate that signaling though Fas is unperturbed in
itk 
-1- T cells.
Although IL-2 is commonly recognzed as a growth-promoting
cytokine that trggers surival and proliferative signals upon bind-
ing its receptor, IL-2 can also potentiate AICD by inducing max-
imal FasL expression (34, 35). Ths is thought to occur through the
action of IL-2R-medated transcription factors such as SP-I (36).
Furhennore, IL-2R signals have also been shown to down-regu-
late Fas-associated death domain-like IL- I-converting enzyme-
like inhbitory protein (FLIP), an anti-apoptotic molecule (37).
Thus, signals through the IL-2R can cooperate with TCR signals to
provide a feedback mechanism that renders activated T cells more
susceptible to apoptotic death. In light of these data, we were in-
terested to detennne whether the reduced ability of itk- T cells
to undergo AICD was due, in par, to decreased levels of IL-
production (Fig. 2B). To address this issue, exogenous IL-2 was
added to cultures durng restimulation. We found that addition of
exogenous IL-2 did not enhance FasL-induced cell death or FasL
surace expression on itk- T cells (data not shown), indicating
that the defect in FasL expression is not secondar to the decreased
levels of IL-2 production seen in itk- CD4+ T cells. Furer-
more, because both itk+ and itk- T cells are cultued in an
excess of exogenous IL-2 durng the primar stiulation, differ-
ences in IL-2R signaling are unlikely to account for differential
expression of FasL or responsiveness to AICD durng the subse-
quent in vitro stimulations.
Calcium, ERK, and INK pathways are defective in previously
activated itk-/-CD4+ T cells
Stimulation of the TCR leads to the activation of signaling path-
ways that ultimately result in the generation of active transcription
factors leading to new gene expression (38). Previous biochemical
studies have demonstrated that Itk plays a role in the phosphory-
lation and activation of PLC)'I following stimulation of the TCR
(17, 39). Activated PLC)'I then converts the membrane phospho-
lipid, phosphatidylinositol 4 bisphosphate, into inositol 1,4,
trphosphate, an activator of calcium release chanels in the en-
doplasmic reticulum, and I diacylglycerol, an activator of the
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Ras and PKC pathways. A sustained increase in intracellular cal-
cium concentrations afer TCR stimulation leads to the cal-
cineurin-dependent dephosphorylation of cytoplasmic NF- , re-
sulting in NF-AT translocation to the nucleus (40-42). To confinn
that previously activated itk- CD4+ T cells retain the biochem-
ical defects characterized in primar resting itk- CD4+ T cells
(17), intracellular calcium mobilization was measured upon re-
stimulation of 5C.C7 itk- T cells initially stimulated with 2 pM
MCC 103 plus APCs and cultued for 10 days in exogenous IL-
As demonstrated in Fig. , itk- T cells show a significant de-
fect in calcium mobilization compared with itk+ T cells afer
stimulation through the TCR. These data indicate that previously
activated itk- T cells exhbit a comparable deficit in signaling
compared with freshly isolated ex vivo itk- T cells.
Recently, several reports focusing on Itk biochemistr have
demonstrated that Itk is recruited to the linker of activated T cells/
SH2 doman-contaning 76-kDa leukocyte protein (SLP-76) com-
plex in response to TCR signaling, thereby providing a scafold for
Itk to activate PLC'Yl, potentially by direct phosphorylation. These
data place Itk intennediate between proximal TCR signaling
events and downstream events such as the activation of the Ras
pathway (Refs. 43-46; reviewed in Ref. 16). Activated Ras is
known to activate the ERKlPK pathway, which subsequently
leads to the transcription of fos proteins, and ultimately to the
fonnation and activation of AP- I complexes (reviewed in Ref. 47).
In addition, the ERK proteins, ERKI and ERK2, have recently
been shown to playa role in AICD by inducing FasL transcription
(9). Consistent with these findings, the FasL promoter was also
found to possess taget sites for AP- I transcription complexes (30).
In light of these data, we were interested in detennning whether
the reduced ability of itk- CD4+ T cells to up-regulate FasL in
response to TCR signaling was due, in par, to defective activation
of the ERK/K pathway. As shown in Fig. 58, after anti-CD3
stimulation, itk- T cells failed to achieve maximal levels of
phosphorylated ERK proteins over the course of a lO-min stimu-
lation. In contrast, treatment with PMA and ionomycin, which by-
pass the proximal signaling events, induced comparable levels of
phosphorylated ERK in both itk+ and itk- T cells, demon-
strating that there is no intrinsic defect in the ability of the Ras
pathway to activate ERK in the absence of Itk. These data are
consistent with previous reports by Schaeffer et al. (32, 48), who
demonstrated that rlk- itk- T cells and thymocytes show a
marked reduction in ERK phosphorylation after TCR stimulation.
Activated Ras also plays a role in the activation of the MAK
kinase kinase- l/JN pathway, which is essential for transcrip-
tional activation of the FasL promoter via the activation of c-Jun
(8, 49). To fuher assess the role of Itk in the activation of the Ras
pathway and its downstream effectors, we examned the level of
JNK/SAPK phosphorylation in itk -1- cells upon TCR stimulation.
As demonstrated in Fig. 58, the activation of the JNK/SAPK path-
way is also impaired in itk- CD4+ T cells. Similar to ERK phos-
phorylation, treatment with PMA and ionomycin induced compa-
rable levels of SAPK/JNK phosphorylation in itk+ and itk-
cells. Collectively, these biochemical data strongly suggest that
itk- CD4+ T cells are unlikely to accumulate nonnallevels of
active c-Fos and c-Jun and thus are likely to have reduced levels of
AP- l complexes after TCR stimulation.
Reduced Egr2, Egr3, and FasL transcription after TCR
stimulation of itk 
/- 
T cells
Several transcription factors such NFAT, NF-KB , Egr2, as well as
Egr3 , have been implicated in the TCR-mediated activation of the
FasL promoter. In fact, the FasL promoter contans consensus se-
quences for NF- , NF-KB, and Egr, as well as the AP- l factors,
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FIGUR 5. SC.C7 ite and SC.C7 itk- CD4+ T cells were
loaded with fluo-3 and fu-Red on day 10 post-intial stimulation with 2
I'M MCC 103 peptide. Intracellular calcium was then measured in re-
sponse to anti-CD3 Ab cross-ling, followed by ionomycin (lono.) sti-
ulation. Data are displayed as the ratio of fluo-3 to iua-Red fluorescence.
Previously activated SC.C7 itk+ and Sc.a itk- CD4+ T cells were
restiulated on day 14 by anti-CD3 Ab cross-linkg for 0, 2, 5, or 10 mi.
As a control, cells were treated with PMA and ionomycin (P+ 1) for IS
mi. Tota Iysates were imunoblotted with an anti-phospho-ERK (p-
ERKI and 2) or an anti-phospho-SAPK/JNK (p-SAPK/JNK) Ab. The
membrae was strpped and reprobed for ERK or SAPK/JNK protein
respectively.
Fos, and c-Jun (27, 29, 50, 51). The Egr2 and Egr3 genes are
nonnally expressed at low basal levels in resting T cells, and are
transcriptionally induced following TCR stimulation (52). Furer-
more, the Egr2 and Egr3 promoters themselves are targets of
NF-A T proteins and in tur function as strong trans activators of
the FasL promoter (31). Consistent with these findings, the over-
expression of either Egr2 or Egr3 in T cell hybridomas or HeLa
cells induces FasL transcription (27, 50). Additional evidence also
indicates that the induction of Egr2 and Egr3 transcription, and
consequently FasL expression, is inhibited by the calcineurin in-
hibitor, cyclosporin A (27, 50). Despite these compelling data,
there have been conflicting results regarding which factor, Egr2 or
Egr3, is more critical for FasL transcription. Nonetheless, the bulk
of the evidence indicate that NF-A T and Egr factors act synergis-
tically in the activation of the FasL promoter.
Recent studies have demonstrated that itk- CD4+ T cells are
defective in the nuclear translocation of NF-AT upon TCR stim-
ulation (19); fuennore, dominant-negative ltk can inhbit TCR-
induced NF-AT-dependent transcription (43). Given these obser-
vations and the fact that the Egr2 imd Egr3 promoters are regulated
by NF-AT, we reasoned that Egr2 and Egr3 transcription might be
defective in itk- T cells, resulting in impaired FasL transcrip-
tion. To test this idea, we used real-time quantitative PCR analysis
to detennne the mRA levels of Egr2, Egr3, FasL, and l3-actin in
resting and stimulated T cells.
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Since Fas-dependent death can occur at low levels in naive
CD4 + T cells upon strong stimulation of the TCR within the first
18 h (53), we first sought to detennne the expression levels of
the Egr2, Egr3, and FasL transcripts in naive 5C.C7 itk+
itk- CD4+ T cells that were stimulated with anti-CD3 Ab for 0,
, 18, or 48 h. For these experiments, CD4+CD441ow T cells were
sorted from mice of each genotype, to prevent ambiguities caused
by the presence of activated/memory T cells in the unsorted pop-
ulations. For the analysis of previously activated T cells, 5C.C7
itk+ and 5C.C7 itk- CD4+ T cells were stimulated with 2JLM
MCC 103 peptide plus APCs in ThI-skewing conditions and then
expanded in IL-2. These cells were then restimulated on day 14
with anti-CD3 Ab for 0, I, 2, 4, and 6 h.
Fig. 6A shows an example of raw data obtaned from ths anal-
ysis. The amount of PCR product present, as measured by fluo-
rescence intensity, is indicated for each PCR cycle. As can be seen
the j3-actin curves for both samples (itk+ and itk- are vir-
ally superimposable, indicating nearly identical amounts of cDNA
in these samples. In contrast, the FasL cures do not superipose,
indicating a difference in the copy number of FasL transcripts be-
tween the stimulated itk+ and itk- T cells. By interpolation of
these data to a standard curve, absolute values for FasL copy num-
bers can be obtained for each sample. To nonnalize for the amount
of cDNA present in each sample, a ratio of the average copy num-
bers of Egr2, Egr3, and FasL to j3-actin copy numbers was calcu-
lated for each data point. The data from a representative experi-
ment of each type are shown in Fig. 6B. Ths analysis
FIGUR 6. Pued naive (CD441ow) SC.C? itk+
or SC.C? itr CD4 + T cells (2 x 10 were stimulated
with anti-CD3 Ab for 0 6, 18, and 48 h (priar). For
seconda cells, 2 x SC.C? itk+ and SC.C?
itk- CD4+ T cells were initially stimulated with 2
f.M MCC peptide plus APCs on day 0 and restimulated
with anti-CD3 Ab on day 14 for 0, 1, 2, 4, and 6 h.
Following stiulation, RNA was isolated and f.g was
reverse trscrbed into cDNA and subjected to real-
tie quantitative PCR analysis for J3-acti, FasL, Egr2,
and Egr3. Example of raw data obtaed from real-
tie quantitative PCR analysis. Dashed line, Cycle
theshold value at which individual samples were com-
pared. Egr2, Egr3, and FasL trscript levels were
detenned for naive (pri) and seconda cells.
Each sample was ru in trplicate, and the average tem-
plate copy number was detenned by interolating the
cycle theshold (CJ value on a stadad cure. These
values were nonnzed to J3-acti trascript values de-
tenned for each respective data point. The y-axis rep-
resents the ratio of Egr2, Egr3, or FasL to J3-acti in the
sample. Error bars, SD of the Egr, Egr3, or FasL values
obtaed from trplicate reactions. These data are repre-
sentative of thee independent experients. RF, Rel-
ative fluorescence unt.
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demonstrated decreased levels of Egr2, Egr3 , and FasL transcripts
in primar ex vivo itk- CD4+ T cells afer stimulation, although
the magnitude of this reduction is modest. A more strng deficit
was seen in the analysis of previously activated itk- T cells,
where we observed, on average, a 5- and 6-fold decrease in Egr2
and Egr3 levels, respectively, and a 3-fold decrease in levels of
FasL transcripts compared with the levels in the itk +1- T cells at
the peak of the response. Interestingly, these data also clearly dem-
onstrate the dramatic enhancement in TCR-mediated Egr3 and
FasL transcription in previously activated compared with naive
CD4 + T cells. For example, the peak of Egr3 expression in pre-
viously activated itk+ T cells is nearly 40-fold higher than in
naive T cells, as is the case for FasL as well. In contrast, peak Egr2
levels only increase by -2-fold in previously activated compared
with naive CD4 + T cells. These data are consistent with a more
important role in FasL transcription for Egr3 than for Egr2. To-
gether these data clearly indicate that signaling through Itk plays
an important role in the TCR-induced up-regulation of Egr factors
and that impaired expression of Egr2 and Egr3 in itk- T cells
correlates with impaired FasL expression.
CD4+ T cells in itk-/- mice are defective in AlCD in vivo
It has been well documented that mice deficient in the expression
of Fas (lpr) or FasL (gld) possess profound defects in the periph-
eral deletion of activated lymphocytes and develop severe auto-
immune disorders as a result of a failure to maintain peripheral T
cell tolerance (reviewed in Ref. 2). Furhennore, CD4 + T cells
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FIGUR 7. itk+ and itk- mice received Lv. injections of SEB on
day O. Periphera blood was drawn from the tal vein on days -1, 7, II,
and 15. Following RBC lysis, cells were staied with anti-VJ3S. lIS. FlTC
or anti-V/3FITC and anti-CD4-Cy. The percentages of VJ3S+ and VJ36+
populatons of the CD4 + subset were deered by F ACS anysis. The data
plott ar mea :: SD of independent mice anyze = 2 itk 
+/-
= 5
itk 
-/-
. These da ar repreentave of two independet experients.
from mice bearing the Ipr or gld mutations are resistant to TCR-
mediated apoptosis upon anti-CD3 or superantigen stimulation
(54-57). When injected into mice, SEB, a bacterial superantigen
selectively activates V(38+ T cells. Ths leads fist to the expansion
of V(38+ T cells, followed by a steep decline in the percentage of
these cells as a result of Fas-mediated cell death (58, 59). Thus, we
were interested in deternning whether Itk-deficient T cells would
possess defects in AICD in vivo, as a result of the defective FasL
expression we observed in vitro. To assess ths, we injected itk+
and itk- mice with SEB and examned peripheral blood T cells
on days 3, 7, II, and 15 postinjection. Fig. 7 shows the percentage
of CD4+ cells bearng V(38, or V(36 as a control, over the course
of the response to SEB. Interestingly, itk+ and itk- mice ini-
tially responded similarly to SEB, as seen by the equivalent in-
creases in V(38+CD4+ T cells on day 3 afer injection. Following
the expansion phase of the response, itk+ V(38+ T cells un-
derwent deletion, as has previously been reported. In contrast,
itk- V(38+ T cells survived to a much greater degree than
control cells, indicative of reduced AICD. Fig. 7B demonstrates
that both itk+ and itk- mice had comparable percentages of
the control V(36+CD4+ T cells, which are not reactive to SEB.
Overall, these data suggest that itk - CD4 + T cells are ineffcient
at undergoing AICD, most likely as a result of reduced FasL ex-
pression. Consistent with ths conclusion, we routinely observe a
fold increase in the proporton of CD4 + T cells with an activat-
ed/memory phenotype in itk- compared with itk+ control
mice (data not shown). However, we cannot rule out the possibilty
that the levels of lL-2 in vivo may be decreased in SEB-injected
itk- mice, thereby rendering itk- CD4+ T cells less suscepti-
ble to FasL-mediated death.
Discussion
Aberrant regulation of the Fas/FasL system has detrimental effects
on the health of an organism. Mutations in the Fas or FasL genes
result in autoimmunity and lymphadenopathy in mice and autoim-
mune Iymphoproliferative syndrome in humans (3-5). Conversely,
increased expression of FasL in ID- infected T cells has been
found to be a factor in the T cell depletion that ultimately causes
AIDS (60, 61). Curently, the signaling requirements for proper
FasL expression are not completely understood. Therefore, inves-
tigation of the molecular mechansms regulating ths pathway is
waranted. In our efforts to elucidate the role of a Tec famly ki-
nase, Itk, in CD4 + T cell effector function, we discovered that Itk
plays a crucial role in the signaling pathway that induces FasL
expression.
Previous studies by several groups have established that Itk is
important for T cell effector functions, including cytokine produc-
tion as well as the development of protective immunity to patho-
gen infections (17-19, 48). The data presented in ths aricle ad-
dress the role of Itk in T cell homeostasis, as opposed to effector
function, and demonstrate that Itk is required for effcient apoptosis
induced by TCR stimulation. These experiments fuer strengthen
the notion that Itk is a crucial component of the TCR signaling
cascade required for the transcription of genes important for proper
immune function. The physiological relevance of these findings is
reflected in the altered response of itk- mice to the
superantigen, SEB.
These results also support the notion that Itk may be involved in
setting the theshold for TCR signaling (32). In the absence of Itk,
the effciency of TCR signalng is reduced, as assessed by a varety
of biochemical and functional readouts, including reduced PLCyl
activation, calcium mobilization, MAK activation, and cytokine
production. Ths reduced signaling lowers the overall effector re-
sponse of the cell. Given that the abilty of CD4 + T cells to up-
regulate FasL is dependent on the integration of TCR signals,
itk- T cells may require more receptor stimulation to attn a
threshold of signals great enough to induce FasL up-regulation.
Ths is consistent with our observation that, at high peptide con-
centrations, itk- T cells do up-regulate low levels of FasL and
can undergo AICD.
These experiments led to the surrising finding that, durng the
initial phase of the response, itk- T cells expand comparably
with itk +1- T cells in response to SEB injection in vivo. Given that
previous studies have documented both reduced lL-2 production
and proliferation of itk -1- T cells in vitro, these findings were
somewhat unexpected. One interesting explanation for ths dis-
crepancy is the possibilty that SEB produces such a strong acti-
vation signal in naive T cells that FasL expression may be induced
early durng the activation process. Thus, the net expansion of
V(38+ T cells in the control mice may reflect the combined effects
of proliferation being offset by some apoptosis. Consistent with
this possibilty, upon infection of Ipr/lpr mice with lymphocytic
choriomeningitis virs, .there is a notable increase in the rate of
expansion of antiviral CTLs during the initial phase of the re-
sponse compared with what is typically observed in wild-type
mice (62). Thus, T cells in itk- mice may proliferate more
poorly but may also undergo less apoptosis, yielding the same net
outcome ofV(38+ T cell numbers at the peak of the response as are
found in itk+ mice.
Although our data directly demonstrate reduced transcription of
FasL in stimulated itk -1- T cells in vitro, the interpretation of the
in vivo experiments is clearly more complex. Activation-induced
cell death can involve the action of other molecules in addition to
FaslasL, such as TNF-a and Bcl-2 famly members. We have not
fully ruled out the possibilties that itk- T cells are defective in
the expression of one or more of these additional molecules and
that such differences might also contribute to the decreased AICD
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of itk -1- cells in vitro and in vivo. Studies addressing ths possi-
bility are cUlently underway. In addition, it is also possible that
itk- T cells express greater amounts of FLIP, an inhbitor of the
Fas pathway. Because IL-2R signaling inhibits FLIP transcription
(37), it is possible that reduced production of IL-2 by itk -1- T cells
in vivo may result in increased FLIP, thereby rendering itk-
cells less susceptible to Fas-mediated apoptosis. Although differ-
ences in FLIP expression in vivo between control and itk-
cells wil be interesting to examne in the future, this concern is
unlikely to be relevant to our in vitro studies, because stimulated
T cells were cultued in an excess of exogenous ll-2. Another
concern is the observation by Bonfoco et al. (63) that nonlymphoid
FasL is essential for the deletion of SEB-reactive T cells. These
investigators also demonstrated that T cell activation was neces-
sar for the induction of nonlymphoid FasL transcription. There-
fore, we cannot fully rule out the possibilty that itk- mice may
be defective in the expression of cytokine(s) or effector mole-
cule(s) necessar to induce the up-regulation of nonlymphoid
FasL. Again, this possibilty applies only to the in vivo studies and
is not relevant to our in vitro studies using purfied T cells.
Finally, we also considered the possibilty that reduced AICD in
vivo by itk- CD4+ T cells may reflect reduced activation andlor
preferential differentiation of itk -1- T cells into Th effectors that
express FasL poorly (64, 65). These possibilities were tested by
examning V(38+CD4+ T cells at the peak of the response (day 3)
after SEB injection. When examned by flow cytometry for a panel
of activation makers, both itk+ and itk- T cells showed com-
parable percentages of activated T cells. Furermore, in vitro
stimulation of these cells followed by intracellular staining for
ll-2, IF- I', and ITA indicated no increased proportion of ll-
producing cells among itk- T cells compared with controls (data
not shown). Thus, we find it unlikely that the reduced AICD we
observe in vivo in itk- mice is due to a skewed differentiation of
itk- T cells into Th effectors.
Similar to the FasL gene, the Fas gene is transcriptionally reg-
ulated by factors such as c-Fos and c-Jun. A report by Li et al.
demonstrated that, although PKC and JNK are involved in the
activation of the Fas gene upon TCR stimulation, phosphatidyl-
inositol 3-kinase, calcineurn, and ERK kinases play no role in the
signaling pathway leading to Fas transcription (66, 67). These
findings suggest that the TCR signalng pathways leading to Fas
and FasL transcription are distinct. Our data support the notion that
Itk does not playa role in the TCR-mediated up-regulation of Fas.
Another recent study indicated that Btk, a Tec kinase famly mem-
ber, acts as an inhibitor of the Fas-signaling pathway in B cells
(33). Based on our observations that itk- T cells are equally
susceptible to apoptosis afer treatment with sFasL, the possibility
that Itk plays a comparable role in the Fas-signaling pathway in T
cells seems unlikely.
On the basis of the data presented here, we speculate that itk -1-
mice may have altered susceptibility to autoimune disease. For
instance, experienta autoimmune encephalomyelitis (EAE),
which can be induced in mice upon adoptive transfer of myelin-
specific Thl cells, is a result of Th I CD4 + T cells initiating tissue
damage to the CNS (68, 69). Interestingly, mice possessing the lpr
or gld mutations are resistant to the induction of EAE (70). These
findings suggest that FasL-expressing T cells may mediate apop-
tosis within a taget tissue, thereby contrbuting to the pathology of
this disease. Given these observations, it is possible that itk-
mice may also show decreased susceptibility to EAE. Alterna-
tively, because the FaslasL pathway has been shown to be crucial
for the removal of autoreactive T cells in the periphery (71), it is
also possible that itk- mice may be more susceptible to other
types of autoimmune diseases. For instance, FasL-expressing
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CD4 + T cells have been shown to be important in the deletion of
autoreacti ve B cells (72), raising the intrguing possibility that
itk- mice might have increased susceptibility to autoantibody-
mediated autoimmune diseases.
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New insights into the regulation and functions of Tec family
tyrosine kinases in the immune system
Andrew T Miler* and Leslie J Bergt
The Tec family of protein tyrosine kinases play an imporant role
In signaling through antigen-receptors such as the TCR. BCR
and Fee receptor. Recent studies have generated new insights
into the domains in Tec kinases that tae par in intramolecular
and Intermolecular binding. Furtherore. the consequences of
these domain Interactions for Tec activation and downregulation
have ben better defined. Genetic studies of kinas-knockout
mice have emphasized the importance of Tec kinases in
lymphocyte development. differentiation and apoptosis.
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Introduction
Over the past tWenty yea, signfICant progres has ben
made in elucidating the signing pathwa that are trggered
by enggement of immune cell antigen-recptOrs, such as the
TCR, the BCR and the Fee recepr. In Iyphoc, several
protein tyosin kinaes are acva followi receptOr enge-
ment and ar crial componenlS of recptOr-induce signl
trnsduction caes. Signin patways that are initite by
thes tyosine kina ca lea to a vaiety of ourome, includ-
ing cykine prouction, clona exanion, cell differentiaton,
and apopris. A major fous of rent swdies in this area has
ben to claif the interstin and divergin branches of
antigen-recptOr siglin pathways, to provide a better under-
stading of how distinct immune ouromes are reglated .
Two of the initial cytOplasmic signling molecules that
were discovered and characterized in lymphocytes, Lck
and Fyn, were revealed to be members of the largest
family of non-receptor protein tyrosine kinaes, the Src
family. In 1990, almost twelve years following the
discvery of the Src kinase, a novel type of non-receptOr
protein tyrosine kinase, termed Tee (tyrosine kinase
expressed in hepatocellular carcinoma), was discovered in
an effort to . identify tyrosine kinases involved in hepato-
carcinogenesis (1). Shortly thereafter, several other related
proteins were discovered and grouped into what is now
recognized as the second largest family of non-receptor
tyrosine kinases, the Tec family.
In 1993, the importace ofTh family kines wa highlighte
by the discovery that point mutations or disruption in the
gene encoding one family member, Btk lead to immuno-
deficiency diseases in both humans and mice (X-linked
agamaglobulinemia (XA) and X-lined immunoeficienc
(xi, respetively) (2-4). 10 date, the Tec family consists of
eight members, onl five of which are exressed in ma-
mals: BrnEtk, BtkAtk ItkklEmt, Tec and Rlk/.
The Tec and Src family members have similar overall
structures. Whereas each Src family kinase contains a Src
homology 1 (SH1) (kinase domain), SH2 and SH3 domain
members of the Tee family possess additional domains
with distinctive functions. With the exception of Rlk, all
Tec kinases have an amino-terminal pleckstrin homology
(PH) domain, which assoiates with phosphatidylinositOl
(3,4,5)-trisphosphate (PIP ) and plays a role in targeting
the proteins to the membrane. Most Tec family members
also possess a Tec homology (TH) domain, which contains
a Zn binding Btk homology (BH) motif, followed by
one or two proline-rich region(s) (PRR). Furthermore, Tec
family kinaes lack the carboxy-terminal negative regulatory
tyrosine found in Src kinases, suggesting a distinct mode
of regulation for these proteins (see modular structure in
Figure la).
In general, Tec family kinaes are expressed in cells of the
hematopoietic lineage, but are not restricted to a particular
cell ty. For instance, Tec is expressed in all hematopoietic
cells, whereas Itk and Rlk are restricted to T lymphoctes,
NK cells and mat cells. Btk is expressed in all hematopoietic
cells, with the exception of T Iympho-cyes and plasma
cells. A more detailed description of Tee family kinas
expression patterns can be found in a recent review by
Smith et 0/. (5..). Interestingly, some Tec kinases are
expressed in cells oUlSide of the hematOpoietic lineage;
however, for the purposes of this review, we will only focus
on those expressed in the immune system.
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Domains and steady-stte Intnnolecular and
intamolecular Interactions of Tee family
Idnase. (a) Similr to Src kinase. Tee
klase posss a carb-tenninal kinase
domain. followed by an SH2 and an SH3
don. The two familie of kinase difer In
their amino-tenninal reions. Whres BIk and
Tee boh possss two PRRs. and Il and Rlk
possss one. Bmx lacks a PRR In the TH
reion. A BH domain. the funcion of which is
stli not clr. and a PH doain are amino
tennlnal 10 the PRR of BIk Tee. Il and Bmx.
Rlk is the only known Tec family member thaI
doe not posse amlnoenlnal BH and PH
domains. Instead. Rlk posssss an amino-
teinal cystne-rth re which. following
palmiloylaton. targe Rlk to the mebrane.
At the carbxyl tenlnus. Tec family kinases
lack th relator tysine found In Src family
members. (b) Steady-state Intennolecular and
Intramoleular Interactios. In thl' Inactive
state. BIk can fonn symmetrt and asymmert
homodlmers via Intennoleeular SH3 domin
and PRR Inteactios. Converly. the SH3
domain and PRR of Ilk can Interact in an
intraolular assoiati, F urtenore. 
novel assiatin of th SH2 doin and
SH3 domains of Il In an Intolular
Interacton has also been desribed: however.
wheter th Intamoleular SH3-PRR can
ocr simultaneusly wit thl'
homlmezatlon Is not knwn. References
for stdies of these domain Interctions are
descbed In the text.
Prior reviews ofTec family kinass provide excellent insights
into the mechanisms ofTec kinase activation and Tec kinase
function within the multi-molecular signalosome, the effects
of Tec kinaes on biological processes such as lymphoce
development and differentiation, and also provide detailed
comparisons ofTec family members to each other (5 7).
The first part of this review will focus on recnt insights
into the biochemical mechanism of Tec family kinase
regulation and the role of specific protein domains in
the functions of these molecules. In the second part of
this review, we wil discuss new data that demonstrate
previously unappreciated or undiscovered functions ofTec
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kinases in immune cell signaling pathways. The majoritY of
new information derives largely from analyses of Btk and
Itk. The emphasis on these tWo members of the Tec kinase
family is largely becuse of the obvious lymphoce signaling
defects that are observed in their absence. In contrast, the
functions of Tec, Rlk and Bmx within the immune system
are stil not fully understood, as mice deficient in Tec or
Rlk, for instance, have no apparent immune deficiencies.
Interestingly, analyses of mice possessing combinatorial
mutations have revealed both overlapping and unique
functions betWeen Tec and Btk, as well as betWeen Rlk and
Itk, as will be discussed in detail below.
Review of Tee kinase activation downstream of
antigen-recptor engagement
The signals required for Tec kinase activation, or positive
regulation, have been discussed in great detail in previous
reviews (S"" 6"" 7); therefore, the section below wil only
briefly revisit the currently accepted mechanism of this
process. For the sake of simplicity this description will
focus on events downstream of TCR engagement; however
comparable events also occur downtream of the BCR
(see Figure 2).
Immediately followi recptor stimulation, Src and Syk faily
kinases are activated (ZAP-70 is an example of the latter),
leading ro the phosphorylation of tWo adaptor molecules-
linker of activate T cells (LA1), which is constitutively asso-
ciated with lipid raf, and SH2-domain-cntaning leukoc
protein of 76 kDa (SLP-76). Concurrentl, stimulation leads
ro a phosphoinositide 3-kinae (PI3-K)-dependent incre in
PIP levels within the cell membrae. The enrichment of
PIP 3 at the site of the activated recpror recuits Tec kinases,
such as Itk or Tee, to the membrae in a PH-domain-depen-
dent manner. Following this recruitment, a multimolecular
signlosome coplex consisting of a Th family membe,
phospholipase C yl (PLC-yl), SLP- , Gads and Grb-2 form
around LAT within lipid rafts. The Th kinase is then
tranphosphorylated by a Src kinae. This is followed by Tec
kinae aurophosphorylation (H Wilcox, LJ Berg unpublished
data), resulting in complet activation of the kinae and,
ultimately to phosphorylation and complete actvation of
PLC.yl, a crucial step in T cell activation (8).
Acivation of PLC-ylleads to hydrlyis of phosphatidylinsi-
tol (4 S)-bisphophate (PIPz) into inosirol (3, S)-trisphosphate
(lP ) and dialglycerol (DAG), which lea to calcium mobi-
liztion and to activation of the protein kine C (PKC)/R1R
pathways, repevely For previous reviews of the Tec kine
domains that are requied for signalosome fonntion and
enze function see (S"" 6""
Intermolecular and intramolecular interactions
regulate Tee klnases In the steady state
The biological activitY of tYrosine kinases is influenced by
their interactions with activators, adaptors and substrates.
These recognition events are dependent on the integritY
and conformational state of specific domains within the
protein. A number of studies over the last several years
have indicated that protein tYrosine kinases are regulated,
in part, via stabilizing intramolecular and/or intermolecular
interaction(s) among their domains. For instance, in the
resting state, Src kinases are folded such that their SH2 and
SH3 domains are involved in interactions with their
catalytic domain (9-12). One important component of the
Src kinase intramolecular interaction is the carbo-terminal
regulatory tYrosine in the catalytic domain which, when
phosphorylated, binds to the Src SH2 domain. Unlike Src
kinases, Tec kinases lack this carboxy-terminal regulatory
tyosine; nonetheless, several recnt studies have indicated
that domains ofTec kinaes can undergo both intrmolecular
and intermolecular interactions (13. 14" IS" 16". 18""
Although the details of the interations differ from those
found in Src kinases, the general principle that these inter-
actions regulate kinase activitY seems certain to hold for
Tec kinases as well.
The importace of individual Tec kinase domains in
enze regulation and signaling was first established by
genetic data demonstrating that specific mutations in any
of the five domains of Btk can result in XLA (19). Initial
biochemical and structural studies ofTec kinase regulation
revealed that the SH3 domain of Itk associates intramole-
cularly with the PRR of the TH domain, and that this
interaction could interfere with ligand binding via these
domains (13). Interestingly, sequence comparisons
between Tec family members show that there are impor-
tat differences in the TH domain, suggesting that
individual Tec family members may engage in distinct
domain associations, and thus may be subject to distinct
modes of self-regulation (see Figure Ib).
For instance, unlike Itk, Btk and Tec each contain two
PRRs within their TH domains. Independent studies have
shown that both of these proteins can form homoimers as
a result of stable intermolecular interactions between the
PRR of one molecule and the SH3 domain of a second
molecule (14" IS. 17). In addition, Tec can also form
intramolecular PRR-SH3 associations that occur with a
lower affnitY, suggesting potential roles for these different
interactions in regulating enzatic activitY and protein
localization (14" IS" I7) A very recent report indicates that
asymmetric homodimers of Btk can also form (see
Figure Ib), adding further complexitY to the modes of
catalytic regulation and substrate specificitY that may ocur
(16""). Finally, a novel intermolecular association has been
described for Itk, where the SH3 domain specifically inter-
acts with the SH2 domain of a second molecule. This latter
interaction may be an important step on the pathway to
full enze activation, possibly by displacing the intra-
molecular interaction of the PRR with the SH3 binding
pocket that occurs in the ' inactive state ' (18"" ). Although
these data provide important clues to the protein domain
interactions regulating Tec kines, further studies wil be
essential to clarify the protein conformations that play
important roles in intact cells.
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Following the discovery that the xi defect in mice results
from an amino acid substitUtion in the PH domain of Btk
(4), it was further demonstrated that the PH domain
functions to directly engge PIP in the plasma membrane.
This finding provided a model to acount for the localiza-
tion of Btk and the other PH-domain-containing Tec
Th regulation an functons of Tee family tyine kineses MiUer and Berg 335
Figure 2 legend
The ro of Tee kinase In TCR and BCR sinaling. (a) Following the
engagement of the TCR-CD3 complex. Src family kinases. such as
lck ar actvated. lck phophoryates the !TAMs (Immunoep
tyrosine activtion motifs) within the CD3 chins. which In tum
recrus the Syk family kise. ZAP-70, leaing to ZAp.
phosphoatn and actation by lck. Activted ZAP-70 procs 
phosphorylate the adapto mocules Slp.76 and LAT. Concurrently,
PI3-K Is actvated. whic catalyzes the coveron of membrane-
assiated PIP2 to PIP . th substrae of PH-dornln ontalnlng
proeins suc as It and PlC-y1. CyA has been shown to be
constutely assiated with Inacte It via It.s SH2 domin.
Howver. the mechanism by which CyA becomes dissoiate Is not
know. Following Itk's reruitent to the membrane vi Its PH doman.
a number of complex Interactions ensue. Whreas Slp.76 binds to the
SH2 and SH3 domains of It. the Interacton of SlP.76 with Gads
les to an Interctio with LAT. Grb.2 can bind to th fre PRR of Itk,
which can also bind to LAT. Furtenre. PlC-y reruitent to the
membrane via Its PH domain allos the amlno-termnal SH2 domain of
PLC-y to bind to a phosphotroln on LA T. Thes Interctios reult
In what Is tenn a slgnaloso complex. Lasty. folowing 
phosphOllan of It by a Src kinase, It can In turn
authosphorate. thn proceed to phosphorate and actate
PLC-y. Refernces for th novel asp of this activation scem are
proded In the text. (b) Btk is thouht to eJdst as eitr an asymetr
or symmetr homime vi Intereclar SH3-PRR interctons in
the inactive state (botto left of figure). Furtermre. in the Inactive
state. IBtk has ben shn to bind th PH doain of Btk. Anlous
to the TCR. upon stmulation of the BCR. Sr family kinese. such as
lyn. are activated. which functon to phosphorylate the !TAM motis of
the Ig and IgP chins. As In T cells, th PI3.K prouc. PIP . beme
avaUable for PH-domaln-cntlnlng proteins. such as Blk to bind.
Following BCR engagement. IBtk becoms dissiate from Blk vi
an unknown mehanism. Btk binds to PIP and G subunits throgh
Its PH domain. Concomitantly Iga and Igp ITAM phosphoryatlon leads
to the reitent of th Syk kise to th Ig chins via the Syk SH2
domains. B LN K/SlP-65 Is recruited to a phosphoted tyrosine on
Iga that is distnct fro the ITAM mot. Syk prcees to phosphorate
BLNK/SlP.65. therby proviing binding si for Btk and PlC-y.
Upo the binding of Btk to BLNK/SLP.65 throh its SH2 domain,
Btk Is phohoryated by a Src kiase. Subseuenty. Btk
authosphates and carrs out It funcs by phophotlng
PlC-y at four tysine reidues. which result In the coplete
actvati of PlC-y. Reereces for the novel aspec of 
actati sceme are pr In the tex.
kinases to the site of an activated recptor (20-22).
Consistent with this discovery is the observtion that in
T cells, the PH domains of Itk or Tec are required for
TCR- induced PI3-K-dependent membrane recruitment
(23-25). More recently, Saito et 0/. demonstrated that the
interaction of the 8tk PH domain with PIP regulates 8tk
activity by two independent mechanisms: trans locting
the protein to the membrane and, in addition, enhancing
substrate binding and kinase activity (26).
These data fit quite well with earlier studies demonstrating
that the PH domain of Itk is indispensable for the
Src-kinase-induced phosphorylation and activation of Itk
(23,27). 80th the PH and TH domains are also crucial for
the recognition of specific substrates that can, in turn bind
and activate kinase activity. Data from Lowr et al have
demonstrated that the tranloction of Btk to the membrane
is not solely dependent on PI3-K, bUt is also dependent
on, and enhanced by, heterotrimeric G protein subunits.
The direct binding of the G y subunits to the PH- TH
module, as well as to the catalytic domain of Btk, was
shown to directly activate kinase activity (28,29"). This
coperative mechanism may faciltate the interaction of
8tk with SLP-65/BLNK, an important adaptor molecule
that assoiates with Iga and is required for BCR signling.
The interaction of the Btk SH2 domain with BLNK has
been shown to be required for phosphorylation and maxi-
mal activation of 8tk kinase activity and, further, for the
subsequent activation of PLC--y (30-32,33"
Interestingly, Rlk, an additional Tec family kinase whose
precise function remains unclear, lacks the amino-terminal
PH domain common to the other Tec kinases. Instead, Rlk
possesses a palmitoylated cyteine-string motif, suggesting
a unique mechanism of regulation. Whereas both Itk and
Rlk are phosphorylated and recruited to lipid rafts in
response to TCR-induced Src kinase activity, the activation
and membrane recruitment of Rlk is independent ofP13-
activity (34,35). Remarkably, the absence of Rlk from
CD4+ T cells does not appear to significantly diminish cell
function; however, signaling defects observed in the
absence ofItk are intensified in cells that lack both Itk and
Rlk (34,36, 38""
Downstream effects of Tec kinase activation
Many biochemical and genetic studies of Btk and Itk
have established that these kinases are important for the
phosphorylation and activation of PLC-y in 8 and T cells,
respectively, which in turn affect calcium mobilization
extracellular related kinae (ERK) and c-jun aminoterminal
kinase ONK) activation, and ultimately effector responses
(for excellent reviews of previous work characterizing
these findings, see (6"" 39)). One recent stUdy has provided
interesting evidence that CD28 signaling enhances the
ability of Itk to activate PLC-y in T cells (40). In studies of
BCR signaling, recent biochemical data have also identi-
fied the four Btk-dependent tyrosine phosphorylation sites
in PLC--y. Furthermore, each of these sites is required for
fu1l8CR-cupied calcium mobilization (41" 42"
New report this past year have also connected the Tec-
kinae-mediated activation of PLC--y to the ultimate
activation of the NF-1C and NFAT tracription factors
(31,32). Yamamoto et al found that in trsfected 293T cells,
a non-lymphoid cell line, NF-1C and NFAT activation
result fro the copeative intetions ofTec and Syk family
members with the adaptor molecules SLP-76 and BLNK
that play an importnt role in PLC-y phosphorylation. (43).
A second pathway involving Tec kinases has been identi-
fied downstream of antigen-receptor signaling, namely the
cytoskeletal reorganization that occurs following TCR or
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Figure 2). CD148. a membrane-assoiated
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back to PIP . probably preventing the furer
reruitent of Il molecules. The mechanism
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and PTEN ar thught to prevent furter
recruitent and acati of Btk by reing
the PH domain substrate. PIP . Recen
evidence has also shown an Impornt roe for
PKCp. which Is actated folloing PLC--
actation. as a feeback loop Inhibitr of
Btk. PKCP phospholates a sene in the
TH domain of Btk leading to a
downreulatin in Btk function. The
mecnism of Btk re-dlmezation and 
re-asslation of IStk are currenly not known.
References for the novel aspects of this
reulatory scem are proded in th tex.
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curr OInlo in Immunoly
BCR stimulation. Data from Woods et 0/. demonstrated
that after anti-CD3 antibody stimulation of Jurkat T cells,
ltk can activate 131 integrins and l3-actin polymerization
following its membrane translocation (44). Previous data
have also supported a role for ltk in cytoskeletal reorgani-
zation - Itk-deficient cells possess reduced cap formation
following TCR stimulation (reviewed in (45)). Consistent
with these data previous studies on Btk have demonstrated
that the PH domain of Btk binds filamentous actin and
can regulate cytOskeletal rearrangement (46,47), further
supporting a role for Tee kinases in this pathway.
These finding are in cotrt to thos of Donnadieu et 0/, who
investigated the role of Lck and Itk in the different patways
downtrea of the TCR (48). These investgatOrs found tht
wherea both kinaes play an importat role in inititing anti-
gen-induc calcium resnses, Lck, but not Itk is required
for a stable T-cll-AP (antigen-presenti cell) interatin
and polartion of the T cell Interestingly, Lck wa found
to be cruial for many intracellula signing events, such as
adhesion, cykelecal reorgiztion and calcium moiliztion;
however, Itk wa discvered to augmnt cacium responses but
wa expendable for the other events stdied (48).
Unlike the T cell stUdies mentioned above, which were
performed on primar T cells from Itk-defcient mic or on the
Jurkat T cell tUmor line, the exeriments of Dodieu et ol
were performed on a murine T cell hybridoma cell line (48).
Thus diferenc in the cells used ma accunt for the discrep-
ancies observed Altetively, as both the Jurkat an murine
hybridoma exeriment were performed using trfection of
kinase-inative Itk costrcts to act as dominant-negative
inibitOrs of endogenous Itk in these cells, diference in the
levels of inhibition achieved in these tW sytems may also
contribute to the different outcmes obsed.
In additional studies on non-lymphoid cells, Btk was found
to associate with the actin-based cytoskeletOn in activated
(human) platelets (49). Furthermore, Btk is a substrate of
calpain (calcium-dependent thiol protease - an important
regulator of signaling events in platelets) in human
platelets (50). Although the physiological relevance of this
latter finding is not . clear, these data provide important
insights intO the function of Tec family members in other
immune cells, such as platelets.
Although the discovery that Rlk trans lote to the nucleus
upon TCR stimulation (51) supports a potential role for Rlk
in gene regulation, its taets and function within the nucleus
are stil unresolved (see Update). Tec family members such
as Btk and Bmx have been previously shown to interat with
transcription factOrs (reviewed in (6 )), suggesting that
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these proteins may play more direct roles in affecting gene
trnsription. Btk, which is mainly loclized to the cyoplasm
in resting cells, trans loctes to the cell membrane following
BCR or growth factor stimulation. In addition, a recent
study has found that Btk can undergo nucleoctoplasmic
shuttling in a nuclear export signal (NES)-dependent
manner (SZ8). The role of Btk in the nucleus was clarified
by the findings of Egloff et ol who showed that Btk could
associate with and phosphorylate a trnscriptional regulator
BAPrrFII-I, in B cells following BCR engagement (53
This finding supports a novel role for Tec family kinases as
direc modulators of gene expression. Likewise, Btk was
also found to associate with another transcription factor,
STAT5A, following the engagement of the BCR (54
This newly proposed function for Tec kinaes in gene
regulation is not restricted to Btk. Itk was also found to
trans locate to the nucleus in Jurkat cells via its association
with a nuclear importin RchlCXaryopherina. This inter-
action is dependent on the Itk SH3 domain as well as a
PRR motif in Rchl/X (55 ). Future experiments wi1 be
required to elucidate the precise role(s) of Tec family
kinases in the nucleus and to determine if they do indeed
modulate gene expression.
Negtive regulatory mecanisms of Tee kinase
Data from a number of laboratories have established that
tWo events are required for the proper activation and
function of Tec kinases: loclization to the membrane and
tyrosine phosphorylation. However, until recently, linle
was known about the mechanisms involved in down-
regulating Tec kinase activity. Several recent report have
identified proteins that inhibit the activity of Tec family
kinases. For instace, IBtk (inhibitor of Btk) was found to
bind to the PH domain of Btk and interfere with Btk-
dependent calcium mobilization and NF -1(B activation in
B cells (56
A more complex feedback loop regulating Tec kinase
activity has been suggested by the studies of Kang et ol
These investigators have presented evidence indicating
that PKC , a classical PKC isoform, phosphorylates a
serine residue in the Btk TH domain thereby decreasing
Btk membrane localization (57 ) (Figure 3). As PKC
activation is one of the downstream consequences of
PLC-y activation, and thus is dependent on Btk activity,
this mechanism provides an autoinhibitory loop that would
function to downregulate Btk activity and thus terminate
the signaling pathway. Interestingly, this region of the TH
domain is conserved among all Tec kinases, suggesting
that this mode of regulation may be in effect for the TCR
signaling pathway as well.
More recntly, biochemical and structural studies of Itk
have demonstrated that Itk kinase activity is inhibited by
a direct interaction between the Itk SHZ domain and the
peptidyl-prolyl isomerase, cyc10philin A (CyA) (Figure Za).
Consistent with this, treatment of Jurkat T cells with
Cyclosporin A, an immunosuppressive drug that binds
CyA and inhibits calcineurin activity, disrupts this interaction
and results in increased Itk phosphorylation and activation
of downstream targets (e.g. PLC-yl). Using NMR (nuclear
magnetic resonance) structural analysis, this study also
showed that the Itk SHZ domain can undergo a proline-
dependent conformational switch via a single prolyl imide
bond. Furthermore, this ci/trans isomerization within Itk,
which is catalyzed by CyA, directly alters Itk binding
specificity for phosphotyosine-containing partners (5S
These intriguing findings suggest a novel mechanism of
Itk regulation by CyA Interestingly, the proline residue
involved in this isomerization reaction is not found in any
of the other Tec kinase family members, suggesting that
this mode of regulation may be unique to Itk.
Fllnctional roles of Tee kinases in lymphocytes
Significant attention over the past year has been focused
on biochemical and functional defects that occur in the
absence of Tec family members. These defects affect
many complex biological processes, such as T and B cell
development, activation, differentiation and effector
function. For instace, the XLA sydrome is manifested
by severe defects in early B cell development, resulting in
a nearly complete absence of peripheral B cells and
immunoglobulins (59). A milder deficiency is observed in
Btk-l- or xi mice, where the block in B cell development
occurs at the later immature-+mature B cell transition
resulting in the accumulation of substantial numbers of
functionally impaired peripheral B cells in these mutant
mice (60). A recent report from Ellmeier and col1eagues
provided one potential explanation for the differences
observed betWeen mice and humans lacking Btk. These
investigators generated Tec- Btk-l- mice, and showed that
these doubly deficient mice have a much more profound
block in B cell development than the Btk-- mice (61).
These findings suggest that, in mice, Tec may partially
compensate for the lack of Btk.
Additional studies of the role of Btk in B cell development
have provided more-detailed information aboUt the precise
role of Btk in the regulation of the pro-B-+pre-B cell
transition that ocurs in the bone marrow and in the later
staes of B cel1 maturation in the periphery (6Z -65
). 
For
instance, recent data indicate that Btk plays an important
role in the regulation of the ",locus for VDJ recombination
within pre-B cells and in the TZ-+T3 transition with the
pol of immature B cells. An additional study focusing on
peripheral B cells showed that, following the exrt of
immature B cells to the periphery, Btk plays a significant
role in the immature-+mature B cel1 transition occurring in
the spleen
Whereas the generation of R\k- mice has revealed a seem-
ingly insignificant role for Rlk in the development and
function of immune celts, the generation of Rlk--Itk-- dou-
ble-knockout mice has enhaned our understanding of the
function(s) ofTec kinases in T cells (37). Upon comparison
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of TCR-induced signaling events in Tec family knockouts
it is evident that there are graded defects where the most
severe defects are observed in the Rlk+ltk-I- double
knockouts, modest defects in Itk-l- and minimal defects
in Rlk-l-. Furthermore, combined studies of Itk-l- and
Rlk-/-Itk-- mice have indicated an importat role for Tec
kinae mediated signling pathways in positive and negative
selection the thymus ((36); JA Luca, L Atherley, LJ Berg,
unpublished data). In addition, both Itk+ and Rlk-/-Itk--
thymi show altered CD4:CD8 ratios, due to fewer matUe
CD4+ thymoc and increased numbers ofCD8+ thym.
These defects in thymic selection correlate with reduced
TCR signaling, resulting in reduced calcium mobilization
and reduced ERK-MAPK (mitogen-activated protein
kinase) activation in Itk+ and Rlk-/-Itk+ thymocytes
(36). Interestingly, in spite of the reduced ERK-MAPK
signaling and the altered CD4:CD8 ratio, detailed analysis
of several TCR transgenic lines on an Itk+ background
did not reveal any alterations in CD4:CD8 lineage
commitment in these mice QA Lucas, L Atherly, LJ Berg,
unpublished data). Instead, the data suggest that, in the
absence of Itk and/or Rlk, peripheral T cell homeostais
may be altered, leading to peripheral expansion of CD8+
cells and their recirculation back into the thymus
QA Lucas, L Atherly, LJ Berg, unpublished data). These
findings suggt a potential role for Tec kinaes in regulating
peripheral T cell homeostasis.
Studies of Itk-l- and Rlk-l-Itk+ mice have also revealed
additional roles for Tec kinases in regulating T cell effector
functions. For instance, after TCR stimulation in vitr,
Rlk- ltk..- CD4+ cells are defective in their ability to
secrete both Thl- and Th2-type cykines, a finding that
correlates with reduced activation of NFAT and AP- l tran-
scription factors (38 ). This report also showed that Itk+
mice are unable to mount an effective Th2 response after
infection with Schitosoma monsoni; remarkably, though , the
compound deficiency in both Itk and Rlk restored the
abilty of the mutant mice to respond to this pathogen and
produce Th2 effector cytokines (38
Additional studies have demonsaated that Itk- CD4+
T cells show a defect in activation-induced cell death
(AlCD) both in vivo and in vitro (66 ). This defect results
from impaired apoptosis via the FasFasL (Fas ligand)
pathway because of a substantial reduCtion in FasL expres-
sion by activated Itk-l- CD4+ T cells. The mechanism
underlying this FasL deficiency appers to be the failure of
Itk..- T cells to effciently upregulate Egr2, Egr3 and, con-
sequently, FasL transcription after TCR stimulation (66
Thgether, these data demonstrte that the absence of Tec
family kinases affects not only T cell activation and differ-
entiation pathways, but also apoptosis effector pathways.
Conclusions
The past year has provided important new insights into the
biology of Tec kinaes. A number of studies, focusing on the
reglation ofTec kinae enzatic activity, have demonstrte
inaamolecular and intermoleclar domain interactions that
are likely to playa crucial role in regulating this process.
Importatly, these studies have indicated tht the detailed
mechanisms regulating Tec kinae activity are clearly distinct
from those describe for the better-charcterized See family of
tyrosine kinaes. In addition, these data have shown that indi-
vidual Tec family members have unique modes of regulation.
Additional studies have also refined our understanding of the
interactions between Tec kinases and other signl tranduc-
tion molecules, and have provided compellng evidence that
Tec kinaes directly phosphorylate and activate PLC-"( in
lymphoctes. Finally, genetic studies using mice and/or cell
lines lacking individual or multiple Tec kinases have begun to
elucidate the functional roles of these kina in lyphoce
biology Overall, these studies have highlighted the complex
interactions between cellular activation, effectOr functions,
homeostis and apoptotic pathways.
Update
Recnt progress has provided additional insights into Tec
kinase functions within immune celts. As mentioned
earlier, Rtk can trans locate to the nucleus upon TCR
stimulation; however, its targets within the nucleus had not
previously been defined. A recent paper from Takeba et 0/.
demonstrated that Rlk can bind to regions of the IFN-"(
promoter and increase promoter activity (67). Interestingly
this event is dependent on Rlk phosphorylation, presumably
in response to TCR engagement.
Lastly, we discussed earlier that many Tec family kinases,
including Btk, are dependent on a (PI3-K)-mediated
increase in membrane PIP3 levels for recruitment to the
membrane, activation and function. A recent study per-
formed by Fruman et 0/. using DNA microarray technology
identified the taget genes that are shared by 8tk- and
PI3- dependent signaling pathways following BCR
engagement (68). This study showed that whereas PI3-
and 8tk share many genes, as expected, PI3-K activity can
affect other genes independent of Btk function.
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The role of Tec famy kiases in
T cell development and function
Summar Thee members of the Tec famy kiases, Itk, R1 
and Tec, have
been implicated in signalng downstream of the T cell receptor 
(TCR).
The activity of these kiases in T cells has been shown to be important for
the ful activation of phospholipaseC-
yl (PLC-yl). Disruptio of Tec
family signalg in Itk - and ltk mice has multiple effects on
T cell development, cytokie production and T -
helper cel differentiation.
Furthermore , mice possessing mutations in 
signalg molecules upstream
of PLC- , such as Src homology 2 (SH2) domai-contaig 
phosph
protein of 76 kDa (SLP-76), lier for activation of T cells (LAT) and
Vavl , or in members of the nuclear factor for 
activated T cells (NFAT)
famy of transcription factors , which are downstream of PLC-
, have
been found to have simar phenotyes to Tec family-
deficient mice
emphasizing the importance of ths pathway in regulatig T cel 
activa-
tion, differentiation and homeostasis.
Introduction
Six members of the Tec family ofnonreceptor protein tyrosin
kiases have been identified. Five of the family members are
expressed in hematopoietic cells , with thee, Itk, Rlk 
and Tec,
expressed in thymocytes and mature T cells. Al 
thee of these
kiases are involved in signalg downstream of 
the T cell
receptor (TCR). The domain structue of each Tec kiase
family member is very similar , consisting of an N-
terminal
pleckstrin homology (PH) domai followed by the protein
bindig Tec homology (TH), Src homology 3 (SH3) and SH2
domains, and a C-terminal kiase domai. Unique 
to this
family of protein tyrosine kiases, the inclusion of a 
domain alows recruitment of Tec kiases 
to the cell
membrane through their binding of phosphatidylinositol
(3, 5)-trphosphate (PIP ). Both Tec and Itk adhere precisely
to this structural organization. R1, on the other hand
, differs
from Tec and Itk in tWo ways. First , R1 lacks the N-
terminal
PH domain and instead contains a string of cystei
nes that can
be palmitoylated. Second, a shortened form of 
R1 can be
generated through an alternative translational start site, and
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this form of the protein can be translocated to the nucleus of
T cells following activation (reviewed in 1-4).
The precise course of events leading to the activation of Itk,
Rlk , and Tec following engagement of the TCR has not been
completely elucidated; however , localization of these kinases
to the plasma membrane , as well as tyrosine phosphorylation
within the kiase domain, appears to be necessary. Prior to
signaling, al thee kinases are predominantly cytoplasmic.
Immediately following TCR stiulation, al three of these
kinases are found to be associated with the plasma membrane
in cultured T cell lines. This membrane association, for Itk
and Tec, occurs via the PH domai (5 , 6) and is dependent on
the activation of phosphoinositide 3-kiase- (PI3K) , which
converts phosphatidylinositol (4 5) -biphosphate (PIP ) into
PIP , thereby generating the ligand for the Itk and Tec PH
domains. Because of the absence of a PH domain , association
ofRlk with the membrane is independent ofPI3K activity, and
instead it is due to pahitoylation of its cysteine string motif
(7). Followig membrane localization, the activation of Tec
family kinases in T cells requires phosphorylation by an Src
kinase, possibly Lck, of a conserved tyrosine withn the acti-
vation loop of the kiase domai (8). For Itk, this activating
phosphorylation event is also dependent on the activity of
zeta-associated protein of 70 kDa (ZAP-70) and liner for
activation of T cells (LAT) (9). This dependence suggests that
the association ofItk with the membrane is not enough to lead
to its activation and, in addition, recruitment to the TCR
signaling complex is required. Consistent with ths notion
both Itk and Tec colocalize with the TCR following TCR
stimulation (5, 9).
Although the association of Itk with the TCR signaling
complex requires ZAP- 70 and LAT, Itk is not a substrate of
ZAP- 70 and does not diectly bind LAT. However , Itk has been
found to bind SH2 domain -containing phosphoprotein 
76kDa (SLP-76) (10 , 11), which does bind LAT via its inter-
action with Gads (12-15) in a ZAP-70-dependent maner
(16). Once the Tec famy members have been activated and
are bound to LAT via SLP-76, they are capable of phosphor-
ylating phospholipase C-y (PLC-y 1) (11). This phosphorylation
leads to the activation of PLC-y I , which then hydrolyzes PIP
into the second messengers inositol (3 5)-triphosphate (IP
and diacylglycerol (DAG). The production of IP causes cal-
cium mobilzation in the T cells, while DAG activates protein
kinaseC (PKC) and Ras-GRP , thereby leadig to the activation
of Ras/Raf/mitogen-activated protein kiase (MAPK) path-
ways. Subsequent to Ca 2+ mobilization, the nuclear factor
for activated T cells (NFAT) transcription factors are depho-
sphorylated, translocate to the nucleus and activate a number
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of genes, including those encoding cytokies. The activation
of PKC and the Ras/MAPK pathways affect a number of serine/
threonine kinases includig Erk1l2 , p38 and c-jun N-terminal
kinase (JNK). These pathways culminate in the activation of
additional transcription factors, such as NF-KB and Elk-
which regulate genes involved in cytokie signaling, surval
and differentiation. Thus, following the activation of PLC-y 1
by the Tec kiases , multiple processes important for T cell
development , activation, effector function and homeostasis are
affected.
Single knockouts of the genes encoding Itk, Rl and Tec have
al been generated in mice and characterized (1 7 -20). Of these
single knockouts , the loss of Itk has the most substantial effect
on T cell development and function , while the loss of Rl has
a mild effect and the loss of Tec appears to have no effect.
Interestingly, these phenotypes correlate with the mRNA
expression levels for these genes in T cells , as recently deter-
mined by real-time polymerase chai reaction (PCR) studies in
our laboratory. We fmd that Itk mRNA is present at the highest
level, Rl mRA levels are two- to theefold lower and Tec
mRNA is present at a level close to 1 oO-fold lower than that of
Itk (Miler, Felices and Berg, unpublished data). As none of the
single knockout phenotyes leads to an absolute block in T cell
signaling, it has been suggested that the activities of the
remaining Tec kinases may compensate for the loss of one.
The analysis of Rl - ltk -/- mice has supported this hypothesis
by demonstrating that the absence of these two Tec kinases
results in defects in T cell development and activation that are
more severe than either single knockout and , furthermore , that
this double deficiency leads to a more substantial decrease in
PLC-yl phosphorylation/activation following stimulation of
the TCR (19 , 21). Because of the close association of the Tec
kinase deficiencies with impaied PLC-yl activation, ths
review focuses on the in vivo consequences of reduced PLC-
activation on T cell development and function. We also com-
pare the phenotypes of the Tec family knockouts to other
mouse mutants with deficiencies in PLC-yl-dependent signal-
ing pathways.
The role of T ec family kinases in T cells development
The development of mature T cells from bone marrow pre-
cursors takes place in the thymus and is criticaly dependent on
both the environment and signals through the pre- and mature
TCRs. Thus makng proteins that are important for TCR signal-
ing play critical roles in T cells development. For instance,
disruption of the gene encoding the protein tyrosine kiase
Lck (22) or ZAP-70 (23, 24) results in severe defects in T cell
development. Furthermore, mutation of the gene encoding
Btk , a Tec family member expressed in B cells, leads to an
immunodeficiency disease due to blocks in B cell development
(2S-27). Based on these findings , disruption of the Itk gene or
the genes encoding both Itk and Rl might be expected to
cause blocks in T cell development; however, this is not the
case (17- , 21 , 2S). Instead, consistent with the observation
that PLC-yl activity in T cells is not completely abolished in
the absence of these Tec kiases, it appears that the loss of Itk
and/ or Rl only partially affects most stages of thymopoiesis.
Are Tec kinases important for pre-TCR signaling?
The most immature T cells precursors in the thymus lack the
expression of the T cells coreceptors CD4 and CDS and thus are
referred to as double negative (DN) thymocytes. These pre-
cursor cells can be further subdivided into four stages of
development , DNI-DN4, based on the expression of CD44
and CD2S. At the DN3 (CD44TD2S ) stage of development
cells are undergoing rearangement of their T cell receptor
chain genes. At this stage of development, the cells progres-
sing down the TCR lineage are dependent on signals
transduced though the pre- TCR, a receptor comprising a
functionaly rearranged TCR chain paired with an invariant
pre- TCR C"chain. These pre- TCR signals induce the transition
from the DN3 stage to the DN4 (CD44 CD2Sl stage, and
subsequently to the double positive (DP , CD4 +CDS ) stage. A
role for Tec famy kiases in pre-TCR signaling would seem
likely in light of evidence that PLC-y activity is important for
ths signal (29).
Consistent with the notion that Tec kinases might playa role
in pre-TCR signaling, analysis of Tec kinase gene expression
indicates that these genes are expressed in early thymic pro-
genitor cells. For instance, early studies performed by North-
ern blot analysis demonstrated that both Itk (30) and Rl (31)
mRNA can be detected by day 14 of fetal development , a time
at which the thymus comprises solely DN 1 and DN2 precursor
cells. More recently, work in our laboratory has demonstrated
the presence of transcripts for Itk, Rl and Tec at all four adult
DN stages by real-tie quantitative PCR (Lucas , Felices and
Berg, unpublished data). Despite these data , analysis of adult
and fetal thymic development as assessed by CD4 and CDS
expression reveals that Itk
-'/-
, Rl-/- and Rl- itk-/- mice al
have relatively normal numbers of both DN and DP thymo-
cytes, suggesting that progression to the DP stage of develop-
ment is unaffected by the absence of these Tec family proteins
(17 , 21). Closer inspection of the DN subsets in Itk -/- mice
based on CD44 and CD2S expression is also in agreement with
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the general CD4/CDS profies , as the distribution of DNl-
DN4 subsets is similar to that seen in wid-type CS7BL/6 mice
(Lucas , Atherly and Berg, unpublished data).
Although phenotypic analysis of thymic subsets in knockout
anmals is useful as an intial tool for examining the role of
certain proteins in lymphocyte development , it may often fai
to reveal al the stages at which the protein may playa role. In
order to determine more conclusively whether Tec family-
deficient thymocyte precursors progress normally to the DP
stage of development, we generated mixed bone marrow
chimeras with a SO: SO mix of wid-type and Itk-/- bone
marrow. In our preliminary analysis of thymi from these
mixed wid-type/Itk-/- chimeras, we have observed equiva-
lent numbers of wild- type and Itk-/- cells at the DNI-DN3
stages of development. However, we find that there are
significantly fewer DN4 cells of Itk -/- origin. This finding
indicates that when Itk-/- cells develop in the presence of
Itk-positive cells, they are at a disadvantage due to intrinsic
defects in pre- TCR signaling. In addition , BrdU labeling sug-
gests that the Itk -/- cells take longer to progress from the DN
to the DP stage of development or that fewer of the Itk -/- cells
surve ths transition (Lucas and Berg, unpublished data).
Further analysis of these chimeras as well as those generated
with Rl - itk -/- bone marrow wi be necessary to confirm
these intial observations and to provide more definitive data
addressing the role ofItk and/or Rl in pre- TCR signaling.
Tee family kinases are importnt for positive and negative
selection
Once developing thymocytes progress though the pre- TCR
checkpoint, they commence rearangement of the TCR C"chai
genes and intiate expression of both the CD4 and CDS corecep-
tor genes. At ths point in development, the cell undergo a
process known as repertoire selection. One component of ths
process, refered to as positive selection, leads to the selective
surval and dierentiation of DP thymocytes whose TCRs
are able to bind self-peptide/major histocompatibilty com-
plex (MHC) complexes present on thymc stromal cells. In
contrast, cells that do not receive ths selection signal due to
the inability of their TCRs to bind self-peptide/self-MHC
complexes do not undergo further differentiation, and even-
tualy these cells die. Although it is necessar that thymocytes
recognize self-peptide/MHC complexes to develop into func-
tional matue T cells , it is also critical that the selected cells do
not become activated by interaction with these same com-
plexes once they are part of the peripheral circulating T cell
pool. Therefore, to ensure self-tolerance , thymocytes whose
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TCRs have strong interactions with self-peptide/MHC com-
plexes undergo negative selection. Although this process can
occur at any point after successful rearrangement of the TCR
()chai, negative selection most often occurs late in the 
stage of development, with strong signals through the TCR
leading to the induction of apoptosis.
The role of Tec family signaling during repertoire selection
has maiy been studied using TCR transgenic model systems.
However, the first suggestion that Tec family members may be
important for thymocyte selection came from analysis ofItk 
mice generated by Liao and Littman (1 7). Analysis of the T cell
subsets in these mice based on CD4 and CD8 expression
indicated a reduced CD4: CD8 ratio in the thymus and the
periphery, together with a twofold reduction in absolute
numbers of peripheral CD4 + T cells. Although these data
initialy suggested that there was a preferential defect in CD4
T cell development, analysis of Itk- mice crossed to either
an MHC class I (HY) (32) or an MHC class II (AND-
(33) specific TCR transgenic line revealed that the absence of
Itk affected both CD4 and CD8 T cell development. In both
cases, very few cells that expressed the transgenic TCR
developed in mice that lacked Itk, in contrast to the signi-
ficant number of transgenic TCR + cells that develop on a
wid-type background.
Schaeffer et al. (21) extended these studies by comparing
Rl- , Itk- and Rl- itk- mice. They found that Rl-
mice were alost indistiguishable from wild-type mice
whereas the Rl- itk- mice were similar to Itk- mice , in
that they showed an altered CD4 : CD8 ratio in the thymus and
somewhat reduced numbers of peripheral CD4 + cells. How-
ever, the total thymocyte number was slightly increased in
Rl- itk- mice compared to Itk- mice. Despite this
increase, when the Rl- itk- mice were crossed to the
same TCR transgenics used in the Itk- analyses, positive
selection of the doubly deficient transgenic T cells was more
severely impaired than was selection of the single Itk-
thymocytes.
In our laboratory we have examned Itk 
1- mice that are
transgenic for a variety of other TCRs (28). Our rationale for
examinig additional TCRs was that the selection of both and
(H2 b) and HY TCR transgenic cells, used in the previous
studies, is ineffcient compared to that seen in other TCR
transgenic lines. This ineffcient selection has been used to
suggest that these TCRs have a low avidity for their selecting
ligands in the thymus. In the light of data showing that the
absence of Itk affects T cell activation and cytokine secretion
to a greater extent when the TCR signals are suboptimal
(Wilcox and Berg, unpublished data), we were interested in
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determinng whether the development of TCR transgenic
thymocytes deficient in Itk would vary based on TCR avidity.
Therefore , we compared the positive selection of 2B4 (34),
SeC7 (35) and AND (33) (H2 ) TCR transgenic cells that
lacked Itk to their wid-type counterparts. These TCRs are all
specific for a pigeon/moth cytochrome c peptide bound to
, and the proposed avidity hierarchy of these TCRs for
positively selecting ligands in the thymus is 2B4 0: SeC7 0:
AND (36). In the 2B4 Itk- and see? Itk- mice, the
development of TCR transgenic cells was significantly reduced
compared to that seen in Itk-positive mice, in agreement
with the results seen in previous studies examining AND
(H2 Itk- mice. However , despite this reduction, a consid-
erable number of TCR transgenic cells in SeC7 Itk- mice
successfuly underwent positive selection. Finaly, in AND
(H2 Itk- mice, the number of transgenic CD4SP thymo-
cytes and peripheral CD4 + T cells was comparable to the AND
(H2 ) Itk +1- mice, although the effciency of positive selec-
tion , as assessed by the DP : CD4 SP ratio in the thymus , was
stil slightly reduced in the absence of Itk. Thus , positive
selection of al class II MHC-specific TCRs is impaied in
Itk- mice , although the severity of the defect is minmized
as the strength of the TCR signal increases.
Although we initialy focused on the development of class II-
restricted T cells, we have also crossed the Itk- mice to mice
transgenic for the OT- l TCR transgenic mice (37). The OT-
TCR is class I restricted and is thought to a have a high avidity
for its selecting ligand(s) in the thymus. Unle the HY Itk 
mice (17, 21), aT - 1 Itk 1- mice develop a significant number
of CD8 SP and peripheral cells that express high levels of the
transgenic TCR. Similar to the AND (H2 Itk- mice, the
difference between aT - 1 mice that express Itk and those that
do not is less dramatic than that seen in previous studies;
however, the effciency of the selection of these cells is stil
reduced (Lucas and Berg, unpublished data). Thus, the con-
clusions stated above appear to hold true for MHC class
I-specific TCRs as well , in that TCRs with higher avidity for
selecting ligands in the thymus are less impaired in their
positive selection in the absence of Itk. Together, these fmd-
ings indicate that , in the absence offul PLC-yl activity, fewer
thymocytes of any specificity are able to maintain the continu-
ous low level of signaling that is required to complete positive
selection. It is important to note , however , that to date al of
the analyses of TCR transgenic mice deficient in Tec family
kinases have been performed with mice that are RAG compe-
tent; thus , these data may be influenced by the expression of
endogenous TCR ()chains on the transgenic thymocytes. In ths
regard , the intial characterization of seC7 RAG itk- mice
in our laboratory suggests that the impaied maturation of
transgenic thymocytes in the absence of Itk, at least in this
line of mice , may be more dramatic than was observed pre-
viously in RAG+/+ mice (Miler and Berg, unpublished data).
This fmding implies that some of the SC.C?+ T cells that were
seen in the initial studies may have surved selection by
coexpressing an endogenous TCR cxchain and were not
selected on the basis of the SC.C? TCR specificity.
Another approach used to assess the role of Tec family-
dependent signaling pathways during T cell development
has been to generate transgenic mice that overexpress Rl in
thymocytes and T cells (38). Based on CD4 vs. CD8 profIes of
the thymus and lymph nodes in these mice , T cell develop-
ment appeared unaltered. However, when the Rl transgenic
mice were crossed to the AND (H2 b) and HY TCR transgenic
mice , Sommers and colleagues (38) observed that the number
of TCR transgenic cells that developed was reduced compared
to non-Rl transgenic controls. Furthermore , the Rl transgene
was able to restore nearly normal levels of positive selection in
HY Itk -/- and AND Itk -
/- 
TCR transgenic lines. These data
confirm that Itk and Rl have at least partially redundant roles
in signaling at the DP stage of development in agreement with
the analysis of Rlk - ltk -/- mice. Finaly, the reduced level of
T cell maturation observed in Itk-suffcient Rl transgenic mice
is interpreted as a shift toward negative selection (discussed
later), rather than as an inhbition of positive selection.
A number of the TCR transgenic Itk- and Rl/ltk-deficient
mice that were used to study the role of Tec kinases in positive
selection have also been used to study the role of these pro-
teins in negative selection. Initial studies by Liao and Littman
(I?) and Schaeffer et al. (21) examined this issue using HY
TCR transgenic male mice (39), in which the cognate antigen
for the male-specific HY TCR is constitutively present. Once
agai, the most dramatic deficit was observed in mice that
lacked both Itk and Rlk (21), whie a more modest effect was
seen in single Itk -/- mice. Specificaly, the HY Rl - ltk -
mice had a significant increase in the percentage and number
ofDP and CD8 SP thymocytes and CD8+ peripheral T cells that
expressed the HY TCR. Notably, these HY+ Rl- ltk-/- T cells
express significantly higher levels of the CD8 coreceptor than
is seen on the HY+ cells that escape deletion in wild-type HY
transgenic male mice.
In our laboratory we have used two systems to look at the
role of Itk in the negative selection of MHC class II-specific
TCRs. In the first approach we examined mice that coexpress a
TCR trans gene (2B4, SC.C7 or AND; al VI33 ) along with an
endogenous superantigen (SAg) that specificaly deletes thymo-
cytes whose TCRs use V 133. For these studies , we compared
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the fates of TCR transgenic cells in SAg + mice (of 129 origin)
in the presence and absence of Itk. Although each of the TCRs
in this study makes use of the same V 13 region , the effciency of
SAg-mediated deletion in the different lines varied, even
among Itk-suffcient mice (Fig. 1A). For instance , deletion in
the 2B4 transgenic line was the most effcient , resulting in a
Is-fold reduction in the total thymic cellularity in 2B4 SAg +
Itk +/- mice. In addition, the DP thymocytes were reduced
800-900 times and alost all of the cells that remained in
these thymi were at the DN stage of development, suggesting
that deletion of the transgenic cells occurs at some point
between the transition from the DN to the DP stage or very
soon after the cells become DP. In the absence ofItk, the 2B4
SAg + mice had a similar reduction in the proportions of DP
and SP thymocytes, but because of a smaller decrease in thymc
cellularity the total number of DP thymocytes was only
reduced 80 times. In contrast , SAg-mediated deletion in the
Itk-suffcient SC.C? and AND TCR transgenic lines seemed to
occur later in development , as these mice sti retaied a
significant proportion of DP thymocytes (Fig. 1A) and had
smaler decreases in total thymic cellularity. When Itk was
absent from either the SC.C? or and SAg+ mice , the propor-
tion and number of DP thymocytes were increased relative to
their wid-type counterparts; moreover , the DP cells that
remained expressed higher levels of the transgenic TCR
(Lucas and Berg, unpublished data). Interestingly, in AND
SAg + mice the reduction in the number of DP thymocytes
compared to their SAg counterparts was similar with or with-
out Itk. A probable explanation for this fmding is that in wid-
type and mice without SAg, there is some level of deletion of
the transgenic cells , presumably due to the high avidity of ths
TCR for its selecting ligands in the thymus (40), which does
not seem to happen in AND Itk-/- mice (28). Thus , the effect
of the SAg on DP thymocyte numbers in the wild-type AND
mice is masked by the sel-deletion that is aleady occurg.
From the analyses of these mice, it appears that the absence of Itk
impais the deletion of sel-reactive thymocytes, and when the
signal is weak, Itk-deficient thymocytes progress to a later stage
of development before succumbing to negative selection signals.
The second approach we used to examine negative selection
in Itk-/- mice used a line of transgenic mice that express a
fusion protein of hen egg lysozyme and cytochrome c (HEL-
cyt) under the control of the metalothionein promoter (41).
These mice have low basal levels of expression of the fusion
protein in the thymus , which can be increased when the mice
are given Zn 2+ to induce the metalothionein promoter. When
the HEL-cyt mice are crossed to the SC.C? TCR transgenic line
the majority of SC.C?+ T cells are deleted; however , due to
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the low basal expression of the antigen , this deletion is some-
what leaky and a smal number of SC.C?+ T cells are found'
the periphery (42). Increasing the levels of the fusion protein
in Zn
+ -
treated mice enhances the extent of deletion of the
SC.C? TCR transgenic cells. This system seemed ideal for our
studies, as it provided an opportunty to test the notion that
signaling though Itk is more critical when signals though the
TCR are weak. Thus , we hypothesized that the leaky deletion
in SC.C? /HEL-cyt mice would be even less effcient in the
absence of Itk. This prediction was borne out , as we observed
increased numbers of DP and CD4 SP thymocytes in SC.C? /
HEL-cyt mice lacking Itk (Fig. IE). In addition , upregulation of
antigen expression by Zn treatment of the Itk 1- mice
negated the differences between Itk- - and Itk 
+1- thymocytes
and led to comparable levels of deletion in both lines of mice
(Lucas and Berg, unpublished data). Despite the reduced
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Fig. 1. Negative selection in ltk-deficient
mice. (A) The average number of DP
thymocytes in 2B4 , SC.C7 and AND (H2
Itk+/- and Itk-/- mice with or without SAg
were calculated from total thymocyte
numbers and percentages of DP cels
determied by flow cytometr. A rrum
of thee mice for each genotye were
analyzed. Numbers above each pai of
colums represent fold decrease from SAg
SAg + mice. Note that the Y-axs is a log scale,
(B) CD4 vs, CDS profies of thymocytes from
SC.C7 Itk 
+1- and Itk -/- mice with and
without HEL-cyt transgene. Thymocytes were
staied with antibodies to CD4 and CDS and
analyzed by flow cytometr.
deletion in SC.C? /HEL- cyt Itk- mice (before Zn treat-
ment) , we observed fewer SC.C?+ cells in the periphery of
these mice compared to those expressing Itk, a findig that
may relate to the reduced effciency of positive selection
accompanying the Itk deficiency. Overal , these data are con-
sistent with al of our fmdings on thymc selection in Itk-
mice , where the absence ofItk leads to a greater impairment of
both positive and negative selection in response to weaker
forms of stimulation. In contrast, these results conflct with
those seen in the HY Itk- and HY Rl- itk- male mice , in
which the decrease in deletion effciency led to an increase in
the numbers of HY+ T cells in the periphery (21). A potential
explanation for this discrepancy is discussed later.
Consistent with the reduced degree of positive and negative
selection that has been observed , the ability of DP thymocytes
to sigJ)al in the absence of Itk or both Itk and Rl is altered.
Biochemical studies verify that at least some aspects of TCR
signaling are reduced in the Tec kiase-deficient thymocytes.
As PLC-y1 has been proposed to be a major substrate of Tec
family kinases in T cells, Schaefer and colleagues (21) stimu-
lated thymocytes from wild-type and Rl - ltk -/- mice with
anti-CD 3 antibodies and found that phosphorylation of
PLC-y1 was more severely impaired in the Rl- ltk-
thymocytes. This change in PLC-y1 phosphorylation affects
downstream pathways, namely Ca mobilization and the
Ras/MAPK pathway. For instance, in both Itk-/- and
Rl- ltk-/- thymocytes , defects in sustained CaH elevation
but not in the initial Ca H spike , were observed upon TCR
stimulation (21). To test the role ofTec kiase signaling on the
Ras/MAPK pathway in thymocyte TCR signalg, changes in
the phosphorylation of the MAKs , ERK and p3 S were
examined in Rl- ltk -/- thymocytes. These studies showed
that there was no change in p3 S activation, but reduced ERK
activation was found in these cells (21).
These biochemical studies, along with the in vivo studies
examining TCR repertoire selection, have led to the hypothesis
that thresholds for positive and negative selection are shifted
when TCR signaling is reduced in Tec kiase-deficient mice
(21). Current models propose that signaling though the TCR
on DP thymocytes can lead to either positive or negative
selection dependig on the strength of the signal or the avidity
of TCR for its selecting ligands in the thymus. Consequently,
cells with high-avidity interactions receive strong signals and
are deleted, cells with very low or no interactions do not
receive any signal and die , and the cells that receive low to
intermediate signals undergo positive selection. Therefore
reduced TCR signals in Itk-/- and Rl- ltk-/- thymocytes
would necessitate that the strength of the interaction necessary
to achieve positive or negative selection be stronger than that
requied for wid-type thymocytes. This hypothesis predicts
that wid-type thymocytes that would normally be positively
selected may die by neglect in Tec family kinase-deficient
mice, and furthermore , cells that would normaly be deleted
would instead be positively selected in Itk -/- and Rl - ltk -
mice. Overal , these changes would result in an altered TCR
repertoire in Tec famy kiase-deficient mice. Although there
is no diect evidence , some of the in vivo studies suggest that
ths altered selection may be at least partialy the case. The
vitual loss of development in Tec family kiase-deficient AND
(H2 b), 2B4 and HY TCR transgenic mice suggests that there is
a loss of development of thymocytes with low-avidity TCR.
Thus, the theshold for positive selection is clearly shifted.
The case of negative selection is less clear. In HY male mice
that lack Itk or both Itk and Rl, the number of CDS+ HY
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cells in the periphery is increased (21). In contrast, the SC.C7/
HEL-cyt Itk-/- mice had reduced numbers of peripheral CD4
SC.C7 + cells. Thus , in one system , the absence of Tec famy
kinases results in a shift from negative selection to positive
selection , but in the other system less effcient negative selec-
tion did not increase the positive selection of 'autoreactive
cells. One possible explanation for ths discrepancy is that
lowering PLC-y 1 activity has a greater effect on positive than
on negative selection. Thus , changes in the outcome of nega-
tive selection when PLC-y1 activity is lowered may only be
apparent when negative selection signals are very weak. In
agreement with ths idea, the absence of Tec famy kiases
affects the activity of the MAKs , ERK 1 and ERK2 (21), which
have been shown to be crucial for positive selection , whie
there is no effect on the activity of the p3 S MAK (21), which
has been shown to affect negative selection.
An alternative explanation is that the disparity in the two
systems is due to differences in the development of MHC
class I- and class II-specific thymocytes. For instance, it has
been shown that the maturation of CD4 + T cells requires
more sustained signaling than the development of CDS
T cells (43). Furthermore , maintenance of at least some TCR
signals is dependent on sustained Ca2+ elevation, which is
impaied in cells deficient in Tec family kiases due to reduced
PLC-y1 activity. Thus , Tee family kiases and PLC-y1 activity
may have a greater effect on CD4 + T cell selection. In agree-
ment with this idea, the total number of CD4 + cells in Itk -
and Rl- ltk-/- mice is reduced by 50%, whie there are
alost normal numbers of CDS+ cells. Therefore , the changes
in negative selection in SC.C7/HEL-cyt Itk -/- mice might be
masked due to a more substantial defect in CD4 + T cell
maturation or surval.
CD4/CD8 lineage commitment is unaffected by the loss ofT ec
family kinases
Concurrent with the processes of positive and negative selec-
tion is a third developmental process , referred to as CD4/CDS
lineage commitment. This process ensures that DP thymocytes
that express MHC class II-specific TCRs develop into CD4 + SP
cells, and those that express MHC class I-specific TCRs develop
in CDS + SP cells. The signals that determie the lineage choice
of a given thymocyte are not completely resolved, but there is
evidence that the levels ofLck activity (44 , 45) as well as ERK-
1/2 activity (46 , 47) playa role , with high activity of both
enzymes leadig to CD4 SP development and low activity
leading to CDS SP development. These data suggested a pos-
sible role for Itk in this process , as Itk is diectly activated by
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Lck (S) and in turn plays a role in activating ERK- 1 /2 (21). In
addition, there are significantly more CDS+ SP cells in the
thymus and lower CD4/CDS ratios in both the thymus and
periphery of It, /- and Rl- itk-/- mice (17- , 21 , 2S).
Thus , we were interested in determining whether CD4/CDS
lineage commitment would be altered in Itk-/- mice or, more
specificaly, whether MHC class II-specific T cells would ""
undergo aberrant selection into CDS+ cells in the absence of 
Itk. We used the Itk-deficient MHC class II-specific TCR trans-
genic lines that we generated to assess positive selection. In al
five of the MHC class II-specific TCR transgenic systems we
examined, we observed no increase in the number of TCR
transgenic CDS+ SP thymocytes or CDS+ peripheral T cells,
suggesting that the signals requied for appropriate lineage
commitment do not require intact Itk signaling (2S).
Tee family kinases are importnt for peripheral T cell
homeostasis and function
Many recent studies have implicated tonic low-level TCR sig-
naling in the maintenance of peripheral T cell pools (4S-5 3).
Together with cytokine signals , these TCR signals are import-
ant for T cell surval, and they may also provide an enhanced
level of reactivity to subsequent mitogenic TCR signals (4S).
Because of the role of Tec kiases in PLC-y1 activation down-
stream of the TCR, it seemed likely that peripheral T cell
homeostasis as well as bona fide T cell activation would be
impaired in Tec kinase-deficient mice.
Altered homeostasis in T ec family-deficient mice
The analysis of T cell subsets in Itk -/- mice has consistently
revealed an increase in the proportions of both CD4 + and
CDS+ T cells that have an activated or memory phenotype
(CD44 ) when compared to cells from control littermates
(Fig. 2). Although the exact proportion of these populations
varies, especially with age, there is generaly a two- to three-
fold increase in the CD44 hi subset among T cells from Itk -
mice. For CD4+ CD44hi cells , this increase is observed in both
nontransgenic mice as well as in Itk-deficient TCR transgenic
RAG+/+ mice , but the increase is not seen in Itk-deficient TCR
transgenic RAG-/- mice. Therefore , it seems liely that these
cells arise following antigen-specific activation and persist to a
greater extent in Itk-/- mice than in wild-type mice. One
potential explanation for the persistence of these cells is that
reduced numbers of CD4+ T cells in Itk-/- mice cause an
increase in available ' space ' or environmental factors that are
necessary for CD4 + T cell survval and homeostasis. Another
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Fig. 2. Altered T cells homeostasis in the perpher of Itk- - mice.
Splenocytes from Itk 
+1- 
and Itk 
1- mice were staied with antibodies to
C04 , COS and C044. C04 vs. COS profies are given. Cels were then
gated on the C04 + and COS+ subsets and histograms of C044 expression
are shown (Itk+ solid lie; Itk- dashed lie). Percentages ofC044
cells are also given (Itk+ . left number; Itk- right number).
possible , but not mutually exclusive , explanation is suggested
by the observations of Miler and Berg (54), which demon-
strated a defect in activation-induced cell death (AICD) in
Itk -/- CD4 + T cells. This reduction in AICD is due , at least in
part, to a decrease in FasL expression following activation of
Itk-/- CD4+ T cells , a consequence of impaied NFATacti-
vation and impaired upregulation of the Egr2/3 transcription
factors. Thus , cells that would normaly be eliminated in wid-
type mice do not undergo apoptosis in the absence of Itk.
Within the peripheral CDS+ T cell compartment of
Itk -/- mice , the percentage of CD44 hi cells ranges from about
60-90% of the total pool. The prevalence of CDS+ CD44
cells in the periphery, along with the discovery that
the increased numbers of CDS+ SP cells in the thymus were
also CD44hi (2S), at first suggested that the CDS+ CD44hi cells
in Itk-/- mice may arise due to abnormal CDS+ T cell
development. However , CDS CD44 cells do not develop
in fetal thymic organ culture of Itk-/- thymi and are absent
from the thymus and periphery of Itk-deficient class
I - restricted aT - 1 TCR transgenic mice (Lucas, Atherly and
Berg, unpublished data). Therefore , we favor the explanation
that peripheral CDS+ T cell homeostasis is altered in
Itk-/- mice. The precise events or mechanisms that cause
this disruption in homeostasis and allow recirculation of
the CDS+ CD44hi cells back to the thymus in Itk-deficient mice
are currently under investigation.
COB effector function
CDS+ T cells are at the forefront of the imune response to
viral and some bacterial infections. During the course of infec-
tion, these cells differentiate into activated kier cytotoxic
Tlymphocytes (CTLs), whose main functions are the lysis of
infected cells and the secretion of antivial effector cytokies.
There are two distinct mechanisms by which CDS CTLs kil:
perforin/granzyme exocytosis and Fas/FasL-mediated cytoly-
sis (55). Both of these functions are dependent on activation of
the CDS + T cells though the TCR, leadig to the gen ration of
a sustaied elevation in cytoplasmic Ca 
+2 subsequent to the
activation of PLC-y1 (56). Thus, FasL expression in CDS
T cells is dependent on sustaied calcium elevation and on
the denovo synthesis of FasL protein (56). Both of these pro-
cesses could potentially involve Tec kinase family members , as
Itk and R1 have been shown to be important for the effcient
activation of PLC-y 1 and for the generation of a sustaied
calcium flux in CD4+ T cells (IS, 19).
Despite the obvious implication of Tec famy kiases in
CDS + T cell function, studies addressing the possible role(s)
of Tec kiases in CDS+ T cell development, signalig or
function are lackig. An early study examed the role of Itk
in CDS + T cell function (57). In this study, Itk- mice were
infected with lymphocytic choriomeningitis vius (LCMV) ,
vaccina vius (VV) or vesicular stomatitis vius (VSV). As
each of these viuses elicits different effector mechansms
involved in vial clearance, ths study could assess CDS
T cells, CD4 + T cells and B cell function in the absence of
Itk. These data showed that the Itk 
J- mice generated impaied
CTL responses to LCMV , VV and VSV, with CTL responses in
the range of two- to sixold reduced. However , despite these
impaied CTL responses, the kietics of viral clearance
appeared comparable between Itk 
J- 
mice and wid-type
mice. No other aspects of the antivial responses were inves-
tigated.
Experiments currently being conducted in our laboratory
are attempting to further defme a role for Tec famy kiases
in CDS + T cell function. Preliminary biochemical data suggest
that Itk 
J- 
and R1 ltk J- CDS+ T cells are impaied in TCR
signaling downstream of PLC-y 1 activation, showing defects
comparable to those observed in CD4 + T cells from these
mice. For instance, the Tec kiase-deficient CDS+ T cells
show a reduced level of sustaied Ca H elevation in response
to TCR signalg, and these cells have impaied phosphoryl-
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ation of Erk 1/2. These biochemical defects are functionaly
relevant , as diect ex vivo stimulation of CDS+ T cells from Itk-
and R1 ltk- mice leads to reduced production of the
effector cytokines interferon (IFN)-y and tumor necrosis fac-
tor (TNF)-cx compared to wid-type mice (Atherly and Berg,
unpublished data).
Our intial assessment of the antigen-specific antivial
response of Itk- mice to LCMV infection provides an inter-
esting comparison to the results reported by Bachmann et al.
(57). In our hands , the CTL response to LCMV in Itk-deficient
mice is comparable to that of wild-type mice. We also fmd
that, in the absence of Itk , CDS + T cells are impaired in their
ability to expand during the early phase of the response to
LCMV infection (Fig. 3A). This defect could be due to deficient
interleukn (IL)-2 production by CD4+ or CDS+ T cells in the
Itk 
J- mice , impaied turnover of the Itk J- CDS + T cells or
death of the CD44hi CDS+ T cells in the initial few days
following the infection. Differential kietics of CDS+ T cell
expansion may also account for the discrepancies seen in the
CTL assays, as Bachman et al. (57) used spleens from day S
post-LCMV infection , a time-point at which the number and
proportion of LCMV responsive cells in the Itk- mice are
greatly dished in comparison to wid-type mice. In con-
trast , our CTL analysis was performed using splenocytes from
day 9 and day 11 postifection , time-points at which the pro-
portions of LCMV responsive cells are more similar between
wid-type and Itk- mice (Fig. 3B). Interestigly, we also
observe a more substantial impairment in the antivial
response in mice deficient for both Itk and R1 compared to
those lackig Itk alone (Atherly and Berg, unpublished data).
CD4 effector function and T helper cell differentiation is
impaired in T ec kinase-deficient mice
CD4 + lymphocytes playa critical role in the defense agaist
many invadig organsms. Following the engagement of the
TCR/CD2S molecules on a naive T cells with specific MHC/
peptide/B7 complexes on antigen-presenting cells (APCs) , a
complex series of signalg cascades are activated in the T cell.
These signals culinate in the transcription of genes that are
involved in the differentiation of na've CD4 + T cells into
either T helper 1 (Th 1) or Th2 effector cells , lineages that are
characterized by their production of distinct sets of effector
cytokines. Th1 cells preferentially produce IFN-y and TNF- cx,
cytokies that support cell-mediated imunity; Th2 effector
cells are characterized by the production of IL- , IL-5 and
IL- , cytokies that function in humoral immunty. The
abilty of a na've CD4 + T cell to differentiate into a Th 1 or
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16 18Fig. 3. CDS T cell responses to LCMV inection
in Itk-deficient mice. (A) Expansion of CD4-
and CD8 T cell subsets in wid-tye and Itk-
mice dUring a tie-course of LCMV infection.
Wild-tye and Itk- - mice were infected
intraperitonealy with LCMV and spleens were
harested at various days postifection. The
expansion of the cel subsets was followed by
CD4- and CDS expression as analyzed by flow
cytometr. Two mice were used per time-point.
This experiment is one of thee. (B) CTL assay
using splenocytes from day 9 and day I 1 LCMV-
inected wid-type and Itk- mice. Whole
splenocytes were incubated for 5 h at 3 C with
RM target cells that were first loaded with the
imunodominant LCMV-specific peptide gp-
and labeled with SI Cr. Cr release was measured
and percent specific lysis calculated.
Th2 effector cell can be influenced by the cytokie milieu
present during the intial stimulation. However , whie many
cell types such as dendritic cells , natural kier cells , and mast
cells can serve as a source of effector cytokies that influence
T helper cell differentiation, the intial source of these cyto-
kies in vivo is not clear. It is also possible that, depending on
the characteristics of their interactions with APCs , T cells them-
selves produce cytokies that can affect their own fate.
The role ofTec family kiases in T cell effector function was
initialy discovered by Liao and Littman (17), who demon-
strated that in the absence of Itk , CD4 + cells were defective in
IL-2 production and consequently proliferation. Liu et al. (18)
extended these findigs by demonstrating biochemically that
Itk is involved in proximal TCR-mediated signaling events , as
Itk-deficient cells were specificaly impaired in the phosphor-
ylation of PLC- , and as a result, in IP production and the
mobilzation of intracellular calcium (18). Schaeffer et al. (21)
further extended these studies by demonstrating that CD4 
T cells from Rl- tk-/- mice had even more severe signaling
defects than cells possessing a mutation in either Rlk or Itk
alone.
Both Fowell et al. (58) and Schaeffer et al. (59) have shown
that .the biochemical defects observed in Tec kinase-deficient
T cells translate in vivo to impaired immune responses to infec-
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tion. These defects are observed in responses to pathogens
requiring both Th 1 and Th2 effector functions for clearance
(Table 1). For instance , both Itk -/- and Rl - ltk -/- mice suc-
cumb rapidly to infection by Toxoplasma gondii , a protozoan that
normaly induces a protective Thl immune response in wid-
type mice. These data indicate that Tec-deficient mice are
incapable of mounting a protective Thl-type CD4+ T cell
response to this pathogen.
In contrast, a second study found that Itk -/- mice on both
the C5 7Bl/ 6 and Balbi c background were able to clear an
infection of Leishmana major , a protozoan that also requires a
Thl response for protective immunty (58). This latter rmding
is particularly interesting as 1. major normally elicits a protective
Th 1 response in C5 7Bl/ 6 mice and a nonprotective Th2
response in Balbi c mice. While at face value these two studies
seem totally incompatible , it is possible that the discrepancy
may result from the different requirements for protective
immunity to these two pathogens. For instance , T. gondii infects
many cell types , proliferates and spreads rapidly in the host
and requires a fast and robust IFN-y response to prevent
lethality. In contrast , 1. major infects primarily macrophages
and dendritic cells , spreads slowly in the host and can be
cleared by a slower and less robust Thl response (60). Thus,
it is possible that reduced kinetics, reduced effciency and
Table 1. Thelper responses in ltk- and Rl- itk- mice
Protective
wild-type responsePathogen (Ref.
L. major (58) Th I (B6)
T. gondii (59) Thl
N. brasiliensis (58)
S. mansoni (59)
Th2 (Balb/c)
Th2
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Response of Itk- - and/or Rlk- ltk-
Itk- - (B6/129)
Itk- - (Balb/c)
Itk-
- (
Rlk- ltk- - (B6)
Itk- - (Balb/c)
Itk 
1- 
Rlk- ltk (B6)
resistant
resistant
susceptible (MST 69 days)
susceptible (MST 41 days)
susceptible
susceptible
susceptible
MST, mean survival time.
a reduction in the overal magnitude of the response in Itk -
mice compared to wid-type mice might explain the different
outcomes in response to these two different pathogens.
The responses of Itk -/- mice to pathogens that requie a Th2
effector response for protective imunity are more consistent.
In response to the nematode Nippostrongylus brasiliensis, Balbi c
mice make a protective Th2 response; however , Itk-/- Balb/c
mice fai to clear the nematode and show a significant reduc-
tion in the number of cells makg IL-4 compared to wild-type
mice (58). Followig ths discovery, Schaeffer et al. (59)
reported that Itk-/- mice on the mixed 129 X C57Bl/6 back-
ground were also unable to mount a suffcient Th2-tye
response to the helminth Schistosoma manoni. Consistent with
the overal reduction in the response to ths pathogen, cells
isolated from the lymph nodes of infected Itk-/- mice pro-
duced less of the Th2 cytokies, IL- , IL-5 and IL- 1 0 , and
more of the Th1 cytokie IFN-y compared to cells from
infected wid-tye mice. Thus , Itk-/- mice seem to have a
significant defect in makg Th2 responses , presumably as a
consequence of the CD4 + T cells havig an impaied ability to
activate NFATc1 and ultimately to produce IL-
Paradoxicaly, the Schaeffer study (59) also showed that
Rl- ltk-/- mice were able to elicit a normal Th2 response
to S. manoni , similar to that elicited in wid- type mice infected
with this parasite (59). We have recently determined that 
is substantialy downegulated following the stimulation of
na'ive wid- type cells in Th2-skewig conditions , whie Itk is
upregulated (Miler and Berg, unpublished data). Further-
more , Takeba et al. (61) recently demonstrated that in Jurkat
cells , Rl functions as a transcriptional regulator of the IFN-
gene by binding to the IFN-y promoter. Therefore , one poten-
tial explanation for thesefmdigs is that in the Itk -/- situation
Rl is either upregulated or functions to compensate for the
absence of Itk in CD4 + T cells , resulting in cells that would
selectively make IFN-y upon differentiation. In contrast, the
absence of Rl in Rl- ltk -/- mice would cause a selective
defect in IFN-y production, potentialy leadig cells to default
to a Th2 differentiation program. Consistent with ths hypoth-
esis is the observation that Rl - ltk -/- mice are unable to
generate a Th1-mediated response to T. gondii , yet they produce
a protective Th2-mediated response to S. manoni (59).
To further dissect the role of Tec family kiases in T helper
cell differentiation , a number of in vitro studies have examined
the abilty of Itk -/- CD4 + T cells to differentiate under defmed
culture conditions. For the most part , the observations made
by Fowell et al. (58) and Schaeffer et al. (59) and also in our
own laboratory are consistent. However , some discrepancies
with respect to the magnitude of the defects in IL-4 and IFN-
production by Itk-/- CD4+ T cells from mice of different
genetic backgrounds have yet to be explained. Both Fowell
et al. (58) and Schaeffer et al. (59) observed defects in IL-
production by Th2 cells that were skewed in vitro. Whie Fowell
et al. (58) observed a 1 OO-fold decrease in the IL-4 production
by Itk-/- Balb/c CD4+ T cells , Schaeffer et al. (59) found
approximately a 2o-fold difference in IL-4 production by
Itk-/- 129 X C57Bl/6 CD4+ T cells compared to their wid-
type counterparts. Even more strikngly, following the resti-
mulation of cels primed in Th1 conditions, Fowell et al. (58)
observed no defect in IFN-y production by cells from Itk-
Balb/c mice , whereas Schaeffer et al. (59) observed substantial
defects (,, 12-fold) in cells from Itk -/- 129 x B6 mixed mice.
These differences suggested that the absence of Itk might have
distict effects in T cells from different strais of mice. One
mechanstic explanation for ths possibilty is that Balbi c and
mixed 129 x C57Bl/6 mice may have different basal expres-
sion levels of transcription factors , kiases or other signalig
molecules that function in T helper cell differentiation path-
ways, and these distinctions may affect how CD4 + cells
respond to certai antigens. Evidence supporting ths possibi-
lity was presented by Bix et al. (62), who identified two
genetic loci in Balbi c mice that could inuence the intrinsic
ability of a CD4 + T cell to produce IL-4. These identified loci
were determined to inuence IL-4 production prior to signals
mediated by the IL-4 receptor.
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14.
Fig. 4-. Increased effector/memory CD4- 
T cells mice. Followig the purfication of
splenic CD4 + T cells (Fig. 2), 1 X 10 cells were
stiulated with PMA (2. 5 ng/mL) and
ionomycin (375 ng/mL) for 6 h in a 96-well
plate. After 4 h , Golgi -blockg reagents were
added to prevent cytokie secretion. The cells
were then surface staied with antibodies to
CD4 and CD44 , fixed , permeabilzed, and
staied intracellularly with antibodies to IL-
and IFN-y. Cells were then imediately
analyzed by flow cytometry.
To add further complexity to ths story, we observe slight
differences in T helper cell differentiation using Itk -/- mice
generated in our laboratory compared to those published by
others. Our Itk -/- mice are completely backcrossed to the
C5 ?Bl/ 6 background , and similar to the fmdings reported by
Schaeffer et al. (59), we have found that CD4 + T cells from
these mice possess defects in both IFN-y and IL-4 production
when skewed in Thl and Th2 conditions , respectively. How-
ever , we have consistently observed an interesting phenom-
enon not reported by either Fowell et al. (58) or Schaeffer et al.
(59). As described above , Itk-/- have a substantial increase in
the steady-state number of peripheral CD4 + T cells with an
activated/memory phenotype. In an effort to determine the
differentiation status of these activated cells in vivo , we stimu-
lated CD4 + T cells from these mice ex vivo with phorbol myr-
istate acetate (PMA) and ionomycin , and examined effector
cytokie production by intracellular staining. This experiment
indicated that many more CD4 + T cells in Itk -/- mice produce
cytokines diectly exvivo (Fig. 4), and the cells responsible for
the increased cytokie production were CD44 . Of these
CD44hi cells most are IFN-y producers; however , a significant
percentage of CD44 
hi cells from Itk -/- mice produce IL-4 in
this assay. The strikng aspect of this finding is that the number
of IL- producing cells is substantialy higher in the Itk -
mice than in the control mice. Likewise , when stimulating
purified CD4 + T cells from 5C.C? TCR transgenic Itk -/- mice
in vitro with peptide plus APCs in nonskewing conditions , we
consistently observe the differentiation ofItk -/- cells into both
Thl- and Th2-type cells (Fig. 5). Interestingly, the Itk-/- cul-
tures always show increased percentages of cells that produce
IL-4 compared to the control cultures where, under these
nonskewig conditions, the T cells unformly differentiate
into IFN-y producers. This increased tendency of cultured
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5C.C? Itk-/- T cells to differentiate into IL-4 producers corre-
lated with an increased percentage of cells that are CD44 hi and
Vex 1 1 in these mice. Together , these fmdings strongly sug-
gest that T cells expressing endogenous TCR exchains are
becoming activated il the 5C.C? Itk -/- mice, differentiating
in vivo into IL- producing cells and then skewig the in vitro
cultures towards Th2 differentiation due to the elevated IL-
production.
The origin and history of the IL- producing CD4 + T cells
in the Itk-/- mice remain unclear. We favor the possibility
that a repertoire of T cells is selected in the thymus of
Itk -/- mice that are either autoreactive and become activated
by self-antigen or , alternatively, are reactive to an environ-
mental antigen that induces differentiation into the Th2
lieage. The explanation for why this occurs in Itk-deficient
mice but not in wid-tye mice has not been determined, but
it may relate to defects in thymic selection or to an altered
peripheral environment due to changes in the non-T cell
populations that express Itk and/or Rl. Nonetheless, several
lines of evidence from Schaeffer et al. (59) and our own
laboratory support the hypothesis that there is some type of
Th2-biased immune response, autoirnune or otherwise
occurring in vivo. First, Schaeffer et al. (59) reported that
Itk -/- mice have a. fivefold increase in serum immunoglobu-
lin E (IgE) levels, an IL- dependent antibody subclass.
Second, we have observed a significant level of eosinophilia
in lymph nodes of Itk-/- mice that is probably the result of
Th2 effector cells in vivo (63). Third, the phenotype observed in
Tec family kiase-deficient mice is strikgly similar to that
seen in mice possessing mutations in signaling molecules such
as LAT , JNK1 and certain NFATs , al of which have all been
implicated in the same pathway(s) as Itk, as is discussed later
in greater detail.
Itk +/-
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Evidence implicating the PLC-y I , calcium, NFA T pathway
in regulating T cell development and differentiation
Tec famy kiases are thought to function in the phosphoryl-
ation and activation of PLC-yl via the formation of a
multimolecular signalosome complex that includes Grb2
Gads, SLP- , LAT and PLC-y1 (for review of mechansm,
see 1). Recently, two independent groups , Aguado et al.
(64) and Sommers et al. (65), described mice that expressed
only a mutated form of LAT , LATYI36F . Previous work had
shown that Y136 of LAT is required for the binding and
activation of PLC-y1 in response to TCR stimulation (16 , 66
67). Interestingly, the LATYl36F mutant mice have a very
similar biochemical and physiological phenotype when com-
pared to the Tec kiase-deficient mice (Fig. 6). Similarly, muta-
tion of another TCR signalig molecule , Vav1 , which has also
been shown to be important for the ful activation of PLC-
( 6 8), results in mice with a similar T cell deficiency (69-7 1) .
Based on their role in PLC-y1 activation , it is not surprising
that each of these molecules has also been shown to playa role
in regulating calcium mobilization in T cells.
Downstream of PLC-y1 activation , IP generation and sub-
sequent calcium mobilization, transcription factors of the
NFAT family are rapidly dephosphorylated and activated by
the calcium-dependent phosphatase , calcineurin. This dephos-
phorylation alows NF A T molecules to translocate to the
nucleus where they bind to specific promoter sequences and
activate transcription. The three NFAT family members
expressed in T cells, NFATc1 (NFATc, NFAT2) , NFATc2
(NFATp, NFATl) and NFATc3 (NFAT4, NFATx), appear to
have overlapping as well as unque functions, as has been
elucidated by studies of mice with single as well as multiple
mutations in NFAT famy members (72). predictably, several
groups including our own have found that Itk- - and
Rl- ltk- CD4 + T cells have a defect in NFAT activation
and! or translocation following TCR stimulation , most prob-
ably as a result of the defects in calcium mobilization (58
63). The resemblance of the phenotypes observed in Itk-
Rl 
Yl36F .an also the LAT mice to those observed in
several NFAT knockouts is intriguing, and this resemblance
further confirms the notion that disruption of PLC-y1 activity
results in defective NFAT activation, which in turn affects a
number of T cell effector functions.
With respect to T cell development, the clearest paralels are
seen between mouse mutants caryig defects in signaling
proteis that are upstream of PLC-y1 activity. The absence of
the adapter molecules SlP-76 and LAT has more severe effects
on T cel development than those seen in Itk- - and Rl- ltk-
mice (21 , 28). Specificay, Tec kiase-deficient mice have
mild, if any, defects in development at the DN to DP transition
whereas thymocytes from both SlP- 1- (73 , 74) and LAr
mice (75) are blocked at ths stage of development. These
results are consistent with the fact that deficiencies in SlP-
(76) or LAT (77) lead to more substantial reductions in PLC-
activity than is seen in Tec family knockouts (19) and lead to a
vitual absence of calcium mobilization in response to TCR
Yl36Fsign mg. e p enotye of the LAT mice with respect to
T cel development is similar to LAr mice, but less severe;
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instead of a complete block at the DN3 to DN4 stage of
thymocyte development, young LATY136F mice have a smal
populatio of DP cells , suggesting that a low level of pre- TCR
signaling is retaied in these mice (65). This early T cel devel-
opment defect in LATY136F mice confIrms previous data indicat-
ing a role for PLC-y1 in pre- TCR signals (29) and further
implicates a role for Tec kiases at this stage of development.
The developmental and biochemical defects observed in
Vav mice show the greatest similarity to the defects seen
in Itk- and Rl- itk- mice (69-71). Vav1 1- mice have
defIciencies in both positive and negative thymic selection
with no affects on lineage commitment (71 , 78). In addition,
these mice have a mild defect in the DN to DE transition
indicatig a role for Vav1 in pre-TCR signaling (78). Recently
it has been shown that Vav1 is required for the ful activation
of PLC-y1; however , unike the Tec kinases, Vav1 plays an
indiect role in ths process and may affect PLC-y1 activity by
at least two mechansms (68). One mechanism is the require-
ment for Vav1 to activate PI3K, which in turn faciltates the
activation of Itk and Tec via recruitment of these kiases to the
activated receptor by the bindig of their PH domains. This
mechanism would then lead to the diect activation ofPLC-
by the Tec kiases. In support of this model , activation of both
Itk and Tec is severely impaired in Vav1 1- DP thymocytes.
The second mechanism by which Vav1 is thought to regulate
PLC-y1 activation is PI3K independent , and is based on the
requirement for Vav1 to promote PLC-y1 association with
SLP- 76 and Gads. It is interesting to note that the develop-
mental defects in Vav1 - mice are more severe than those
seen in Itk- mice, but they are similar to those seen in
Rl- itk- mice. This similarity correlates well with the fact
that both Itk and Rl contribute to the ful activation of PLC-y 1
in thymocytes and that the pathway involvig Itk is PI3K
dependent, une the pathway involvig Rl.
The most strikg similarities seen among these signalig
protein-defIcient mice involves alterations in CD4 + T cell
homeostasis and the apparent in vivo skewing to a Th2-domi-
ated environment in noniunized mice. Both groups that
generated LATY136F mice described the peripheral CD4 + T cells
isolated from these mice as havig an activated phenotype
(CD62L , CD44 , CD69 ), showing defects in TCR-mediated
cell death and selectively producing type-2 cytokies (64 , 65).
Furthermore , in vitro, CD4+ T cells from LAT
Y136F mice are
defective in calcium mobilzation, IL-2 production and FasL
expression, analogous to the milder defects seen in Itk-defI-
cient CD4+ T cells. However , unike Itk- and Rl- itk-
cells, the ERK pathway remaied intact in the LAT
Y136F T cells,
although the explanation for ths fInding is not clear. Interest-
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ingly, both groups aluded to the fact that, as a result of
impaiments in thymic selection, cells reactive towards self-
ligands may be escaping from the thymus. Whie both studies
described similar phenotypes of the LATY136F mice , Aguado
et al. (64) maitained their mice on the Balbi c background
whereas Sommers et al. (65) maintained their mice on the
C57B1I6 background. Thus , genetic differences between these
two mouse strains that affect Th 1 vs. Th2 differentiation in
other circumstances appear unelated to the phenotype
observed in the LATY136F mice.
Mice deficient in NFAT family members also share some of
the common phenotypes with the Tec family-deficient and
LATY136F mice, but the relationships are more complex.
NFATel l- mice are unable to induce Th2 responses, as
demonstrated by decreased IL-4 production by T cells from
these mice (79 , 80). Remarkably, whie CD4+ T cells from
NFA Tel-defIcient mice possess a reduced proliferative capacity
in vitro , they exhibit no defect in IL- , IFN-y or TNF-Cl produc-
tion when skewed in Th1 conditions in vitro. A second NFAT
family member , NFATc2, that is expressed at high levels in
resting T cells and then downregulated following activation
(81), has been found to diectly regulate the expression of
NFATc1 by transactivating the NFATc1 promoter following
TCR activation (82). Lymphocytes from mice possessing
mutations in NFATc2 exhibit an activated phenotype, show
moderate increases in IL-4 production and have defects in
activation-induced cell death in addition to severe eosinophiia
in the lungs (83). Further studies by Hodge et al. (84) and
Kiani et al. (85) demonstrated that NFATc2 is required for the
termination of the late phase of IL- transcription and
ultimately for the downegulation of the Th2 response.
NFATc3 , comparable to NFATc2 , is expressed in resting T cells
and is downegulated following activation (81). NFATc3-
deficient peripheral T cells, although they lack defects in
cytokine production, have an activated phenotype and exhibit
increased apoptosis as a result of elevated FasL expression
(86). These latter data are consistent with the notion that
NFATc3 may function to repress FasL expression and thus
may play an important role in T cell surval.
Mice contaiing combined mutations in NFAT family mem-
bers have proven to be invaluable in the dissection of NFAT-
regulated pathways. NFATc2/NFATc3 doubly-deficient mice
develop a lymphoproliferative disorder as a result of increased
resistance to apoptosis. These mice have allergic blepharitis
interstitial pneumonitis and 1000- 1 OOOO-foid increase in
serum IgG 1 and IgE levels, secondary to a dramatic and
selective increase in Th2 cytokines (81). In contrast, T cells
from mice contaig combined mutations in both NFATel
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and NFATc2 exhibit an activated phenotype but show
substantial defects in the development of multiple effector
functions , such as cytokine production , surface effector mole-
cule expression and cytolytic activity (87). Al of the above
findings suggested that, while NFATcl may playa positive role
in proliferative functions , NFATc2 and NFATc3 essentially
function to repress specific T cell functions. These data imply
that, depending on the strength or qualty of the TCR signal
some NFAT family members may be selectively activated
relative to others. Furthermore , it is evident that lymphoid
homeostasis and Th2 development require a critical balance
among NFAT family member activities.
Based on the observations arising from analyses of NFAT-
deficient T cells, it seems likely that upon stimulation of
T lymphocytes lackig Itk, Rlk and Itk, or LAT, there would
be an initial defect in NFATc2 activation, followed by a more
substantial defect in NFATc2-induced NFATcl upregulation.
In addition, as a result of their impairment in NFAT activation
Itk -/- and Rlk- ltk -/- T cells may also show decreased repres-
sion mediated by NFATc2 and NFATc3 , providing an explan-
ation for many of the observed defects in T cells effector
functions seen in these cells as well as those expressing
LATY136F . The more severely impaied Rl- ltk-/- CD4
T cells may be more ak to the NFATcl/c2 double knockout
cells, where there is a more profound defect in NFAT-
mediated effector functions. The relationships between Itk
Rl and LAT, signaling molecules that function to amplify
calcium signals, and NFATs, calcium sensitive transcription
factors , and between NFATs and specific effector genes may
not be simple. To obtain a clearer pictue of these relation-
ships, it wi be necessary to determine how individual NFAT
molecules are spatiotemporally regulated in T cells during
T cell stimulation , expansion and contraction.
Another T cell signaling protein , JNK, has also been impli-
cated in pathways downstream of Itk activation and other
proximal TCR signaling events. We have shown that Itk-
CD4 + T cells are defective in the activation of the JNK path-
way, a defect that is likely to contribute to the impaied FasL
expression in these cells (54). CD4 + T cells from JNK 1 -defi-
cient mice synthesize augmented levels of IL-4 production but
normal levels of IFN-y production, when stimulated in vitro in
nonskewing conditions (88). NFATcl has been identified as a
substrate for JNKl , and it may function to inhibit Th2
responses (88). Consistent with this, JNKl /- mice are suscep-
tible to Leishmana infection , which is not due to their inability
to make a Th 1 response but rather to their inability to suppress
the development of a Th2 response (89). Exactly how
dysregulation of JNKI signaling in Itk -/- mice contributes to
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the T helper imbalance seen in these mice is unclear. Perhaps a
better understanding of the complex interactions and cross-
talk between al these signaling molecules through gene
expression array analyses wil aid in our future understandig
of how these signaling molecules and pathways integrate to
affect T cell development, activation and differentiation.
Role of T ec kinase-dependent signals in non- T cells
Whereas T helper cell differentiation can clearly be altered by
modification of genes withi the T cells themselves , it is clear
that envionmental factors , especialy cytokies , elicited from
other cell types can also influence ths process. Three of the
most important . cell tyes that have been shown to influence
the T helper response are natural killer (NK) cells , NK- T cells
and mast cells. Interestingly, Tec family kiases, the adapters
SLP- 76 and LAT and the NFAT family of transcription factors
are al involved in signaling with these cells. Thus , it is
possible that, along with intrinsic T cell changes in the signal-
ing mutants discussed, disruption of signaling in other cell
types may affect the T cell phenotype observed in these mutant
mice.
Activation of the NK cell cytolytic machinery is mediated by
signaling though the low-affnity FcyRIIIA complex on the
cell surface. This receptor belongs to the same superfamily of
receptors as the TCR, and it uses related signaling molecules
and pathways to mediate its function (reviewed in 90).
Among the signaling molecules that can associate with
FcyRIIIA are Lck , ZAP-70 and SLP- 7 6 , al of which are mole-
cules that influence Itk activity in response to signaling down-
stream of the TCR. Despite the familial similarities of receptors
expressed on NK cells and T cells , the similar functions of NK
cells and CD8 T cells and the expression of Itk in human NK
cells, data from our own laboratory indicate that murine NK
cells do not express Itk. Consistent with this, we have found
that the functions of NK cells in Itk -/- mice are unmpaired in
response to LCMV infection (Fig. 7). However, real-time quan-
titative PCR analysis on cDNA generated from IL-2-activated
NK cells shows that NK cells do express transcripts for both 
and Tec (Atherly, Miler and Berg, unpublished data). Data
from Schaeffer et al. (59) suggest that Rl, like Itk, is not
necessary for NK cell function in mice, as normal levels of
serum IFN-y are detected early after infection with T. gondii in
both Rl-/- and Rl- ltk-/- mice. Therefore , as NK cell func-
tions in Itk-deficient and Itk/Rl-deficient mice seem to be
normal , it is unikely that alterations in the T helper cell phe-
notype observed in the periphery of these mice is due to
aberrant NK cell function.
Fig. 7. Normal NK cell fuction in Itk-
mice. Spleens were harested from wid- type
and It, I- LCMV-infected mice 3 days
postifection. Splenocytes were then incubated
with Cr-labeled MHC class I-deficient YAC
target cells at varous effector (E) : target (T)
ratios for 5 hat 37 C. Cr release was
measured and percent specific lysis was
calculated.
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A role for mast cells in the Th2-type skewing observed in the
mutant mice described earlier is a possibility, as mast cells play
an integral role in Th2 effector responses. Both Itk and Btk are
expressed in mast cells and become phosphorylated followig
crosslinking of the high-affmity IgE receptor, Fc€RI, present
on mast cells (91 , 92). There is substantial evidence indicating
a role for Btk in mast cell function (93), but little is currently
known about the role ofItk in these cells. Interestingly, many
of the same molecules that are involved in the Tec kiase-
dependent signal downstream of the TCR are found to asso-
ciate followig activation of Fc€RI, includig Vav 1 , SLP-
and LAT. Additionaly, both PLC- , which is activated by Itk
in T cells, and PLC- , which is activated by Btk in B cells
associate with this complex, suggesting a possible role for both
of these Tec kiases in mast cell signaling. In mast cells , the
activation of both of these PLC-y isoforms is thought to be
important for calcium responses and for the activation of the
NFAT famy of transcription factors, signals that are critical for
optimal mast cell function and cytokine production (reviewed
in 94). Thus, a possible role for Itk in mast cells remains
leaving open the possibility that mast cell deregulation might
affect T cell homeostasis and/or differentiation.
NK T cells are important regulators of T helper responses
and Itk has recently been shown to be important for the
development and homeostasis of different NK T cell subsets
(95). In this study, four stages/fractions of NK T cell
development were defmed based on the expression of various
cell surface markers. Moreover , they found that fractions 1 and
2 predominately secrete IL- , whie fractions 3 and 4 express
IFN-y upon activation. Comparison of the NK T cell subsets
present in young Itk-deficient mice and wild-type mice
demonstrated that there is a partial block at the transition
from fraction 2 to fraction 3 in the Itk -/- mice , with a twofold
increase in the percentage of cells at fraction 2 and a reduction
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in fraction 3 cells. Additionaly, as Itk-deficient mice age , they
progressively lose a significant proportion of their NK T cells
suggesting a role for Itk in the maintenance of these cells.
Based on these fmdings it seems liely that during the first few
weeks of life , Itk -/- mice would have an increase in the
immature IL- producing population of NK T cells as well as
a progressive loss of this immunoregulatory population as a
whole as the mice age. Thus, it seems possible that these
effects on the NK T cell population could contribute to the
Th2 skewed phenotype we observe in Tec family-deficient
mice. Because of the limited studies caried out to address
the role of various signalig molecules in NK T cell
development , it remains to be seen whether changes in the
population of these cells could be responsible for the
phenotypes observed in other signaling molecule knockouts.
Nonetheless , it wi be interesting to detennine whether or not
the in vivo Th2 skewing observed in Tec f ily-deficient mice is
T cell intrinsic, or is influenced by changes in the NK T cells,
mast cells or both.
Conclusions
Determination of the precise and possibly unque role 
each Tec family kinase in T cells requires further investigation
using a combination of genetics and biochemistry. A compli-
cation of the genetic studies is the possibility that when one
member of the Tec family is absent, compensatory mechan-
isms may emerge to counteract the imbalance. Consistent
with this possibility, RNA isolated from lymphoid organs of
R1 -/- mice was found to have somewhat increased levels of
Itk mRNA (19). In contrast, we have found that neither R1
nor Tec mRNA expression is upregulated in Itk -/- CD4 + T cells
(Miler and Berg, unpublished data). Whie this fmdig does
not rule out the possibility that R1 or Tec might compensate
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for Itk in its absence, we favor the notion that under
normal physiological circumstances, each Tec kiase family
member has a specific and nonredundant role in hematopoie-
tic cell signaling. Supporting this idea, individual Tec kiases
show distinct requirements for activation, such as the
dependence on PI3K, in addition to the common need for
phosphorylation by an Src kinase. Furthermore , activation of
Tee kinases in T cells leads to overlapping as well as unque
downstream consequences, as ilustrated by the observation
that Rl but not Itk can translocate to the nucleus and act as a
transcription factor. Future work with Tec famy kiases
should begin to reveal the precise roles of Itk , Rl and Tec in
T cell signaling.
The contradictory and somewhat mystifying data discussed
above warrant further investigation of the role of Tec family
kiases in CD4 + T cell differentiation. More specifically, a
more complete understandig of the pathways from Tec
kiase activation to transcription factor activation is needed.
Despite many of the unowns, al of the current data collect-
ively emphasize the importance of Tec kinases in regulating
T cell homeostasis as well as global immune responses. These
data also highlight the role of Tec kiases in the regulation of
T helper cell differentiation. Finaly, the data described here
underscore the important role of TCR signal strength in main-
taiing the appropriate balance of T cell survval, activation
and differentiation.
References
1. Miler AT . Berg LJ. New insights
into the regulation and functions
of Tec family tyosine kiases in the
imune system. Cur Opin Imunol
2002; 14:331-340.
2. Yang WC , Collette Y . Nunes JA, Olive D. Tec
kiases: a famy with multiple roles in
imunty. Immunty 2000;12:373-382.
3. August A. Fischer A, Hao S . Mueller C
Ragin M. The Tec famy of tyosine
kiases in T cels, amplifiers of T cel
receptor signals. Int J Biochem Cel BioI
2002;34: 1184-1189.
4. Czar MJ. Debnath J, Schaeffer EM
Lewis CM, Schwartzberg PI. Biochemcal
and genetic analyses of the Tec kiases Itk
and Rl/Txk. Biochem Soc Trans
2001 ;29:863-867.
5. Yang WC . cWng re. Tsoukas CD.
Berg LJ. Tec kiase signalg in T cels
is regulated by phosphatidyUnositol
3 -kiase and the T ec pleckstr
homology domai. J Imunol
2001;166:387-395.
6. cWng re, Kawakam Y, Kawakam T
Tsoukas CD. Emt/Itk associates with
activated TCR complexes: role of the
pleckstrin homology domai. J Immunol
1999;163:6006-6013.
7. Chamorro M . et al. Requirements for
activation and RAT localation of the
Iymphocyte kiase Rl/Txk. BMC
ImmunoI2001;2:3.
8. Heyeck SD . Wilcox HM . Bunell SC
Berg LJ. Lck phosphorylates the activation
loop tyosine of the Itk kiase domai and
activates Itk kiase activity. J BioI Chem
1997;272:25401-25408.
136
9. Shan X. Wange Ri. Itk/Emt/Tsk
activation in response to CD3
cross-lig in Jurkat T cels requies
ZA-70 and Lat and is independent of
membrane recrtment. J BioI Chern
1999;274:29323-29330.
10. Su YW, ZhangY . SchweikertJ.
Koretzy GA, Reth M, Wienands
J. Interaction of SLP adaptors with
the SH2 domai of Tec famy
kiases.
Eur J Immunol 1999;29:3702-3711.
11. Bunell SC. Dieh M . Yafe MB
Findell PR, Cantley LC, Berg LJ.
Biochemical interactions integratig
Itk with the T cel receptor-intiated
signaling cascade. J BioI Chern
2000;275:2219-22,30.
12. Uu SK, Fang N . Koretzky GA
McGlade CJ. The hematopoietic-specic
adaptor protein gads functions in T-cel
signaling via interactions with the SLP-
and lAT adaptors. Cur BioI 1999;
9:67-75.
13. Ishiai M . Kurosak M , Inabe K. Chan AC,
Sugamura K. Kurosak T. Involvement
of lAT . Gads . and Grb2 in compartmentati
on ofSLP-76 to the plasma membrane. J Exp
Med 2000;192:847-856.
14. Law CL . et al. GrpL . a Grb2-related
adaptor protein, interacts with SLP-76 to
regulate nuclear factor of activated T cel
activation. J Exp Med 1999;189:
1243-1253.
15. Asada H . et al. Grf40 . a novel Grb2 famy
member. is involved in T cell signalg
though interaction with SLP-76 and lAT. J
Exp Med 1999;189:1383-1390.
Immunological Reviews 191/2003
16. Zhang W, Trible RP. Zhu M . Uu SK
McGlade CJ. Samelson LE. Association
of Grb2 . Gads . and phospholipase
gama 1 with phosphorylated
lAT tyrosine residues. Effect of lAT
tyosine mutations on T cel antigen
receptor-mediated signalg. J BioI
Chem 2000;275:23355-23361.
1 7. Uao XC, Uttman DR. Altered T cell
receptor signalg and disrupted
T cel development in mice lackg
Itk. Imunty 1995;
3:757-769.
18. UU KQ. Bunell SC. Gurak CB , Berg LJ.
T cels receptor-intiated calcium release is
uncoupled from capacitative calcium entr in
Itk-deficient T cels. J Exp Med
1998;187: 1721-1727.
19. Schaeffer EM . et al. Requiement for Tec
kiases Rl and Itk in T cels receptor
signalg and imunty. Science
1999;284:638-641.
20. Eleier W , et al. Severe B cell deficiency
in mice lackg the Tec kiase famy
members Tec and Btk. J Exp Med
2000;192:1611-1624.
21. Schaeffer EM, Broussard C, Debnath J.
Anderson S , McVicar DW . Schwartzberg
PI. Tec family kiases modulate
thesholds for thymocyte development
and selection. J Exp Med 2000;
192: 987-1000.
22. MoUna TJ. et al. Profound block in thymocyte
development in mice lackig p561ck. Natue
1992;357:161-164.
23. Negishi I . et al. Essential role for Zap-70 in
both positive and negative selection of
thymocytes. Natue 1995;376:435--38.
24. Wiest DL, et al. A spontaneously arising
mutation in the DLA motif of murine
ZA-70 abrogates kiase activity and arests
thymocyte development. Imunty
1997;6:663-671.
25. Thomas JD, Sideras P , Smith CIE,
Vorechovsky I , Chapman V , Paul WE.
Colocalization of x-lied
agamaglobulemia and X-lied
immunodeficiency genes. Science
1993;261:355-358.
26. Rawligs DJ, et al. Mutation of unique
region of Bruton s tyosine kinase in
immunodeficient XI mice. Science
1993;261 :358-361.
27. de Weers M , Mensin RG, Kraakan ME,
Schuunan RK, Hendriks RW. Mutation
analysis of the Bruton s tyosine kiase
gene in X-lied agamaglobulemi
identication of a mutation which affects
the same codon as is altered in
imunodeficient xid mice. Hum
Mol Genet 1994;3:161-166.
28. Lucas JA , Atherly La , Berg LJ. The absence of
Itk inbits positive selection without
changing lieage commtment. J Immunol
2002;168:6142-6151.
29. Aifantis I , Gounari F, Scorrano
, Borowski C, von Boehmer
H. Constitutive pre- TCR signalg
promotes dierentiation though Ca
mobilzation and activation of NF-
andNFAT. NatImuno12001;
2:403-409.
30. Heyeck SD , Berg LJ. Developmental
regulation of a mure T cell-specific tyosine
kiase gene, Tsk. Proc Natl Acad Sci USA
1993;90:669-673.
31. Hu Q, et al. Identification of Rl , a novel
protein tyosine kiase with predomiant
expression in the T cel lieage. J BioI Chem
1995;270: 1928-1934.
32. Kisielow P , Teh HS, Bliithan H, von
Boehmer H. Positive selection of antigen-
specific T cells in thymus by restrctig MHC
molecules. Natue 1988;335:730-733.
33. Kaye J, Hsu M-L, Sauron M- , Jameson SC
Gascoigne NRJ, Hedrick SM. Selective
development of CD4+ T cells in
transgenic mice expressing a class II
MHC-restrcted antigen receptor.
Natue 1989;341:746-749.
34. Berg LJ, Puen AM , Fazekas de St Groth B
Maths D, Benoist C , Davis MM. Antigen/
MHC-specic T cels are preferentialy
exported from the thymus in the presence of
their MHC ligand. Cell 1989;58:1035- 1046.
35. Seder RA, Paul WE, Davis MM, Fazekas de St
Groth B. The presence of interleuk 4 during
in vitro primg deteres the lymphokie-
producing potential of CD4+ T cells from
T cel receptor transgenic mice. J Exp Med
1992;176: 1 091- 1 098.
36. Yelon D , Berg LJ. Strctualy simar TCRs
differ in their effciency of positive selection.
J ImunoI1997;158:5219-5228.
37. Hogquist KA, Jameson SC , Heath WR,
Howard JL, Bevan MJ, Carbone FR. T cell
receptor antagonist peptides induce positive
selection. Cell 1994;76:17-27.
38. Sommers CL, Rabin RL, Grinberg A , Tsay HC
Farber J, Love PE. A role for the Tec family
tyosine kiase Txk in T cell activation and
thymocyte selection. J Exp Med
1999;190: 1427-1438.
39. Kisielow P, Bluthan H , Staerz UD,
Steinetz M , von Boehmer H. Tolerance in
T cells receptor transgenic mice involves
deletion of nonmatue CD4+CD8+
thymocytes. Natue 1988;333:742-726.
40. Kaye J, Vasquez NJ, Hedrck SM. Involvement
of the same region of the T cell antigen
receptor in thymc selection and foreign
peptide recognition. J 1mmunol
1992;148:3342-3353.
41. Fazekas de St Groth B , et al. An analysis of
T cell receptor-ligand interaction using a
transgenc antigen model for T cell receptor
tolerance and T cell receptor mutagenesis. In:
Alt FW, Vogel HJ, eds. Molecular
mechansms of imunological self-
recognition. San Diego: Academic Press,
1993:125-127.
42. Ho WY. Transgenic mouse models ofT cel
tolerance and in vitro T cels-B cell
collaboration. palo Alto: Stanord University
Press , 1995.
43. Singer A. New perspectives on a
developmental diema. the kietic
signalg model and the importance
of signal duration for the CD4/CD8
lieage decision. Cur Opin Imunol
2002;14:207-215.
44. Herandez-Hoyos G, Sohn SJ, Rothenberg
, Alberola- lla J. Lck activity controls CD4/
CD8 T cell lieage commtment. Imunty
2000;12:31.-322.
45. Legname G , et al. Inducible expression of a
p56Lck transgene reveals a central role for Lck
in the dierentiation of CD4 SP thymocytes.
Imunty 2000;12:537-546.
46. Bommardt U , Basson MA Krei 
Zamoyska R. Activation of the extracelular
signal-related kiase/mitogen-activated
protein kiase pathway discrinates CD4
versus CD8 lieage commtment in the
thymus. J ImunoI1999;163:715-722.
47. Shar LL, Schwarz DA, Bott CM
Marshal CJ, Hedrck SM. The inuence
of the MAK pathway on T cel
lieage commtment. Immunity
1997;7:609-618.
48. Gerai RN, Stefanova I, Dorfman J. Self-
recognition and the regulation of CD4+
T cel surval. Adv Exp Med BioI
2002;512:97-105.
Lucas et al . T ec kinases in T cell development and function
49. Tanchot C, Lemonnier FA , Perarau B , Freitas
, Rocha B. Differential requiements for
surval and proliferation of CD8 naive or
memory T cells. Science 1997;276:2057-
2062.
50. Kiberg J, Berns A, von Boehmer H.
Peripheral T cels surval requires contiual
ligation of the T cell receptor to major
histocompatibilty complex-encoded
molecules. J Exp Med 1997;186:1269-1275.
51. Brocker T. Surval of matue CD4 T
lymphocytes is dependent on major
histocompatibilty complex class II-
expressing dendritic cells. J Exp Med
1997;186: 1223-1232.
52. Viret C , Wong FS , Janeway CA Jr. Desigrug
and maitaig the matue TCR repertoire:
the contiuum of self-peptide: self-MHC
complex recognition. Immunty
1999; 10:559-568.
53. Rooke R, Waltziger C, Benoist C, Maths D.
Targeted complementation of MHC class II
deficiency by intrathymc delivery of
recombinant adenovises. Immunty
1997;7: 123-134.
54. Mier AT, Berg LJ. Defective Fas ligand
expression and activation-induced cell death
in the absence of IL- inducible T cell kiase.
J Immunol 2002;168:2163-2172.
55. Fuler CL , Ravichandran KS , Braciale Vl.
Phosphatidyliositol 3-kiase-dependent and
- independent cytolytic effector functions.
J ImmunoI1999;162:6337-6340.
56. Esser MT, Haverstick DM, Fuler CL, Gulo
CA, Braciale Vl. Ca H signalg modulates
cytolytic T lymphocyte effector functions.
J Exp Med 1998;187:1057-1067.
57. Bachman MF, Uttman DR, Liao Xc. Antivial
immune responses in Itk-deficient mice.
J ViroI1997;71:7253-7257.
58. Fowell DJ, et al. Impaied NFATc
translocation and faiure of Th2 development
in Itk-deficient CD4+ T cells. Imunty
1999;11 :399-409.
59. Schaeffer EM, et al. Mutation ofTec famy
kiases alters T helper cel dierentiation. Nat
Immunol 2001;2: 1183-1188.
60. Scott P , Hunter CA. Dendrtic cells and
imunty to leishmanasis and
toxoplasmosis. Cur Opin Imunol
2002; 14:466-470.
61. Takeba Y, Nagafuch H, Takeno M
Kashiwakura J, Suzuk N. Txk, a
member of nonreceptor tyosine kiase
of Tec famy, acts as a Th1 cel-specifc
transcrption factor and regulates
IFN-gama gene transcrption.
J ImunoI2002;168:2365-2370.
62. Bix M , Wang ZE , Thiel B , Schork NJ, Locksley
RM. Genetic regulation of commtment to
interleuk 4 production by a CD4( +) T cell-
intrsic mechansm. J Exp Med
1998;188:2289-2299.
Immunological Reviews 191/2003 137
Lucas et al . T ec kinases in T cell development and function
63. Uu KQ. Role ofItk in T cel activation and
signal transduction. Cambridge , MA: Harard
University, 1998.
64. Aguado E, et al. Induction of T helper type 2
imunty by a point mutation in the LAT
adaptor. Science 2002;296:2036-2040.
65. Sommers CL, et al. A LAT mutation that
inhibits T cell development yet induces
lymphoproliferation. Science
2002;296:2040-2043.
66. Un J, Weiss A. Identification of the minial
tyosine residues requied for liner for
activation of T cel function. J Bioi Chern
2001 ;276:29588-29595.
67. Paz PE, Wang S , Clarke H , Lu X , Stokoe D
Abo A. Mapping the Zap- 70 phosphorylation
sites on LA T (lier for activation of T cells)
requied for recrtment and activation of
signalg proteins in T cells. Biochem J
2001;356:461-471.
68. Reynolds LF , et al. Vavl transduces T cell
receptor signals to the activation of
phospholipase C-gamal via
phosphoinositide 3-kiase-dependent
and - independent pathways. J Exp Med
2002;195:1103-1114.
69. Tarakovsky A, et al. Defective antigen
receptor-mediated proliferation of B and
T cells in the absence ofVav. Natue
1995;374:467-470.
70. Zhang R. Alt FW , Davidson L, Orki SH
Swat W. Defective signalg though the
T - and B-cel antigen receptors in lymphoid
cels lackg the vav proto-oncogene. Natue
1995;374:470-473.
71. Fischer K- , Zmuldzas A, Gardner S,
Barbacid M , Berstein A, Guidos
C. Defective T-cel receptor signalg
and positive selection of Vav-deficient
CD4+CD8+ thymocytes. Natue
1995;374:474-77.
72. Crabtree GR, Olson EN. NFAT signalg:
choreographig the social lives of cells. Cell
2002;109:S67-S79.
73. Pivnouk V, Tsitsikov E , Switon P , Rathbun
, Alt FW, Geha RS. Impaied viabilty and
profound block in thymocyte development in
mice lackg the adaptor protein SLP-76. Cell
1998;94:229-238.
74. dements JL, et al. Requiement for the
leukocyte-specific adapter protein SLP-76 for
normal T cel development. Science
1998;281:416-419.
138
75. Zhang W. Irv BJ, Trible RP, Abraham RT
Samelson LE. Functional analysis of LATin
TCR-mediated signalg pathways using 
LA T -deficient Jurkat cell lie. Int Imunol
1999;11:943-950.
76. Yablonski D , Kuhe MR, Kadlecek T
Weiss A. Uncouplig ofnonreceptor
tyosine kiases from PLC-gama 1 in
an SLP- 76-deficient T cells. Science
1998;281:413-416.
77. Finco TS . Kadlecek T , Zhang W , Samelson LE
Weiss A. LAT is required for TCR-mediated
activation ofPLCgamal and the Ras
pathway. Immunty 1998;9:617-626.
78. Turer M , et al. A requiement for the
Rho-fary GTP exchange factor Vav in
positive and negative selection ofthymocytes.
Imunty 1997;7:451-460.
79. Ranger AM , et al. Delayed lymphoid
repopulation with defects in IL- driven
responses produced by inactivation of
NF-ATc. Imunty 1998;8:125-134.
80. Yoshida H , et al. The transcription factor
NF-A Tc 1 regulates lymphocyte proliferation
and Th2 cytokie production. Imunty
1998;8:115-124.
81. Ranger AM , Ouka M, Rengarajan J,
Glicher LH. Inbitory function of two
NFAT fary members in lymphoid
homeostasis and Th2 development.
Immunty 1998;9:627-635.
82. Zhou B, et al. Regulation of the murine
Nfatcl gene by NFATc2. J Bioi Chern
2002;277: 1 0704-1 0711.
83. Xanthoudaks S, et al. An enhanced
imune response in mice lackg the
transcription factor NFATl. Science
1996;272:892-895.
84. Hodge MR, Ranger AM , Charles de la
Brousse F , Hoey T, Grusby MJ,
Glicher LH. Hyperroliferation and
dysregulation of IL-4 exression in
NF-ATp-deficient mice. Imunty
1996;4:397-405.
85. Kian A , Viola JP , Lichtman AH. Rao A.
Down-regulation of IL-4 gene transcrption
and control of Th2 cell differentiation by a
mechansm involvig NFAT1. Immunty
1997;7:849-860.
86. Ouka M. Ho IC , de la Brousse FC , Hoey T
Grusby MJ, Glicher LH. The transcription
factor NFAT4 is involved in the generation
and surval of T cell. Imunty
1998;9:295-304.
87. Peng SL , Gerth AJ, Ranger AM, Glicher LH.
NFATcl and NFATc2 together control bQth T
and B cell activation and differentiation.
Immunty 2001;14:13-20.
88. Dong C , Yang DD , Wysk M , Whitmarsh AJ.
Davis RJ, Flavell RA. Defective T cell
differentiation in the absence of Jnk 1. Science
1998;282:2092-2095.
89. Constat SL, Dong C, Yang DD , Wysk M
Davis RJ, Flavel RA. JNKI is requied for
T cel-mediated immunty agaist Leishmana
major infection. J ImmunoI2000;165:2671-
2676.
90. Leibson PJ. Signal transduction during natural
kier cell activation: inside the mid of a
kier. Immunity 1997;6:655-661.
91. Kawakam Y , Yao LB , Miura T , Tsukada S,
Witte ON , Kawakami T. Tyrosine
phosphorylation and activation of Bruton
tyrosine kiase upon Fc€RI cross-lig. Mol
Cell Bioi 1994;14:5108-51 13.
92. Kawakami Y , Yao L, Tashio M , Gibson S
Mils GB , Kawakam T. Activation and
interaction with protein kiase C of a
cytoplasmic tyosine kinase , Itk/Tsk/Emt. on
Fc€RI cross-lig on mast cels. J Immunol
1995;155:3556-3562.
93. Hata D, et al. Involvement of Bruton s tyosine
kiase in FcepsilonR-dependent mast cel
degranulation and cytokie production. J 
Med 1998;187:1235-1247.
94. Rivera J, et al. Macromolecular protein
signalng complexes and mast cel responses:
a view of the organzation of IgE-dependent
mast cell signalg. Mol Immunol
2002;38: 1253-1258.
95. Gadue P , Stein PI. NK T cells precursors
exbit differential cytokie regulation and
requie Itk for effcient matuation. J
ImunoI2002;169:2397-2406.
96. Costelo PS , et al. The Rho-fary GTP
exchange factor Vav is a critical transducer of
T cel receptor signals to the calcium , ERK
and NF-kappaB pathways. Proc Natl Acad Sci
USA 1999;96:3035-3040.
Immunological Reviews 191/2003 7," /j ,I 
., 
:l. 
:! '-
